{"meta":{"query_hash":"7ee5ebf6e17c","filters":{"venue":"Prostate Cancer and Prostatic Diseases"},"cohort_total":214,"direct_labels_cover":0,"predictions_cover":214,"exported":214,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/7ee5ebf6e17c","api":"https://metacan.xera.ac/api/v1/cohort?venue=Prostate+Cancer+and+Prostatic+Diseases"},"results":[{"id":"W1043765364","doi":"10.1038/pcan.2015.35","title":"Metformin and prostate cancer stem cells: a novel therapeutic target","year":2015,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Metformin; Prostate cancer; Medicine; Cancer stem cell; Biguanide; Cancer; Cancer research; Cancer cell; Internal medicine; Prostate; Oncology; Insulin","score_opus":0.03678158198773397,"score_gpt":0.3251102813842328,"score_spread":0.28832869939649886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1043765364","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014430462,0.9983525,0.000117915566,0.0005162459,0.0002761138,0.0000027975807,0.000018714813,0.000006217794,0.00056517613],"genre_scores_gemma":[0.0010751843,0.9974571,0.00015261256,0.0003733181,0.00031586102,0.000005614016,0.00003976379,0.0000012542438,0.00057940587],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988043,0.00001982269,0.0000144631695,0.00002170852,0.00004680257,0.00001678826],"domain_scores_gemma":[0.99985015,0.00006392805,0.000023772263,0.0000050314634,0.00003387341,0.000023324565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004244486,0.00073955464,0.0013155155,0.0011889684,0.0002452032,0.0010016465,0.0007645036,0.0012206121,0.0032022565],"category_scores_gemma":[0.00046473547,0.00023867958,0.00039948244,0.0012341923,0.00042228782,0.0011311662,0.000769525,0.002357254,0.0011192311],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001589576,0.000087440145,0.00022565795,0.007988421,0.000091001624,0.0002599897,0.000038454502,0.00038364247,0.002710121,0.005700637,0.04344871,0.93890697],"study_design_scores_gemma":[0.000051819807,0.00011707882,0.0006839014,0.0016188148,0.00015084358,0.0009559213,0.00004813284,0.00016818142,0.00077776687,0.003423828,0.99198115,0.000022618608],"about_ca_topic_score_codex":0.00051178643,"about_ca_topic_score_gemma":0.0015940928,"teacher_disagreement_score":0.0032022565,"about_ca_system_score_codex":0.0004570355,"about_ca_system_score_gemma":0.00071033655,"threshold_uncertainty_score":0.010712624},"labels":[],"label_agreement":null},{"id":"W1051548727","doi":"10.1038/pcan.2015.37","title":"Oral simvastatin administration delays castration-resistant progression and reduces intratumoral steroidogenesis of LNCaP prostate cancer xenografts","year":2015,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Saskatchewan; Vancouver Coastal Health","funders":"","keywords":"Castration; Simvastatin; LNCaP; Medicine; Prostate cancer; Internal medicine; Endocrinology; Androgen; Dihydrotestosterone; Testosterone (patch); Androgen deprivation therapy; Tumor progression; Prostate; Cancer; Hormone","score_opus":0.01944481742243922,"score_gpt":0.31069436878452816,"score_spread":0.29124955136208897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1051548727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949922,0.0013739796,0.0006674507,0.00022901528,0.00009234427,0.000036420653,0.0007061854,0.00025724605,0.0016451215],"genre_scores_gemma":[0.99306935,0.00084518694,0.00047680186,0.000039994113,0.000022577286,0.00003541296,0.00088568794,0.000036344725,0.0045886743],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979156,0.0000321831,0.000013843336,0.00002345008,0.000037540907,0.00010143124],"domain_scores_gemma":[0.9998068,0.000027729782,0.000036118887,0.00002575458,0.000016088226,0.000087481065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020359423,0.0003947692,0.00057355734,0.00053130474,0.00031161422,0.00048621764,0.00048596025,0.0003028267,0.0027350164],"category_scores_gemma":[0.00019768842,0.00025291706,0.00044160135,0.00040742278,0.0004727354,0.00043698706,0.00019088833,0.0012723798,0.0006167364],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053390115,0.0008724774,0.0007229961,0.00009066085,0.000028316956,0.00007882153,0.00005905482,0.00038272724,0.9853512,0.0003244681,0.0006630094,0.0060873143],"study_design_scores_gemma":[0.00022788787,0.004860286,0.006820879,0.000008223769,0.000051032628,0.00015787724,0.00012237643,0.001368547,0.9829859,0.00012653171,0.0032514117,0.000019024306],"about_ca_topic_score_codex":0.0043230457,"about_ca_topic_score_gemma":0.009081157,"teacher_disagreement_score":0.0043230457,"about_ca_system_score_codex":0.00064669404,"about_ca_system_score_gemma":0.0012687087,"threshold_uncertainty_score":0.009149551},"labels":[],"label_agreement":null},{"id":"W1104332235","doi":"10.1038/pcan.2015.36","title":"The significance of circulating tumor cells in prostate cancer patients undergoing adjuvant or salvage radiation therapy","year":2015,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Canadian Institutes of Health Research; Ontario Ministry of Research and Innovation; Association of Canadian Universities for Research in Astronomy","keywords":"Medicine; Circulating tumor cell; Prostate cancer; Prostatectomy; Oncology; Internal medicine; Hazard ratio; Disease; Adjuvant; Urology; Cancer; Metastasis; Confidence interval","score_opus":0.02528327488445458,"score_gpt":0.2948578776557875,"score_spread":0.26957460277133294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1104332235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99844885,0.0009463649,0.00010826302,0.0000596185,0.0000110583715,0.000006063031,0.00010818457,0.0000067550586,0.00030465616],"genre_scores_gemma":[0.99967,0.0000852877,0.000053600557,0.000015838432,0.000011730465,0.0000030385554,0.00009791702,9.43551e-7,0.000061753664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983907,0.000047026748,0.000012590562,0.000032304066,0.000037972448,0.00003094056],"domain_scores_gemma":[0.99888164,0.00036059113,0.00037847494,0.000034959394,0.0000859384,0.0002583635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028170864,0.0001622635,0.00024186821,0.00024889343,0.0001629061,0.00040199538,0.00019013774,0.0002971964,0.0011824697],"category_scores_gemma":[0.0020368584,0.000085805696,0.00014349188,0.00031265308,0.00017613545,0.00020956674,0.0001355531,0.00047177167,0.00015910718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087084674,0.00005399084,0.9909473,0.000021741827,0.000036441492,0.00017950837,0.000046171655,0.00018041265,0.001101423,0.00001739585,0.00020502375,0.0063396846],"study_design_scores_gemma":[0.00003242147,0.000729566,0.9963127,0.0000099302415,0.000060556093,0.0009954477,0.000060866954,0.00084999646,0.0005051282,0.000055992306,0.0003820174,0.0000055176006],"about_ca_topic_score_codex":0.0011540448,"about_ca_topic_score_gemma":0.0013488432,"teacher_disagreement_score":0.0011824697,"about_ca_system_score_codex":0.0002843921,"about_ca_system_score_gemma":0.00032574998,"threshold_uncertainty_score":0.003955722},"labels":[],"label_agreement":null},{"id":"W1533237712","doi":"10.1038/pcan.2015.16","title":"The effect of bicycling on PSA levels: a systematic review and meta-analysis","year":2015,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Toronto Rehabilitation Institute; York University; University of Guelph-Humber","funders":"","keywords":"Medicine; Meta-analysis; Cycling; Prostate cancer; Confidence interval; CINAHL; Time trial; Internal medicine; Physical therapy; Cancer; Psychological intervention","score_opus":0.09842698844184647,"score_gpt":0.4121411945434068,"score_spread":0.3137142061015603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1533237712","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004668124,0.9943539,0.00024018342,0.00008110958,0.00013334988,0.00008614307,0.00025383357,0.000013540482,0.0001698672],"genre_scores_gemma":[0.15537438,0.8409122,0.0014250783,0.0008664424,0.00024131063,0.0002582821,0.00045024537,0.00002516371,0.0004468894],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9967444,0.0012212744,0.0009840572,0.00049804477,0.00035563557,0.00019659326],"domain_scores_gemma":[0.99401087,0.0043418403,0.00092817936,0.00020293427,0.00039502245,0.000121083685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052354583,0.002785585,0.015604809,0.0033069095,0.0006027194,0.0023276273,0.0018849721,0.00254638,0.00488759],"category_scores_gemma":[0.013982955,0.0017006812,0.031174285,0.0050092004,0.0007168722,0.0017147321,0.001583449,0.0026491613,0.00039356903],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043754075,0.00005556641,0.0032549088,0.35839373,0.61821747,0.00015795977,0.00008596508,0.00044067815,0.00029290406,0.00009937311,0.0006354232,0.0139906425],"study_design_scores_gemma":[0.0009206666,0.00021222902,0.0031991364,0.01067772,0.9834907,0.00007524527,0.0000421087,0.000084577296,0.00007001133,0.00011021065,0.0010944995,0.000022993025],"about_ca_topic_score_codex":0.012204626,"about_ca_topic_score_gemma":0.031765822,"teacher_disagreement_score":0.015604809,"about_ca_system_score_codex":0.0017392351,"about_ca_system_score_gemma":0.0024388686,"threshold_uncertainty_score":0.027688086},"labels":[],"label_agreement":null},{"id":"W1546881760","doi":"10.1038/pcan.2015.28","title":"Effects of resistance training frequency on physical functioning and quality of life in prostate cancer survivors: a pilot randomized controlled trial","year":2015,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Cancer survivorship and care","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canada Research Chairs","keywords":"Medicine; Prostate cancer; Quality of life (healthcare); Randomized controlled trial; Physical therapy; Psychosocial; Confidence interval; Internal medicine; Physical fitness; Cancer","score_opus":0.037268438245400826,"score_gpt":0.32182061757796343,"score_spread":0.2845521793325626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1546881760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881053,0.0035067988,0.0006049692,0.00040622315,0.0005137206,0.0051415046,0.0006051914,0.00011081671,0.0010054258],"genre_scores_gemma":[0.98470205,0.0021286453,0.0018829603,0.000529674,0.00057394855,0.0078808,0.0005317707,0.000017640896,0.0017525681],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99875724,0.0006034021,0.00010853798,0.00026312965,0.000084808526,0.00018281695],"domain_scores_gemma":[0.9978179,0.00085007586,0.00045769263,0.00019051759,0.00015038747,0.0005334664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019562654,0.0020576348,0.0049600513,0.0006572367,0.0009534946,0.0010706374,0.0014162173,0.002744949,0.009218303],"category_scores_gemma":[0.002980653,0.001247328,0.003405246,0.00077552185,0.001667923,0.0011896017,0.00075927435,0.0036791575,0.00083362777],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9867552,0.007176051,0.00039952926,0.00048038596,0.0010586174,0.000014768633,0.000027633228,0.00011660961,0.00062776334,0.000026058606,0.00014604685,0.0031712838],"study_design_scores_gemma":[0.93673104,0.059958864,0.0017765554,0.000040137806,0.0010303569,0.00000789869,0.000019287738,0.00016509127,0.00010954021,0.00004112646,0.000109476496,0.00001057519],"about_ca_topic_score_codex":0.0030061116,"about_ca_topic_score_gemma":0.0030340208,"teacher_disagreement_score":0.009218303,"about_ca_system_score_codex":0.0008211918,"about_ca_system_score_gemma":0.0014496283,"threshold_uncertainty_score":0.03083831},"labels":[],"label_agreement":null},{"id":"W1574759345","doi":"10.1038/pcan.2015.17","title":"Extracellular vesicles such as prostate cancer cell fragments as a fluid biopsy for prostate cancer","year":2015,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Prostate cancer; Liquid biopsy; Prostate; Medicine; Vesicle; Microvesicles; Extracellular vesicle; Biomarker; PCA3; Exocytosis; Cancer research; Biomarker discovery; Pathology; Circulating tumor cell; Cancer; Internal medicine; Chemistry; microRNA; Proteomics; Metastasis; Membrane; Secretion; Biochemistry","score_opus":0.022365617936069615,"score_gpt":0.3375827562394811,"score_spread":0.31521713830341147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1574759345","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000119383476,0.9988192,0.00019166309,0.00016575101,0.0001827948,0.0000034885652,0.000012993473,0.0000045219713,0.0005001931],"genre_scores_gemma":[0.001192035,0.99731004,0.0003071995,0.00019000503,0.0001526777,0.0000066948965,0.00002975514,0.000002142527,0.0008094976],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998118,0.00003434254,0.000025424937,0.00003124322,0.00007851294,0.000018675779],"domain_scores_gemma":[0.9997619,0.00012547775,0.00003281669,0.000007837769,0.000054858225,0.000017236409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006385898,0.00077796885,0.0013493868,0.001651717,0.0002521961,0.0012193826,0.00063004496,0.0013730347,0.0020549675],"category_scores_gemma":[0.0007663563,0.0003157134,0.00042071455,0.0012389979,0.0006378739,0.0015236005,0.0008209763,0.0016272685,0.0011492376],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012329502,0.00005817522,0.00022766963,0.013996802,0.00008488923,0.00033047135,0.000067976755,0.00050646084,0.0053924206,0.009420948,0.027397601,0.94239336],"study_design_scores_gemma":[0.000015463389,0.000056039655,0.00048099688,0.0020525693,0.0000904728,0.0013521163,0.000063473395,0.000208485,0.0021065418,0.0026484972,0.99089855,0.00002686003],"about_ca_topic_score_codex":0.00090044836,"about_ca_topic_score_gemma":0.0018325818,"teacher_disagreement_score":0.0020549675,"about_ca_system_score_codex":0.0006486641,"about_ca_system_score_gemma":0.0007736797,"threshold_uncertainty_score":0.0068745017},"labels":[],"label_agreement":null},{"id":"W1593747583","doi":"10.1038/pcan.2015.22","title":"High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer","year":2015,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"National Institute of General Medical Sciences; National Cancer Institute; Prostate Cancer Foundation","keywords":"Prostate cancer; Medicine; Transcriptome; Oncology; Prostatectomy; Biomarker; Internal medicine; Gene; Cancer; Bioinformatics; Gene expression; Biology; Genetics","score_opus":0.03065867305798077,"score_gpt":0.32150383907430213,"score_spread":0.2908451660163214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1593747583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98589504,0.0031861167,0.0074710627,0.00013926104,0.000016408121,0.000037939084,0.0025257675,0.000070001275,0.00065844896],"genre_scores_gemma":[0.98374116,0.0017476156,0.00894197,0.00012010018,0.000029085373,0.00005775729,0.0046734093,0.000012577001,0.0006762671],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99987805,0.000018856039,0.000007013044,0.000026556429,0.000045623237,0.000023797335],"domain_scores_gemma":[0.9998398,0.000058176636,0.000041365733,0.000010874099,0.00003235712,0.000017498158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002931662,0.00022015396,0.00030764448,0.0006310257,0.00016950641,0.000282723,0.00011874777,0.0001625424,0.00053886167],"category_scores_gemma":[0.00026723047,0.00005465616,0.00037471953,0.0005943695,0.00014506627,0.00014521809,0.00014914933,0.0002285117,0.00017414337],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005491262,0.00010744526,0.0996109,0.00026296228,0.00014995389,0.00010160816,0.00008345451,0.0026052578,0.8685797,0.00021584178,0.00051585265,0.02721792],"study_design_scores_gemma":[0.000028233282,0.000783785,0.77005273,0.000027786262,0.0003278104,0.0005181095,0.00016299338,0.009023009,0.21301366,0.00067424134,0.0053590667,0.000028599996],"about_ca_topic_score_codex":0.00063237763,"about_ca_topic_score_gemma":0.0016790872,"teacher_disagreement_score":0.00063237763,"about_ca_system_score_codex":0.00021795592,"about_ca_system_score_gemma":0.00022643998,"threshold_uncertainty_score":0.0018026233},"labels":[],"label_agreement":null},{"id":"W1964631256","doi":"10.1038/pcan.2008.36","title":"The relationship of body mass index and serum testosterone with disease outcomes in men with castration-resistant metastatic prostate cancer","year":2008,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Prostate cancer; Testosterone (patch); Body mass index; Internal medicine; Docetaxel; Prednisone; Prostate-specific antigen; Androgen deprivation therapy; Obesity; Oncology; Endocrinology; Cancer; Urology","score_opus":0.030696377723422916,"score_gpt":0.31454059866551276,"score_spread":0.28384422094208983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964631256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980465,0.0011619153,0.000036868878,0.00013052605,0.000021447466,0.0000030770793,0.00016518476,0.0000049572036,0.0004295351],"genre_scores_gemma":[0.9994993,0.00018493999,0.000017529306,0.000022786338,0.00003886173,0.0000014654098,0.000108928485,0.0000013370426,0.00012490057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996681,0.0001230855,0.000037112335,0.00003993624,0.00006613215,0.00006562783],"domain_scores_gemma":[0.9975509,0.00082610745,0.0008145748,0.00011001811,0.00011833742,0.0005800553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075836823,0.00037996113,0.00057508674,0.0007476813,0.0004725996,0.000823341,0.00046921617,0.00057933695,0.0011279759],"category_scores_gemma":[0.0036587096,0.00033759253,0.0008745239,0.0011621608,0.0004113449,0.000584412,0.0004990315,0.0011072113,0.00015342131],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090968655,0.00005522337,0.99722445,0.000010593729,0.00017650709,0.000070302674,0.00004342604,0.000096032534,0.00011563912,0.000017988687,0.00005241429,0.0012277877],"study_design_scores_gemma":[0.000016272788,0.00012893727,0.9993383,0.0000023114412,0.00008370847,0.00009052865,0.000059409165,0.000179927,0.000019707188,0.00002424705,0.00005287585,0.0000036758984],"about_ca_topic_score_codex":0.006692449,"about_ca_topic_score_gemma":0.009449032,"teacher_disagreement_score":0.006692449,"about_ca_system_score_codex":0.00036244458,"about_ca_system_score_gemma":0.00050563004,"threshold_uncertainty_score":0.013306975},"labels":[],"label_agreement":null},{"id":"W1965854209","doi":"10.1038/sj.pcan.4500827","title":"Integrating risk profiles for disease progression in the treatment choice for patients with lower urinary tract symptoms/benign prostatic hyperplasia: a combined analysis of external evidence and clinical expertise","year":2005,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Lower urinary tract symptoms; Hyperplasia; Urology; Dutasteride; Disease; Benign prostatic hyperplasia (BPH); Prostate; Urinary system; Internal medicine; Cancer","score_opus":0.029686171883303112,"score_gpt":0.38986581859990843,"score_spread":0.3601796467166053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965854209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74797034,0.1981066,0.020476187,0.008153787,0.00044607258,0.0015537142,0.007020046,0.00011694873,0.016156247],"genre_scores_gemma":[0.98431695,0.0075023836,0.005504805,0.00055147405,0.00025179074,0.00009766903,0.0015611165,0.000026707745,0.00018704309],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.91929406,0.06235411,0.0066721234,0.0029204236,0.007976436,0.000782908],"domain_scores_gemma":[0.6763802,0.28722826,0.021034956,0.0061154854,0.0072210026,0.0020201108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07563768,0.0012807016,0.0053206244,0.007520615,0.0007236518,0.004121899,0.001553361,0.0020151294,0.0025472487],"category_scores_gemma":[0.13913848,0.00050725107,0.011245303,0.0070933783,0.00095864653,0.0027962269,0.0027989899,0.001978275,0.00021581707],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00744354,0.00026579297,0.8014708,0.0032792487,0.07102704,0.00018003242,0.00032052712,0.004063614,0.00018565482,0.0008226704,0.0007170178,0.110223964],"study_design_scores_gemma":[0.004909309,0.0045634564,0.71676135,0.0038706472,0.22443026,0.00083817093,0.001150385,0.026394615,0.00085932587,0.00890048,0.007023065,0.00029895143],"about_ca_topic_score_codex":0.004316659,"about_ca_topic_score_gemma":0.008425011,"teacher_disagreement_score":0.07563768,"about_ca_system_score_codex":0.0016186045,"about_ca_system_score_gemma":0.0032737697,"threshold_uncertainty_score":0.40001506},"labels":[],"label_agreement":null},{"id":"W1968526777","doi":"10.1038/sj.pcan.4500845","title":"Novel antiproliferative flavonoids induce cell cycle arrest in human prostate cancer cell lines","year":2005,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Flavonoids in Medical Research","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Canadian Prostate Cancer Research Initiative; Prostate Cancer Canada","keywords":"Medicine; Prostate cancer; Cell cycle checkpoint; Prostate; Cancer research; Cell cycle; Cancer; Cell; Oncology; Internal medicine; Biology; Biochemistry","score_opus":0.021669050931275535,"score_gpt":0.3514898500490039,"score_spread":0.3298207991177284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968526777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826874,0.00950089,0.0025501794,0.00018092732,0.000085886604,0.00011594995,0.0014644238,0.00008832002,0.0033259722],"genre_scores_gemma":[0.98269284,0.0060608606,0.0025522106,0.0000855821,0.000048978538,0.000101947626,0.004010329,0.000026133346,0.004421046],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999349,0.000013053982,0.0000072023518,0.000010585449,0.000016230966,0.000018136245],"domain_scores_gemma":[0.9999063,0.000038147922,0.000008685541,0.000012626316,0.000021417278,0.000012799383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014606048,0.00029132506,0.00032191342,0.000495364,0.00028002856,0.00018027227,0.00024311182,0.00020298094,0.0026567513],"category_scores_gemma":[0.00011394155,0.00011251152,0.00029821848,0.00037402875,0.00015294338,0.0001706585,0.00010978618,0.00047011764,0.0003973263],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058176427,0.00018196847,0.0004290037,0.00014125598,0.000016952421,0.00008312275,0.00006589342,0.00012047172,0.9936422,0.00014355777,0.00027407354,0.0043197377],"study_design_scores_gemma":[0.000117872725,0.0012502574,0.0071354606,0.000015700512,0.00005803628,0.00030704148,0.000052703323,0.0003731488,0.98252493,0.000050390874,0.008108714,0.000005694538],"about_ca_topic_score_codex":0.0016558416,"about_ca_topic_score_gemma":0.0035572825,"teacher_disagreement_score":0.0026567513,"about_ca_system_score_codex":0.00027292193,"about_ca_system_score_gemma":0.00024299018,"threshold_uncertainty_score":0.008887768},"labels":[],"label_agreement":null},{"id":"W1971036762","doi":"10.1038/pcan.2013.35","title":"RTOG 0518: randomized phase III trial to evaluate zoledronic acid for prevention of osteoporosis and associated fractures in prostate cancer patients","year":2013,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Bone health and treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre Hospitalier Universitaire de Sherbrooke; University of Saskatchewan","funders":"National Cancer Institute","keywords":"Medicine; Zoledronic acid; Prostate cancer; Femoral neck; Urology; Osteoporosis; Bone mineral; Vitamin D and neurology; Internal medicine; Surgery; Bisphosphonate; Cancer","score_opus":0.016950115889743454,"score_gpt":0.3651718139738224,"score_spread":0.348221698084079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971036762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97894216,0.0071656727,0.0008379154,0.0015685337,0.00085778674,0.0028261782,0.004023367,0.00044033217,0.0033380536],"genre_scores_gemma":[0.9753132,0.0041836426,0.002277357,0.0028374433,0.0008666869,0.0038415561,0.0042443373,0.00006474885,0.006371046],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999572,0.00020233619,0.000028972418,0.00007119955,0.00003628449,0.00008913824],"domain_scores_gemma":[0.9993055,0.00016804977,0.00018048823,0.000050547562,0.000037937305,0.00025759733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011643947,0.0018351479,0.003457067,0.00062905013,0.00043806122,0.0010974627,0.0012625554,0.0014702694,0.012751525],"category_scores_gemma":[0.0015325908,0.0008334892,0.0023665628,0.0005548013,0.0011530081,0.0008894899,0.0004772773,0.002976586,0.0016764252],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9753253,0.0031733776,0.0009981772,0.00061275123,0.0013508804,0.00003565045,0.00003497468,0.0004180747,0.0013856713,0.00016373124,0.0020405261,0.014460827],"study_design_scores_gemma":[0.9812928,0.016567899,0.0009616388,0.000016757656,0.0003806456,0.000026807225,0.000010342037,0.0001773179,0.000103621926,0.00007477257,0.00038049315,0.0000068727777],"about_ca_topic_score_codex":0.0025267834,"about_ca_topic_score_gemma":0.0057693585,"teacher_disagreement_score":0.012751525,"about_ca_system_score_codex":0.00090075645,"about_ca_system_score_gemma":0.0016567949,"threshold_uncertainty_score":0.04265809},"labels":[],"label_agreement":null},{"id":"W1976718636","doi":"10.1038/sj.pcan.4500956","title":"Importance of the intracrine metabolism of adrenal androgens in androgen-dependent prostate cancer","year":2007,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Prostate cancer; LNCaP; Androstenediol; Intracrine; Flutamide; Endocrinology; Dihydrotestosterone; Internal medicine; Androgen receptor; Testosterone (patch); Dehydroepiandrosterone; Androgen; Medicine; Finasteride; Prostate; Cancer research; Cancer; Hormone; Receptor; Paracrine signalling","score_opus":0.014736589792067562,"score_gpt":0.31646917910765776,"score_spread":0.3017325893155902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976718636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6888185,0.27942607,0.0050451388,0.0020499702,0.00046271263,0.000025161049,0.00040913845,0.000103395905,0.023659894],"genre_scores_gemma":[0.97735274,0.01839728,0.0008867475,0.0001383371,0.00040507392,0.0000057209136,0.00013317406,0.000017015713,0.0026639083],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998385,0.00005620723,0.000011372514,0.000022381606,0.00004810498,0.000023447314],"domain_scores_gemma":[0.9996705,0.000087740824,0.000056122535,0.000049449667,0.000055603323,0.00008051674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023305984,0.0002647606,0.00035786832,0.000411066,0.00035496504,0.0009986231,0.0002969047,0.0003891677,0.0017780649],"category_scores_gemma":[0.000454028,0.00017078874,0.00022166078,0.00034212883,0.0005463819,0.0006465775,0.00030687643,0.0007618346,0.00023391981],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008710514,0.00047671836,0.072460584,0.0014397124,0.00047923732,0.008850871,0.00068715826,0.0015733582,0.5713885,0.011361679,0.002058048,0.3205136],"study_design_scores_gemma":[0.00020828923,0.004525046,0.5676879,0.00024719205,0.00076954137,0.03387876,0.0012514037,0.0020972595,0.306184,0.009110154,0.07392131,0.00011902771],"about_ca_topic_score_codex":0.0012650237,"about_ca_topic_score_gemma":0.002048553,"teacher_disagreement_score":0.0017780649,"about_ca_system_score_codex":0.00047714447,"about_ca_system_score_gemma":0.0004909156,"threshold_uncertainty_score":0.0059482455},"labels":[],"label_agreement":null},{"id":"W1977468633","doi":"10.1038/pcan.2010.24","title":"Effect of intermittent fasting on prostate cancer tumor growth in a mouse model","year":2010,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Dietary Effects on Health","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Prostate cancer; Medicine; Prostate; Internal medicine; Endocrinology; Cancer; Hormone; Insulin-like growth factor; Growth factor; Receptor","score_opus":0.010338710391479704,"score_gpt":0.31207291702759155,"score_spread":0.30173420663611183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977468633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931358,0.0022632156,0.0013315433,0.00039273544,0.00018990647,0.00008307032,0.0011021337,0.00021337856,0.0012881985],"genre_scores_gemma":[0.98635316,0.001961209,0.0028519426,0.00022331452,0.000094339615,0.0002342462,0.0008890987,0.00010107543,0.007291746],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996402,0.00007059487,0.000024243693,0.00009455055,0.000054523814,0.00011585018],"domain_scores_gemma":[0.99924064,0.00012686888,0.00017897728,0.00011933628,0.000040331863,0.00029371973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004248929,0.0011623291,0.000657927,0.0014800183,0.00054828165,0.000498639,0.00077778357,0.0010561012,0.0023821],"category_scores_gemma":[0.0002502514,0.0006113578,0.0009258973,0.0005617033,0.0009226789,0.0006935615,0.00036651304,0.0025347737,0.00034888135],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018290032,0.002722243,0.0011295803,0.00012663161,0.00006584622,0.00021649049,0.000086409054,0.0004064461,0.9709787,0.00027264166,0.00037347618,0.005331533],"study_design_scores_gemma":[0.0010139055,0.02485796,0.013034985,0.00004658941,0.00029281847,0.00043605448,0.0002261011,0.003055152,0.9529055,0.0004014116,0.0036576018,0.000071868315],"about_ca_topic_score_codex":0.0030359207,"about_ca_topic_score_gemma":0.0048202793,"teacher_disagreement_score":0.0030359207,"about_ca_system_score_codex":0.0006813945,"about_ca_system_score_gemma":0.00055821304,"threshold_uncertainty_score":0.007968903},"labels":[],"label_agreement":null},{"id":"W1979075547","doi":"10.1038/sj.pcan.4501003","title":"Antidepressants and risk of prostate cancer: a nested case – control study","year":2007,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Health; University of British Columbia; McGill University; University of Manitoba; Jewish General Hospital","funders":"National Cancer Institute; National Institutes of Health","keywords":"Prostate cancer; Medicine; Cancer; Internal medicine; Oncology; Nested case-control study; Population; Case-control study; Gynecology; Environmental health","score_opus":0.009832213195647652,"score_gpt":0.29657458182804536,"score_spread":0.2867423686323977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979075547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998858,0.0005343631,0.00019529996,0.0000329531,0.000015412847,0.000026246355,0.00013995715,0.000003214567,0.00019454153],"genre_scores_gemma":[0.9991566,0.00018537231,0.00021642147,0.000044349898,0.00001772228,0.000025182386,0.00014146186,0.0000024807468,0.00021037512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987746,0.00055927405,0.00007202737,0.0003097553,0.00014598297,0.00013833812],"domain_scores_gemma":[0.99858993,0.00037425125,0.00032400934,0.0003111721,0.00012622827,0.00027440238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010769613,0.00059515936,0.0010856439,0.00041892927,0.0010012381,0.0007998854,0.0006219892,0.0009050317,0.0013013416],"category_scores_gemma":[0.0021466194,0.0010992708,0.0011347071,0.00067759224,0.0005532939,0.00033993737,0.00042238404,0.00088498235,0.00022215334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010978689,0.0018491526,0.9740965,0.00010272281,0.0025757377,0.0009619497,0.0007494102,0.00015030659,0.0056090956,0.00014420105,0.00040562017,0.0023766912],"study_design_scores_gemma":[0.0010207733,0.0020749562,0.99245584,0.000024475996,0.0014370308,0.0012414869,0.0003381878,0.00061029586,0.00026120007,0.0000878971,0.00042304915,0.000024831654],"about_ca_topic_score_codex":0.011468489,"about_ca_topic_score_gemma":0.013440838,"teacher_disagreement_score":0.011468489,"about_ca_system_score_codex":0.00044296507,"about_ca_system_score_gemma":0.0005364653,"threshold_uncertainty_score":0.022803485},"labels":[],"label_agreement":null},{"id":"W1981128163","doi":"10.1038/sj.pcan.4500628","title":"Cell death in irradiated prostate epithelial cells: role of apoptotic and clonogenic cell kill","year":2003,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"National Cancer Institute; Office of Defense Programs; Princess Margaret Hospital Foundation; University of Pennsylvania","keywords":"LNCaP; Radioresistance; Clonogenic assay; Prostate cancer; Cancer research; Stromal cell; Medicine; Prostate; DU145; Programmed cell death; Apoptosis; Cell cycle; Radiation therapy; Cell; Survivin; Pathology; Cancer; Biology; Internal medicine","score_opus":0.004360400295008405,"score_gpt":0.21505831210199208,"score_spread":0.2106979118069837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981128163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97150254,0.016695023,0.0066960216,0.00017365144,0.000050793125,0.00003678289,0.00043508378,0.00017012568,0.0042398893],"genre_scores_gemma":[0.993218,0.0023381556,0.0010843398,0.000036595215,0.0000107056885,0.000015037505,0.00020209074,0.00002380919,0.0030713528],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99978536,0.000051481216,0.00001698383,0.00002670436,0.000053830816,0.00006553219],"domain_scores_gemma":[0.99976116,0.00007452279,0.000031704523,0.00004089935,0.00005118878,0.000040513052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032970356,0.0003424885,0.00042998797,0.00055763446,0.0003299938,0.0005553407,0.00040680997,0.00040836277,0.0016010016],"category_scores_gemma":[0.0002592,0.00016166878,0.000293728,0.00032307068,0.00031854937,0.00051119993,0.0002620436,0.0005595325,0.00030212593],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016456316,0.000069932605,0.0018237254,0.00017624148,0.000026231606,0.00024965304,0.00018462376,0.000324753,0.98355836,0.002489525,0.00009392547,0.0093574105],"study_design_scores_gemma":[0.00002136026,0.00046661933,0.00906567,0.000008116136,0.00003147865,0.0005687187,0.00011968299,0.00090052915,0.98671895,0.00035985935,0.0017314407,0.0000074854674],"about_ca_topic_score_codex":0.0008248562,"about_ca_topic_score_gemma":0.00078167254,"teacher_disagreement_score":0.0016010016,"about_ca_system_score_codex":0.0005183519,"about_ca_system_score_gemma":0.00029137338,"threshold_uncertainty_score":0.0053558946},"labels":[],"label_agreement":null},{"id":"W1984150537","doi":"10.1038/sj.pcan.4500431","title":"Studies on phenotypic expression patterns of proteases and protease inhibitors in benign compared to malignant prostate tissues","year":2000,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Proteases; Protease; Prostate cancer; Phenotype; Prostate; Medicine; Pathology; Cancer research; Enzyme; Biology; Cancer; Internal medicine; Biochemistry; Gene","score_opus":0.030563533287147986,"score_gpt":0.34424379768507213,"score_spread":0.3136802643979241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984150537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952892,0.0017917552,0.00083422475,0.00003637869,0.000015186762,0.000011066078,0.0002564299,0.000013818173,0.0017519442],"genre_scores_gemma":[0.99662787,0.0009467389,0.0005360258,0.000023221895,0.000020169282,0.000016084587,0.00047069884,0.000008542459,0.0013505562],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998462,0.000025409525,0.000014981358,0.000029955387,0.00003780322,0.000045619046],"domain_scores_gemma":[0.99973243,0.00006999853,0.000048878966,0.000017657465,0.000055690834,0.00007535824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018810746,0.00013329908,0.0002057936,0.0006694899,0.00025324544,0.00041438584,0.00011701717,0.00014539974,0.0012581599],"category_scores_gemma":[0.00037943412,0.00010797231,0.00018121961,0.0005217427,0.00017898956,0.00022135601,0.00019193538,0.00029678273,0.00024947408],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011064039,0.00005324532,0.038069572,0.00011268939,0.000034015895,0.0003626221,0.0001611357,0.00003772394,0.9531557,0.00017419783,0.00007760769,0.006655123],"study_design_scores_gemma":[0.00001982304,0.00065344205,0.6603152,0.000009276148,0.00008280532,0.004126458,0.00063232175,0.0005579547,0.32978183,0.00014643221,0.003662377,0.000012015763],"about_ca_topic_score_codex":0.0004219412,"about_ca_topic_score_gemma":0.0004212491,"teacher_disagreement_score":0.0012581599,"about_ca_system_score_codex":0.00012084653,"about_ca_system_score_gemma":0.00011220211,"threshold_uncertainty_score":0.004208982},"labels":[],"label_agreement":null},{"id":"W1985421348","doi":"10.1038/sj.pcan.4500411","title":"Neoadjuvant hormonal therapy prior to radical prostatectomy: promises and pitfalls","year":2000,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Prostatectomy; Hormonal therapy; Prostate cancer; Urology; Hormone therapy; Neoadjuvant therapy; Benign prostatic hyperplasia (BPH); Internal medicine; Cancer","score_opus":0.012076998825165554,"score_gpt":0.283179520623381,"score_spread":0.2711025217982154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985421348","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011578334,0.8194878,0.0051815915,0.15109453,0.0040364666,0.000034047815,0.00012094771,0.00006091094,0.008405402],"genre_scores_gemma":[0.19356498,0.68375796,0.0155867,0.05325349,0.05016959,0.00015693431,0.0002491158,0.00011264813,0.0031485227],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.995752,0.0018275413,0.0006972099,0.0003736057,0.0010699298,0.00027958472],"domain_scores_gemma":[0.95593697,0.035587106,0.002917,0.0010952676,0.0024013359,0.0020624392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028365906,0.0008198122,0.0027540945,0.0011393125,0.0014535298,0.00371542,0.00151034,0.0034879842,0.0037136374],"category_scores_gemma":[0.023433102,0.00059308123,0.0010394359,0.001154197,0.005901301,0.008721202,0.0014488085,0.00964159,0.0010244888],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039351024,0.00051962654,0.020252958,0.0028737541,0.00030317786,0.0014063226,0.0004811228,0.002590515,0.002860344,0.023834579,0.024461238,0.91648114],"study_design_scores_gemma":[0.0017156026,0.0071835844,0.09075969,0.014999343,0.001988328,0.02079852,0.0064471764,0.0076601775,0.004107757,0.23243743,0.61111563,0.00078673457],"about_ca_topic_score_codex":0.0018183662,"about_ca_topic_score_gemma":0.011123035,"teacher_disagreement_score":0.028365906,"about_ca_system_score_codex":0.0022752134,"about_ca_system_score_gemma":0.0050440743,"threshold_uncertainty_score":0.15001506},"labels":[],"label_agreement":null},{"id":"W1985491628","doi":"10.1038/pcan.2014.28","title":"Imaging, procedural and clinical variables associated with tumor yield on bone biopsy in metastatic castration-resistant prostate cancer","year":2014,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Hospital; Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"GlaxoSmithKline; National Cancer Institute; Stand Up To Cancer; Prostate Cancer Foundation","keywords":"Medicine; Prostate cancer; Biopsy; Radiology; Soft tissue; Lesion; Cancer; Metastasis; Bone metastasis; Urology; Pathology; Internal medicine","score_opus":0.027456323346360906,"score_gpt":0.3402750758007429,"score_spread":0.312818752454382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985491628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99890363,0.00042850818,0.000112914255,0.000048793565,0.0000037566326,0.0000031704028,0.00007917403,0.0000050590756,0.00041504565],"genre_scores_gemma":[0.9996836,0.00008717697,0.000059967762,0.000014829833,0.000010009173,0.0000015081329,0.000073879666,0.0000024060646,0.0000665734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997346,0.00009121334,0.000034915414,0.000035487003,0.00006145783,0.000042234962],"domain_scores_gemma":[0.9971679,0.0013361616,0.0008906843,0.00012242608,0.00015065889,0.00033218227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005536885,0.00027099205,0.00027547078,0.0005227582,0.00024696736,0.00067973376,0.00042578392,0.00051551673,0.0010697494],"category_scores_gemma":[0.004981265,0.00016615837,0.00035246296,0.0007404481,0.00035313398,0.00039552615,0.00021481112,0.000536643,0.0001274246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092457543,0.000070351794,0.99520326,0.000015983329,0.00008923699,0.00022024382,0.00003975218,0.00023558781,0.00094835786,0.00003034946,0.00006227857,0.0021600465],"study_design_scores_gemma":[0.000007669409,0.00014349639,0.9983436,0.0000039670454,0.00006576658,0.0004971936,0.000088173016,0.00055434386,0.00016830914,0.000042029722,0.00008069441,0.000004772132],"about_ca_topic_score_codex":0.003436402,"about_ca_topic_score_gemma":0.005420603,"teacher_disagreement_score":0.003436402,"about_ca_system_score_codex":0.00027688793,"about_ca_system_score_gemma":0.00037234294,"threshold_uncertainty_score":0.006832838},"labels":[],"label_agreement":null},{"id":"W1985553828","doi":"10.1038/pcan.2012.18","title":"Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer","year":2012,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Bone health and treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Denosumab; Femoral neck; Bone mineral; Prostate cancer; Urology; Placebo; Androgen deprivation therapy; Osteoporosis; Internal medicine; Bone density; Oncology; Cancer","score_opus":0.015761991326350044,"score_gpt":0.3190172405698565,"score_spread":0.30325524924350644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985553828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984242,0.000674049,0.00011480451,0.000056176777,0.000020716818,0.000058228336,0.00025888134,0.000014053519,0.00037889055],"genre_scores_gemma":[0.9986468,0.00011892735,0.00012553125,0.00009276259,0.00005579581,0.00004630234,0.00031464366,0.000005254877,0.0005940144],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9977137,0.0011231945,0.00023316503,0.00030116359,0.00042973307,0.00019915761],"domain_scores_gemma":[0.99716127,0.0015008464,0.0005697336,0.00030851673,0.00018602028,0.00027360607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031689496,0.0004670357,0.0019830603,0.0010099376,0.0003898342,0.000553296,0.00051548553,0.000756173,0.0026213774],"category_scores_gemma":[0.005071154,0.00031644292,0.0019196237,0.0006396369,0.00031564868,0.0005727709,0.00046074597,0.00085097505,0.00031396915],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.537796,0.0039879745,0.36506477,0.00044166518,0.007042554,0.00041026057,0.0005102942,0.0017005152,0.018211707,0.00014054199,0.0005454292,0.06414822],"study_design_scores_gemma":[0.005692269,0.03233473,0.9542364,0.000018914547,0.0027551411,0.00021126303,0.00024390596,0.0011457482,0.0021258744,0.00016924221,0.00101705,0.000049452552],"about_ca_topic_score_codex":0.0012912307,"about_ca_topic_score_gemma":0.0018561321,"teacher_disagreement_score":0.0031689496,"about_ca_system_score_codex":0.0004505732,"about_ca_system_score_gemma":0.00030407126,"threshold_uncertainty_score":0.016759217},"labels":[],"label_agreement":null},{"id":"W1985809233","doi":"10.1038/sj.pcan.4500806","title":"Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH): a systematic analysis of expert opinion","year":2005,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Lower urinary tract symptoms; Benign prostatic hyperplasia (BPH); Hyperplasia; Disease; Urology; Prostate cancer; Prostate; Gynecology; Internal medicine; Cancer","score_opus":0.013410148046538572,"score_gpt":0.31899173663788044,"score_spread":0.3055815885913419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985809233","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39151034,0.59339964,0.0013812421,0.0013712991,0.00034941107,0.00036874457,0.010071277,0.000034229866,0.0015137439],"genre_scores_gemma":[0.93321574,0.061232816,0.0012229823,0.0008996614,0.00023973393,0.00016055284,0.0028247265,0.00000815304,0.00019557036],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.99539787,0.001736463,0.0011309093,0.00080581434,0.00078726484,0.00014158872],"domain_scores_gemma":[0.97550815,0.016715933,0.005102812,0.00064775284,0.0015865868,0.00043881225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052319453,0.00047691393,0.0039044728,0.0019343679,0.000341055,0.00062874175,0.0007932538,0.0011682137,0.0015320895],"category_scores_gemma":[0.020553749,0.00041920508,0.0068550403,0.0024406859,0.0003409734,0.0005015353,0.0003726649,0.0005815421,0.00012257414],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004665843,0.00013298355,0.7882068,0.037487924,0.10096787,0.00036028994,0.00034874355,0.00032145294,0.000922497,0.000068619825,0.0026162218,0.0639006],"study_design_scores_gemma":[0.0017928947,0.00091677083,0.8178996,0.005632707,0.16912006,0.00068410404,0.00019985376,0.00037275357,0.00031844602,0.00013193424,0.002871055,0.00005974237],"about_ca_topic_score_codex":0.008976287,"about_ca_topic_score_gemma":0.020379484,"teacher_disagreement_score":0.008976287,"about_ca_system_score_codex":0.00057223614,"about_ca_system_score_gemma":0.001854135,"threshold_uncertainty_score":0.02766949},"labels":[],"label_agreement":null},{"id":"W1990447329","doi":"10.1038/pcan.2009.32","title":"Utility and health-related quality of life in prostate cancer patients 12 months after radical prostatectomy or radiation therapy","year":2009,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute; University of Toronto; Toronto General Hospital; University Health Network; Toronto Public Health; Public Health Ontario","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Prostate cancer; Prostatectomy; Quality of life (healthcare); Radiation therapy; Urology; Androgen deprivation therapy; Sexual function; Cancer; Internal medicine; Physical therapy","score_opus":0.03144020545641437,"score_gpt":0.3372288299231845,"score_spread":0.30578862446677013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990447329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985089,0.00048181278,0.000025947937,0.000109216766,0.000012890197,0.000007528227,0.0003000188,0.0000022422414,0.0005515801],"genre_scores_gemma":[0.99926704,0.00012972779,0.000029381023,0.00003935404,0.000011262538,0.0000041214903,0.00027597696,0.0000010896529,0.00024205989],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99959475,0.00012750404,0.00004440457,0.000033796034,0.00006630688,0.00013326573],"domain_scores_gemma":[0.99746263,0.00044259598,0.0009068294,0.000053819116,0.00022022215,0.00091390515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006559679,0.00031242424,0.00068841776,0.001063556,0.0006968772,0.0010119298,0.00040693348,0.0007821781,0.0020166612],"category_scores_gemma":[0.0043066326,0.00022693038,0.0013203298,0.0014918796,0.0004196739,0.00087595376,0.0006761002,0.0014680737,0.00031861194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063874363,0.00020859887,0.99652356,0.000014996919,0.00012870549,0.000104337494,0.00016384874,0.00016764522,0.00008181823,0.000019374907,0.00009662302,0.0018517727],"study_design_scores_gemma":[0.0000148071285,0.00039418816,0.99871206,0.000005366823,0.00006014023,0.00010840956,0.00023761869,0.00028901745,0.000029408258,0.000029918183,0.000108242304,0.0000107537035],"about_ca_topic_score_codex":0.017110119,"about_ca_topic_score_gemma":0.025862033,"teacher_disagreement_score":0.017110119,"about_ca_system_score_codex":0.0008330104,"about_ca_system_score_gemma":0.0006239732,"threshold_uncertainty_score":0.03402102},"labels":[],"label_agreement":null},{"id":"W1993759141","doi":"10.1038/sj.pcan.4500792","title":"The relationship between the androgen receptor CAG repeat polymorphism length and the response to intermittent androgen suppression therapy for advanced prostate cancer","year":2005,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Prostate cancer; Medicine; Androgen suppression; Androgen receptor; Oncology; Androgen; Internal medicine; Endocrinology; Urology; Cancer; Hormone","score_opus":0.03136007122502136,"score_gpt":0.3477048475817159,"score_spread":0.3163447763566945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993759141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980627,0.0008993504,0.0001268505,0.00017930497,0.00003115889,0.0000075018334,0.00015364656,0.000011719805,0.00052770873],"genre_scores_gemma":[0.999398,0.00009632201,0.00008833679,0.000057828573,0.000047457608,0.000005400988,0.000107253385,0.0000031752465,0.00019620475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938035,0.0002935152,0.000076330034,0.00007240718,0.00011538282,0.00006194513],"domain_scores_gemma":[0.9907486,0.0055320016,0.0020345952,0.0003063357,0.00035088672,0.0010275372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012540873,0.00023302785,0.0005746857,0.0006020563,0.00032028058,0.0003928392,0.00038295778,0.0007278385,0.0014673873],"category_scores_gemma":[0.0061712926,0.0002443996,0.0006628746,0.0007596637,0.0003531109,0.0004020661,0.00021643343,0.0013758392,0.000181684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004662226,0.0002141496,0.9878329,0.000022473685,0.0003795434,0.00013745522,0.00005517047,0.0003644602,0.0018429485,0.000031615757,0.00013158402,0.004325411],"study_design_scores_gemma":[0.00004888513,0.0008228293,0.997721,0.000003674639,0.00011927155,0.00028145642,0.000030769253,0.00063161174,0.00016303685,0.00003099121,0.00013896916,0.0000074712184],"about_ca_topic_score_codex":0.0016630177,"about_ca_topic_score_gemma":0.0016331776,"teacher_disagreement_score":0.0016630177,"about_ca_system_score_codex":0.00033695504,"about_ca_system_score_gemma":0.00034122332,"threshold_uncertainty_score":0.0066322684},"labels":[],"label_agreement":null},{"id":"W1999572088","doi":"10.1038/sj.pcan.4500478","title":"High risk genes predisposing to prostate cancer development—do they exist?","year":2000,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; Coalition for Research in Women's Health","funders":"Cancer Research Institute","keywords":"Prostate cancer; Medicine; Penetrance; Cancer; Gene; Prostate; Genetic predisposition; Breast cancer; Oncology; Bioinformatics; Internal medicine; Genetics; Biology; Disease; Phenotype","score_opus":0.008081150156248804,"score_gpt":0.2689742305288607,"score_spread":0.2608930803726119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999572088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9240255,0.048237048,0.0016051189,0.010883552,0.00036497912,0.00002764628,0.00060878927,0.000063294436,0.014184158],"genre_scores_gemma":[0.98692644,0.0085172495,0.00073455076,0.0010963703,0.0010111089,0.000018267077,0.00025526903,0.00001958727,0.0014212511],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99948466,0.00017832118,0.00004205481,0.00007924162,0.000110949404,0.000104716106],"domain_scores_gemma":[0.9970029,0.0013019796,0.0007151027,0.00021542837,0.00020091452,0.0005637131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068421505,0.00045238205,0.0008749257,0.0014451604,0.00051223056,0.0013633001,0.00080015487,0.0019055624,0.0068984786],"category_scores_gemma":[0.0035745879,0.00043697102,0.00041894082,0.0014392918,0.0012490763,0.0017043768,0.00057061994,0.0011475469,0.00067262875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013671254,0.0003084894,0.9422171,0.00020657128,0.00045435346,0.0025726017,0.00031124768,0.00017043912,0.00583341,0.0071349307,0.0020391217,0.037384614],"study_design_scores_gemma":[0.000078059755,0.0002617712,0.9750542,0.00009948514,0.000517609,0.007970102,0.0011028508,0.00031128997,0.0006521789,0.007551247,0.006361214,0.00003991734],"about_ca_topic_score_codex":0.0009762136,"about_ca_topic_score_gemma":0.0013610332,"teacher_disagreement_score":0.0068984786,"about_ca_system_score_codex":0.00026353766,"about_ca_system_score_gemma":0.00041117315,"threshold_uncertainty_score":0.023077786},"labels":[],"label_agreement":null},{"id":"W2001209876","doi":"10.1038/pcan.2012.16","title":"Metformin enhances the antiproliferative and apoptotic effect of bicalutamide in prostate cancer","year":2012,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":103,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University; Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Health Canada; National Institutes of Health; Prostate Cancer Canada","keywords":"Bicalutamide; LNCaP; Prostate cancer; Metformin; Medicine; Cell growth; Cancer research; Endocrinology; DU145; Internal medicine; In vivo; Cell cycle; Apoptosis; Clonogenic assay; Androgen receptor; Cancer; Pharmacology; Biology; Diabetes mellitus; Biochemistry","score_opus":0.005760686546217126,"score_gpt":0.2776471420424563,"score_spread":0.27188645549623913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001209876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919974,0.004888946,0.00027200262,0.00025606388,0.000081682774,0.00002078017,0.00019009899,0.000084628264,0.0022082792],"genre_scores_gemma":[0.9962442,0.0019028415,0.00029842363,0.000063046056,0.000025256224,0.000016777149,0.00023959308,0.000010163713,0.0011997444],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998441,0.000047626767,0.000013239357,0.0000095992555,0.0000336985,0.000051714836],"domain_scores_gemma":[0.99987304,0.000025016496,0.00001772092,0.000012754056,0.000015898177,0.00005560292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017975939,0.00024546776,0.0004543408,0.00038839367,0.0003122688,0.00037795343,0.00035583615,0.00028254814,0.0024901668],"category_scores_gemma":[0.0002954505,0.00021633624,0.00028568212,0.0003155822,0.0002048119,0.00032704757,0.00027441044,0.00089301285,0.00037674667],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01590235,0.0011730763,0.0019810868,0.0003450763,0.000096970274,0.0002856011,0.00007404973,0.00058954937,0.94557637,0.00052681443,0.0012966341,0.032152534],"study_design_scores_gemma":[0.0013777027,0.01480766,0.03952204,0.000046641762,0.00025160584,0.001134064,0.00025637075,0.0023143515,0.9278478,0.0002926397,0.012099644,0.000049362086],"about_ca_topic_score_codex":0.0017159358,"about_ca_topic_score_gemma":0.0043495893,"teacher_disagreement_score":0.0024901668,"about_ca_system_score_codex":0.00030487188,"about_ca_system_score_gemma":0.00060236186,"threshold_uncertainty_score":0.008330405},"labels":[],"label_agreement":null},{"id":"W2001463090","doi":"10.1038/pcan.2011.34","title":"PSA affects prostate cancer cell invasion in vitro and induces an osteoblastic phenotype in bone in vivo","year":2011,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Bone health and treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Lakehead University","funders":"Canadian Institutes of Health Research","keywords":"Prostate cancer; Metastasis; Cancer research; In vivo; Prostate-specific antigen; Transfection; Medicine; Bone metastasis; Prostate; Cancer; Cell culture; Pathology; Biology; Internal medicine","score_opus":0.023648968650867467,"score_gpt":0.28725544707716044,"score_spread":0.263606478426293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001463090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872754,0.0040150485,0.0013332806,0.00030145378,0.00009032752,0.00003346175,0.0004431922,0.000101995036,0.0064059203],"genre_scores_gemma":[0.9883747,0.0015482416,0.0006243745,0.00012595054,0.000025578885,0.000023820528,0.00072641793,0.000028442066,0.008522353],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99953187,0.00014767444,0.000023214256,0.000027430871,0.00013829957,0.00013142341],"domain_scores_gemma":[0.99976367,0.00008035501,0.000030050567,0.000022965103,0.000024869352,0.00007813137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022263976,0.00036848968,0.00040042188,0.000669733,0.0003876638,0.00051467784,0.00024079205,0.00038492272,0.0037913152],"category_scores_gemma":[0.00023794838,0.00055955094,0.0006227413,0.000490497,0.00053271727,0.00020859769,0.00025523506,0.0011244821,0.00094511284],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000976042,0.00029955126,0.0009442188,0.00008057578,0.000025568435,0.0003404295,0.00007272705,0.00015029556,0.99436176,0.00021599607,0.00030844702,0.0022243287],"study_design_scores_gemma":[0.00013977246,0.0029439945,0.04016314,0.000012840212,0.00006695862,0.0012298774,0.0002889245,0.0013717734,0.9480787,0.00018748661,0.0054967282,0.000019882777],"about_ca_topic_score_codex":0.0053143017,"about_ca_topic_score_gemma":0.010566584,"teacher_disagreement_score":0.0053143017,"about_ca_system_score_codex":0.00029980578,"about_ca_system_score_gemma":0.00064975396,"threshold_uncertainty_score":0.012683153},"labels":[],"label_agreement":null},{"id":"W2006157165","doi":"10.1038/pcan.2013.49","title":"A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy","year":2013,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Institutes of Health; Astellas Pharma; Johns Hopkins University; Howard Hughes Medical Institute","keywords":"Medicine; Nomogram; Biochemical recurrence; Prostatectomy; Receiver operating characteristic; Internal medicine; Oncology; Prostate cancer; breakpoint cluster region; Metastasis; Population; Proportional hazards model; Hazard ratio; Cohort; Area under the curve; Urology; Cancer; Confidence interval","score_opus":0.01234736474473224,"score_gpt":0.2829393336874096,"score_spread":0.27059196894267734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006157165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929309,0.00092371437,0.0023798156,0.0005164801,0.00009300433,0.000029191384,0.0019715794,0.00009146163,0.0010637926],"genre_scores_gemma":[0.9945716,0.00023172647,0.0015710623,0.00010844728,0.00011088613,0.00001539188,0.0028986414,0.0000072389084,0.0004850051],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977165,0.000047779395,0.000025192168,0.000065498985,0.000049581988,0.000040387793],"domain_scores_gemma":[0.9991648,0.0004066672,0.00015382752,0.00004681463,0.00011672052,0.00011127538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043947014,0.00035054047,0.0005877505,0.0011112075,0.00032598234,0.0007663851,0.00038033279,0.00062441285,0.0011530695],"category_scores_gemma":[0.0023174018,0.00010379996,0.0004922497,0.000555404,0.00012894894,0.00033674375,0.00034264705,0.00045417587,0.0003147517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009479252,0.00023455436,0.932888,0.00005509684,0.00024187208,0.00032560594,0.00004103765,0.0033985476,0.0030750176,0.00013409929,0.0024822014,0.056176014],"study_design_scores_gemma":[0.00013442474,0.0012846199,0.86888224,0.00007010928,0.0008695507,0.0017394603,0.00028765562,0.118995965,0.003457094,0.0014856969,0.0027473865,0.00004581578],"about_ca_topic_score_codex":0.0032577512,"about_ca_topic_score_gemma":0.0060573583,"teacher_disagreement_score":0.0032577512,"about_ca_system_score_codex":0.0002327705,"about_ca_system_score_gemma":0.00035086382,"threshold_uncertainty_score":0.0064775944},"labels":[],"label_agreement":null},{"id":"W2011330675","doi":"10.1038/sj.pcan.4500841","title":"Enlarged prostate: A landmark national survey of its prevalence and impact on US men and their partners","year":2005,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lower urinary tract symptoms; Spouse; Quality of life (healthcare); Quarter (Canadian coin); Prostate cancer; Erectile dysfunction; Urinary incontinence; Demography; Gynecology; Internal medicine; Prostate; Gerontology; Family medicine; Urology","score_opus":0.03978182301884718,"score_gpt":0.3792458090790004,"score_spread":0.3394639860601532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011330675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910228,0.0012240841,0.00011820234,0.00032550827,0.000010883959,0.000028793518,0.0050707315,0.000013802322,0.0021852343],"genre_scores_gemma":[0.99633515,0.00080357236,0.0001272679,0.00014508606,0.000013312354,0.000018191042,0.0020033738,0.0000027170888,0.00055140007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999708,0.00009856769,0.000023666964,0.0000379683,0.00007273931,0.000059059592],"domain_scores_gemma":[0.9991478,0.000132819,0.0003100463,0.00006925845,0.00017505074,0.0001649737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041015708,0.00017370455,0.00022307025,0.00076667883,0.00038873072,0.00041080723,0.00031709316,0.00038519103,0.0009301658],"category_scores_gemma":[0.0013011539,0.00022284132,0.0003123614,0.0019727703,0.00019408319,0.00058387034,0.00065101753,0.0004761143,0.00018079573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004336002,0.000029985411,0.99623835,0.00001616902,0.00003332756,0.000031612064,0.00020866013,0.00003132053,0.00006420785,0.000018878747,0.00076567184,0.0025185135],"study_design_scores_gemma":[0.0000012978971,0.000021025855,0.9992513,0.000003815001,0.0000107672595,0.00005546796,0.00023554702,0.000013615986,0.000013358182,0.0000028496136,0.00038944586,0.0000016518821],"about_ca_topic_score_codex":0.07504064,"about_ca_topic_score_gemma":0.12434851,"teacher_disagreement_score":0.07504064,"about_ca_system_score_codex":0.00048836914,"about_ca_system_score_gemma":0.000629269,"threshold_uncertainty_score":0.14920771},"labels":[],"label_agreement":null},{"id":"W2016429587","doi":"10.1038/pcan.2008.15","title":"Partial androgen suppression consequent to increased secretion of adrenal androgens in a patient with prostate cancer treated with long-acting GnRH agonists","year":2008,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Prostate cancer; Internal medicine; Endocrinology; Testosterone (patch); Dehydroepiandrosterone; Androgen; Androsterone; Prostate; Hormone; Cancer; Steroid","score_opus":0.015882726841104523,"score_gpt":0.2717730189973405,"score_spread":0.255890292156236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016429587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783215,0.0031308534,0.00070142234,0.0059479154,0.000396212,0.0001075938,0.0002548561,0.00012809032,0.011011476],"genre_scores_gemma":[0.9966079,0.0006389199,0.00018417228,0.0011131787,0.00047501395,0.000007183291,0.000056935525,0.000012823885,0.00090402015],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99968255,0.000047446723,0.000042361924,0.00006045342,0.00005806645,0.00010924101],"domain_scores_gemma":[0.99829835,0.00086489605,0.00016858602,0.00009146512,0.00006404432,0.00051267736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028035181,0.0011743467,0.0011640625,0.0020773802,0.002191759,0.0008806582,0.001273628,0.004587033,0.0023735543],"category_scores_gemma":[0.0029999213,0.00096627226,0.001675692,0.0011371966,0.001491633,0.0009816085,0.0005639134,0.0042518284,0.000406039],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038450825,0.00008896289,0.010174042,0.000030529533,0.00002125232,0.9870726,0.00013125686,0.00009154367,0.0008001984,0.000117618634,0.00015192818,0.0009355611],"study_design_scores_gemma":[0.000095573174,0.0009804007,0.035267804,0.000014422402,0.00007510479,0.9609753,0.0001932254,0.0006098955,0.0010257001,0.00019935275,0.00053407927,0.00002921499],"about_ca_topic_score_codex":0.0050378675,"about_ca_topic_score_gemma":0.005330228,"teacher_disagreement_score":0.0050378675,"about_ca_system_score_codex":0.0012845031,"about_ca_system_score_gemma":0.0010443212,"threshold_uncertainty_score":0.010017097},"labels":[],"label_agreement":null},{"id":"W2021573908","doi":"10.1038/pcan.2013.13","title":"Oxidative stress in prostate cancer: changing research concepts towards a novel paradigm for prevention and therapeutics","year":2013,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":130,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Oxidative stress; Carcinogenesis; Prostate cancer; Medicine; Reactive oxygen species; Cancer; Cancer prevention; Cancer research; Bioinformatics; Internal medicine; Biology; Cell biology","score_opus":0.07937347459368194,"score_gpt":0.4206013587301901,"score_spread":0.3412278841365082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021573908","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004451343,0.99893206,0.00011865064,0.00049055147,0.00019254841,0.000001686787,0.000009367103,0.000003669092,0.00020696809],"genre_scores_gemma":[0.00034106817,0.9987551,0.00015962233,0.00024706035,0.00030054842,0.0000026017663,0.000013569269,7.059736e-7,0.0001797044],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972266,0.00006281631,0.00003452399,0.000050681057,0.00010425412,0.0000250191],"domain_scores_gemma":[0.99928695,0.00033676336,0.0000705615,0.000019892634,0.00022659324,0.000059305803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011135224,0.0008900745,0.0020071971,0.0020764372,0.0003351197,0.0011844587,0.0011312175,0.0016246065,0.0022425714],"category_scores_gemma":[0.0012072099,0.00027656526,0.00048845087,0.0025535673,0.0007762738,0.0015639554,0.000935585,0.0026491587,0.0009922897],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012016742,0.00010374304,0.00045525425,0.01509292,0.0001647272,0.0002475576,0.000062575826,0.0003730206,0.0015636276,0.0050824285,0.046267338,0.93046665],"study_design_scores_gemma":[0.000038052545,0.00013682211,0.0012223627,0.0036315604,0.0002208082,0.001133637,0.00012538666,0.00013430438,0.00042792992,0.00521884,0.9876738,0.00003644081],"about_ca_topic_score_codex":0.0016312149,"about_ca_topic_score_gemma":0.0034672585,"teacher_disagreement_score":0.0022425714,"about_ca_system_score_codex":0.0008028984,"about_ca_system_score_gemma":0.0019454837,"threshold_uncertainty_score":0.0075021386},"labels":[],"label_agreement":null},{"id":"W2023595415","doi":"10.1038/pcan.2009.64","title":"Accurate prediction of repeat prostate biopsy outcomes by a mitochondrial DNA deletion assay","year":2010,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Ontario Genomics","funders":"Industry Canada","keywords":"Medicine; Biopsy; Prostate cancer; Cutoff; Receiver operating characteristic; Prostate biopsy; Polymerase chain reaction; Prostate; Predictive value of tests; Pathology; Cancer; Radiology; Internal medicine; Oncology; Gene; Biology","score_opus":0.014374844803174643,"score_gpt":0.3074316387798778,"score_spread":0.29305679397670314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023595415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99647254,0.0007074438,0.0017687851,0.00014233813,0.000029554656,0.0000119265815,0.00027035055,0.000055972512,0.00054111116],"genre_scores_gemma":[0.99840754,0.000099409386,0.0009860235,0.000036203633,0.00002389277,0.0000063118314,0.00017983145,0.0000042477513,0.00025656912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991617,0.00028887883,0.000054747914,0.00018120487,0.0002355787,0.000077858866],"domain_scores_gemma":[0.99622536,0.0017607762,0.0009928477,0.00028716648,0.00046984598,0.0002640906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011698846,0.0005145229,0.0006649107,0.000997819,0.0002699186,0.00059496745,0.0005806748,0.0008147621,0.0007432842],"category_scores_gemma":[0.005609446,0.00031940572,0.00032544733,0.00042352406,0.00024705427,0.00038068354,0.0002872909,0.00071502186,0.00035417933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008148272,0.000078731166,0.9805069,0.000012600663,0.0000753713,0.000115742005,0.000037584745,0.00046126026,0.0054269102,0.000033046894,0.00023686222,0.012200241],"study_design_scores_gemma":[0.00005083633,0.00088595174,0.98136157,0.000012715676,0.0001821198,0.0014996082,0.000089077104,0.009909437,0.0052035702,0.00021470521,0.00056761235,0.000022847373],"about_ca_topic_score_codex":0.002374618,"about_ca_topic_score_gemma":0.004596976,"teacher_disagreement_score":0.002374618,"about_ca_system_score_codex":0.00035408358,"about_ca_system_score_gemma":0.00030490037,"threshold_uncertainty_score":0.0061870217},"labels":[],"label_agreement":null},{"id":"W2030714208","doi":"10.1038/pcan.2014.24","title":"An open-label, phase 2 trial of bicalutamide dose escalation from 50 mg to 150 mg in men with CAB and castration resistance. A Canadian Urology Research Consortium Study","year":2014,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Bicalutamide; Medicine; Discontinuation; Antiandrogen; Urology; Prostate cancer; Clinical endpoint; Androgen; Internal medicine; Androgen deprivation therapy; Goserelin; Randomized controlled trial; Cancer; Androgen receptor; Hormone","score_opus":0.06466855488777716,"score_gpt":0.4243131971048261,"score_spread":0.35964464221704895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030714208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851248,0.0030724434,0.0004522315,0.0010062781,0.000310217,0.002671127,0.0029215878,0.00017197157,0.004269218],"genre_scores_gemma":[0.98483306,0.0018934523,0.0013819357,0.0016296526,0.00022412115,0.0017656962,0.00408818,0.000056232904,0.004127715],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995358,0.0001873695,0.000015719017,0.00008434676,0.00006069802,0.00011618348],"domain_scores_gemma":[0.9992213,0.000104708284,0.00008327192,0.000060681243,0.00007051019,0.00045950033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011297873,0.0016818694,0.0018947049,0.000489333,0.0005454313,0.0008965231,0.0012593751,0.0013533069,0.0072165253],"category_scores_gemma":[0.0011613285,0.00063624914,0.001186957,0.0004835807,0.0012633505,0.0009040548,0.00037142987,0.0035413203,0.0014778712],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9104723,0.024306225,0.0018509557,0.00052946986,0.001149187,0.00009675597,0.00020980787,0.0010367545,0.010488059,0.00023936419,0.006373942,0.043247208],"study_design_scores_gemma":[0.87983173,0.1046147,0.010303577,0.00003366638,0.00045353992,0.000120212164,0.00008384849,0.00080505956,0.0007352758,0.00030050805,0.0026755843,0.000042371837],"about_ca_topic_score_codex":0.013657664,"about_ca_topic_score_gemma":0.039875116,"teacher_disagreement_score":0.013657664,"about_ca_system_score_codex":0.0019154934,"about_ca_system_score_gemma":0.0023557183,"threshold_uncertainty_score":0.027156353},"labels":[],"label_agreement":null},{"id":"W2032597933","doi":"10.1038/sj.pcan.4500440","title":"Castration-induced upregulation of insulin-like growth factor binding protein-5 potentiates IGF-1 and accelerates androgen-independent progression in prostate cancer","year":2000,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Prostate cancer; Medicine; Downregulation and upregulation; Insulin-like growth factor; Internal medicine; Androgen; Endocrinology; Insulin-like growth factor-binding protein; Castration; Prostate; Growth factor; Cancer; Oncology; Cancer research; Hormone; Receptor; Biology","score_opus":0.024295949977459725,"score_gpt":0.3224459150868357,"score_spread":0.29814996510937597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032597933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891683,0.0061511053,0.0008697091,0.00022070197,0.00017309835,0.000036515583,0.000480016,0.00014720553,0.0027533774],"genre_scores_gemma":[0.994947,0.0014662694,0.0005246147,0.00007598505,0.000028141914,0.00001606003,0.0004983756,0.000014112746,0.002429525],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998944,0.000015680927,0.000005155333,0.000010330277,0.000025421874,0.00004904519],"domain_scores_gemma":[0.99990666,0.000012633054,0.000016107519,0.000008807316,0.0000067625538,0.00004906118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014646829,0.0003678737,0.00030539435,0.0005517916,0.00021635502,0.00039651812,0.00023882616,0.0001791463,0.0016993402],"category_scores_gemma":[0.00013912558,0.00018581445,0.00042281614,0.00024272852,0.00026825076,0.00024447744,0.00027850055,0.00080418243,0.0003409027],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028640674,0.00034332916,0.0008590595,0.000102238104,0.000019092224,0.00017261131,0.000030892217,0.00025692582,0.98701084,0.00027272204,0.00041988216,0.0076483586],"study_design_scores_gemma":[0.00020483791,0.005012486,0.08279245,0.000026214275,0.000080499616,0.00055740215,0.00017057962,0.0021239214,0.90073836,0.0002381563,0.008024793,0.00003020014],"about_ca_topic_score_codex":0.0037287981,"about_ca_topic_score_gemma":0.008241385,"teacher_disagreement_score":0.0037287981,"about_ca_system_score_codex":0.0006115466,"about_ca_system_score_gemma":0.000558719,"threshold_uncertainty_score":0.0074142218},"labels":[],"label_agreement":null},{"id":"W2032995675","doi":"10.1038/sj.pcan.4500716","title":"Whole-mount prostate sections reveal differential endoglin expression in stromal, epithelial, and endothelial cells with the development of prostate cancer","year":2004,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"McGill University","keywords":"Endoglin; Prostate cancer; Stromal cell; Prostate; Stroma; Intraepithelial neoplasia; Medicine; Pathology; Cancer; Epithelium; Cancer research; Biology; Internal medicine; Immunohistochemistry","score_opus":0.015062955589734191,"score_gpt":0.29029172600732,"score_spread":0.2752287704175858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032995675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923819,0.0024118773,0.002029983,0.0000820942,0.0000122572865,0.000011242836,0.00033860147,0.00006429161,0.00266766],"genre_scores_gemma":[0.9926582,0.0008514676,0.0013420515,0.000057790563,0.0000083806935,0.000013596594,0.00042881517,0.000016810074,0.0046228883],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99989426,0.000011843618,0.0000053508506,0.00001932014,0.00003398132,0.000035257395],"domain_scores_gemma":[0.99985075,0.000023205213,0.000032250016,0.000013924184,0.000021066757,0.000058642854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013403464,0.00011315774,0.0001776406,0.00048088134,0.00019868805,0.00034063892,0.00014363232,0.00026488508,0.0020376425],"category_scores_gemma":[0.00012853304,0.00021835176,0.00018021297,0.00031911107,0.0001736024,0.0002474293,0.00018711197,0.00059970526,0.0002555789],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043559252,0.000030201818,0.007954729,0.000035933605,0.000025438107,0.0003717866,0.000056008823,0.000071378796,0.98734504,0.0002443977,0.00013858905,0.0032908875],"study_design_scores_gemma":[0.000030422092,0.00036267246,0.53520304,0.000014144282,0.00007834128,0.005136197,0.00035246572,0.0011515243,0.45047793,0.00028815036,0.0068886317,0.00001648809],"about_ca_topic_score_codex":0.0009369124,"about_ca_topic_score_gemma":0.0015936495,"teacher_disagreement_score":0.0020376425,"about_ca_system_score_codex":0.00016678567,"about_ca_system_score_gemma":0.00019775306,"threshold_uncertainty_score":0.0068166256},"labels":[],"label_agreement":null},{"id":"W2040030396","doi":"10.1038/pcan.2011.15","title":"The clinical significance of in-depth pathological assessment of extraprostatic extension and margin status in radical prostatectomies for prostate cancer","year":2011,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Pathological; Radiation therapy; Adjuvant radiotherapy; Surgical margin; Brachytherapy; Oncology; Metastasis; Urology; Biochemical recurrence; Adjuvant; Prostate; Cancer; Internal medicine","score_opus":0.060147858851421786,"score_gpt":0.3768407451938635,"score_spread":0.31669288634244175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040030396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99439186,0.002875161,0.00025619674,0.0002044395,0.000041176845,0.000007828623,0.00007705146,0.0000060049833,0.0021403385],"genre_scores_gemma":[0.9993905,0.0002493162,0.00012533514,0.000024640956,0.000044648506,0.000001738288,0.00003656836,0.0000026781977,0.00012453602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990132,0.00044778077,0.000118798416,0.00008415437,0.00022467076,0.000111326],"domain_scores_gemma":[0.9917453,0.0042057056,0.0018085685,0.00043254156,0.0007902279,0.0010175945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021938225,0.0003338512,0.00033706476,0.0008114316,0.00041175899,0.0010503798,0.00072222773,0.00060874654,0.0011967187],"category_scores_gemma":[0.014140882,0.00029679548,0.00034825265,0.00059041375,0.0007932119,0.0010736581,0.0006539255,0.00085671985,0.00020458784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065114663,0.0000274331,0.9927235,0.00002780074,0.000048608545,0.00014812595,0.000057380003,0.00013956134,0.00091622886,0.00003363014,0.000053411713,0.005173216],"study_design_scores_gemma":[0.000008755166,0.00022008226,0.9969213,0.000013627731,0.00011028882,0.0008499096,0.0002357799,0.00070768007,0.00042954294,0.00014784998,0.00034759977,0.0000076153665],"about_ca_topic_score_codex":0.0011530163,"about_ca_topic_score_gemma":0.0035920816,"teacher_disagreement_score":0.0021938225,"about_ca_system_score_codex":0.00033636708,"about_ca_system_score_gemma":0.00045542658,"threshold_uncertainty_score":0.011602163},"labels":[],"label_agreement":null},{"id":"W2041507131","doi":"10.1038/pcan.2015.1","title":"Evaluation of models predicting insignificant prostate cancer to select men for active surveillance of prostate cancer","year":2015,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Hutchison Whampoa Limited; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Prostate cancer; Cancer; Prostate; Oncology; Internal medicine","score_opus":0.06571098803567554,"score_gpt":0.3584957700870056,"score_spread":0.2927847820513301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041507131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97374946,0.002118579,0.016766375,0.0015776514,0.00028528846,0.00020896965,0.0029346116,0.00059525546,0.0017638771],"genre_scores_gemma":[0.9867748,0.0003625828,0.0070180073,0.00016908623,0.00010142896,0.00006719592,0.004514562,0.000047020185,0.0009453227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873096,0.00069564336,0.000103056846,0.00022568472,0.000110838875,0.00013376684],"domain_scores_gemma":[0.98753077,0.010285106,0.0003887615,0.0002694767,0.0010654422,0.00046051975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009390433,0.0021093555,0.0015525854,0.0016914175,0.0006023691,0.0017655417,0.0017398082,0.0011320108,0.0021555708],"category_scores_gemma":[0.011630011,0.00038361823,0.0018830469,0.0007783062,0.0003248376,0.00086298765,0.0007216515,0.00134679,0.00048241636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011357707,0.0041933185,0.44729462,0.00037836502,0.0037804167,0.00034503988,0.00015832129,0.39645606,0.0012064272,0.00060314266,0.008963753,0.12526286],"study_design_scores_gemma":[0.00024772566,0.000963061,0.019730266,0.00005249794,0.00070272957,0.00009299144,0.00008294297,0.9768143,0.00044331994,0.00044683248,0.00040161918,0.000021732094],"about_ca_topic_score_codex":0.020588037,"about_ca_topic_score_gemma":0.01159104,"teacher_disagreement_score":0.020588037,"about_ca_system_score_codex":0.0010934143,"about_ca_system_score_gemma":0.0024803919,"threshold_uncertainty_score":0.049661934},"labels":[],"label_agreement":null},{"id":"W2045276800","doi":"10.1038/pcan.2009.24","title":"Androgens induce oxidative stress and radiation resistance in prostate cancer cells though NADPH oxidase","year":2009,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Redox biology and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; University of Toronto; Ontario Institute for Cancer Research; McMaster University","funders":"","keywords":"Oxidative stress; Medicine; Prostate cancer; NADPH oxidase; Cancer research; Internal medicine; Oncology; Oxidative phosphorylation; Endocrinology; Cancer; Biochemistry; Biology","score_opus":0.006767439209000566,"score_gpt":0.2708904809739309,"score_spread":0.26412304176493034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045276800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98484623,0.009165394,0.0019413604,0.000261924,0.00009597027,0.000039583436,0.00031301327,0.00011250834,0.0032240995],"genre_scores_gemma":[0.99190533,0.0031710556,0.00073003065,0.000091307935,0.000032120122,0.000016983146,0.00030820398,0.000009905037,0.0037350522],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999089,0.000020752019,0.0000060968187,0.000012700028,0.00003095311,0.000020489722],"domain_scores_gemma":[0.9999441,0.000008279716,0.000012832794,0.00000975389,0.000010044259,0.000014938467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000102022306,0.00020953038,0.0001688212,0.00017431598,0.00017872623,0.0002677451,0.000093263705,0.00014029337,0.0018109496],"category_scores_gemma":[0.00008937899,0.00011075197,0.00024396842,0.00017201694,0.00012905695,0.0001254925,0.00017043181,0.00033139202,0.000339466],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001852319,0.000064377535,0.0006112601,0.000040682524,0.0000106386215,0.000082544546,0.000025741478,0.000047686543,0.9954971,0.00014294923,0.00010446218,0.0031873328],"study_design_scores_gemma":[0.000049433296,0.0011959122,0.025640963,0.0000090881485,0.000030762814,0.00082271406,0.00008681177,0.0004416783,0.9627369,0.00023301218,0.008743409,0.000009250124],"about_ca_topic_score_codex":0.00070718763,"about_ca_topic_score_gemma":0.0009489345,"teacher_disagreement_score":0.0018109496,"about_ca_system_score_codex":0.00015277635,"about_ca_system_score_gemma":0.00018630904,"threshold_uncertainty_score":0.006058216},"labels":[],"label_agreement":null},{"id":"W2051133253","doi":"10.1038/pcan.2011.35","title":"18F-fluorocholine for prostate cancer imaging: a systematic review of the literature","year":2011,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Canadian Institutes of Health Research","keywords":"Prostate cancer; Medicine; Positron emission tomography; Radiosynthesis; Docetaxel; Nuclear medicine; Biodistribution; Prostate; Cancer; Radiation therapy; Radiology; Oncology; Internal medicine; In vivo","score_opus":0.03672072542709307,"score_gpt":0.38188996847583273,"score_spread":0.34516924304873964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051133253","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026319246,0.9995189,0.000021039528,0.00005239768,0.00001925569,0.000012677193,0.000048910766,0.0000012013626,0.00006246006],"genre_scores_gemma":[0.003672441,0.99591297,0.00015882541,0.00013228398,0.000028258944,0.000017560908,0.00004392822,9.3603836e-7,0.000032834512],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9985274,0.00046128253,0.0004735465,0.00018996575,0.0002821808,0.000065571374],"domain_scores_gemma":[0.991924,0.0058480664,0.0014580288,0.00008164542,0.00058758305,0.000100744626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030107698,0.0011101142,0.005750045,0.005515464,0.0003762842,0.0011335198,0.0012889317,0.0013393984,0.003144834],"category_scores_gemma":[0.011027724,0.0006141262,0.0040521338,0.0066106627,0.0005920274,0.001229078,0.0007849127,0.00069553335,0.00022666117],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006727778,0.00003893288,0.0013438277,0.80736244,0.010612982,0.00022511734,0.00013100084,0.00016840745,0.00041007297,0.00017605376,0.0042466405,0.17461167],"study_design_scores_gemma":[0.0009697665,0.0007950462,0.0161326,0.70623153,0.18523303,0.002850066,0.0004790432,0.00022816133,0.0008358842,0.00048740886,0.08562338,0.00013417416],"about_ca_topic_score_codex":0.0107948175,"about_ca_topic_score_gemma":0.03366769,"teacher_disagreement_score":0.0107948175,"about_ca_system_score_codex":0.0017139872,"about_ca_system_score_gemma":0.0042791897,"threshold_uncertainty_score":0.02146399},"labels":[],"label_agreement":null},{"id":"W2054119554","doi":"10.1038/pcan.2013.44","title":"Predicting utility scores for prostate cancer: mapping the Prostate Cancer Index to the Patient-Oriented Prostate Utility Scale (PORPUS)","year":2013,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health; Toronto General Hospital; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Prostate cancer; Statistics; Quality of life (healthcare); Gynecology; Cancer; Mathematics; Internal medicine","score_opus":0.1272868722019275,"score_gpt":0.3632615826472255,"score_spread":0.23597471044529802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054119554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865312,0.00059150154,0.009636418,0.00022097804,0.000020995123,0.00007032241,0.0010597432,0.00007195773,0.0017968112],"genre_scores_gemma":[0.99675226,0.0001088668,0.0023096267,0.000015997262,0.000007853375,0.00001974099,0.00062047265,0.000007417422,0.00015774871],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99835134,0.0010729161,0.000069597576,0.00017509682,0.0001946642,0.00013636371],"domain_scores_gemma":[0.99354666,0.0043073217,0.0008941057,0.00036929146,0.0005261944,0.0003563494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003564065,0.00093135505,0.0007593908,0.0029321986,0.00022305643,0.0017992886,0.0006675269,0.0006775684,0.0016071629],"category_scores_gemma":[0.019542528,0.00022003015,0.0011786558,0.0021583552,0.00041767815,0.00089961913,0.0013810489,0.0011666146,0.0005616005],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004531767,0.00014721068,0.94962484,0.00003230319,0.00027768503,0.00006478861,0.00013583533,0.009866053,0.00019725812,0.00056548393,0.0006325952,0.03800277],"study_design_scores_gemma":[0.00005141871,0.0005660734,0.8727929,0.00004709028,0.00017421137,0.00022410863,0.00047309973,0.11729798,0.00044301795,0.006977513,0.00090563326,0.000046988716],"about_ca_topic_score_codex":0.008822473,"about_ca_topic_score_gemma":0.0042554233,"teacher_disagreement_score":0.008822473,"about_ca_system_score_codex":0.00050389627,"about_ca_system_score_gemma":0.00066841434,"threshold_uncertainty_score":0.018848777},"labels":[],"label_agreement":null},{"id":"W2054816445","doi":"10.1038/sj.pcan.4500811","title":"Role of transrectal ultrasound guided salvage cryosurgery for recurrent prostate carcinoma after radiotherapy","year":2005,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Clair College; University of Toronto; Capital District Health Authority; Alberta Cancer Foundation; Winnipeg Regional Health Authority; University of Calgary","funders":"","keywords":"Medicine; Cryosurgery; Urology; Prostate cancer; Prostate; Radiation therapy; External beam radiotherapy; Prospective cohort study; Ultrasound; Carcinoma; Urethra; Fistula; Surgery; Cancer; Radiology; Brachytherapy; Internal medicine","score_opus":0.011205764852964626,"score_gpt":0.28263900007751486,"score_spread":0.2714332352245502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054816445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61534977,0.3368748,0.0032659615,0.011775939,0.0026488723,0.000120064164,0.00027963237,0.0002734346,0.029411547],"genre_scores_gemma":[0.9611941,0.029486025,0.0013608132,0.0017289029,0.0029877024,0.00004055584,0.00015572403,0.000049054324,0.00299714],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996879,0.00015299824,0.000029340941,0.000031763113,0.000043853,0.000054159595],"domain_scores_gemma":[0.9978573,0.0011816977,0.00030535908,0.00015779608,0.00018689758,0.00031094704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015818886,0.00044029683,0.0009618739,0.0005038917,0.00049136434,0.0009162041,0.0009063101,0.00066828856,0.005378986],"category_scores_gemma":[0.004128942,0.000119002696,0.0008211581,0.00031384735,0.00061917823,0.00084259943,0.00022017244,0.00087053457,0.0006228114],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010859418,0.000975734,0.09790212,0.0011265025,0.00068839034,0.005915235,0.00045964,0.0036472955,0.0052655055,0.001859145,0.008211261,0.86308974],"study_design_scores_gemma":[0.0025271846,0.034521203,0.7252244,0.0032089492,0.004093861,0.082663774,0.0019119098,0.016725106,0.0111475475,0.0063080783,0.11140696,0.0002610186],"about_ca_topic_score_codex":0.002301254,"about_ca_topic_score_gemma":0.006304203,"teacher_disagreement_score":0.005378986,"about_ca_system_score_codex":0.0008755249,"about_ca_system_score_gemma":0.001331587,"threshold_uncertainty_score":0.017994523},"labels":[],"label_agreement":null},{"id":"W2059953383","doi":"10.1038/sj.pcan.4501010","title":"A genome-wide association screen identifies regions on chromosomes 1q25 and 7p21 as risk loci for sporadic prostate cancer","year":2007,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Health Sciences Centre; Mount Sinai Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Prostate cancer; Single-nucleotide polymorphism; International HapMap Project; SNP array; Cancer; Haplotype; Oncology; Prostate; Biology; Medicine; Genetics; Genotype; Gene","score_opus":0.018147923178076123,"score_gpt":0.3254779086371734,"score_spread":0.3073299854590973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059953383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975382,0.0005334598,0.0005578399,0.0001634957,0.000021346452,0.000017021586,0.00039849346,0.000050939343,0.00071921985],"genre_scores_gemma":[0.9976857,0.00021720205,0.0007465036,0.00006075427,0.000030822932,0.000012281955,0.0004990569,0.000011654767,0.0007360275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994949,0.00011635547,0.000033999866,0.00014487993,0.00013256795,0.00007726252],"domain_scores_gemma":[0.9990226,0.00043664727,0.00018951949,0.000060950904,0.000084138956,0.00020624026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063783344,0.00079375564,0.00054863165,0.0028250834,0.0009482789,0.0006153267,0.0009198091,0.0007551012,0.0031588147],"category_scores_gemma":[0.0020458817,0.00038364422,0.00084934634,0.0014754323,0.00046597378,0.00018477188,0.00052529864,0.00049432466,0.0003394825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065772533,0.00079128233,0.70581883,0.0001880753,0.0024126892,0.009826733,0.0006745231,0.00087098643,0.24089412,0.0006766209,0.0035998332,0.02766896],"study_design_scores_gemma":[0.000367595,0.00086939096,0.9751304,0.000017099146,0.0015695386,0.0071327696,0.00024193882,0.0013210098,0.01041905,0.00037200647,0.0025336433,0.000025545534],"about_ca_topic_score_codex":0.0059714955,"about_ca_topic_score_gemma":0.010227791,"teacher_disagreement_score":0.0059714955,"about_ca_system_score_codex":0.00027627376,"about_ca_system_score_gemma":0.0004805214,"threshold_uncertainty_score":0.011873484},"labels":[],"label_agreement":null},{"id":"W2060432974","doi":"10.1038/pcan.2013.2","title":"Phase III, randomized, placebo-controlled study of once-daily oral zibotentan (ZD4054) in patients with non-metastatic castration-resistant prostate cancer","year":2013,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Nitric Oxide and Endothelin Effects","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"AstraZeneca","keywords":"Medicine; Placebo; Prostate cancer; Hazard ratio; Internal medicine; Interim analysis; Adverse effect; Randomized controlled trial; Confidence interval; Oncology; Cancer; Urology; Pathology","score_opus":0.008647926792209042,"score_gpt":0.2850561213410108,"score_spread":0.2764081945488018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060432974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918813,0.0015451441,0.0006721655,0.0004119404,0.00036147155,0.0028178657,0.0008392151,0.00013801026,0.0013328909],"genre_scores_gemma":[0.9885056,0.0017560463,0.0012670693,0.00084469427,0.00029812753,0.0027087668,0.0011835358,0.00002950683,0.003406599],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996153,0.00015540641,0.000018411554,0.00007187965,0.00003613164,0.000102821155],"domain_scores_gemma":[0.9993036,0.00013591173,0.00011886775,0.000057789923,0.000042439337,0.00034142568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011981084,0.0017360392,0.0036313634,0.00049657666,0.0005773013,0.0010636998,0.0012884414,0.0013301336,0.0061095553],"category_scores_gemma":[0.0010126902,0.00095727795,0.0013547112,0.0005013083,0.001438788,0.0009272171,0.0004003986,0.0032678777,0.0009935034],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96644974,0.014012923,0.0007132305,0.00033465508,0.00071644795,0.000033524473,0.000052723746,0.0003812363,0.0060091172,0.000094636845,0.0005422286,0.010659464],"study_design_scores_gemma":[0.9285086,0.068272494,0.0019412875,0.000007363373,0.00023421166,0.00001966375,0.000021869593,0.00027050052,0.00037448466,0.000053626543,0.00028610002,0.000009886545],"about_ca_topic_score_codex":0.0025668826,"about_ca_topic_score_gemma":0.0049894964,"teacher_disagreement_score":0.0061095553,"about_ca_system_score_codex":0.0009273425,"about_ca_system_score_gemma":0.0016790448,"threshold_uncertainty_score":0.020438552},"labels":[],"label_agreement":null},{"id":"W2066271681","doi":"10.1038/sj.pcan.4500437","title":"Serum and tissue lycopene and biomarkers of oxidation in prostate cancer patients: a case control study","year":2000,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Antioxidant Activity and Oxidative Stress","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Lycopene; Medicine; Prostate cancer; Prostate; Oncology; Internal medicine; Biomarker; Cancer; Urology; Pathology; Carotenoid; Biochemistry","score_opus":0.008382514440925002,"score_gpt":0.2912678996175582,"score_spread":0.2828853851766332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066271681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992718,0.00027346524,0.00011941081,0.000016401184,0.000007667203,0.00002244568,0.000106414016,0.000005152605,0.00017725481],"genre_scores_gemma":[0.9991721,0.00015102376,0.00012652525,0.000025701782,0.000018974273,0.000020767997,0.00017216396,0.0000032508706,0.00030960623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990901,0.0002668873,0.00009274837,0.00026865187,0.00015955228,0.00012196161],"domain_scores_gemma":[0.9987587,0.00034560688,0.00028929347,0.00018134055,0.00014258406,0.00028244837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084313424,0.000892505,0.001343744,0.0016690666,0.0017629158,0.001449168,0.0006978778,0.0013080618,0.002292025],"category_scores_gemma":[0.002176049,0.0014041535,0.0008206853,0.0017970281,0.0009782927,0.0007949224,0.0005582056,0.0012203633,0.0003903574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039807856,0.0011820279,0.9881395,0.000058742346,0.0003522716,0.0010450311,0.0005258303,0.000046673103,0.0028738852,0.000059620652,0.00012557098,0.0016099671],"study_design_scores_gemma":[0.00021774544,0.0020514487,0.9936615,0.0000080807395,0.00033284075,0.0023466325,0.00043835872,0.00023809841,0.00035512642,0.00005084364,0.00028019206,0.000019169029],"about_ca_topic_score_codex":0.0043831295,"about_ca_topic_score_gemma":0.0036440268,"teacher_disagreement_score":0.0043831295,"about_ca_system_score_codex":0.0005242729,"about_ca_system_score_gemma":0.00055252126,"threshold_uncertainty_score":0.008715212},"labels":[],"label_agreement":null},{"id":"W2067439152","doi":"10.1038/sj.pcan.4500967","title":"Androgen receptor CAG repeat length contraction in diseased and non-diseased prostatic tissues","year":2007,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; Hôpital du Sacré-Cœur de Montréal; McGill University Health Centre","funders":"","keywords":"Androgen receptor; Prostate cancer; Prostate; Medicine; Pathology; Pathological; Carcinogenesis; Contraction (grammar); Prostatic Diseases; Internal medicine; Cancer","score_opus":0.013856387851474907,"score_gpt":0.3233200927002464,"score_spread":0.3094637048487715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067439152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992029,0.00019600976,0.00007055793,0.0000074207887,0.0000036481129,0.0000020102016,0.00007330666,0.0000060429225,0.00043812062],"genre_scores_gemma":[0.9990219,0.000070026406,0.000065349326,0.000012803767,0.0000053595923,0.0000028218512,0.00021365515,0.0000044879193,0.0006035436],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998254,0.000032063115,0.000017432447,0.000038152153,0.0000370519,0.000049918915],"domain_scores_gemma":[0.99943215,0.00016808581,0.00008636084,0.000044021854,0.00006302508,0.00020637538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002356172,0.00011167545,0.00023654276,0.0007684474,0.0002673742,0.00030238676,0.00017351088,0.00023304673,0.0021744394],"category_scores_gemma":[0.0005636058,0.00016232046,0.00021492319,0.00031918503,0.00033847647,0.0002190664,0.0002176301,0.00026681574,0.00020601683],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013061737,0.00021413983,0.26998943,0.00011849395,0.00020127898,0.0018025171,0.0007306156,0.00042613258,0.70550275,0.0005044739,0.00029851444,0.00715003],"study_design_scores_gemma":[0.000039075978,0.00085938873,0.96267694,0.0000044193516,0.00006523283,0.0039228885,0.0004788874,0.0009346716,0.029922994,0.00012695172,0.0009536273,0.000014911445],"about_ca_topic_score_codex":0.0020798321,"about_ca_topic_score_gemma":0.0016799835,"teacher_disagreement_score":0.0021744394,"about_ca_system_score_codex":0.0001480704,"about_ca_system_score_gemma":0.00015968186,"threshold_uncertainty_score":0.0072742105},"labels":[],"label_agreement":null},{"id":"W2069245461","doi":"10.1038/sj.pcan.4500988","title":"Randomized trial comparing cryoablation and external beam radiotherapy for T2C-T3B prostate cancer","year":2007,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Cryoablation; Prostate cancer; Randomized controlled trial; External beam radiotherapy; Radiation therapy; Prostate; Brachytherapy; Clinical endpoint; Urology; Perioperative; Surgery; External beam radiation; Internal medicine; Cancer; Oncology","score_opus":0.024035522450967132,"score_gpt":0.33857635746234205,"score_spread":0.3145408350113749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069245461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96415675,0.014453724,0.0021783924,0.0027178058,0.005163914,0.0045165136,0.0018791511,0.00029207196,0.004641678],"genre_scores_gemma":[0.9834812,0.0028436983,0.0017176964,0.0018882044,0.0011796809,0.0029083553,0.0009279671,0.000046668876,0.0050065396],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981987,0.0009978449,0.00013396279,0.0003764382,0.000092735114,0.00020033268],"domain_scores_gemma":[0.9971852,0.0014545801,0.00048954884,0.00023920243,0.00014047578,0.0004909941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026245385,0.0021716913,0.005904292,0.00052744447,0.0007606649,0.0014394089,0.0019077592,0.003333881,0.01668439],"category_scores_gemma":[0.004588899,0.0012962315,0.0041723126,0.00058522273,0.0018311467,0.0016385948,0.0007608123,0.0054635094,0.0018232707],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9959145,0.000647157,0.000095622265,0.00026314604,0.00083639193,0.000008061757,0.000011560297,0.00014884975,0.00022613003,0.00006463688,0.00017522568,0.0016085911],"study_design_scores_gemma":[0.9848103,0.013422955,0.00029928546,0.000028392164,0.0007587417,0.000010360893,0.00001119579,0.00023456731,0.00008422338,0.00014443917,0.0001876059,0.000007973215],"about_ca_topic_score_codex":0.0032255354,"about_ca_topic_score_gemma":0.0040207994,"teacher_disagreement_score":0.01668439,"about_ca_system_score_codex":0.0015476355,"about_ca_system_score_gemma":0.0016804722,"threshold_uncertainty_score":0.055814803},"labels":[],"label_agreement":null},{"id":"W2074007812","doi":"10.1038/sj.pcan.4500458","title":"Sural nerve graft during non-nerve-sparing radical retropubic prostatectomy restores erectile function in patients with locally advanced prostate cancer","year":2000,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Urology; Erectile function; Prostate cancer; Radical retropubic prostatectomy; Nerve sparing; Prostatectomy; Erectile dysfunction; Surgery; Cancer; Internal medicine","score_opus":0.005300858957443372,"score_gpt":0.23560871368050088,"score_spread":0.2303078547230575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074007812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992042,0.00026900382,0.00012007396,0.000020555144,0.000017885104,0.000005086014,0.000012288187,0.0000067636447,0.0003442288],"genre_scores_gemma":[0.9997155,0.000101151316,0.00004477361,0.000009766104,0.000013228114,0.0000018325937,0.000024498935,7.533828e-7,0.00008849591],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9999572,0.000011034509,0.000002967774,0.000005010472,0.000006583158,0.00001715783],"domain_scores_gemma":[0.9999113,0.000020474808,0.000010810746,0.00001034988,0.0000048534075,0.000042148382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011504082,0.00016769911,0.00034920548,0.00009419933,0.00018817383,0.00018817562,0.00014352937,0.00015017182,0.0008672386],"category_scores_gemma":[0.00027557323,0.000042388012,0.0002360361,0.00011426525,0.00018830753,0.0002524576,0.00010143716,0.00028199697,0.00008961428],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.116407156,0.011703542,0.15344219,0.0008818497,0.0011277524,0.017606275,0.0012325941,0.0069298516,0.23645706,0.0007647153,0.0017067059,0.45174032],"study_design_scores_gemma":[0.0027754395,0.098114826,0.84371114,0.000074180956,0.0006474267,0.021354385,0.001149591,0.0052454947,0.023977242,0.00050611893,0.0023958962,0.00004828695],"about_ca_topic_score_codex":0.00064550067,"about_ca_topic_score_gemma":0.0015003635,"teacher_disagreement_score":0.0008672386,"about_ca_system_score_codex":0.000086391985,"about_ca_system_score_gemma":0.00019580104,"threshold_uncertainty_score":0.002901256},"labels":[],"label_agreement":null},{"id":"W2074088397","doi":"10.1038/pcan.2015.8","title":"Multidrug and toxin extrusion 1 and human organic cation transporter 1 polymorphisms in patients with castration-resistant prostate cancer receiving metformin (SAKK 08/09)","year":2015,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Metformin; Medicine; Prostate cancer; Allele; Internal medicine; Pharmacogenetics; Toxicity; Oncology; Cancer; Organic cation transport proteins; Pharmacology; Genotype; Transporter; Genetics; Gene; Biology","score_opus":0.012067715619579167,"score_gpt":0.25405930997923004,"score_spread":0.24199159435965087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074088397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992716,0.00018232991,0.000029517903,0.00006650446,0.000016974293,0.000004078705,0.00014014174,0.0000022254214,0.00028678423],"genre_scores_gemma":[0.9993061,0.00007576819,0.000058501177,0.000046868336,0.000016478461,0.000005139893,0.00017362824,0.000003113171,0.00031434646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997814,0.00004233425,0.000029461597,0.000068127745,0.00003096705,0.00004764659],"domain_scores_gemma":[0.9995484,0.000085345986,0.00018359623,0.000024063349,0.000040503346,0.00011805612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018938648,0.0004162984,0.0004489374,0.00038454332,0.00053711276,0.00056091364,0.0003483365,0.00073637837,0.0027496635],"category_scores_gemma":[0.00083851855,0.00035725796,0.0006624666,0.00073066907,0.00021325528,0.0003026899,0.00023144399,0.0009844013,0.00028992165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023739715,0.00023805599,0.9895745,0.000024696572,0.0002276786,0.0009877974,0.00013882016,0.00008543161,0.0037761314,0.000050387105,0.00023881526,0.0022837545],"study_design_scores_gemma":[0.00008060989,0.000317808,0.99729794,0.000009938469,0.00018848115,0.0011780218,0.0001809067,0.00024601197,0.00018024283,0.000052982854,0.00025449312,0.000012568507],"about_ca_topic_score_codex":0.0043473267,"about_ca_topic_score_gemma":0.005030943,"teacher_disagreement_score":0.0043473267,"about_ca_system_score_codex":0.00026137018,"about_ca_system_score_gemma":0.0003066369,"threshold_uncertainty_score":0.009198487},"labels":[],"label_agreement":null},{"id":"W2076954411","doi":"10.1038/pcan.2012.3","title":"MicroRNAs in prostate cancer: from biomarkers to molecularly-based therapeutics","year":2012,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Sunnybrook Hospital; University of Toronto","funders":"","keywords":"Prostate cancer; microRNA; Medicine; Metastasis; Cancer; Prostate; Biomarker; Bioinformatics; Pathogenesis; Cancer research; Oncology; Computational biology; Internal medicine; Gene; Biology; Genetics","score_opus":0.026646885730918612,"score_gpt":0.32467942795159266,"score_spread":0.29803254222067405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076954411","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000104870014,0.9982492,0.00041274118,0.00038599744,0.0002817927,0.0000037135635,0.000012773942,0.000011361889,0.00053761486],"genre_scores_gemma":[0.0011983815,0.99694,0.0004961815,0.00039734153,0.000385816,0.000010077774,0.00002824229,0.0000031092793,0.00054073473],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99969065,0.00006366271,0.000040539642,0.00005513144,0.00011768688,0.000032264263],"domain_scores_gemma":[0.9994406,0.00033484199,0.00006210912,0.000015036802,0.00009770941,0.000049716353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010742316,0.0012531738,0.0022106953,0.0015423262,0.00029782497,0.0013237131,0.001014499,0.0017245493,0.0019023519],"category_scores_gemma":[0.0012035329,0.0004396675,0.00042807276,0.0018581323,0.0010720019,0.0014935476,0.00096758496,0.0028847766,0.0014419649],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014169239,0.0000865756,0.00020625285,0.006777185,0.0000903227,0.00020586397,0.00004917926,0.00063294114,0.0037725607,0.0057459245,0.028868321,0.9534232],"study_design_scores_gemma":[0.000048710546,0.00014601205,0.0007858778,0.0018058311,0.0001514099,0.001384419,0.0000792722,0.0004064219,0.0019290178,0.0051113665,0.9881066,0.00004510629],"about_ca_topic_score_codex":0.0006732207,"about_ca_topic_score_gemma":0.0014555855,"teacher_disagreement_score":0.0022106953,"about_ca_system_score_codex":0.0007976913,"about_ca_system_score_gemma":0.0011243005,"threshold_uncertainty_score":0.006363988},"labels":[],"label_agreement":null},{"id":"W2077244514","doi":"10.1038/pcan.2014.53","title":"Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel","year":2015,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Docetaxel; Enzalutamide; Medicine; Prostate cancer; Abiraterone; Oncology; Internal medicine; Urology; Cabazitaxel; Context (archaeology); Cancer; Androgen deprivation therapy; Androgen receptor","score_opus":0.034063736327393984,"score_gpt":0.33233267774957,"score_spread":0.29826894142217597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077244514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99531823,0.0032434955,0.000060214705,0.00007788878,0.000015348505,0.000006070581,0.00016989934,0.000016002869,0.0010928856],"genre_scores_gemma":[0.9991171,0.0002965541,0.000031830983,0.000022051538,0.000008674514,0.0000015138501,0.00015735412,0.0000025789946,0.00036247508],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984026,0.00005494861,0.000013807566,0.000022570961,0.000036354922,0.000032070046],"domain_scores_gemma":[0.9995995,0.00011903263,0.00012461159,0.000021936932,0.00001958759,0.000115384464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024436883,0.00022056891,0.00040010517,0.0003075046,0.00014070253,0.00034608447,0.00018865458,0.00023302852,0.0012965476],"category_scores_gemma":[0.0011052149,0.0001552751,0.00034076656,0.0002572852,0.0001701634,0.00018393411,0.00013322843,0.0003709311,0.00020852787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06647054,0.001547124,0.7393957,0.00021857607,0.0012390418,0.0013543052,0.00033226804,0.0015659761,0.08889192,0.00016820886,0.0011391571,0.09767711],"study_design_scores_gemma":[0.00034844186,0.0034208405,0.9907012,0.000010493092,0.00023368016,0.0010214126,0.00005377817,0.00063881406,0.0026920969,0.000055973112,0.0008127657,0.000010561452],"about_ca_topic_score_codex":0.0036565026,"about_ca_topic_score_gemma":0.00612943,"teacher_disagreement_score":0.0036565026,"about_ca_system_score_codex":0.00030169907,"about_ca_system_score_gemma":0.00026844803,"threshold_uncertainty_score":0.0072704554},"labels":[],"label_agreement":null},{"id":"W2077533945","doi":"10.1038/sj.pcan.4500852","title":"Effects of geldanamycin on HIF-1α mediated angiogenesis and invasion in prostate cancer cells","year":2006,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Geldanamycin; Angiogenesis; Prostate cancer; Medicine; Cancer research; Benign prostatic hyperplasia (BPH); Oncology; Cancer; Hsp90; Internal medicine; Biology; Heat shock protein; Biochemistry","score_opus":0.0037896294199983656,"score_gpt":0.22350433310506387,"score_spread":0.21971470368506552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077533945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99122554,0.0045738174,0.0008101012,0.00036453165,0.00009113813,0.000025682088,0.0005652496,0.00012130452,0.002222663],"genre_scores_gemma":[0.9938454,0.0016260184,0.0014202443,0.00009402029,0.000025648793,0.00003849345,0.0008108694,0.000026072737,0.002113262],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997832,0.00008363576,0.000012486547,0.000023565792,0.000027627715,0.000069477996],"domain_scores_gemma":[0.9998361,0.000053787724,0.000016349197,0.000027576343,0.000016191132,0.000049928687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017997994,0.00039480286,0.00046377673,0.00024188367,0.00027477933,0.00018419174,0.0002780148,0.00034318236,0.0012201837],"category_scores_gemma":[0.00016506654,0.00017673688,0.00039910522,0.00023314673,0.00028780522,0.00014466954,0.00019297308,0.00077435316,0.00031826706],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011413319,0.00013241745,0.00019522237,0.000121321915,0.00002419086,0.00015006954,0.000087028115,0.00033112275,0.9952507,0.00016561213,0.00025679928,0.00214423],"study_design_scores_gemma":[0.000055757533,0.00090850395,0.004706241,0.000011023816,0.000020553778,0.00025573626,0.00005126289,0.0008065535,0.9902654,0.00005394206,0.0028533158,0.000011733605],"about_ca_topic_score_codex":0.0033236248,"about_ca_topic_score_gemma":0.00390525,"teacher_disagreement_score":0.0033236248,"about_ca_system_score_codex":0.00043799987,"about_ca_system_score_gemma":0.0003729451,"threshold_uncertainty_score":0.006608546},"labels":[],"label_agreement":null},{"id":"W2081331475","doi":"10.1038/pcan.2008.53","title":"Salvage HIFU for recurrent prostate cancer after radiotherapy","year":2008,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Salvage therapy; Prostatectomy; Prostate cancer; Cryotherapy; Radiation therapy; Surgery; Urology; Radiology; Cancer; Internal medicine; Chemotherapy","score_opus":0.03403857844623547,"score_gpt":0.3671935461100091,"score_spread":0.3331549676637736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081331475","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030331852,0.9985153,0.00016191526,0.000082907005,0.00012733016,0.0000063377756,0.000020574204,0.000007727469,0.00077462476],"genre_scores_gemma":[0.0026660783,0.9955978,0.00021041936,0.00025620186,0.00024465562,0.000013932781,0.00006622743,0.0000035927321,0.00094119314],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989927,0.000021393284,0.000018921251,0.000022708404,0.000027199509,0.000010454571],"domain_scores_gemma":[0.9997986,0.000114090864,0.000050616025,0.00000698706,0.000016370504,0.000013374296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037120137,0.0006897424,0.0018390311,0.0013368331,0.00021488406,0.00047018935,0.0008313428,0.0005932845,0.005289494],"category_scores_gemma":[0.0006399177,0.00022915796,0.000667734,0.0010612978,0.0002772612,0.00071302336,0.00043861885,0.0008856383,0.0013206701],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012671176,0.000046128596,0.00012500225,0.014217637,0.00017992531,0.00020181086,0.000026366859,0.00034701297,0.00070511166,0.00031473942,0.012178444,0.97153115],"study_design_scores_gemma":[0.00026325378,0.000844943,0.0040877555,0.01181229,0.0013164629,0.010378748,0.0000956306,0.00037381952,0.0024075431,0.0012902796,0.9670715,0.000057789326],"about_ca_topic_score_codex":0.0007525503,"about_ca_topic_score_gemma":0.001922115,"teacher_disagreement_score":0.005289494,"about_ca_system_score_codex":0.0003664463,"about_ca_system_score_gemma":0.00047094518,"threshold_uncertainty_score":0.017695129},"labels":[],"label_agreement":null},{"id":"W2082705146","doi":"10.1038/pcan.2014.20","title":"A pilot ‘window of opportunity’ neoadjuvant study of metformin in localised prostate cancer","year":2014,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; University Health Network; Princess Margaret Cancer Centre","funders":"Fondation de l'Hôpital général juif","keywords":"Medicine; Metformin; Prostate cancer; Prostatectomy; Internal medicine; Urology; Prostate; Cancer; Oncology; Insulin","score_opus":0.01612543437376494,"score_gpt":0.2819140811216804,"score_spread":0.26578864674791547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082705146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968573,0.00047457128,0.00029079622,0.00036143442,0.00017400009,0.0006746649,0.00026140793,0.000026433487,0.00087936973],"genre_scores_gemma":[0.994544,0.0005876528,0.0007692957,0.0005672306,0.00041436087,0.001235078,0.000641321,0.000025395633,0.0012155293],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99900407,0.0005004661,0.000046774076,0.0001152246,0.00004012843,0.0002933708],"domain_scores_gemma":[0.99848783,0.00029835786,0.0001244062,0.00018477785,0.000051341496,0.0008532983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00159799,0.0012760377,0.002452006,0.0003949211,0.00089744705,0.0012341617,0.0008070151,0.0016734615,0.0047789197],"category_scores_gemma":[0.0013942948,0.00068730366,0.0019056585,0.00064149185,0.0017540775,0.0016821504,0.00084559753,0.0040841154,0.0007477333],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89770186,0.05855762,0.0032948565,0.0001839075,0.00045455663,0.00045911415,0.00020729046,0.00083183846,0.017814523,0.00016072855,0.00076278264,0.019570917],"study_design_scores_gemma":[0.13487913,0.8473047,0.012848966,0.000023647257,0.00030934007,0.00021638413,0.00014581782,0.000382961,0.002155016,0.00020073463,0.0014773533,0.000055999775],"about_ca_topic_score_codex":0.0028345224,"about_ca_topic_score_gemma":0.0045668767,"teacher_disagreement_score":0.0047789197,"about_ca_system_score_codex":0.0010990482,"about_ca_system_score_gemma":0.0018074741,"threshold_uncertainty_score":0.015987098},"labels":[],"label_agreement":null},{"id":"W2084761829","doi":"10.1038/pcan.2013.14","title":"The influence of growth hormone/insulin-like growth factor deficiency on prostatic dysplasia in pbARR2-Cre, PTEN knockout mice","year":2013,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of British Columbia; Vancouver General Hospital","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"PTEN; Tensin; Prostate cancer; Endocrinology; Internal medicine; Prostate; Dysplasia; Biology; Insulin-like growth factor; Protein kinase B; Cancer research; Growth factor; Medicine; PI3K/AKT/mTOR pathway; Cancer; Signal transduction","score_opus":0.008128152773860116,"score_gpt":0.24397842424241742,"score_spread":0.2358502714685573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084761829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890191,0.0016000782,0.0033417356,0.00036967706,0.00008069305,0.00005943977,0.0012877532,0.0003147577,0.0039268113],"genre_scores_gemma":[0.9851099,0.0013452218,0.002279853,0.00015409273,0.000022918985,0.00007633347,0.0007668279,0.0002053797,0.010039446],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993961,0.00008680277,0.00005373253,0.00013187285,0.00019694997,0.00013460671],"domain_scores_gemma":[0.9993135,0.00007740328,0.00017994142,0.000050070106,0.000031094987,0.0003481351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000304379,0.00072390283,0.00043606246,0.0015914964,0.0004366321,0.0007644493,0.0005034028,0.0006533761,0.0035388982],"category_scores_gemma":[0.00031015155,0.00068242353,0.0005889522,0.00047685645,0.00082225393,0.00053027115,0.0006251616,0.0013390675,0.00050372217],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050170114,0.00005245137,0.00028864216,0.000031699885,0.000011578943,0.00021949757,0.00002566026,0.000078450714,0.99773204,0.000251071,0.00005272168,0.0007544898],"study_design_scores_gemma":[0.00007477522,0.00038852423,0.007375842,0.000013495405,0.0000635578,0.00084587466,0.00011511599,0.000626578,0.9879673,0.00015944548,0.0023536193,0.00001579605],"about_ca_topic_score_codex":0.002073868,"about_ca_topic_score_gemma":0.004136727,"teacher_disagreement_score":0.0035388982,"about_ca_system_score_codex":0.00039011767,"about_ca_system_score_gemma":0.00062664703,"threshold_uncertainty_score":0.011838794},"labels":[],"label_agreement":null},{"id":"W2085683046","doi":"10.1038/pcan.2010.36","title":"Relationship between initial PSA density with future PSA kinetics and repeat biopsies in men with prostate cancer on active surveillance","year":2010,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Prostate cancer; Prostate-specific antigen; Benign prostatic hyperplasia (BPH); Urology; Oncology; Internal medicine; Cancer","score_opus":0.015854379580131656,"score_gpt":0.2933177365647662,"score_spread":0.27746335698463453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085683046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99913436,0.00053083786,0.00006623843,0.000018875753,0.0000029692458,0.0000030456108,0.000046950467,0.0000029265452,0.00019386555],"genre_scores_gemma":[0.9997447,0.00007165261,0.00004388001,0.0000059128347,0.0000060107386,0.0000016077863,0.000067452005,7.78699e-7,0.00005800226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997137,0.00009587352,0.00002531751,0.000049444356,0.00007459967,0.000041106017],"domain_scores_gemma":[0.99735487,0.0010004622,0.00094185217,0.00011923427,0.00023385623,0.0003496948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060560834,0.00019533692,0.00031932048,0.0005869581,0.00026913945,0.0005000996,0.00024979634,0.00038222177,0.00078399666],"category_scores_gemma":[0.0051257373,0.00022040894,0.00023678242,0.00056078774,0.00026174024,0.00036817434,0.0002845212,0.0005463577,0.0001436345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011832032,0.000016114514,0.99857366,0.0000035206986,0.000012638033,0.00003945856,0.000027986982,0.00004731619,0.00009130799,0.00000490665,0.000015689813,0.0010491317],"study_design_scores_gemma":[0.000005893893,0.00024033121,0.9986656,0.000002843704,0.000016219055,0.00051922014,0.0000646918,0.00030244092,0.00007649019,0.000014914728,0.00008839883,0.0000029739272],"about_ca_topic_score_codex":0.002916202,"about_ca_topic_score_gemma":0.0029484495,"teacher_disagreement_score":0.002916202,"about_ca_system_score_codex":0.00024442383,"about_ca_system_score_gemma":0.00022598641,"threshold_uncertainty_score":0.005798459},"labels":[],"label_agreement":null},{"id":"W2086011885","doi":"10.1038/pcan.2014.48","title":"Diagnostic prostate biopsy performed in a non-academic center increases the risk of re-classification at confirmatory biopsy for men considering active surveillance for prostate cancer","year":2014,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Prostate cancer; Confidence interval; Odds ratio; Biopsy; Internal medicine; Logistic regression; Multivariate analysis; Prostate biopsy; Urology; Cancer; Gastroenterology","score_opus":0.01955615925783065,"score_gpt":0.3014110646465736,"score_spread":0.2818549053887429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086011885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98533696,0.0058535147,0.0005579667,0.0017420198,0.00021473719,0.000027600885,0.00041628326,0.000053207932,0.005797738],"genre_scores_gemma":[0.99799275,0.00068393984,0.00036179952,0.0003104443,0.00013365089,0.000003011935,0.00019796751,0.000011226677,0.0003052928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821776,0.00062301196,0.00013921641,0.00019729398,0.00052425603,0.00029843705],"domain_scores_gemma":[0.989087,0.0033666398,0.004255535,0.000666275,0.0010857012,0.0015387868],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0012416099,0.0003855417,0.00058521575,0.0011883717,0.0013068408,0.0014546008,0.001093991,0.0011772582,0.006745517],"category_scores_gemma":[0.015089654,0.0003754996,0.0010513108,0.0013202903,0.00042969422,0.0008245462,0.00059641834,0.001972407,0.0004661037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003422481,0.00008429675,0.9903869,0.000038331702,0.00011806151,0.00034773056,0.00005873059,0.000072769166,0.00026349304,0.0000640723,0.00074669824,0.0074765477],"study_design_scores_gemma":[0.000018366678,0.00017591793,0.9924845,0.00011087442,0.00022479957,0.0038684679,0.0006519752,0.0008537476,0.00032209774,0.00022969268,0.0010407928,0.000018626899],"about_ca_topic_score_codex":0.014420474,"about_ca_topic_score_gemma":0.02757733,"teacher_disagreement_score":0.9987584,"about_ca_system_score_codex":0.0007110921,"about_ca_system_score_gemma":0.0014986863,"threshold_uncertainty_score":0.028673112},"labels":[],"label_agreement":null},{"id":"W2091226970","doi":"10.1038/pcan.2013.1","title":"Measuring symptoms in localized prostate cancer: a systematic review of assessment instruments","year":2013,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Prostate cancer; Medicine; Quality of life (healthcare); Medical physics; Prostate; Cancer; Internal medicine","score_opus":0.04086769189593535,"score_gpt":0.3569626694149249,"score_spread":0.3160949775189895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091226970","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008874302,0.9983506,0.00011278106,0.000074316435,0.00004655299,0.00014205613,0.0002729959,0.0000041392586,0.00010914958],"genre_scores_gemma":[0.013451287,0.9847825,0.0009259696,0.00030112217,0.000037082395,0.00022603372,0.00021355957,0.0000040797186,0.000058331345],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9935933,0.0020624644,0.002513043,0.000640627,0.0010397565,0.0001508575],"domain_scores_gemma":[0.9827366,0.012915609,0.0029384033,0.00022538823,0.001019687,0.00016439948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007964379,0.0016296648,0.009764211,0.00521359,0.00053009985,0.001988549,0.0020300972,0.0014325189,0.0029163016],"category_scores_gemma":[0.030700447,0.0010032835,0.010735258,0.0081472695,0.00091930135,0.0019803077,0.0018239964,0.0015521434,0.0001931406],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037133772,0.000029150146,0.0020423662,0.90404165,0.028458035,0.000051146733,0.00018286225,0.00015960544,0.000112926646,0.00015743788,0.001321482,0.06307191],"study_design_scores_gemma":[0.0013098078,0.00044413598,0.022318617,0.6147415,0.33666375,0.0004810923,0.00055356097,0.00023048681,0.0002707536,0.0005765584,0.02225912,0.00015054553],"about_ca_topic_score_codex":0.012010983,"about_ca_topic_score_gemma":0.039170623,"teacher_disagreement_score":0.012010983,"about_ca_system_score_codex":0.002387851,"about_ca_system_score_gemma":0.006792006,"threshold_uncertainty_score":0.04212016},"labels":[],"label_agreement":null},{"id":"W2095148489","doi":"10.1038/sj.pcan.4500707","title":"Synergistic effect of vitamin E and selenium in human prostate cancer cell lines","year":2004,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Antioxidant Activity and Oxidative Stress","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"LNCaP; Prostate cancer; Vitamin E; Selenium; Medicine; Antioxidant; Cancer; Cancer research; Pharmacology; Internal medicine; Oncology; Biology; Biochemistry; Chemistry","score_opus":0.007647331829436479,"score_gpt":0.29092326831940457,"score_spread":0.28327593648996807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095148489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98841864,0.0072181122,0.0013677487,0.00022896646,0.00012433302,0.00006240968,0.00070947927,0.00007746651,0.0017929295],"genre_scores_gemma":[0.98543614,0.004563141,0.002225963,0.000106627165,0.00003819021,0.000089878435,0.0022535997,0.00002015429,0.0052662874],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994248,0.00021425623,0.000085269545,0.00006212615,0.00011478026,0.00009873364],"domain_scores_gemma":[0.99950457,0.00024022226,0.000031181593,0.00007694824,0.000087281645,0.000059740247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006882213,0.0005125898,0.0009788385,0.00080225634,0.00039320503,0.000572273,0.00043274823,0.0005560163,0.0025015874],"category_scores_gemma":[0.00040119045,0.00037553595,0.00084020814,0.0007298681,0.00030071582,0.0004135165,0.00043426544,0.00081852765,0.0004499309],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043429527,0.0005405443,0.0014604945,0.00029678777,0.00013519054,0.00032478158,0.00023057472,0.00022751515,0.98694396,0.00022005138,0.00032039097,0.0049567716],"study_design_scores_gemma":[0.00017385003,0.0038939929,0.005537112,0.000022284403,0.00016499269,0.00039661588,0.00018805561,0.00049886,0.98525226,0.00006685184,0.0037889066,0.00001632979],"about_ca_topic_score_codex":0.0023592005,"about_ca_topic_score_gemma":0.0048882603,"teacher_disagreement_score":0.0025015874,"about_ca_system_score_codex":0.0002548725,"about_ca_system_score_gemma":0.0005082604,"threshold_uncertainty_score":0.008368611},"labels":[],"label_agreement":null},{"id":"W2097508750","doi":"10.1038/pcan.2013.31","title":"Impact of statin use on biochemical recurrence in patients treated with radical prostatectomy","year":2013,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Biochemical recurrence; Statin; Hazard ratio; Prostatectomy; Interquartile range; Prostate cancer; Urology; Proportional hazards model; Internal medicine; Confidence interval; Surgery; Cancer","score_opus":0.006892572276219289,"score_gpt":0.2572155209166899,"score_spread":0.2503229486404706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097508750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99658066,0.0018120741,0.000033007465,0.00029398565,0.000041253,0.0000054394864,0.00032753334,0.000004513322,0.0009015968],"genre_scores_gemma":[0.99900347,0.00037354312,0.000021512154,0.0000632999,0.000043678363,0.000002260031,0.00022396349,0.0000017722494,0.0002664964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999574,0.00012134483,0.000047768677,0.000058472953,0.00007289392,0.0001255103],"domain_scores_gemma":[0.9987472,0.00027866248,0.00041407417,0.00007236393,0.000092185255,0.0003955359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003455647,0.00020539078,0.00063896365,0.00040718846,0.0005398384,0.0007944544,0.00039212606,0.0007421806,0.0021608502],"category_scores_gemma":[0.002631604,0.0002543879,0.0015704759,0.00084673637,0.00022317386,0.00047060812,0.0005286991,0.0011576705,0.00018444449],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015075098,0.00008537431,0.99529546,0.000017829318,0.00031566474,0.00010260739,0.000032499232,0.00006471929,0.00015960552,0.000020419066,0.00009703274,0.0023012925],"study_design_scores_gemma":[0.000022912418,0.00014661506,0.9991904,0.00000630721,0.00019062596,0.00007958774,0.000080810845,0.00013114294,0.000026214258,0.000022000115,0.00009751954,0.000005878977],"about_ca_topic_score_codex":0.015931183,"about_ca_topic_score_gemma":0.026159609,"teacher_disagreement_score":0.015931183,"about_ca_system_score_codex":0.0004698777,"about_ca_system_score_gemma":0.0010424366,"threshold_uncertainty_score":0.031676948},"labels":[],"label_agreement":null},{"id":"W2103449692","doi":"10.1038/sj.pcan.4500674","title":"Immunohistochemical localization of human kallikreins 6, 10 and 13 in benign and malignant prostatic tissues","year":2003,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"National Cancer Institute; Natural Sciences and Engineering Research Council of Canada","keywords":"Medicine; Prostatectomy; Immunohistochemistry; Prostate cancer; Pathology; Immunostaining; Kallikrein; Intraepithelial neoplasia; Prostate; Cancer; High-grade prostatic intraepithelial neoplasia; PCA3; Internal medicine; Biology","score_opus":0.016526133277327156,"score_gpt":0.32448141718630363,"score_spread":0.3079552839089765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103449692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98394,0.006755552,0.0033600344,0.000105724546,0.000052422365,0.00002882888,0.00019677303,0.000086788095,0.0054738135],"genre_scores_gemma":[0.98982775,0.0021738776,0.0035144866,0.000039955634,0.00004221005,0.000034144814,0.00040991406,0.000017619646,0.003939935],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997441,0.000046805424,0.000034231372,0.00004298,0.000051473744,0.000080422054],"domain_scores_gemma":[0.99969864,0.00009291061,0.000046245317,0.000028707278,0.000053406966,0.00008017985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042519698,0.00024968252,0.00025758488,0.001040717,0.00049998524,0.00032778925,0.00039447125,0.00034262906,0.0024299014],"category_scores_gemma":[0.00039880344,0.00027394202,0.00034492766,0.00050124835,0.0005588175,0.0004987222,0.00036285564,0.0003446698,0.00058060256],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016563855,0.000080682024,0.014772266,0.00027714315,0.00007680868,0.0016414276,0.00022183526,0.000119773234,0.97328544,0.0008921743,0.00019931016,0.0067767976],"study_design_scores_gemma":[0.00016361654,0.00152994,0.25296456,0.000055850327,0.0004101859,0.020899985,0.0010650454,0.002246667,0.70299846,0.0014999036,0.016112274,0.000053509757],"about_ca_topic_score_codex":0.0009106407,"about_ca_topic_score_gemma":0.0010040527,"teacher_disagreement_score":0.0024299014,"about_ca_system_score_codex":0.00022230843,"about_ca_system_score_gemma":0.00026908686,"threshold_uncertainty_score":0.008128822},"labels":[],"label_agreement":null},{"id":"W2140315940","doi":"10.1038/pcan.2011.53","title":"Adiponectin inhibits oxidative stress in human prostate carcinoma cells","year":2012,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"Prostate Cancer Foundation","keywords":"Adiponectin; Medicine; Oxidative stress; Prostate cancer; Prostate carcinoma; Prostate; Internal medicine; Oncology; Cancer research; Carcinoma; Endocrinology; Cancer; Obesity; Insulin resistance","score_opus":0.01485088986799966,"score_gpt":0.283794377701279,"score_spread":0.26894348783327937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140315940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982133,0.010792186,0.0014580695,0.0006734048,0.00045368253,0.00006309318,0.0007885501,0.00010779564,0.0035301626],"genre_scores_gemma":[0.98588747,0.00592859,0.0009549667,0.00026708032,0.000079913094,0.000042565516,0.0012038592,0.000018862214,0.0056166346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996119,0.00012231052,0.000046160676,0.000040676867,0.00006979719,0.00010920934],"domain_scores_gemma":[0.9997818,0.00007465607,0.000025082149,0.000044549084,0.000028567127,0.000045438177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044660238,0.00041229455,0.000533082,0.0004490977,0.00036673548,0.00056550116,0.00037530638,0.0002395016,0.0033258796],"category_scores_gemma":[0.00025877284,0.0002700921,0.00055106235,0.0006490082,0.00028926428,0.00023847212,0.00036580584,0.0014491183,0.00048483568],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049336683,0.001444672,0.0012796492,0.00046233097,0.00012424277,0.00033224252,0.0003378467,0.00046167293,0.9737803,0.0005264637,0.0013736901,0.014943296],"study_design_scores_gemma":[0.0008442398,0.008660169,0.022648562,0.00007154022,0.00022566725,0.0004887022,0.0006406075,0.0025044386,0.94977903,0.0002992221,0.01380485,0.00003299207],"about_ca_topic_score_codex":0.0027693203,"about_ca_topic_score_gemma":0.0044238605,"teacher_disagreement_score":0.0033258796,"about_ca_system_score_codex":0.00025539062,"about_ca_system_score_gemma":0.0005326645,"threshold_uncertainty_score":0.011126161},"labels":[],"label_agreement":null},{"id":"W2153460792","doi":"10.1038/sj.pcan.4500982","title":"Adjuvant androgen deprivation therapy augments cure and long-term cancer control in men with poor prognosis, nonmetastatic prostate cancer","year":2007,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Medicine; Prostate cancer; Oncology; Androgen deprivation therapy; Goserelin; Internal medicine; Prostatectomy; Cancer; Population; Hormonal therapy; Adjuvant therapy; Adjuvant","score_opus":0.043354475830214054,"score_gpt":0.38166789010624,"score_spread":0.33831341427602596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153460792","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004778414,0.99902534,0.00003372615,0.00006724905,0.000057781217,0.000006231563,0.000026004076,0.000002826537,0.00030307143],"genre_scores_gemma":[0.0036153493,0.9956678,0.00011493983,0.00017663625,0.00006986822,0.000008723026,0.000047818234,9.36482e-7,0.0002979303],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998872,0.000024487983,0.000025577549,0.000017652486,0.000035336252,0.000009762976],"domain_scores_gemma":[0.9997639,0.00014155783,0.000053222066,0.000004305451,0.000025794006,0.00001123031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040050552,0.00047742293,0.00196084,0.0007857031,0.00010534646,0.0003603347,0.00060630706,0.00040008954,0.0029721246],"category_scores_gemma":[0.0006594741,0.00017409008,0.0007018834,0.001011874,0.00014861881,0.0003380584,0.0002164807,0.00073925976,0.00041952514],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070223643,0.00009214574,0.0005546145,0.044088487,0.00075139164,0.0001375539,0.000032188214,0.0002478146,0.00087952754,0.00037450515,0.010952539,0.9411869],"study_design_scores_gemma":[0.0023458016,0.00252098,0.024199791,0.029463913,0.010616187,0.0041506044,0.00018748103,0.0005085339,0.0016048993,0.0015701876,0.92276263,0.00006907402],"about_ca_topic_score_codex":0.0015352294,"about_ca_topic_score_gemma":0.00648136,"teacher_disagreement_score":0.0029721246,"about_ca_system_score_codex":0.00032369714,"about_ca_system_score_gemma":0.00061754015,"threshold_uncertainty_score":0.00994277},"labels":[],"label_agreement":null},{"id":"W2160890865","doi":"10.1038/pcan.2009.30","title":"Awareness of prostate cancer among patients and the general public: results of an international survey","year":2009,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Prostate cancer; Family medicine; Sample (material); Public health; Telephone survey; Demography; Gerontology; Environmental health; Gynecology; Cancer; Internal medicine; Pathology; Advertising","score_opus":0.022705369155415222,"score_gpt":0.3186575450526654,"score_spread":0.2959521758972502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160890865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99648225,0.00055075967,0.00010875141,0.00036570706,0.00001440283,0.000028122618,0.0005461068,0.00000888192,0.0018948963],"genre_scores_gemma":[0.9988164,0.00030196406,0.000065110464,0.00026575368,0.0000140383,0.000019577805,0.00033644287,0.0000022244378,0.00017864606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986798,0.0005511066,0.00017390843,0.00013392746,0.0002466368,0.00021455805],"domain_scores_gemma":[0.9935735,0.0015916211,0.0023538948,0.00025362492,0.0010392028,0.00118809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017767155,0.00021604045,0.00035793486,0.00096784363,0.00036517205,0.0008124301,0.000321584,0.00072080333,0.0012247575],"category_scores_gemma":[0.0059737517,0.00025687463,0.00044541177,0.0012438685,0.00041158238,0.00089121505,0.00066102523,0.0008366139,0.00031078648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053140495,0.00006400865,0.99486625,0.000031837884,0.000033634402,0.000038719936,0.0011108349,0.000022825468,0.0000701773,0.000009975827,0.0003399709,0.003358695],"study_design_scores_gemma":[0.000005374533,0.00013269478,0.99723995,0.000014917916,0.0000167042,0.000107154134,0.001962502,0.000051761683,0.000027385675,0.0000059775125,0.00043038707,0.000005223264],"about_ca_topic_score_codex":0.009153767,"about_ca_topic_score_gemma":0.0060510575,"teacher_disagreement_score":0.009153767,"about_ca_system_score_codex":0.00038051666,"about_ca_system_score_gemma":0.00035652696,"threshold_uncertainty_score":0.018200934},"labels":[],"label_agreement":null},{"id":"W2163752799","doi":"10.1038/pcan.2008.42","title":"Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes","year":2008,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":199,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Interstitial cystitis; Medicine; Prostatitis; Pelvic pain; Etiology; Urinary system; Chronic pain; Chronic prostatitis/chronic pelvic pain syndrome; Psychosocial; Multimodal therapy; Urology; Physical therapy; Internal medicine; Prostate; Surgery","score_opus":0.04596255791948079,"score_gpt":0.35272672319280984,"score_spread":0.30676416527332906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163752799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9398304,0.014021724,0.0141221,0.015487247,0.0006768908,0.00050016906,0.00056746515,0.0001868384,0.014607147],"genre_scores_gemma":[0.98482174,0.0029717335,0.0087440405,0.0016129522,0.0005941472,0.00014413838,0.00031454448,0.000024926654,0.0007718009],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990947,0.00043479056,0.00015994684,0.000079917576,0.0001499511,0.0000806323],"domain_scores_gemma":[0.9981895,0.0006406959,0.0003162416,0.000054495227,0.0004948731,0.0003041022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001480719,0.00070968224,0.0008614242,0.0017682693,0.0008292201,0.0007673344,0.00047392974,0.0005789862,0.0010955438],"category_scores_gemma":[0.0058483332,0.0001639239,0.0002750013,0.0009191359,0.00030143373,0.00074168114,0.0006483359,0.00072985206,0.00028355364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072583643,0.00023287903,0.90739566,0.00016771312,0.000047159894,0.0056550605,0.00029967807,0.0005859103,0.003998881,0.0005224737,0.004874902,0.075493895],"study_design_scores_gemma":[0.00013110458,0.0008687855,0.9499619,0.00035641677,0.00018288234,0.027663186,0.0022331916,0.007331252,0.0021546471,0.0021214772,0.0069443244,0.000050811333],"about_ca_topic_score_codex":0.0014787904,"about_ca_topic_score_gemma":0.0025098321,"teacher_disagreement_score":0.0017682693,"about_ca_system_score_codex":0.00033469475,"about_ca_system_score_gemma":0.0008794239,"threshold_uncertainty_score":0.007830858},"labels":[],"label_agreement":null},{"id":"W21826098","doi":"10.1038/pcan.2011.34","title":"PENGEMBANGAN BAHAN AJAR MATA KULIAH STUKTUR DATABERBASIS WEB","year":2008,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Decision Support System Applications","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"The Internet; World Wide Web; Computer science","score_opus":0.030676272073444675,"score_gpt":0.26821668796480846,"score_spread":0.2375404158913638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W21826098","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21148124,0.030776268,0.08828941,0.014838275,0.0026631986,0.0004965387,0.017061852,0.039079685,0.5953135],"genre_scores_gemma":[0.56283814,0.019060297,0.10718229,0.0012436984,0.0008465746,0.00033273967,0.022750273,0.004090538,0.2816555],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99920195,0.000125108,0.000093496,0.00013442537,0.00031597752,0.00012899296],"domain_scores_gemma":[0.99824166,0.0005437216,0.00014094682,0.00026911168,0.00061440485,0.00019023712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010859241,0.00061050185,0.00051388034,0.0020622704,0.001104857,0.0053875227,0.00054337876,0.0007072608,0.038259447],"category_scores_gemma":[0.0025138513,0.0003915439,0.00032950056,0.0024283181,0.0005362181,0.0051225866,0.001634745,0.00086106843,0.022803737],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008124085,0.0003631542,0.007671693,0.001220342,0.0000627472,0.0023611803,0.0016789229,0.0010318529,0.016227137,0.016486777,0.086845,0.86523885],"study_design_scores_gemma":[0.00006035165,0.00013064708,0.010423297,0.00035937148,0.00009913923,0.002725882,0.0019006933,0.004158059,0.021250196,0.007373194,0.951411,0.00010823732],"about_ca_topic_score_codex":0.0049083536,"about_ca_topic_score_gemma":0.0046614106,"teacher_disagreement_score":0.038259447,"about_ca_system_score_codex":0.00061186665,"about_ca_system_score_gemma":0.0014707623,"threshold_uncertainty_score":0.1279906},"labels":[],"label_agreement":null},{"id":"W2266348975","doi":"10.1038/pcan.2015.60","title":"The prognostic role of preoperative serum C-reactive protein in predicting the biochemical recurrence in patients treated with radical prostatectomy","year":2016,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"OeAD-GmbH","keywords":"Medicine; Biochemical recurrence; Prostatectomy; C-reactive protein; Prostate cancer; Nomogram; Pathological; Proportional hazards model; Internal medicine; breakpoint cluster region; Urology; Stage (stratigraphy); Gastroenterology; Cancer; Oncology; Inflammation","score_opus":0.0046435328983497354,"score_gpt":0.23208314376422126,"score_spread":0.22743961086587153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2266348975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99742573,0.001855376,0.00009673226,0.00016463565,0.000041254916,0.0000036255005,0.000070632006,0.0000044231097,0.00033739672],"genre_scores_gemma":[0.9995334,0.00020201103,0.00005070671,0.000027560292,0.00004717819,0.000001697384,0.00007143192,0.0000010447592,0.000064899476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996779,0.000114108545,0.000037751248,0.00003453825,0.000060962797,0.00007463956],"domain_scores_gemma":[0.9985436,0.0005688061,0.00032588711,0.00007378641,0.00011530535,0.00037252807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005995067,0.00030321904,0.00046418674,0.00062354037,0.00038130028,0.0006410558,0.0003604189,0.000589783,0.00083496334],"category_scores_gemma":[0.0033261725,0.0002286575,0.000530139,0.00071013416,0.00041009646,0.0004357944,0.00031901404,0.00086168764,0.00011249039],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041143343,0.000034375353,0.99697185,0.00001034977,0.00006560504,0.00008581869,0.000026540298,0.00008359263,0.00017173849,0.00001227105,0.00006628311,0.002060167],"study_design_scores_gemma":[0.000019464724,0.00022557855,0.9979298,0.000008436794,0.00015138766,0.00035664698,0.00013435655,0.0008354442,0.00011412996,0.000050743052,0.00016519017,0.000008768496],"about_ca_topic_score_codex":0.0027374718,"about_ca_topic_score_gemma":0.0038133545,"teacher_disagreement_score":0.0027374718,"about_ca_system_score_codex":0.00026846415,"about_ca_system_score_gemma":0.00073351833,"threshold_uncertainty_score":0.0054430366},"labels":[],"label_agreement":null},{"id":"W2336722738","doi":"10.1038/pcan.2015.66","title":"Greater extent of prostate inflammation in negative biopsies is associated with lower risk of prostate cancer on repeat biopsy: results from the REDUCE study","year":2016,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Prostate cancer; Prostate; Prostate biopsy; Biopsy; Prostatitis; PCA3; Oncology; Internal medicine; Prostatic Diseases; Inflammation; Prostate Diseases; Cancer; Urology; Pathology","score_opus":0.017628400332588785,"score_gpt":0.2811335083577889,"score_spread":0.2635051080252001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336722738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973373,0.00089809875,0.000112719674,0.00009549331,0.000028920605,0.00001862396,0.00061298045,0.00001052337,0.000885404],"genre_scores_gemma":[0.9984516,0.0002897533,0.00013494676,0.00006559835,0.000057860598,0.000012396308,0.00052720576,0.000008234177,0.00045243578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915206,0.00035925154,0.00004748513,0.00017340026,0.00017353527,0.00009424068],"domain_scores_gemma":[0.9980465,0.0004399448,0.0007702459,0.00028526262,0.00016968955,0.00028835778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012053411,0.0008040376,0.0010569511,0.00054896664,0.00047873083,0.0009148921,0.00065590825,0.00081004645,0.0014455823],"category_scores_gemma":[0.0029089237,0.0008179149,0.0022515997,0.0007935994,0.0004763242,0.0004988601,0.00082426536,0.0012968255,0.00022579063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062743733,0.00035817918,0.9850316,0.000101801765,0.0033081933,0.00010007257,0.00018707092,0.00009654947,0.0011349174,0.00005661843,0.00049837097,0.0028522462],"study_design_scores_gemma":[0.00014770337,0.00040597594,0.99753726,0.000006504777,0.0012016936,0.00011707857,0.00008506679,0.00007162776,0.00009375516,0.00004237216,0.00028141963,0.000009469198],"about_ca_topic_score_codex":0.007156251,"about_ca_topic_score_gemma":0.009988931,"teacher_disagreement_score":0.007156251,"about_ca_system_score_codex":0.00022581968,"about_ca_system_score_gemma":0.00032179285,"threshold_uncertainty_score":0.014229178},"labels":[],"label_agreement":null},{"id":"W2345560358","doi":"10.1038/pcan.2016.15","title":"Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk","year":2016,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"National Cancer Institute; Rutgers Cancer Institute of New Jersey; U.S. Department of Defense","keywords":"Medicine; Prostatectomy; Prostate cancer; Hazard ratio; Confidence interval; Internal medicine; Oncology; Proportional hazards model; Retrospective cohort study; Radiation therapy; Brachytherapy; Urology; Cancer","score_opus":0.022355774218737242,"score_gpt":0.3515906131877919,"score_spread":0.32923483896905464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345560358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984212,0.00093300914,0.00010975166,0.000040958825,0.000010439355,0.000009861112,0.00025909618,0.00000464984,0.00021100401],"genre_scores_gemma":[0.99939203,0.00014849243,0.000052004747,0.00001937609,0.000017987602,0.00000947196,0.00029416705,0.0000020326418,0.00006437678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909794,0.00035762077,0.000059797836,0.00027815698,0.00010610013,0.00010037478],"domain_scores_gemma":[0.99557185,0.0020975373,0.0011905483,0.00048347373,0.00014085275,0.00051569275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023489213,0.00027528175,0.0006551329,0.0004609725,0.00023374036,0.000621397,0.00047375198,0.00046540244,0.0014198391],"category_scores_gemma":[0.0045558843,0.00020327419,0.0014640397,0.00039128755,0.0003875358,0.00035655874,0.00035022516,0.00063481514,0.00013979115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011665101,0.00022105552,0.97983986,0.000047761587,0.001352516,0.00010754867,0.00004845306,0.0003564018,0.00071645627,0.000033729175,0.00016777834,0.0054433774],"study_design_scores_gemma":[0.0001794608,0.0035838888,0.9941041,0.00001013428,0.0007904201,0.000302478,0.000043031177,0.00047586786,0.00025123224,0.000053534728,0.00019598873,0.000009957601],"about_ca_topic_score_codex":0.0011328927,"about_ca_topic_score_gemma":0.0010733452,"teacher_disagreement_score":0.0023489213,"about_ca_system_score_codex":0.0002587563,"about_ca_system_score_gemma":0.0004269777,"threshold_uncertainty_score":0.012422383},"labels":[],"label_agreement":null},{"id":"W2346720680","doi":"10.1038/pcan.2016.12","title":"Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomies","year":2016,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Canary Foundation","keywords":"Medicine; Prostatectomy; Prostate cancer; Stage (stratigraphy); Proportional hazards model; Tissue microarray; Urology; Carcinoma; Hazard ratio; Internal medicine; Cancer; Prostate; Prostate carcinoma; Biochemical recurrence; Immunostaining; Oncology; Pathology; Immunohistochemistry","score_opus":0.017743986411726215,"score_gpt":0.2913312668738565,"score_spread":0.2735872804621303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346720680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991425,0.00026678885,0.000047670073,0.00003157459,0.000004431788,0.000003637606,0.0003634028,0.0000035691946,0.00013635938],"genre_scores_gemma":[0.9994248,0.00008278034,0.00002302685,0.000011937221,0.000007973318,0.0000023443413,0.00037265758,0.0000019921647,0.000072536604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938214,0.00017764502,0.000073607065,0.00014316414,0.00009496147,0.0001284025],"domain_scores_gemma":[0.9971367,0.00052268396,0.0013622307,0.00029229597,0.0001931811,0.0004929271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070482504,0.00032859555,0.0004630397,0.0012622818,0.00057994993,0.0009076655,0.0006129865,0.0006503121,0.0013394157],"category_scores_gemma":[0.0038032006,0.0004976312,0.0007328797,0.0022921187,0.00047533453,0.0010997866,0.0008429495,0.0007445123,0.00022841063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007825712,0.000016241243,0.9992416,0.0000029375358,0.00006185136,0.000026073882,0.000029237695,0.000039771832,0.00006917834,0.000004365943,0.000037141883,0.00039343096],"study_design_scores_gemma":[0.0000045177694,0.000039283925,0.99948823,0.0000021400638,0.000034284283,0.00012885187,0.00011189594,0.000097872515,0.000025930594,0.0000060521356,0.00005737295,0.0000035316946],"about_ca_topic_score_codex":0.012847656,"about_ca_topic_score_gemma":0.017090084,"teacher_disagreement_score":0.012847656,"about_ca_system_score_codex":0.0006129693,"about_ca_system_score_gemma":0.00046130936,"threshold_uncertainty_score":0.025545776},"labels":[],"label_agreement":null},{"id":"W2471406539","doi":"10.1038/pcan.2016.22","title":"The role of lifestyle characteristics on prostate cancer progression in two active surveillance cohorts","year":2016,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Cancer Research UK","keywords":"Medicine; Prostate cancer; Cohort; Disease; Cohort study; Demography; Lower risk; Gerontology; Internal medicine; Cancer; Confidence interval","score_opus":0.007327450246434401,"score_gpt":0.30724813917906296,"score_spread":0.2999206889326286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2471406539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992291,0.0001910042,0.00006298531,0.00006066788,0.000011062939,0.000004811251,0.00022880147,0.0000031191123,0.0002084197],"genre_scores_gemma":[0.99926215,0.000059617578,0.000035197492,0.000020849488,0.000011899989,0.000004821838,0.00034478205,0.000003160538,0.00025742062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990846,0.00025645533,0.0000557375,0.00024970574,0.00009496181,0.000258591],"domain_scores_gemma":[0.9976641,0.0004937577,0.00054936286,0.0003573651,0.0002328206,0.0007025955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00135637,0.00047097253,0.00057852524,0.0008692141,0.0011506387,0.0016171094,0.0009090084,0.0008772626,0.0015330242],"category_scores_gemma":[0.004018625,0.0005671519,0.0013213665,0.0008215173,0.0004412635,0.0008919027,0.001347658,0.0015667859,0.00016822362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011187604,0.0001103084,0.9963977,0.0000065095514,0.00021052978,0.000064150176,0.00032984748,0.000029108562,0.00037944614,0.000040171,0.000090912516,0.0012226148],"study_design_scores_gemma":[0.000021278407,0.00016929691,0.998872,0.0000033457104,0.0001058942,0.000091857124,0.00038539257,0.00014565024,0.00005165017,0.000033563378,0.00011422649,0.000005791287],"about_ca_topic_score_codex":0.015593358,"about_ca_topic_score_gemma":0.01709142,"teacher_disagreement_score":0.015593358,"about_ca_system_score_codex":0.0004162343,"about_ca_system_score_gemma":0.00062920543,"threshold_uncertainty_score":0.031005144},"labels":[],"label_agreement":null},{"id":"W2504671323","doi":"10.1038/pcan.2016.28","title":"A diagnosis of prostate cancer and pursuit of active surveillance is not followed by weight loss: potential for a teachable moment","year":2016,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Teachable moment; Overweight; Underweight; Body mass index; Prostate cancer; Weight loss; Weight change; Internal medicine; Prospective cohort study; Obesity; Cancer","score_opus":0.009507725580842166,"score_gpt":0.2756957537449728,"score_spread":0.2661880281641306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2504671323","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026377538,0.028078314,0.007545792,0.8556385,0.031395797,0.000037032307,0.0001475983,0.0004596194,0.05031991],"genre_scores_gemma":[0.6262463,0.04964566,0.028428175,0.2075671,0.057117786,0.000120659504,0.0003782071,0.00023555571,0.030260537],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991104,0.0004028469,0.000038612994,0.00009263145,0.0002213336,0.00013422845],"domain_scores_gemma":[0.98745954,0.006116779,0.0011759844,0.00058838486,0.0009263499,0.003733053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002881559,0.00039630837,0.00038661237,0.0005225288,0.0019683356,0.0022759703,0.0010208348,0.0038178132,0.009775453],"category_scores_gemma":[0.014798722,0.00022686852,0.0004727208,0.00015737188,0.0035895193,0.004902316,0.0020646742,0.009314315,0.00195146],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005781571,0.0011538218,0.022988757,0.0009935384,0.000112810274,0.009088934,0.0026948256,0.0007306471,0.0042774426,0.10802484,0.40747854,0.44187766],"study_design_scores_gemma":[0.00028520357,0.0015722028,0.029540557,0.004410111,0.00015953722,0.019947138,0.00767241,0.0017307785,0.0046725855,0.24182579,0.68790334,0.00028032088],"about_ca_topic_score_codex":0.0012084254,"about_ca_topic_score_gemma":0.005255378,"teacher_disagreement_score":0.009775453,"about_ca_system_score_codex":0.0017490425,"about_ca_system_score_gemma":0.003477269,"threshold_uncertainty_score":0.032702148},"labels":[],"label_agreement":null},{"id":"W2508782022","doi":"10.1038/pcan.2016.38","title":"Decipher correlation patterns post prostatectomy: initial experience from 2 342 prospective patients","year":2016,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"DECIPHER; Prostatectomy; Medicine; Prostate cancer; Confidence interval; Correlation; Prospective cohort study; Internal medicine; Biomarker; Oncology; Cancer; Pathology; Bioinformatics; Biology; Genetics","score_opus":0.009477846045960017,"score_gpt":0.2835348265256513,"score_spread":0.2740569804796913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508782022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989145,0.00020998523,0.00039561515,0.00002589718,0.0000035187243,0.00001511931,0.00016076588,0.0000069974444,0.0002675929],"genre_scores_gemma":[0.99858105,0.00018810769,0.00055907853,0.000044045653,0.000013353309,0.000017860593,0.00034831432,0.000009864892,0.00023827958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989403,0.00034045876,0.00008267174,0.00031764904,0.00019926805,0.000119759],"domain_scores_gemma":[0.99760985,0.0008235965,0.0006034005,0.0003081144,0.00026856764,0.00038644747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015872719,0.00034424273,0.00031781316,0.00059503916,0.0005135297,0.0006925592,0.00032412115,0.00027791673,0.0013648538],"category_scores_gemma":[0.0036019664,0.00035429478,0.00024606715,0.00079585734,0.00042559727,0.00047666146,0.00092291494,0.0004744229,0.00044401624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025590893,0.00012637531,0.9904889,0.000015775995,0.000025695914,0.0005374604,0.0005604866,0.000073099276,0.0006600739,0.000017829145,0.00020558643,0.007032786],"study_design_scores_gemma":[0.000027018436,0.0010789245,0.99193925,0.000012932284,0.000048264934,0.0035137828,0.0009787983,0.0003050947,0.0008956403,0.00005749883,0.0011211573,0.000021678186],"about_ca_topic_score_codex":0.0010108983,"about_ca_topic_score_gemma":0.0020018276,"teacher_disagreement_score":0.0015872719,"about_ca_system_score_codex":0.00028852362,"about_ca_system_score_gemma":0.00040786734,"threshold_uncertainty_score":0.00839442},"labels":[],"label_agreement":null},{"id":"W2523960744","doi":"10.1038/pcan.2016.44","title":"Impact of single-agent daily prednisone on outcomes in men with metastatic castration-resistant prostate cancer","year":2016,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Bristol-Myers Squibb","keywords":"Medicine; Hazard ratio; Placebo; Internal medicine; Prostate cancer; Docetaxel; Oncology; Prednisone; Abiraterone acetate; Confidence interval; Enzalutamide; Randomized controlled trial; Cancer; Androgen deprivation therapy; Pathology","score_opus":0.03437655681682068,"score_gpt":0.34857019579536724,"score_spread":0.3141936389785466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523960744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99049765,0.0073664687,0.000038472965,0.00052268174,0.000086061154,0.000011596206,0.00026695474,0.000007730922,0.0012022757],"genre_scores_gemma":[0.9984068,0.00093587954,0.000023456518,0.00010068582,0.0000842008,0.0000036008182,0.00023352515,0.0000013324884,0.0002105975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996346,0.00013075507,0.000030222307,0.00004958082,0.000066385765,0.00008842227],"domain_scores_gemma":[0.99887115,0.00028419227,0.00031552275,0.000040679028,0.000055533863,0.00043293164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005811008,0.0002485927,0.0005996862,0.00023495742,0.00033477705,0.0005342848,0.0003158058,0.00040663432,0.0012285982],"category_scores_gemma":[0.0022853774,0.00010011173,0.0012745642,0.00040389755,0.00022027637,0.00045709257,0.0004157109,0.00076328503,0.00009202179],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06761651,0.002604428,0.7455713,0.0004769751,0.0039910977,0.00041530404,0.00024203293,0.002736937,0.0014107313,0.0002259981,0.0021064738,0.17260231],"study_design_scores_gemma":[0.0009899052,0.009726965,0.98628354,0.000060430917,0.0010838129,0.00016954674,0.00017368911,0.0005855191,0.000118846685,0.00018120451,0.000608475,0.000018158205],"about_ca_topic_score_codex":0.00490724,"about_ca_topic_score_gemma":0.0107837785,"teacher_disagreement_score":0.00490724,"about_ca_system_score_codex":0.0006255467,"about_ca_system_score_gemma":0.0006610678,"threshold_uncertainty_score":0.0097574},"labels":[],"label_agreement":null},{"id":"W2532502732","doi":"10.1038/pcan.2016.50","title":"SOCS1 inhibits migration and invasion of prostate cancer cells, attenuates tumor growth and modulates the tumor stroma","year":2016,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université de Sherbrooke","funders":"Fonds de Recherche du Québec - Santé; Memorial Sloan-Kettering Cancer Center; Alexander von Humboldt-Stiftung","keywords":"Suppressor of cytokine signaling 1; DU145; Cancer research; Prostate cancer; Cytokine; Gene silencing; Medicine; Biology; LNCaP; Cancer; Internal medicine; Suppressor","score_opus":0.013458994841296356,"score_gpt":0.2586133613492471,"score_spread":0.24515436650795075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2532502732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98669344,0.006225231,0.0012311861,0.0004805254,0.00014289073,0.000023674269,0.0004873514,0.00019008257,0.004525492],"genre_scores_gemma":[0.99494666,0.0015209026,0.00047098112,0.000087926644,0.000036231228,0.000016744118,0.0004416602,0.000016626716,0.002462272],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998481,0.000033674994,0.0000073909973,0.000014629306,0.000033691696,0.0000623849],"domain_scores_gemma":[0.9999279,0.000006088846,0.000017009497,0.000005669927,0.000007666532,0.000035693152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012522248,0.00038416663,0.00021209435,0.0002993468,0.00022720211,0.00031382372,0.0001493178,0.00015500217,0.003105288],"category_scores_gemma":[0.000105604144,0.00012244693,0.00031526014,0.00017976642,0.00033142866,0.00014231211,0.00022130918,0.0006950966,0.00038329654],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001053169,0.0001890851,0.0009135177,0.00017604008,0.000030269599,0.00006157415,0.00002915283,0.0003016271,0.98525757,0.00036129,0.0007417739,0.010884889],"study_design_scores_gemma":[0.0001346272,0.0021654356,0.024325842,0.000023086428,0.00007839356,0.00045943988,0.0001432905,0.0020856143,0.9594994,0.0002321365,0.010834337,0.000018487397],"about_ca_topic_score_codex":0.00096775003,"about_ca_topic_score_gemma":0.0026966545,"teacher_disagreement_score":0.003105288,"about_ca_system_score_codex":0.0002944469,"about_ca_system_score_gemma":0.00070345507,"threshold_uncertainty_score":0.0103881955},"labels":[],"label_agreement":null},{"id":"W2547629658","doi":"10.1038/pcan.2016.49","title":"Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis","year":2016,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Prostate Cancer Canada; Genome British Columbia","funders":"National Cancer Institute","keywords":"Prostate cancer; Androgen receptor; Medicine; Cancer research; Immune checkpoint; Oncology; Cancer; Biology; Internal medicine; Immunotherapy","score_opus":0.013502321125658235,"score_gpt":0.2759243260925506,"score_spread":0.26242200496689233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547629658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984199,0.00046961097,0.00026064576,0.000035117184,0.0000046968617,0.0000067127676,0.00032825614,0.0000061512696,0.0004688936],"genre_scores_gemma":[0.9990017,0.00009951228,0.00018499022,0.000022122753,0.000009005446,0.000009539027,0.0004136641,0.0000032764776,0.00025620402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997578,0.0000651235,0.000014179848,0.00004268607,0.000052847674,0.000067361216],"domain_scores_gemma":[0.99967575,0.000102260165,0.00008210248,0.000027970293,0.000049248734,0.00006266408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053207105,0.00018067234,0.00034763003,0.00076021516,0.00030026174,0.0006438381,0.00028251662,0.0002974022,0.0018313393],"category_scores_gemma":[0.0005226374,0.00013137735,0.00041561638,0.0010000037,0.00035886385,0.00021036352,0.0003546065,0.00040107116,0.00029779345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014269532,0.00008900193,0.9678159,0.000025771584,0.00041623626,0.000079577476,0.00006722134,0.00030211796,0.02323163,0.00007812849,0.00019953986,0.0062678405],"study_design_scores_gemma":[0.000016906142,0.00017548644,0.9952207,0.0000037545726,0.00015289888,0.00028108305,0.00013596412,0.0012220973,0.0021063897,0.00011165272,0.00056663656,0.0000063736125],"about_ca_topic_score_codex":0.0019672418,"about_ca_topic_score_gemma":0.0023428057,"teacher_disagreement_score":0.0019672418,"about_ca_system_score_codex":0.0002556664,"about_ca_system_score_gemma":0.00023848553,"threshold_uncertainty_score":0.0061264634},"labels":[],"label_agreement":null},{"id":"W2548278160","doi":"10.1038/pcan.2016.51","title":"Active surveillance for intermediate-risk prostate cancer","year":2016,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"National Institutes of Health","keywords":"Medicine; Prostate cancer; Oncology; Watchful waiting; Benign prostatic hyperplasia (BPH); Internal medicine; Cancer","score_opus":0.026314902702281217,"score_gpt":0.35826755119011494,"score_spread":0.33195264848783373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548278160","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05771353,0.9290305,0.0011992618,0.0019381267,0.00034836758,0.00010127688,0.0008150073,0.00006451753,0.0087894425],"genre_scores_gemma":[0.62174946,0.36954898,0.0024743206,0.001805741,0.0013372791,0.00010082945,0.00219209,0.000017169463,0.00077419437],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993648,0.00020936686,0.00011513195,0.000084213694,0.00018543462,0.000041061823],"domain_scores_gemma":[0.9952554,0.002349916,0.0014738329,0.00011477559,0.0005019411,0.0003041197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014899083,0.00020035665,0.00047422593,0.001884755,0.00020198764,0.0006036631,0.0005375771,0.00027666547,0.0021755912],"category_scores_gemma":[0.005359454,0.00007966525,0.0005687022,0.0013031723,0.00030836128,0.00056654785,0.00041860092,0.00049507397,0.0002557327],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012519063,0.00012828092,0.15526469,0.036578305,0.0007787234,0.0012407899,0.00043270277,0.0003701323,0.001542043,0.0017468289,0.015703872,0.7849618],"study_design_scores_gemma":[0.0006344161,0.0034745054,0.54557335,0.088405594,0.0048644803,0.035125546,0.0014887333,0.0012052358,0.0046617584,0.008061193,0.30633345,0.00017171651],"about_ca_topic_score_codex":0.0011142158,"about_ca_topic_score_gemma":0.0017330972,"teacher_disagreement_score":0.0021755912,"about_ca_system_score_codex":0.00037162733,"about_ca_system_score_gemma":0.0010993808,"threshold_uncertainty_score":0.007879496},"labels":[],"label_agreement":null},{"id":"W2562421418","doi":"10.1038/pcan.2016.62","title":"Skeletal-related events significantly impact health-related quality of life in metastatic castration-resistant prostate cancer: data from PREVAIL and AFFIRM trials","year":2017,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Astellas Pharma; Pfizer","keywords":"Medicine; Prostate cancer; Oncology; Castration; Quality of life (healthcare); Internal medicine; Clinical trial; Cancer; Hormone","score_opus":0.1459457076350776,"score_gpt":0.43416176169276083,"score_spread":0.28821605405768325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562421418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9150611,0.079955146,0.00028400775,0.00083577714,0.000092456794,0.0003155583,0.001636178,0.00002938802,0.0017902667],"genre_scores_gemma":[0.98622084,0.011311159,0.00032012264,0.00042635886,0.00016854,0.00015599746,0.0011197935,0.0000065725376,0.00027049505],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9985505,0.0008986284,0.0001697932,0.000113289854,0.00017730499,0.00009048204],"domain_scores_gemma":[0.9943287,0.002633981,0.0022608312,0.00021169132,0.00022593536,0.0003389512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004940999,0.0004679229,0.0016363459,0.00022739713,0.00022669404,0.00062639057,0.0003181378,0.0004760333,0.0017386434],"category_scores_gemma":[0.004604659,0.00018892818,0.0022143861,0.00045253753,0.00042941002,0.00044549626,0.00035369577,0.000990321,0.00014058719],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.58823913,0.003300109,0.12150555,0.010361072,0.028222458,0.00019102305,0.0003905675,0.0036536488,0.008478603,0.00040300927,0.0044044824,0.2308504],"study_design_scores_gemma":[0.1820272,0.20350063,0.56778437,0.0015742407,0.023956593,0.0009249036,0.00026824028,0.0012573424,0.003525836,0.00068070495,0.0143837,0.00011623143],"about_ca_topic_score_codex":0.00057827635,"about_ca_topic_score_gemma":0.002694933,"teacher_disagreement_score":0.004940999,"about_ca_system_score_codex":0.000341176,"about_ca_system_score_gemma":0.0005908112,"threshold_uncertainty_score":0.026130855},"labels":[],"label_agreement":null},{"id":"W2569135863","doi":"10.1038/pcan.2016.65","title":"Metformin and the risk of prostate cancer across racial/ethnic groups: a population-based cohort study","year":2017,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Metformin; Prostate cancer; Confidence interval; Cohort; Internal medicine; Diabetes mellitus; Proportional hazards model; Oncology; Demography; Cohort study; Population; Cancer; Gerontology; Gynecology; Endocrinology; Environmental health","score_opus":0.010838044560048318,"score_gpt":0.3181343328813764,"score_spread":0.30729628832132805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569135863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99880505,0.00030372728,0.00009976044,0.000052739837,0.0000138688765,0.000011444055,0.00038811448,0.000004593389,0.00032080789],"genre_scores_gemma":[0.99917597,0.00015171235,0.00010806737,0.000042608004,0.000014160801,0.000011556662,0.00018416604,0.000003449575,0.00030840127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995277,0.00011820769,0.000036137153,0.00014805343,0.0000742994,0.00009562868],"domain_scores_gemma":[0.99943215,0.000044418008,0.00015684063,0.0001206288,0.00006542469,0.00018060564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007242951,0.00054481556,0.00062118174,0.0006297406,0.0013769626,0.0010487475,0.00049886055,0.0010552779,0.0014865149],"category_scores_gemma":[0.000854868,0.0010204741,0.0012001868,0.0014104237,0.00033082257,0.0006001301,0.0006084551,0.0013438507,0.000267313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010293842,0.00024372147,0.99524707,0.000011084357,0.00063785125,0.00012107608,0.00015011708,0.000057868834,0.0012161357,0.000039765117,0.0001661925,0.0010797397],"study_design_scores_gemma":[0.000052534062,0.00017277672,0.99857914,0.000004125953,0.0003132622,0.0001564119,0.00021910372,0.00020011415,0.00007615808,0.000034569748,0.00018154153,0.000010160435],"about_ca_topic_score_codex":0.020341488,"about_ca_topic_score_gemma":0.021724416,"teacher_disagreement_score":0.020341488,"about_ca_system_score_codex":0.00042848755,"about_ca_system_score_gemma":0.000505182,"threshold_uncertainty_score":0.040446162},"labels":[],"label_agreement":null},{"id":"W2570119467","doi":"10.1038/pcan.2016.66","title":"Prognostic value of the new Grade Groups in Prostate Cancer: a multi-institutional European validation study","year":2017,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Prostate cancer; Prostatectomy; Interquartile range; Biochemical recurrence; Proportional hazards model; Internal medicine; Biopsy; Urology; Cohort; Pathological; Cancer; Oncology","score_opus":0.031087874633744454,"score_gpt":0.323423961941959,"score_spread":0.29233608730821453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570119467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99862134,0.00020509378,0.00017669723,0.000025381929,0.000010269554,0.000024589188,0.0006473355,0.0000036363465,0.00028572732],"genre_scores_gemma":[0.99745506,0.000093627714,0.00021069571,0.000034074517,0.000011242801,0.000026205593,0.001998644,0.000009221171,0.00016109247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99710315,0.001367026,0.00023890623,0.0005746068,0.0003835618,0.00033276505],"domain_scores_gemma":[0.9924366,0.0016834491,0.0023374783,0.0013474544,0.0012717805,0.0009231322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050139963,0.0009238973,0.00093919237,0.0015171855,0.0010054513,0.0017471081,0.0014904652,0.0013232052,0.0007767262],"category_scores_gemma":[0.008885126,0.00048917654,0.001461757,0.0022730476,0.0010359209,0.0012682738,0.0022955025,0.0010574925,0.0002774939],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013876588,0.000179237,0.9940241,0.00002376266,0.000521634,0.00007883846,0.00034613162,0.00030496455,0.00043649567,0.00006507681,0.0002635196,0.002368641],"study_design_scores_gemma":[0.00006950189,0.00015092193,0.9985374,0.000009826621,0.000154632,0.00015439857,0.00016847737,0.00021991746,0.00013483074,0.000042491447,0.00034583293,0.000011773539],"about_ca_topic_score_codex":0.009352104,"about_ca_topic_score_gemma":0.009770981,"teacher_disagreement_score":0.009352104,"about_ca_system_score_codex":0.00087978184,"about_ca_system_score_gemma":0.0010355854,"threshold_uncertainty_score":0.026516914},"labels":[],"label_agreement":null},{"id":"W2582799849","doi":"10.1038/pcan.2016.58","title":"Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancer","year":2017,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"Prostate Cancer Foundation","keywords":"Medicine; Prostate cancer; Hazard ratio; Biopsy; Metastasis; Confidence interval; Internal medicine; Cumulative incidence; Prostate biopsy; Oncology; Androgen deprivation therapy; Urology; Cancer; Cohort","score_opus":0.027665179497161123,"score_gpt":0.32148463215020745,"score_spread":0.2938194526530463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582799849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992299,0.00019813544,0.00036291,0.000018485283,0.0000027180145,0.000005548775,0.00006259679,0.000005491525,0.000114266986],"genre_scores_gemma":[0.999602,0.00002314053,0.00024394292,0.000006457088,0.0000028828738,0.000002424798,0.000093127564,7.0663765e-7,0.000025222867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996753,0.00012805051,0.000024030855,0.00006419201,0.00006982592,0.00003862635],"domain_scores_gemma":[0.9988193,0.0005321759,0.00033634505,0.000054138654,0.00012341182,0.00013462311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072103005,0.00022551027,0.000224377,0.00040969715,0.00012774834,0.00034541995,0.00021290156,0.0002518537,0.0006198712],"category_scores_gemma":[0.0030795422,0.00009933196,0.00021116796,0.00024092983,0.00016450734,0.00022051804,0.00022003455,0.00025463518,0.000143774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033524,0.000027824291,0.9926098,0.00000859856,0.000040839812,0.00002748686,0.000015889858,0.000391297,0.0007285231,0.000006708545,0.000043216925,0.005764648],"study_design_scores_gemma":[0.00003923551,0.0012205025,0.9879512,0.000007495831,0.00009488699,0.0006780601,0.00008220811,0.008278374,0.0013366446,0.00006902642,0.00023250253,0.000009815812],"about_ca_topic_score_codex":0.0008127863,"about_ca_topic_score_gemma":0.00164774,"teacher_disagreement_score":0.0008127863,"about_ca_system_score_codex":0.00018135308,"about_ca_system_score_gemma":0.00016273811,"threshold_uncertainty_score":0.0038132668},"labels":[],"label_agreement":null},{"id":"W2591591165","doi":"10.1038/pcan.2016.73","title":"Impact of carbohydrate restriction in the context of obesity on prostate tumor growth in the Hi-Myc transgenic mouse model","year":2017,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Diet and metabolism studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Queen's University; National Institute of Environmental Health Sciences; Queen's University Belfast","keywords":"Internal medicine; Endocrinology; Prostate cancer; Medicine; Prostate; Context (archaeology); Tramp; Calorie restriction; PTEN; PI3K/AKT/mTOR pathway; Biology; Apoptosis; Cancer; Biochemistry","score_opus":0.025247345377097212,"score_gpt":0.3155157537162026,"score_spread":0.2902684083391054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591591165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99600804,0.00077003037,0.0011638289,0.0002559586,0.00006302919,0.000030973344,0.0006558154,0.00009556944,0.00095679506],"genre_scores_gemma":[0.99134105,0.0009793005,0.0018137771,0.00012301133,0.00004438322,0.00008856381,0.0006279033,0.00011504208,0.004866828],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99969983,0.000050637726,0.000020051755,0.00007645755,0.00005965228,0.00009343087],"domain_scores_gemma":[0.99947613,0.000043282365,0.00013209903,0.000053704098,0.0000270974,0.0002677403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026519515,0.0008051076,0.000482538,0.0010669983,0.00044420373,0.0007037105,0.00052781036,0.0006526495,0.002275902],"category_scores_gemma":[0.00017519378,0.00039355044,0.0004974884,0.0005376362,0.0009662925,0.0006554883,0.00037168065,0.0020700376,0.00030226796],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005662691,0.00088289555,0.0008886596,0.00005314512,0.000027013664,0.00015124698,0.0000356596,0.00017816253,0.9896779,0.00040475136,0.00012071647,0.0019171183],"study_design_scores_gemma":[0.0002961711,0.005305841,0.01598618,0.000033976637,0.00022366957,0.0005463575,0.00025075593,0.002146451,0.9715798,0.00050316873,0.0030782828,0.000049449158],"about_ca_topic_score_codex":0.0022322969,"about_ca_topic_score_gemma":0.0037879522,"teacher_disagreement_score":0.002275902,"about_ca_system_score_codex":0.0006281503,"about_ca_system_score_gemma":0.0007004921,"threshold_uncertainty_score":0.0076137185},"labels":[],"label_agreement":null},{"id":"W2601227959","doi":"10.1038/pcan.2017.8","title":"Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project","year":2017,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Prostate cancer; Delphi method; Prostate; Biopsy; Prostate biopsy; Medical physics; Radiology; Cancer; Internal medicine","score_opus":0.03165717327410852,"score_gpt":0.35534757483682755,"score_spread":0.32369040156271905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601227959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62081015,0.016922208,0.08434303,0.17809501,0.0028816105,0.03382804,0.0017826786,0.00021580792,0.061121505],"genre_scores_gemma":[0.9012053,0.005862543,0.068566486,0.01057816,0.00040838151,0.011168864,0.0008747176,0.00007815639,0.0012575246],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.8882699,0.08897715,0.011267974,0.0018812437,0.0058847717,0.0037190397],"domain_scores_gemma":[0.87087667,0.087988555,0.0050281454,0.0034205446,0.02650305,0.006183065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.17046282,0.0005269902,0.0009167303,0.0022338927,0.00283955,0.0027701014,0.0018672887,0.0018344022,0.0029152997],"category_scores_gemma":[0.11871999,0.0004516504,0.0015239351,0.0016455168,0.001602442,0.0024719716,0.0067374897,0.0034599658,0.0003625522],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020210831,0.00086787535,0.09886577,0.011162885,0.0011283279,0.0010892865,0.09085958,0.0039544045,0.0035676244,0.016302744,0.07757698,0.6926034],"study_design_scores_gemma":[0.001835983,0.0026017188,0.17315769,0.057047036,0.0021864825,0.0044331984,0.30890784,0.023125244,0.0065481537,0.045985345,0.37324053,0.00093072647],"about_ca_topic_score_codex":0.0036359453,"about_ca_topic_score_gemma":0.006142742,"teacher_disagreement_score":0.17046282,"about_ca_system_score_codex":0.0056089615,"about_ca_system_score_gemma":0.029040428,"threshold_uncertainty_score":0.90150434},"labels":[],"label_agreement":null},{"id":"W2611203694","doi":"10.1038/pcan.2017.27","title":"Media reporting of ProtecT: a disconnect in information dissemination?","year":2017,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Likert scale; Medicine; Descriptive statistics; Family medicine; Psychology; Statistics","score_opus":0.029252826031231614,"score_gpt":0.3797350866537166,"score_spread":0.35048226062248494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611203694","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05126321,0.018718716,0.0070937336,0.72617084,0.005199259,0.00017506981,0.0027987354,0.00036824623,0.18821222],"genre_scores_gemma":[0.849179,0.013260976,0.0039954367,0.109672524,0.010333447,0.00023865284,0.0010768704,0.00054600363,0.011696996],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9253882,0.048591867,0.004877713,0.0038046183,0.013325359,0.0040122247],"domain_scores_gemma":[0.6098137,0.2659018,0.040996157,0.029308798,0.043186214,0.010793319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.078181334,0.0006037724,0.00091903773,0.00759131,0.0037102744,0.017139664,0.0032649965,0.0069694268,0.027043171],"category_scores_gemma":[0.33822805,0.0008184458,0.0008180392,0.0067709726,0.0062814667,0.023601338,0.007924738,0.006530968,0.0044983393],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007328857,0.00032109322,0.093600504,0.0021378133,0.0004982313,0.0006613573,0.038271252,0.00049079146,0.0009703386,0.20919053,0.26844174,0.38468352],"study_design_scores_gemma":[0.00031242325,0.00045844394,0.11320477,0.0090599675,0.0005642738,0.0013928098,0.05338096,0.0019031715,0.0025644286,0.15426947,0.66250837,0.00038097095],"about_ca_topic_score_codex":0.013012177,"about_ca_topic_score_gemma":0.009103179,"teacher_disagreement_score":0.078181334,"about_ca_system_score_codex":0.00433906,"about_ca_system_score_gemma":0.007176878,"threshold_uncertainty_score":0.41346735},"labels":[],"label_agreement":null},{"id":"W2624454383","doi":"10.1038/pcan.2017.30","title":"The combination of histological prostate atrophy and inflammation is associated with lower risk of prostate cancer in biopsy specimens","year":2017,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Prostate cancer; Atrophy; Prostate; Prostatitis; Biopsy; Inflammation; Cancer; Prostate biopsy; PCA3; Pathology; Oncology; Internal medicine; Urology","score_opus":0.0113527368048572,"score_gpt":0.273247179307701,"score_spread":0.26189444250284377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624454383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940572,0.0035905153,0.0005515999,0.00013958072,0.000044881268,0.000011146864,0.00031157993,0.000024370964,0.0012691553],"genre_scores_gemma":[0.99880385,0.000351762,0.00028325262,0.000036115394,0.000035792404,0.0000029304972,0.00016401394,0.000004014793,0.0003182803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991215,0.00027728925,0.00010472139,0.00012014843,0.00024233852,0.0001340258],"domain_scores_gemma":[0.9967918,0.0005702551,0.0015826016,0.00018906979,0.0003795837,0.00048668243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008327192,0.00039825105,0.00053775974,0.0015282285,0.0005128745,0.0007899232,0.00036271248,0.0005037162,0.0029387134],"category_scores_gemma":[0.003063947,0.0003288337,0.00070704607,0.0012917442,0.0004557975,0.0004463809,0.0005068801,0.0007456189,0.00033977116],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021829011,0.00002789188,0.99509877,0.00004192397,0.00014510819,0.00009829877,0.000022324146,0.000028623492,0.002358535,0.00001552553,0.00006032367,0.0018843286],"study_design_scores_gemma":[0.0000022042923,0.00010166978,0.9981274,0.0000075182993,0.00009178235,0.00084864924,0.00008194616,0.000083240906,0.00043414967,0.00003943991,0.00017846224,0.0000034836762],"about_ca_topic_score_codex":0.001676177,"about_ca_topic_score_gemma":0.0039996966,"teacher_disagreement_score":0.0029387134,"about_ca_system_score_codex":0.00021352201,"about_ca_system_score_gemma":0.0003850721,"threshold_uncertainty_score":0.009831011},"labels":[],"label_agreement":null},{"id":"W2731572658","doi":"10.1038/pcan.2017.31","title":"Periprostatic adipose inflammation is associated with high-grade prostate cancer","year":2017,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institutes of Health; Movember Foundation; National Cancer Institute; Prostate Cancer Foundation","keywords":"Medicine; Internal medicine; Adiponectin; Inflammation; Prostate cancer; Adipokine; Oncology; Endocrinology; Leptin; Cancer; Obesity; Insulin resistance","score_opus":0.013932122299907944,"score_gpt":0.2823569029425436,"score_spread":0.2684247806426357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2731572658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783958,0.018822208,0.00058876054,0.00026923962,0.00006766163,0.000014170197,0.0004192939,0.000027587468,0.0013952838],"genre_scores_gemma":[0.99723685,0.001970194,0.00017090027,0.00004844668,0.00008589169,0.00000475833,0.00016097829,0.0000029887626,0.00031884707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995815,0.00014739264,0.00004229181,0.000060114573,0.00010029004,0.000068380905],"domain_scores_gemma":[0.9988048,0.00014166743,0.0006716963,0.00007272635,0.00011420988,0.00019493156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040396533,0.00029915367,0.0004384989,0.0007212806,0.0003602099,0.00097041746,0.00029944358,0.00038426058,0.0020064274],"category_scores_gemma":[0.0012955039,0.00027936616,0.00055549474,0.0018151366,0.00030727987,0.0003147799,0.00045816108,0.0008170385,0.00017559917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010872128,0.000110200825,0.98406166,0.00020507333,0.0004251066,0.00039717177,0.000072481154,0.0000848119,0.004449755,0.00008884516,0.00021182977,0.008805715],"study_design_scores_gemma":[0.000007686448,0.00009754308,0.9983779,0.000017208396,0.0001324688,0.0005387855,0.000083705905,0.00012588619,0.0002313536,0.00008733812,0.00029382764,0.0000062547374],"about_ca_topic_score_codex":0.0012233078,"about_ca_topic_score_gemma":0.0021240017,"teacher_disagreement_score":0.0020064274,"about_ca_system_score_codex":0.00017154144,"about_ca_system_score_gemma":0.00034517405,"threshold_uncertainty_score":0.0067121983},"labels":[],"label_agreement":null},{"id":"W2772419959","doi":"10.1038/s41391-017-0018-5","title":"Germline BRCA mutation in male carriers—ripe for precision oncology?","year":2017,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Germline; Prostate cancer; Germline mutation; Oncology; Cancer; Synthetic lethality; Population; Disease; Mutation; BRCA mutation; DNA repair; Internal medicine; Genetics; Bioinformatics; Cancer research; Gene; Biology; Ovarian cancer","score_opus":0.11789031156022121,"score_gpt":0.48265006692905915,"score_spread":0.3647597553688379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772419959","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016158879,0.99617416,0.000111139176,0.0021525188,0.00038378776,0.000002153115,0.000030030238,0.000011636067,0.0009730271],"genre_scores_gemma":[0.002960843,0.9919802,0.00034628983,0.003021584,0.00088680553,0.000004115248,0.000084630185,0.0000040636314,0.00071153307],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972314,0.00006534184,0.000044809534,0.000056085682,0.00008745238,0.00002314276],"domain_scores_gemma":[0.9994823,0.00030003212,0.00007141689,0.000016305426,0.00009487792,0.00003514245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005809513,0.00040142593,0.001357382,0.0012610524,0.00022469793,0.0010013955,0.00081575767,0.0011303907,0.0039553735],"category_scores_gemma":[0.001912207,0.00018367298,0.0005881212,0.00090487214,0.00050305977,0.0012233596,0.0005378269,0.0017959516,0.0010255846],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008716376,0.00002598855,0.0010634555,0.007120306,0.0001938277,0.00063076307,0.00004403591,0.00015787246,0.00054369034,0.0033240258,0.07007998,0.916729],"study_design_scores_gemma":[0.000057007077,0.00008040321,0.0026305083,0.012422822,0.00058795506,0.00799004,0.00015413607,0.00014893546,0.00035621677,0.0053748135,0.9701589,0.000038220725],"about_ca_topic_score_codex":0.0016732311,"about_ca_topic_score_gemma":0.003832092,"teacher_disagreement_score":0.0039553735,"about_ca_system_score_codex":0.0004940635,"about_ca_system_score_gemma":0.0011728219,"threshold_uncertainty_score":0.013231993},"labels":[],"label_agreement":null},{"id":"W2772827846","doi":"10.1038/s41391-017-0015-8","title":"Elevated preoperative neutrophil–lymphocyte ratio predicts upgrading at radical prostatectomy","year":2017,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Prostatectomy; Neutrophil to lymphocyte ratio; Prostate cancer; Internal medicine; Biochemical recurrence; Urology; Gastroenterology; Proportional hazards model; Pathological; Lymphocyte; Cancer","score_opus":0.015118945889179213,"score_gpt":0.29055455989850953,"score_spread":0.2754356140093303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772827846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99545175,0.0017378045,0.00015665058,0.00018496803,0.00007594049,0.000009056573,0.00020333914,0.000016233322,0.0021642584],"genre_scores_gemma":[0.9993476,0.00017222721,0.00007304712,0.000029407614,0.00004752043,0.000002235653,0.00013433206,0.000001666328,0.00019197051],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968183,0.0000706335,0.00004507319,0.00004040165,0.0000805493,0.00008149847],"domain_scores_gemma":[0.99840254,0.0004093656,0.00046049352,0.000092644696,0.00015324383,0.00048173455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003589643,0.00033140057,0.00042743213,0.0007327575,0.00033396418,0.0007308578,0.00037017674,0.00048264084,0.0026168071],"category_scores_gemma":[0.0026159524,0.00018572941,0.0003882648,0.00073571375,0.00032838667,0.00048637265,0.00036762582,0.00079220615,0.0002934716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021735684,0.000031593503,0.9957807,0.000017415325,0.00004930759,0.000112016925,0.000018385583,0.00007804426,0.00029438877,0.000018738874,0.00017236799,0.0032097322],"study_design_scores_gemma":[0.0000061028104,0.00010602416,0.99830437,0.00001035089,0.00007207817,0.0005267735,0.00010456761,0.00033249907,0.00014609288,0.00008157873,0.00030217416,0.000007324644],"about_ca_topic_score_codex":0.0014759985,"about_ca_topic_score_gemma":0.0030887595,"teacher_disagreement_score":0.0026168071,"about_ca_system_score_codex":0.00023756165,"about_ca_system_score_gemma":0.00049867015,"threshold_uncertainty_score":0.008754015},"labels":[],"label_agreement":null},{"id":"W2773842285","doi":"10.1038/s41391-017-0010-0","title":"Total energy expenditure and vigorous-intensity physical activity are associated with reduced odds of reclassification among men on active surveillance","year":2017,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Physical Activity and Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Western University; Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Medicine; Physical activity; Energy expenditure; Odds; Intensity (physics); Physical therapy; Odds ratio; Benign prostatic hyperplasia (BPH); Internal medicine; Demography; Prostate cancer; Gerontology; Environmental health; Logistic regression","score_opus":0.027509091742609938,"score_gpt":0.3099503026694433,"score_spread":0.28244121092683333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2773842285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984004,0.00047939413,0.00011218241,0.0001182699,0.00003287712,0.000003578994,0.00015512356,0.000008741079,0.00068947615],"genre_scores_gemma":[0.99914455,0.00009716083,0.000052976982,0.000039916576,0.000031007796,0.0000016514899,0.00022366105,0.0000039717884,0.00040506624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992441,0.00023579232,0.00006788002,0.00017004974,0.00009496212,0.00018722926],"domain_scores_gemma":[0.99665904,0.0009105001,0.0013009969,0.00037171048,0.00020359256,0.0005541428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094984355,0.00057483005,0.00065475435,0.00070015405,0.00063621457,0.001372347,0.0006544608,0.0011541425,0.0028586455],"category_scores_gemma":[0.004665745,0.00052836834,0.0015320742,0.00083478994,0.0004317488,0.000790703,0.0007820335,0.0014749244,0.0002953449],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023224004,0.000050831288,0.9979315,0.000006872631,0.00013826591,0.000026508042,0.000042373347,0.000038715498,0.00010396168,0.0000126814175,0.00006523183,0.0013509996],"study_design_scores_gemma":[0.0000044723515,0.00005177108,0.99931383,0.0000053593644,0.000071011185,0.00006041522,0.00010033309,0.00024602475,0.000029848266,0.000035564775,0.00007805578,0.0000034157868],"about_ca_topic_score_codex":0.0092961565,"about_ca_topic_score_gemma":0.009657698,"teacher_disagreement_score":0.0092961565,"about_ca_system_score_codex":0.00018114326,"about_ca_system_score_gemma":0.00036226978,"threshold_uncertainty_score":0.018484056},"labels":[],"label_agreement":null},{"id":"W2777550987","doi":"10.1038/s41391-017-0030-9","title":"Serum cholesterol and risk of high-grade prostate cancer: results from the REDUCE study","year":2017,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":112,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Queen's University; National Cancer Institute; Irish Cancer Society; Queen's University Belfast","keywords":"Medicine; Prostate cancer; Internal medicine; Prostate biopsy; Prostate; Cholesterol; Biopsy; Prostate-specific antigen; Urology; Cancer; High-density lipoprotein; Oncology; Statin; Logistic regression; Gynecology; Gastroenterology","score_opus":0.012327705238890192,"score_gpt":0.28434135874220223,"score_spread":0.272013653503312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2777550987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99564457,0.0011638758,0.000117684576,0.00013006461,0.00001929081,0.000034105633,0.0019256448,0.000020161473,0.0009445599],"genre_scores_gemma":[0.9964443,0.0006246012,0.00017082927,0.000088807814,0.0000595164,0.000036221732,0.001875106,0.00001028483,0.0006903842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935275,0.00028566705,0.000040140065,0.00009456908,0.00013298453,0.00009394765],"domain_scores_gemma":[0.9988682,0.0002137735,0.00033193958,0.00020183367,0.00014095812,0.00024322858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011326623,0.00094493764,0.0016478514,0.0007614731,0.00059226324,0.0009973072,0.00071346987,0.0010230322,0.0011812528],"category_scores_gemma":[0.0015721733,0.0010470335,0.0019643856,0.0016867892,0.00035908443,0.00043523998,0.0009764038,0.0012248164,0.0003208328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011043481,0.0005636748,0.97842866,0.00011172395,0.0042692414,0.00014800609,0.00018209747,0.0002733555,0.0013740858,0.0001260852,0.0007162136,0.0027634846],"study_design_scores_gemma":[0.00052486267,0.00034872748,0.996148,0.000008442091,0.0019389599,0.00008155217,0.000109401255,0.00016178822,0.00012761293,0.00005338151,0.00048400366,0.000013305004],"about_ca_topic_score_codex":0.019972384,"about_ca_topic_score_gemma":0.01961302,"teacher_disagreement_score":0.019972384,"about_ca_system_score_codex":0.00038869499,"about_ca_system_score_gemma":0.00046423404,"threshold_uncertainty_score":0.03971225},"labels":[],"label_agreement":null},{"id":"W2783950449","doi":"10.1038/s41391-017-0006-9","title":"Tumor characteristics, treatments, and oncological outcomes of prostate cancer in men aged ≤50 years: a population-based study","year":2018,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Prostate cancer; Prostatectomy; Brachytherapy; Radiation therapy; Oncology; Cancer; Prostate; Internal medicine; Epidemiology; Stage (stratigraphy); Lymph node; Surveillance, Epidemiology, and End Results; Gynecology; Urology; Cancer registry","score_opus":0.019509864302917526,"score_gpt":0.32917574868156213,"score_spread":0.3096658843786446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783950449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99869126,0.00045958892,0.000054059336,0.000029354602,0.0000065116433,0.0000066050975,0.00043373962,0.0000026278024,0.00031636073],"genre_scores_gemma":[0.9993455,0.000137254,0.000023684273,0.000030510006,0.0000124689695,0.000005513519,0.00032591654,0.0000013712615,0.000117740645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995994,0.00009014458,0.000039940536,0.00010690314,0.0000687432,0.00009487891],"domain_scores_gemma":[0.9992849,0.0001089075,0.00030355345,0.00006756084,0.000056754558,0.00017836003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042599908,0.00031541855,0.00054261176,0.00073779374,0.0005620147,0.0007830977,0.00037963165,0.00065994944,0.0011704988],"category_scores_gemma":[0.0011268992,0.0005077527,0.0009697691,0.0016567743,0.00031040475,0.000812808,0.0005061561,0.00073263847,0.00021606703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001544556,0.000060070244,0.9988606,0.0000078381,0.00013738433,0.000037167185,0.000045184886,0.000031553973,0.00011754802,0.0000091546435,0.000054707358,0.00048446128],"study_design_scores_gemma":[0.0000067010596,0.00007568415,0.9995227,0.0000026786465,0.00005363315,0.00007298192,0.000107877575,0.000049253358,0.000011880421,0.000010512628,0.000083396306,0.0000027555648],"about_ca_topic_score_codex":0.010297491,"about_ca_topic_score_gemma":0.0138561465,"teacher_disagreement_score":0.010297491,"about_ca_system_score_codex":0.00040641558,"about_ca_system_score_gemma":0.0004123822,"threshold_uncertainty_score":0.02047509},"labels":[],"label_agreement":null},{"id":"W2792294365","doi":"10.1038/s41391-018-0033-1","title":"Contemporary approach to predict early biochemical recurrence after radical prostatectomy: update of the Walz nomogram","year":2018,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"Memorial Sloan-Kettering Cancer Center","keywords":"Nomogram; Medicine; Prostatectomy; Prostate cancer; Biochemical recurrence; Urology; Surgical margin; Cutoff; Lymph node; Oncology; Internal medicine; Cancer","score_opus":0.014345637019967977,"score_gpt":0.2704611743642489,"score_spread":0.2561155373442809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792294365","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0860326,0.6286621,0.14699812,0.0698009,0.012314966,0.00048764973,0.008598702,0.0013109997,0.045793995],"genre_scores_gemma":[0.47436783,0.3428944,0.12441812,0.014587142,0.022229958,0.0006799866,0.013297206,0.0006349001,0.0068904576],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978934,0.0006184988,0.00032300738,0.00030493917,0.00073874183,0.00012149717],"domain_scores_gemma":[0.9916289,0.0032867258,0.0009614812,0.00039733504,0.0032974617,0.00042805646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008106212,0.00155482,0.0027274885,0.0048368867,0.00079542486,0.0037115528,0.0023352106,0.0010269289,0.0025228038],"category_scores_gemma":[0.014635903,0.00046242922,0.001963937,0.003258789,0.0010934804,0.0032519705,0.002115175,0.0031844673,0.0014327139],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004786964,0.00012400257,0.14873596,0.0018122394,0.0009167872,0.00016376647,0.00022546921,0.005165168,0.0005927776,0.005507716,0.04367289,0.79260457],"study_design_scores_gemma":[0.00043806017,0.0017059252,0.36573765,0.00969069,0.0064525395,0.0062158126,0.0017266022,0.061642084,0.0025825459,0.048829053,0.49422887,0.00075016596],"about_ca_topic_score_codex":0.006569018,"about_ca_topic_score_gemma":0.014384647,"teacher_disagreement_score":0.008106212,"about_ca_system_score_codex":0.0015756831,"about_ca_system_score_gemma":0.0026594982,"threshold_uncertainty_score":0.042870283},"labels":[],"label_agreement":null},{"id":"W2807263742","doi":"10.1038/s41391-018-0053-x","title":"Statin use and time to progression in men on active surveillance for prostate cancer","year":2018,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Prostate cancer; Hazard ratio; Statin; Internal medicine; Proportional hazards model; Biopsy; Oncology; Odds ratio; Prostate biopsy; Veterans Affairs; Cancer; Confidence interval","score_opus":0.009936188862071796,"score_gpt":0.29954680451586746,"score_spread":0.28961061565379564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807263742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966827,0.0018344197,0.000055940396,0.00010819299,0.000016813083,0.000005930961,0.00035104944,0.0000072251096,0.0009376486],"genre_scores_gemma":[0.99890614,0.00033764687,0.000031842144,0.000028400967,0.000015790374,0.000002509346,0.00018760092,0.0000015527453,0.00048848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982613,0.00003933136,0.00001629872,0.000033224347,0.000026460428,0.000058573496],"domain_scores_gemma":[0.9991375,0.0001630259,0.0003030153,0.00004969663,0.00005502752,0.00029170333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037882096,0.00018289094,0.00037654923,0.0005218449,0.00045511173,0.0006706317,0.00029559786,0.0007413222,0.0021142785],"category_scores_gemma":[0.0016096698,0.0002944014,0.00077594206,0.00073376374,0.00015618402,0.00048664465,0.00040966566,0.0009361829,0.0001980059],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013097522,0.00009060201,0.9959573,0.0000146385955,0.00013383495,0.00004573224,0.000054205924,0.00007749542,0.00018471373,0.00002835696,0.00007611279,0.002027088],"study_design_scores_gemma":[0.000016400567,0.00020778051,0.9988825,0.000009403692,0.00011573984,0.00008076738,0.0001164351,0.00029130423,0.000051114195,0.00003469858,0.00018859096,0.000005241066],"about_ca_topic_score_codex":0.015010531,"about_ca_topic_score_gemma":0.01651049,"teacher_disagreement_score":0.015010531,"about_ca_system_score_codex":0.0002938633,"about_ca_system_score_gemma":0.0005254659,"threshold_uncertainty_score":0.02984631},"labels":[],"label_agreement":null},{"id":"W2888204653","doi":"10.1038/s41391-018-0079-0","title":"Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations","year":2018,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":377,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Medicine; Prostate cancer; Androgen deprivation therapy; Oncology; Prostate-specific antigen; Orchiectomy; Internal medicine; Disease; Androgen; Cancer; Hormone","score_opus":0.0343580190018654,"score_gpt":0.37411717218706964,"score_spread":0.3397591531852042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888204653","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011050996,0.85276306,0.00095628365,0.13977876,0.001955531,0.000015365951,0.000061581864,0.00004698897,0.0033173608],"genre_scores_gemma":[0.014022685,0.9493375,0.003484303,0.023088243,0.00912984,0.000045555174,0.000102814585,0.00002064822,0.000768309],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974564,0.0010564742,0.0003715965,0.00032306116,0.00064547715,0.00014705978],"domain_scores_gemma":[0.99031633,0.004596988,0.0012027747,0.00018904237,0.0024723846,0.0012224505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074073947,0.00048025418,0.0011373487,0.0014542623,0.0006726374,0.0025046412,0.0014747229,0.003018493,0.0038265951],"category_scores_gemma":[0.010150002,0.00023798832,0.0008118964,0.001559665,0.0016099265,0.004256426,0.001443908,0.0045314054,0.001096118],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016089532,0.00014243922,0.0044524805,0.0048882305,0.00007902634,0.00053030706,0.00035374783,0.00072082767,0.0004104169,0.009442402,0.08284467,0.8959745],"study_design_scores_gemma":[0.00016385238,0.0006891105,0.012141561,0.03312899,0.00028881436,0.006628919,0.002138677,0.0018305125,0.00038943358,0.031115534,0.91136134,0.00012333726],"about_ca_topic_score_codex":0.0036100054,"about_ca_topic_score_gemma":0.007769879,"teacher_disagreement_score":0.0074073947,"about_ca_system_score_codex":0.0026538281,"about_ca_system_score_gemma":0.0065513174,"threshold_uncertainty_score":0.039174557},"labels":[],"label_agreement":null},{"id":"W2898214566","doi":"10.1038/s41391-018-0103-4","title":"Distinct transcriptional repertoire of the androgen receptor in ETS fusion-negative prostate cancer","year":2018,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"National Cancer Institute; Prostate Cancer Foundation; American Cancer Society","keywords":"Androgen receptor; Prostate cancer; TMPRSS2; Fusion gene; Gene; Transcriptome; Biology; Cancer research; Gene expression; Computational biology; Cancer; Genetics; Medicine; Internal medicine","score_opus":0.02060646178513444,"score_gpt":0.31552128378867295,"score_spread":0.2949148220035385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898214566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961455,0.0008378227,0.0006298036,0.000030460376,0.0000055842856,0.000008732831,0.0017894913,0.000043956996,0.0005085894],"genre_scores_gemma":[0.993932,0.00037732502,0.0005048671,0.000054165954,0.0000060114694,0.000018566583,0.004622757,0.000016745062,0.00046760062],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998417,0.000012976569,0.000007786598,0.000052011772,0.000055768036,0.000029778656],"domain_scores_gemma":[0.9998964,0.000025372032,0.000029178002,0.000009490849,0.000020128262,0.000019423176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012532317,0.00016148019,0.00020967548,0.00052505004,0.00016018815,0.0003058285,0.00010889162,0.00015219243,0.0011090132],"category_scores_gemma":[0.00021182818,0.00010435922,0.00026505662,0.00054950744,0.00017009366,0.000097562515,0.00024558412,0.000186485,0.00028424006],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012216431,0.00007143352,0.15019447,0.00024298854,0.00014430478,0.0003581247,0.00020713624,0.00094487634,0.83023584,0.00031079876,0.00059685623,0.015471595],"study_design_scores_gemma":[0.00002313792,0.0003250489,0.9455739,0.000020934891,0.00012758303,0.0018483805,0.00032286247,0.0021693541,0.045602124,0.0005531056,0.0034123948,0.000021134669],"about_ca_topic_score_codex":0.0006698428,"about_ca_topic_score_gemma":0.0015690476,"teacher_disagreement_score":0.0011090132,"about_ca_system_score_codex":0.00017060693,"about_ca_system_score_gemma":0.00017090146,"threshold_uncertainty_score":0.003709972},"labels":[],"label_agreement":null},{"id":"W2904591950","doi":"10.1038/s41391-018-0101-6","title":"Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillance","year":2018,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bible College; University of Toronto; University of Calgary; Genome British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Prostate cancer; DECIPHER; Odds ratio; Internal medicine; Cancer; Prostate; Oncology; Prospective cohort study; Confidence interval; Pathology; Bioinformatics; Biology","score_opus":0.014028717673787399,"score_gpt":0.30657281169247086,"score_spread":0.2925440940186835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904591950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957677,0.0005542003,0.0011557844,0.0001043042,0.00003790307,0.000028055776,0.001070331,0.00005974602,0.0012220346],"genre_scores_gemma":[0.99741083,0.00009321436,0.0011114982,0.00004696621,0.00002636207,0.000015569887,0.00100147,0.000008787402,0.00028528465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998387,0.000481932,0.0001227793,0.00043801012,0.00042394246,0.00014636312],"domain_scores_gemma":[0.99115187,0.0039281645,0.0024273193,0.00065852166,0.0010346621,0.0007994364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003563303,0.0005661867,0.0006073392,0.0015163515,0.00033239948,0.0015644581,0.0006256796,0.0006977258,0.0018987104],"category_scores_gemma":[0.010567706,0.00028616708,0.00046418232,0.0006745681,0.0004901577,0.000627394,0.0009645803,0.0007810132,0.00068504363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087313703,0.00007162304,0.99033433,0.00003499665,0.00011661044,0.00006118981,0.000043340395,0.00053901284,0.0011250315,0.000050157643,0.00033133134,0.006419266],"study_design_scores_gemma":[0.00006043651,0.0010636715,0.98304015,0.000043572945,0.0001795408,0.0018130117,0.00014772624,0.008637545,0.0034609558,0.00024366626,0.0012833712,0.000026370246],"about_ca_topic_score_codex":0.00048514406,"about_ca_topic_score_gemma":0.00084616046,"teacher_disagreement_score":0.003563303,"about_ca_system_score_codex":0.00026995025,"about_ca_system_score_gemma":0.0003257329,"threshold_uncertainty_score":0.018844783},"labels":[],"label_agreement":null},{"id":"W2916721669","doi":"10.1038/s41391-019-0134-5","title":"MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer","year":2019,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"U.S. National Library of Medicine; National Cancer Institute; Stand Up To Cancer; Prostate Cancer Foundation","keywords":"Medicine; Prostate cancer; Castration; Oncology; MAPK/ERK pathway; Prostate; Cancer research; Cancer; Internal medicine; Orchiectomy; Signal transduction; Hormone","score_opus":0.012716193190937043,"score_gpt":0.26943046605789966,"score_spread":0.25671427286696263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916721669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98924583,0.007257534,0.0006340679,0.00024678023,0.000014161014,0.000038101916,0.00051887095,0.00005812503,0.001986517],"genre_scores_gemma":[0.99636734,0.0018848577,0.0005459907,0.00006800104,0.000010768834,0.000014592425,0.0005646126,0.0000051544175,0.0005387067],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999126,0.000011007814,0.000005345481,0.000016717579,0.000037895723,0.000016416821],"domain_scores_gemma":[0.99992216,0.000011829443,0.000030218089,0.00000562103,0.000012868984,0.000017254997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017925481,0.00026772954,0.00020403537,0.00023099888,0.00016448615,0.00031054093,0.00013691357,0.00012981254,0.0011504501],"category_scores_gemma":[0.00016217194,0.000088020446,0.0001840887,0.00022776276,0.0001566988,0.000103030674,0.0001372232,0.00037206014,0.00018791422],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016136448,0.00020344768,0.050166186,0.0008527007,0.000107077074,0.0005906744,0.00008609335,0.0019468224,0.8839284,0.00037166354,0.0012533972,0.058879923],"study_design_scores_gemma":[0.00020404751,0.0034773152,0.587657,0.00014448963,0.00031761552,0.009202784,0.00022825318,0.0076678577,0.3675697,0.0007722125,0.022724263,0.00003437219],"about_ca_topic_score_codex":0.0005818714,"about_ca_topic_score_gemma":0.0018117616,"teacher_disagreement_score":0.0011504501,"about_ca_system_score_codex":0.00041090688,"about_ca_system_score_gemma":0.00026767876,"threshold_uncertainty_score":0.003848672},"labels":[],"label_agreement":null},{"id":"W2970718683","doi":"10.1038/s41391-019-0169-7","title":"The development and comparative effectiveness of a patient-centered prostate biopsy report: a prospective, randomized study","year":2019,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Cancer Institute; Institute for Prostate Cancer Research","keywords":"Medicine; Prostate cancer; Prostate biopsy; Prostate; Biopsy; Randomized controlled trial; Health literacy; Critical appraisal; Gynecology; Internal medicine; Cancer; Health care; Pathology; Alternative medicine","score_opus":0.0783889632913936,"score_gpt":0.3989811399414064,"score_spread":0.3205921766500128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970718683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98409677,0.005379453,0.0013389201,0.00051479647,0.000848795,0.0052673337,0.00041502048,0.00004837755,0.0020905181],"genre_scores_gemma":[0.99074614,0.001709564,0.0022768017,0.0006217996,0.0007552318,0.0028827293,0.00032060212,0.000018280489,0.00066878827],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9730724,0.02067108,0.0018179294,0.0018535809,0.0018030936,0.0007819239],"domain_scores_gemma":[0.96715087,0.019937804,0.0068665873,0.0022056862,0.0011601232,0.0026789862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014186364,0.0020295687,0.0039097783,0.0011638036,0.0010531854,0.0023933572,0.0021070733,0.005316331,0.0072448635],"category_scores_gemma":[0.027807081,0.001550063,0.004448534,0.0011136021,0.0036226816,0.003408338,0.0015042666,0.0051364596,0.0009948398],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9760705,0.012322734,0.0021905284,0.0003607108,0.0014792202,0.000016945844,0.000077533616,0.00014611246,0.00024954177,0.00011123296,0.00009522956,0.006879548],"study_design_scores_gemma":[0.7482817,0.2427543,0.004829889,0.000092859525,0.002573823,0.000030206478,0.000103016464,0.0005187866,0.00028907665,0.00017826658,0.0003078439,0.000040151142],"about_ca_topic_score_codex":0.0016195509,"about_ca_topic_score_gemma":0.0015796346,"teacher_disagreement_score":0.014186364,"about_ca_system_score_codex":0.0020508529,"about_ca_system_score_gemma":0.0027014255,"threshold_uncertainty_score":0.07502556},"labels":[],"label_agreement":null},{"id":"W2971000693","doi":"10.1038/s41391-019-0167-9","title":"Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance","year":2019,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Genome British Columbia","funders":"DOD Prostate Cancer Research Program; U.S. Department of Defense","keywords":"DECIPHER; Prostatectomy; Medicine; Prostate cancer; Odds ratio; Interquartile range; Internal medicine; Biochemical recurrence; Logistic regression; Cancer; Oncology; Bioinformatics; Biology","score_opus":0.011843077504119537,"score_gpt":0.3020673336915859,"score_spread":0.29022425618746633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971000693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99889094,0.00022799338,0.00017457502,0.00004956014,0.0000070518913,0.0000052123046,0.00014232835,0.0000069773955,0.00049549824],"genre_scores_gemma":[0.99941945,0.000054220338,0.00020953751,0.000023342462,0.000011968231,0.0000024705896,0.00017170297,0.0000019071076,0.00010544018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997352,0.00006585605,0.00002596524,0.00007541445,0.000044858178,0.00005273672],"domain_scores_gemma":[0.99853337,0.00038789847,0.0007168653,0.000086862674,0.000078714336,0.00019630873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006622476,0.00043375656,0.0003167641,0.0006003418,0.0002851795,0.0007410637,0.00030122657,0.00036426715,0.0013246048],"category_scores_gemma":[0.002235564,0.00016365638,0.00034802515,0.00034908997,0.00028999685,0.00041937517,0.00052275695,0.00041326132,0.00028582162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016522266,0.00001360435,0.99763787,0.000007010691,0.0000129467935,0.00006253151,0.000019851192,0.00006636143,0.0002796282,0.000017618708,0.000055278728,0.0016621524],"study_design_scores_gemma":[0.00001037148,0.00027841027,0.995751,0.000014385866,0.00006363701,0.0013471975,0.00014805266,0.0009355159,0.00079226133,0.00012326559,0.00052913564,0.0000066700836],"about_ca_topic_score_codex":0.00055294565,"about_ca_topic_score_gemma":0.0013860059,"teacher_disagreement_score":0.0013246048,"about_ca_system_score_codex":0.00015739333,"about_ca_system_score_gemma":0.00021532604,"threshold_uncertainty_score":0.004431188},"labels":[],"label_agreement":null},{"id":"W2986207312","doi":"10.1038/s41391-019-0183-9","title":"Temporal trends and social barriers for inpatient palliative care delivery in metastatic prostate cancer patients receiving critical care therapies","year":2019,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Logistic regression; Prostate cancer; Odds ratio; Internal medicine; Palliative care; Guideline; Cancer; Confidence interval; Emergency medicine; Oncology","score_opus":0.04898119967804012,"score_gpt":0.39570985567276235,"score_spread":0.34672865599472225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986207312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962837,0.0004752853,0.000064133914,0.00091468985,0.000015370708,0.000012317257,0.00082871073,0.0000030149952,0.0014028039],"genre_scores_gemma":[0.9989279,0.00024937387,0.000045065535,0.00008462651,0.00001692201,0.000013629686,0.00045627117,0.0000029496962,0.00020332835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998926,0.00018234702,0.0001947053,0.00012709567,0.0001270678,0.0004428061],"domain_scores_gemma":[0.99354047,0.0010825229,0.0036130683,0.00011933881,0.00067420676,0.0009704731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089959765,0.00012861322,0.00024215526,0.0012134544,0.0011015644,0.001475114,0.00065518945,0.0006547662,0.004905976],"category_scores_gemma":[0.00749227,0.0002526729,0.00070403755,0.0029408894,0.0004374856,0.0018054834,0.0014056279,0.0013728065,0.00025483995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008791676,0.000045899127,0.9968054,0.00002161787,0.000043088028,0.00005339107,0.0008391628,0.000059089627,0.00003101396,0.0001606961,0.0002818331,0.001570946],"study_design_scores_gemma":[0.0000031677405,0.000042879747,0.99031675,0.00004646113,0.000020048365,0.000112031084,0.008419364,0.00028549103,0.000029994011,0.000087422224,0.00062653807,0.000009885402],"about_ca_topic_score_codex":0.05002614,"about_ca_topic_score_gemma":0.08552405,"teacher_disagreement_score":0.05002614,"about_ca_system_score_codex":0.0019964695,"about_ca_system_score_gemma":0.002475065,"threshold_uncertainty_score":0.0994699},"labels":[],"label_agreement":null},{"id":"W2987812493","doi":"10.1038/s41391-019-0184-8","title":"Prostate cancer characteristics and cancer-specific mortality of Native American patients","year":2019,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Propensity score matching; Internal medicine; Native american; Cohort; Cancer; Oncology; Epidemiology; Prostate cancer; Proportional hazards model; Incidence (geometry); Cumulative incidence","score_opus":0.014596022023864364,"score_gpt":0.2994869626917785,"score_spread":0.28489094066791415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987812493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998514,0.00015100146,0.00003568761,0.000031956384,0.000006965868,0.0000022231832,0.00045323189,0.0000033393576,0.0008015651],"genre_scores_gemma":[0.9992368,0.000061523795,0.000015106314,0.000021711372,0.000010511066,0.0000017514667,0.0003163365,0.0000013132099,0.00033510558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998216,0.00003829293,0.000013499739,0.000039149614,0.00002533679,0.000062146195],"domain_scores_gemma":[0.9994031,0.00011439649,0.0001865002,0.000034527147,0.000049342336,0.00021214841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023389418,0.00016620288,0.00023957352,0.0006348611,0.000426087,0.00055236334,0.00020059463,0.0003589376,0.0032597508],"category_scores_gemma":[0.0010737123,0.00025474155,0.00040836845,0.0009929069,0.00020736779,0.0005944131,0.00032967495,0.0004976817,0.00032495375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016020103,0.000049121303,0.9986442,0.000004846176,0.000054608827,0.00004496985,0.00006349886,0.00006364765,0.00014651367,0.000021041897,0.00012257353,0.0006248404],"study_design_scores_gemma":[0.0000034083134,0.000042109958,0.9993285,0.0000016387331,0.000017226308,0.00009784362,0.00021152229,0.00012086143,0.000018991852,0.000016806302,0.00013795703,0.000003087812],"about_ca_topic_score_codex":0.014681026,"about_ca_topic_score_gemma":0.017429095,"teacher_disagreement_score":0.014681026,"about_ca_system_score_codex":0.00026490985,"about_ca_system_score_gemma":0.00034997304,"threshold_uncertainty_score":0.029191196},"labels":[],"label_agreement":null},{"id":"W2989585042","doi":"10.1038/s41391-019-0190-x","title":"A polymeric paste-drug formulation for intratumoral treatment of prostate cancer","year":2019,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of British Columbia","funders":"","keywords":"LNCaP; Medicine; Prostate cancer; In vivo; Toxicity; Urology; Drug; Prostate; Bicalutamide; Context (archaeology); Internal medicine; Oncology; Pharmacology; Cancer; Biology","score_opus":0.010629452941724286,"score_gpt":0.26602333177113396,"score_spread":0.25539387882940967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989585042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8751788,0.022356896,0.08901616,0.0008276765,0.0005475582,0.00037323916,0.00030047522,0.0006429791,0.010756241],"genre_scores_gemma":[0.9603028,0.0036105162,0.03052192,0.00013846728,0.000056874887,0.00008883965,0.00012882282,0.00007362699,0.0050781234],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999329,0.000012003581,0.0000046639825,0.00001921367,0.000023029594,0.000008199732],"domain_scores_gemma":[0.9999583,0.000011583019,0.000009850566,0.0000027636888,0.000007731495,0.000009737595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017223506,0.00022386413,0.00019528421,0.00024585563,0.000141286,0.00016487243,0.00021114643,0.00034179795,0.001055395],"category_scores_gemma":[0.00016005045,0.00012998893,0.00013930732,0.00011929447,0.0001208137,0.00027184913,0.00016328758,0.0004585445,0.00034375244],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008233105,0.00005603054,0.000036691832,0.000096145115,0.0000047337644,0.00007190568,0.00001190234,0.00016612117,0.9846994,0.0002093975,0.0001313698,0.01443407],"study_design_scores_gemma":[0.000041760657,0.0007652522,0.0006920998,0.000010755598,0.000022264769,0.0004982403,0.000006323433,0.0023445173,0.98834246,0.000063096835,0.0072052116,0.000008005201],"about_ca_topic_score_codex":0.00025090243,"about_ca_topic_score_gemma":0.00052561966,"teacher_disagreement_score":0.001055395,"about_ca_system_score_codex":0.00014651885,"about_ca_system_score_gemma":0.00016999473,"threshold_uncertainty_score":0.0035306215},"labels":[],"label_agreement":null},{"id":"W2989637365","doi":"10.1038/s41391-019-0188-4","title":"Germline polymorphisms associated with impaired survival outcomes and somatic tumor alterations in advanced prostate cancer","year":2019,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Prostate Cancer Foundation; U.S. Department of Health and Human Services","keywords":"Prostate cancer; Germline; Somatic cell; Biology; Androgen deprivation therapy; Cancer research; Germline mutation; Cancer; Oncology; Genetics; Internal medicine; Medicine; Gene; Mutation","score_opus":0.014099709778439133,"score_gpt":0.30703609069556975,"score_spread":0.29293638091713065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989637365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99877197,0.00038071358,0.00013230629,0.00007791011,0.0000130750095,0.0000019363004,0.00025297463,0.000007133745,0.00036191472],"genre_scores_gemma":[0.99962175,0.0000657764,0.000043735,0.0000147646515,0.000011640969,8.807035e-7,0.00009862754,0.0000023878738,0.00014034266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975294,0.00005558638,0.000026634949,0.00006760937,0.000037361235,0.00005996529],"domain_scores_gemma":[0.9990864,0.00020091319,0.00044579044,0.000049311973,0.0000547072,0.00016296332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021402219,0.0002872794,0.00024219288,0.00056402385,0.00032841013,0.00055362703,0.00031682753,0.00045050812,0.002858356],"category_scores_gemma":[0.0011914184,0.00016664833,0.0004390393,0.0011231819,0.00026828452,0.0002218879,0.0003042328,0.00062123744,0.00019484953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012212757,0.00008720126,0.98484415,0.000033408553,0.0004697164,0.00083201635,0.00011353455,0.00043641482,0.006079107,0.00019704366,0.00023463758,0.005451522],"study_design_scores_gemma":[0.000027710796,0.00012415812,0.9969854,0.000008693657,0.00017228314,0.0010707868,0.00009337003,0.0004759095,0.00042949396,0.00027537253,0.00032791737,0.000008955255],"about_ca_topic_score_codex":0.002518841,"about_ca_topic_score_gemma":0.0021241636,"teacher_disagreement_score":0.002858356,"about_ca_system_score_codex":0.00016148297,"about_ca_system_score_gemma":0.00019292452,"threshold_uncertainty_score":0.009562194},"labels":[],"label_agreement":null},{"id":"W2995508660","doi":"10.1038/s41391-019-0197-3","title":"Validation of a genomic classifier for prediction of metastasis and prostate cancer-specific mortality in African-American men following radical prostatectomy in an equal access healthcare setting","year":2019,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Decipher Biosciences (Canada)","funders":"Decipher Biosciences","keywords":"Medicine; Prostatectomy; Prostate cancer; Veterans Affairs; Cohort; Oncology; Metastasis; Internal medicine; Proportional hazards model; Cancer","score_opus":0.046102383448168444,"score_gpt":0.3629684454035066,"score_spread":0.3168660619553382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995508660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980452,0.00008758331,0.00083744864,0.0001349693,0.000018135857,0.000028220287,0.00053442316,0.000013729933,0.00030028066],"genre_scores_gemma":[0.99783427,0.000038569186,0.0011198486,0.00005165904,0.000022515582,0.000019744974,0.00078418426,0.0000036525748,0.00012556004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998992,0.00035320228,0.00008664224,0.00021650555,0.00017629158,0.00017532751],"domain_scores_gemma":[0.9976318,0.001142305,0.00035865005,0.00018202917,0.00047192513,0.00021326143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002229571,0.00039914402,0.00050099136,0.0010592928,0.0006290166,0.0010603757,0.0005804445,0.00074825576,0.0010691946],"category_scores_gemma":[0.006408978,0.00015939555,0.0004357894,0.00062710204,0.00032335692,0.00051006535,0.00063334,0.0005739677,0.00034452672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055954163,0.00037105696,0.98322624,0.000019902354,0.0001362434,0.0001224512,0.00013081923,0.0010882542,0.0017085053,0.00007206014,0.0006373088,0.011927584],"study_design_scores_gemma":[0.00013656516,0.00074233115,0.9248908,0.000040938805,0.00031828534,0.000580998,0.0011627898,0.06793457,0.002569822,0.0004687312,0.001127957,0.000026334706],"about_ca_topic_score_codex":0.006227929,"about_ca_topic_score_gemma":0.0086364215,"teacher_disagreement_score":0.006227929,"about_ca_system_score_codex":0.00036436872,"about_ca_system_score_gemma":0.0006816663,"threshold_uncertainty_score":0.012383401},"labels":[],"label_agreement":null},{"id":"W2998787624","doi":"10.1038/s41391-020-0204-8","title":"“TREXIT 2020”: why the time to abandon transrectal prostate biopsy starts now","year":2020,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; North York General Hospital","funders":"Academy of Medical Sciences; Medical Research Council; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Urology; Prostate; Prostate biopsy; General surgery; Biopsy; Prostatic Diseases; Radiology; Internal medicine; Cancer","score_opus":0.01912169922602932,"score_gpt":0.30679842372236965,"score_spread":0.28767672449634035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998787624","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007707462,0.9856775,0.00008618787,0.009796193,0.0025881329,0.0000051740444,0.00009423318,0.00002143631,0.0016541397],"genre_scores_gemma":[0.0013089229,0.9792388,0.00030539825,0.016217545,0.0013189927,0.0000124244525,0.00016507492,0.00001652905,0.0014164248],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99934226,0.00019288484,0.00009413321,0.00007294613,0.00019705715,0.00010068362],"domain_scores_gemma":[0.9981616,0.0008239962,0.00024028166,0.000031313073,0.0005383031,0.00020450455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025401094,0.0007338589,0.0016351895,0.0011818897,0.00039028394,0.0019530281,0.0010624835,0.0028418663,0.011678724],"category_scores_gemma":[0.0039687078,0.00028505447,0.0010428106,0.0018726554,0.00081683113,0.0033736066,0.0011119366,0.00462945,0.003785411],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017327156,0.000031754036,0.00018302172,0.020725114,0.0001017973,0.00010252508,0.000078659104,0.00023076615,0.00039237057,0.010284238,0.2715141,0.69618237],"study_design_scores_gemma":[0.00004745516,0.00006536339,0.0007286639,0.014278135,0.000107598,0.00029132812,0.00008403927,0.000048337624,0.000054453703,0.0026485394,0.98162717,0.000018998624],"about_ca_topic_score_codex":0.006083392,"about_ca_topic_score_gemma":0.015288712,"teacher_disagreement_score":0.011678724,"about_ca_system_score_codex":0.0019204088,"about_ca_system_score_gemma":0.005925722,"threshold_uncertainty_score":0.039069235},"labels":[],"label_agreement":null},{"id":"W2999247109","doi":"10.1038/s41391-020-0202-x","title":"GLUT1 expression in high-risk prostate cancer: correlation with 18F-FDG-PET/CT and clinical outcome","year":2020,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Prostate cancer; Standardized uptake value; Prostatectomy; Biochemical recurrence; GLUT1; Positron emission tomography; Cancer; Oncology; Internal medicine; Nuclear medicine; Urology; Glucose uptake","score_opus":0.03135587439209314,"score_gpt":0.3583003405511894,"score_spread":0.3269444661590963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999247109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99656963,0.0017072927,0.00014169053,0.00008634828,0.0000105880645,0.0000060339335,0.00015248987,0.000010327515,0.0013156235],"genre_scores_gemma":[0.99939394,0.0002011808,0.00006258623,0.000013316839,0.0000103154425,0.0000027154397,0.000112676906,0.0000022633842,0.00020097294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985325,0.000035598197,0.000010913173,0.00003158256,0.000028351058,0.000040175877],"domain_scores_gemma":[0.99936455,0.0001338692,0.0002492905,0.000029603256,0.00005862557,0.0001640788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035600647,0.00025706182,0.0003440239,0.00067356724,0.00024278638,0.000733468,0.00029075594,0.00056963204,0.0015870458],"category_scores_gemma":[0.0013205651,0.0001815356,0.0002980093,0.00077099603,0.00034507303,0.00046270105,0.00030803867,0.00050510885,0.00023726263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005184904,0.000036494777,0.9951448,0.000017797875,0.00006955582,0.00017285708,0.000036586498,0.00010540896,0.0011182108,0.00002389575,0.00008131782,0.0026746558],"study_design_scores_gemma":[0.0000041666394,0.00010436456,0.99819,0.000005898113,0.000058027326,0.00077020924,0.00007923079,0.00027556144,0.00028134315,0.000068646594,0.0001570313,0.0000054253737],"about_ca_topic_score_codex":0.0012007334,"about_ca_topic_score_gemma":0.0013105402,"teacher_disagreement_score":0.0015870458,"about_ca_system_score_codex":0.00038107389,"about_ca_system_score_gemma":0.0001950795,"threshold_uncertainty_score":0.0053091645},"labels":[],"label_agreement":null},{"id":"W3010512320","doi":"10.1038/s41391-020-0222-6","title":"Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Enzalutamide; Prostate cancer; Internal medicine; Hazard ratio; Meta-analysis; Oncology; Abiraterone; Prostate-specific antigen; Subgroup analysis; Systematic review; Confidence interval; MEDLINE; Cancer; Androgen receptor","score_opus":0.10707339501233894,"score_gpt":0.41024200089539536,"score_spread":0.30316860588305644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010512320","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005964138,0.99279684,0.0003369097,0.00008706368,0.00014167292,0.00012658862,0.00029757567,0.000022015012,0.0002271325],"genre_scores_gemma":[0.19472587,0.8009222,0.0016418158,0.0010183718,0.00018533375,0.0003219755,0.0006040902,0.00003208429,0.00054828095],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9970126,0.0012966287,0.0008267873,0.0004001883,0.00032044176,0.00014334416],"domain_scores_gemma":[0.99624616,0.0024148528,0.0008595769,0.00013832164,0.000238761,0.00010233084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045873243,0.0021986596,0.013622065,0.0023764863,0.000396247,0.002135534,0.0016696635,0.0016865389,0.0044714846],"category_scores_gemma":[0.010295548,0.0011897144,0.024046091,0.0037739808,0.00050471467,0.001514751,0.0011223038,0.0021858716,0.0003487831],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008571792,0.000059329897,0.0024978963,0.2946235,0.66966534,0.000110498026,0.00008730084,0.00072107103,0.00036188363,0.0001298071,0.0007843398,0.022387246],"study_design_scores_gemma":[0.0024558376,0.00038618493,0.002700498,0.011044986,0.9812267,0.00006779259,0.00004379031,0.00015796651,0.0000839426,0.00015612182,0.0016473947,0.000028736824],"about_ca_topic_score_codex":0.008841135,"about_ca_topic_score_gemma":0.02880868,"teacher_disagreement_score":0.013622065,"about_ca_system_score_codex":0.0020491458,"about_ca_system_score_gemma":0.0022433952,"threshold_uncertainty_score":0.024260342},"labels":[],"label_agreement":null},{"id":"W3010797324","doi":"10.1038/s41391-020-0225-3","title":"Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical prostatectomy","year":2020,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Frailty in Older Adults","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Prostatectomy; Comorbidity; Poisson regression; Prostate cancer; Logistic regression; Body mass index; Internal medicine; Adverse effect; Proportional hazards model; Surgery; Cancer; Population","score_opus":0.016901421123786682,"score_gpt":0.2789260181397211,"score_spread":0.26202459701593445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010797324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99879044,0.0005678255,0.00003674362,0.000083893,0.000024091007,0.0000030631256,0.00012188422,0.0000019561496,0.00037012523],"genre_scores_gemma":[0.99960774,0.00013247196,0.000019527337,0.000028653278,0.000020581163,0.0000013545625,0.00011677772,6.2348124e-7,0.00007225202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978596,0.000041714968,0.000030180507,0.000030545994,0.000039764178,0.000071794355],"domain_scores_gemma":[0.99881136,0.00018944635,0.00046270218,0.000053720145,0.00008006912,0.00040283042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028791965,0.00031367506,0.00045712024,0.00049999665,0.00044939425,0.0006688346,0.00031589856,0.00056066987,0.00181119],"category_scores_gemma":[0.002572085,0.00022735466,0.0006647016,0.0006902319,0.00038709788,0.00046494664,0.00063261,0.00085182366,0.00015529672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013303914,0.000030131529,0.99864525,0.000009155822,0.000059793718,0.000050434355,0.00003597362,0.0000414388,0.000082131264,0.000008585986,0.000065427506,0.0008385982],"study_design_scores_gemma":[0.0000037292514,0.00006975347,0.9994517,0.000006320596,0.000031027954,0.0001044882,0.00011339481,0.00012712048,0.000011524913,0.0000236851,0.000053812084,0.0000034250756],"about_ca_topic_score_codex":0.0056280983,"about_ca_topic_score_gemma":0.0079334555,"teacher_disagreement_score":0.0056280983,"about_ca_system_score_codex":0.0002854311,"about_ca_system_score_gemma":0.0004726753,"threshold_uncertainty_score":0.011190712},"labels":[],"label_agreement":null},{"id":"W3010996088","doi":"10.1038/s41391-020-0221-7","title":"A pilot window-of-opportunity study of preoperative fluvastatin in localized prostate cancer","year":2020,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; Sunnybrook Hospital; University of Toronto; University Health Network","funders":"Canada Research Chairs; Prostate Cancer Canada; Government of Canada; Canadian Urological Association Scholarship Fund; Movember Foundation; Princess Margaret Cancer Foundation; Canadian Institutes of Health Research; Canadian Urological Association","keywords":"Fluvastatin; Medicine; Prostate cancer; Urology; Prostatectomy; Statin; Internal medicine; Prostate; HMG-CoA reductase; Gastroenterology; Cancer; Reductase; Endocrinology; Simvastatin; Enzyme; Chemistry","score_opus":0.02436231324144302,"score_gpt":0.2957526616567957,"score_spread":0.2713903484153527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010996088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99912626,0.00012821278,0.00014834455,0.000027660426,0.000012059434,0.00035401108,0.0001018763,0.000007942368,0.000093604714],"genre_scores_gemma":[0.9984358,0.00008055561,0.000329792,0.00007061236,0.000051394814,0.0004592519,0.00023789982,0.0000039648253,0.00033063535],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992299,0.0003304136,0.000029960458,0.00013797526,0.00006875403,0.00020290237],"domain_scores_gemma":[0.99880314,0.00017407839,0.00016182884,0.0001499541,0.00007059665,0.0006403599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014473689,0.0010847063,0.0013968559,0.00034951855,0.000803289,0.0005450984,0.0004885994,0.0007163092,0.0025869233],"category_scores_gemma":[0.0009248934,0.00054899673,0.0012580222,0.0003622361,0.0010109647,0.0005399568,0.00066900096,0.0012881474,0.000498538],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6636277,0.09892634,0.15560672,0.00033458497,0.0010953662,0.0011447379,0.0009631114,0.0006023058,0.055965967,0.00012859223,0.0007236809,0.02088094],"study_design_scores_gemma":[0.035842896,0.708918,0.24811247,0.000013072069,0.0006449829,0.00046016782,0.0003203473,0.00063460565,0.0038117976,0.00013181161,0.0010426063,0.000067238216],"about_ca_topic_score_codex":0.0021414899,"about_ca_topic_score_gemma":0.0027097783,"teacher_disagreement_score":0.0025869233,"about_ca_system_score_codex":0.00083078496,"about_ca_system_score_gemma":0.0020172514,"threshold_uncertainty_score":0.008654118},"labels":[],"label_agreement":null},{"id":"W3011253373","doi":"10.1038/s41391-020-0218-2","title":"Long-term use of 5-alpha-reductase inhibitors is safe and effective in men on active surveillance for prostate cancer","year":2020,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Prostate cancer; Proportional hazards model; Dutasteride; Internal medicine; Cohort; Tumor progression; Cancer; Prostatectomy; Interquartile range; Prostate; Oncology; Gynecology; Urology","score_opus":0.020697620251121502,"score_gpt":0.3076824948219813,"score_spread":0.2869848745708598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011253373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9286421,0.05813401,0.00060327206,0.0019596857,0.00024413243,0.00007239281,0.0008022085,0.000085805754,0.009456443],"genre_scores_gemma":[0.99331653,0.004755571,0.00022507751,0.00049440755,0.00015130414,0.000009840735,0.00029104814,0.0000052136616,0.00075092586],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996443,0.0001352793,0.00002641314,0.00003458356,0.00010494259,0.000054383203],"domain_scores_gemma":[0.9979601,0.00076996617,0.0006997403,0.00008220487,0.00011645189,0.00037146697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068278785,0.00014750053,0.0006128881,0.00029510647,0.0002940903,0.00045833975,0.00023433972,0.00042422675,0.002216997],"category_scores_gemma":[0.003079583,0.00011322078,0.00075099996,0.00034579064,0.00020650339,0.00038236333,0.0001684925,0.0007144831,0.00022052602],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03147428,0.0033477081,0.46988454,0.00073804444,0.0015194254,0.0005269967,0.00019975136,0.00034150283,0.004145698,0.00025903818,0.0032951671,0.48426774],"study_design_scores_gemma":[0.0010443517,0.007935226,0.9848557,0.00016227583,0.000531859,0.0005667555,0.00013745824,0.00026234475,0.00057436584,0.00021144623,0.003705802,0.00001225444],"about_ca_topic_score_codex":0.00163587,"about_ca_topic_score_gemma":0.0062729986,"teacher_disagreement_score":0.002216997,"about_ca_system_score_codex":0.00029423193,"about_ca_system_score_gemma":0.0005594242,"threshold_uncertainty_score":0.007416606},"labels":[],"label_agreement":null},{"id":"W3013252558","doi":"10.1038/s41391-020-0226-2","title":"Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier","year":2020,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Decipher Biosciences (Canada)","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Cancer Institute; U.S. Department of Health and Human Services; Prostate Cancer Foundation; National Institutes of Health; Myriad Genetics; U.S. Department of Defense","keywords":"Medicine; Prostate cancer; Prostatectomy; Internal medicine; Hazard ratio; Proportional hazards model; Oncology; Confidence interval; Receiver operating characteristic; Androgen deprivation therapy; Retrospective cohort study; Cancer; Metastasis","score_opus":0.024925093902370066,"score_gpt":0.29739661438848863,"score_spread":0.27247152048611856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013252558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878721,0.0014583943,0.005077448,0.0014801123,0.00021054229,0.000036782647,0.001975663,0.00025792123,0.0016309669],"genre_scores_gemma":[0.9958597,0.00020813828,0.0013049089,0.00012537,0.00009350302,0.000010391245,0.0018979432,0.000033104534,0.00046693406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845994,0.0008251619,0.00009221869,0.0003097463,0.00017917836,0.00013376064],"domain_scores_gemma":[0.9933861,0.004949432,0.00044866305,0.00040148804,0.0003748706,0.00043934677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0063109635,0.0011352596,0.0010303573,0.0012136127,0.0004590584,0.0017750907,0.0006631927,0.0009204513,0.001410478],"category_scores_gemma":[0.012037629,0.00022737397,0.0012858289,0.0005379466,0.00037710313,0.0009964516,0.00080936134,0.00087803736,0.00063333753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040346053,0.00047250537,0.8707916,0.00011154738,0.0014796306,0.0003279554,0.00011652388,0.060977425,0.0012576084,0.00025735822,0.0047804527,0.055392697],"study_design_scores_gemma":[0.00029014263,0.002043437,0.25917962,0.00008507332,0.0016453774,0.0010175998,0.00051315245,0.72845894,0.002102105,0.0023132088,0.0022714157,0.0000799084],"about_ca_topic_score_codex":0.0060398793,"about_ca_topic_score_gemma":0.0057870494,"teacher_disagreement_score":0.0063109635,"about_ca_system_score_codex":0.00054565567,"about_ca_system_score_gemma":0.0011391932,"threshold_uncertainty_score":0.03337598},"labels":[],"label_agreement":null},{"id":"W3024250410","doi":"10.1038/s41391-020-0238-y","title":"Association between metformin medication, genetic variation and prostate cancer risk","year":2020,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Metformin; Prostate cancer; Medicine; Single-nucleotide polymorphism; Genome-wide association study; Oncology; Internal medicine; Cancer; SNP; Genotype; Genetics; Biology; Gene; Insulin","score_opus":0.007682693245645688,"score_gpt":0.2504964930523784,"score_spread":0.24281379980673273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024250410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949463,0.002553747,0.0004057106,0.00022968012,0.000051890558,0.0000057478023,0.0005545277,0.00001771907,0.0012345323],"genre_scores_gemma":[0.99865496,0.0003022004,0.00037031333,0.00004306271,0.00003772708,0.0000037764498,0.00012075613,0.0000043397504,0.00046284177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994972,0.00020963076,0.000046523055,0.00011916026,0.00007698092,0.00005052853],"domain_scores_gemma":[0.998887,0.00045462308,0.00033146495,0.000105706305,0.00006135147,0.00015984544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052510685,0.00023405682,0.00027001332,0.0005376319,0.0003192407,0.00051744725,0.00023102356,0.00054269447,0.0028446312],"category_scores_gemma":[0.0021366817,0.00019385129,0.00057181035,0.00086273026,0.00017762433,0.00017476466,0.00021339886,0.00060429313,0.00012382373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010846193,0.00006810356,0.98920166,0.000033165048,0.0009729863,0.00017109157,0.000045128643,0.00017542034,0.0031163555,0.00016961059,0.00018445923,0.004777423],"study_design_scores_gemma":[0.0000139598205,0.000091488204,0.99859315,0.000005396911,0.00018694767,0.00019120132,0.00002568711,0.00044090083,0.00013255878,0.00008598178,0.00022816313,0.0000044598823],"about_ca_topic_score_codex":0.005996136,"about_ca_topic_score_gemma":0.005769722,"teacher_disagreement_score":0.005996136,"about_ca_system_score_codex":0.00017534888,"about_ca_system_score_gemma":0.00027199896,"threshold_uncertainty_score":0.011922479},"labels":[],"label_agreement":null},{"id":"W3024368357","doi":"10.1038/s41391-020-0236-0","title":"Concurrent or layered treatment with radium-223 and enzalutamide or abiraterone/prednisone: real-world clinical outcomes in patients with metastatic castration-resistant prostate cancer","year":2020,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Bayer","keywords":"Enzalutamide; Medicine; Prednisone; Prostate cancer; Abiraterone; Internal medicine; Oncology; Abiraterone acetate; Urology; Cancer; Surgery; Androgen deprivation therapy","score_opus":0.06797416319239474,"score_gpt":0.38368940349988756,"score_spread":0.3157152403074928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024368357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99731785,0.0009940214,0.00019233245,0.00004197188,0.000004868,0.000027160171,0.001036238,0.000007240105,0.00037834726],"genre_scores_gemma":[0.998126,0.00020611884,0.00024363055,0.000031065734,0.000008551825,0.000018486939,0.0013158008,0.000002393265,0.00004793378],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878055,0.00044527336,0.00019368455,0.00024408089,0.00024849625,0.000087922264],"domain_scores_gemma":[0.9945167,0.00066556723,0.0039498555,0.0002652532,0.00026809008,0.00033463677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015891902,0.00021265283,0.00041406264,0.00052849523,0.00022789808,0.0009071278,0.0003663773,0.00024589148,0.0009382018],"category_scores_gemma":[0.003771443,0.00014935854,0.00064922,0.0012034951,0.00030008433,0.00043818823,0.000550746,0.0003536833,0.00017402203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002858982,0.000107267355,0.9879117,0.00010096469,0.0003990448,0.00007303699,0.00006273664,0.0005269899,0.00036362562,0.00002275629,0.00018401958,0.0073888274],"study_design_scores_gemma":[0.00026138753,0.0015894995,0.99365777,0.0000561927,0.00041729072,0.00080054323,0.00015187114,0.001247703,0.0005107592,0.00007449721,0.001210696,0.000021854754],"about_ca_topic_score_codex":0.0020659587,"about_ca_topic_score_gemma":0.0040405346,"teacher_disagreement_score":0.0020659587,"about_ca_system_score_codex":0.0006475362,"about_ca_system_score_gemma":0.00051249575,"threshold_uncertainty_score":0.008404553},"labels":[],"label_agreement":null},{"id":"W3040939293","doi":"10.1038/s41391-020-0248-9","title":"The deleterious association between proton pump inhibitors and prostate cancer-specific mortality – a population-based cohort study","year":2020,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute; Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre; Public Health Ontario; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Prostate cancer; Internal medicine; Androgen deprivation therapy; Proportional hazards model; Oncology; Comorbidity; Population; Cohort; Cancer","score_opus":0.019052532879357244,"score_gpt":0.30562329382675785,"score_spread":0.2865707609474006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040939293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99708885,0.0007195629,0.00026756918,0.00014421628,0.000046103658,0.000012639644,0.0010852675,0.000011551411,0.00062409695],"genre_scores_gemma":[0.9985201,0.0002769527,0.000119652694,0.00006541593,0.00003602936,0.000008078887,0.00048048585,0.0000060067837,0.0004871519],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924904,0.0002118218,0.00006379342,0.00025122837,0.000094760486,0.0001291842],"domain_scores_gemma":[0.9983524,0.00018076856,0.0003966086,0.0005536004,0.00021820828,0.00029851176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010928191,0.00052054157,0.00050968456,0.00057445344,0.00089341664,0.0012287187,0.00065537804,0.0010046432,0.0028172627],"category_scores_gemma":[0.0020277877,0.00089564675,0.0016570726,0.0010860938,0.00034100705,0.00066943344,0.0006397963,0.0013830344,0.0003976196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007047786,0.00011420218,0.99483997,0.000017246373,0.0011532619,0.00021137703,0.000094141935,0.00008195403,0.0009538188,0.000061920226,0.0003980264,0.0013692811],"study_design_scores_gemma":[0.000032177828,0.00015733595,0.99842167,0.000004734927,0.0003605348,0.00031229353,0.000112822214,0.00019772555,0.00005573032,0.000052355343,0.00028205462,0.000010557844],"about_ca_topic_score_codex":0.015578198,"about_ca_topic_score_gemma":0.018720862,"teacher_disagreement_score":0.015578198,"about_ca_system_score_codex":0.00033324223,"about_ca_system_score_gemma":0.00066984823,"threshold_uncertainty_score":0.030975044},"labels":[],"label_agreement":null},{"id":"W3042563221","doi":"10.1038/s41391-020-0253-z","title":"The use of a novel smartphone app for monitoring male luts treatment during the COVID-19 outbreak","year":2020,"lang":"en","type":"letter","venue":"Prostate Cancer and Prostatic Diseases","topic":"Genital Health and Disease","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Société Internationale D'Urologie","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Smartphone app; Outbreak; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Smartphone application; Internal medicine; Virology; Internet privacy; Disease; Computer science; Multimedia; Infectious disease (medical specialty)","score_opus":0.08337341857376741,"score_gpt":0.34082639771717926,"score_spread":0.25745297914341186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042563221","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012966328,0.0009728736,0.00031651065,0.9587525,0.006297418,0.00006781735,0.00018808193,0.00008986328,0.020348534],"genre_scores_gemma":[0.05146521,0.0012224636,0.0007696764,0.9166594,0.008196669,0.00011724563,0.00007373914,0.000046319015,0.021449286],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9979231,0.0008100272,0.00019441468,0.00016515818,0.0004398388,0.00046754067],"domain_scores_gemma":[0.99457586,0.0025009974,0.00043134426,0.0001254094,0.00076901185,0.0015974091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015684203,0.00044590628,0.00045368733,0.00041394797,0.004522932,0.0019102077,0.0008972458,0.017942693,0.007315638],"category_scores_gemma":[0.010221073,0.00038219462,0.0006227796,0.0002591439,0.0009310663,0.0016451636,0.0016941556,0.011571623,0.002263089],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022058877,0.00028657133,0.019560331,0.00017108643,0.000037829963,0.022212867,0.0038503318,0.00014335079,0.001838595,0.0022645935,0.88099355,0.06842037],"study_design_scores_gemma":[0.0001322582,0.00093676674,0.022860134,0.00086713175,0.00007600688,0.014174234,0.01780985,0.0015950729,0.0010524776,0.0027024406,0.93764013,0.00015350473],"about_ca_topic_score_codex":0.023348024,"about_ca_topic_score_gemma":0.041892257,"teacher_disagreement_score":0.023348024,"about_ca_system_score_codex":0.002346981,"about_ca_system_score_gemma":0.0037067404,"threshold_uncertainty_score":0.04642427},"labels":[],"label_agreement":null},{"id":"W3046907373","doi":"10.1038/s41391-020-0264-9","title":"Cardiac biomarkers in patients with prostate cancer and cardiovascular disease receiving gonadotrophin releasing hormone agonist vs antagonist","year":2020,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Ferring","keywords":"Medicine; Prostate cancer; Internal medicine; Agonist; Endocrinology; Myocardial infarction; Cancer; Oncology; Receptor","score_opus":0.009119572914218468,"score_gpt":0.22997595008592514,"score_spread":0.22085637717170667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046907373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99708253,0.0014274287,0.000051032894,0.0001032274,0.000026382837,0.000008601664,0.00015435884,0.0000023609095,0.0011440674],"genre_scores_gemma":[0.99901795,0.0003298506,0.00004094818,0.000093662784,0.00003936754,0.0000065240442,0.00015945453,8.3834277e-7,0.00031136128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998529,0.000033249005,0.000014616337,0.000031704527,0.000025242098,0.000042142186],"domain_scores_gemma":[0.99962056,0.00009868435,0.00013589779,0.000013907072,0.000027323513,0.00010364918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019716471,0.00015189407,0.00033486102,0.00025973262,0.00020489472,0.00038813494,0.000106305735,0.00030610268,0.0015087762],"category_scores_gemma":[0.0009682753,0.00010490709,0.0003535498,0.00046190032,0.00011243162,0.00030345557,0.00019913528,0.00056432496,0.00010030551],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031566217,0.00013156887,0.9886408,0.00004543171,0.00017404645,0.00021975406,0.00005826947,0.00007809425,0.001046752,0.000057148434,0.00015697702,0.006234708],"study_design_scores_gemma":[0.000046028363,0.0007981401,0.99794036,0.00000923357,0.0001256545,0.00030096842,0.00013633515,0.00010976797,0.00013715855,0.0000610021,0.00033039504,0.0000049275536],"about_ca_topic_score_codex":0.00084542943,"about_ca_topic_score_gemma":0.001797953,"teacher_disagreement_score":0.0015087762,"about_ca_system_score_codex":0.00022067242,"about_ca_system_score_gemma":0.00025801995,"threshold_uncertainty_score":0.0050473213},"labels":[],"label_agreement":null},{"id":"W3051475848","doi":"10.1038/s41391-020-00265-5","title":"Long-term outcomes of two ablation techniques for treatment of radio-recurrent prostate cancer","year":2020,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; St Joseph's Health Centre; Western University","funders":"","keywords":"Medicine; Prostate cancer; Salvage therapy; Biochemical recurrence; Androgen deprivation therapy; Urology; Internal medicine; Cryotherapy; Radiation therapy; Oncology; Cancer; Surgery; Prostatectomy; Chemotherapy","score_opus":0.038160783801801205,"score_gpt":0.3603547399509359,"score_spread":0.3221939561491347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3051475848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960349,0.002586768,0.00020784562,0.00007021218,0.000033688048,0.000017945944,0.00027055436,0.000007804255,0.00077028625],"genre_scores_gemma":[0.9987374,0.00030387647,0.000057028516,0.000044139095,0.00004572813,0.00001422893,0.00046700492,0.000004106527,0.00032653307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990314,0.00021107962,0.0001002313,0.00013459854,0.00021670455,0.0003058718],"domain_scores_gemma":[0.99709845,0.00083290937,0.0008335729,0.00026861797,0.00035483806,0.000611653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010460599,0.00031374357,0.000883638,0.00075962424,0.00063725986,0.00097389077,0.0006266016,0.000908911,0.0015608334],"category_scores_gemma":[0.0038484512,0.00015247073,0.0020477069,0.0006007703,0.0005576507,0.00066716346,0.0007693087,0.00096160226,0.0003299872],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034305878,0.0041776425,0.82373875,0.00045938406,0.0042464957,0.0015395181,0.0010475842,0.0021991737,0.004773605,0.00027082494,0.0009098984,0.1223313],"study_design_scores_gemma":[0.00041244854,0.012413683,0.9811127,0.00006738812,0.0013572675,0.0016098103,0.00047258,0.00058497785,0.00085675373,0.00018191672,0.00086855335,0.00006177941],"about_ca_topic_score_codex":0.0017430036,"about_ca_topic_score_gemma":0.0033274894,"teacher_disagreement_score":0.0017430036,"about_ca_system_score_codex":0.0007788404,"about_ca_system_score_gemma":0.0004104381,"threshold_uncertainty_score":0.005650878},"labels":[],"label_agreement":null},{"id":"W3071791057","doi":"10.1038/s41391-020-00266-4","title":"Association of neurovascular bundle preservation with oncological outcomes in patients with high-risk prostate cancer","year":2020,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Neurovascular bundle; Prostate cancer; Prostatectomy; Biochemical recurrence; Proportional hazards model; Internal medicine; Stage (stratigraphy); Urology; Oncology; Metastasis; Cancer; T-stage; Surgery","score_opus":0.010438806374501586,"score_gpt":0.2495457903005261,"score_spread":0.2391069839260245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3071791057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971945,0.0011280989,0.00009477538,0.00017031381,0.000025287092,0.0000036509643,0.00014914884,0.0000029649595,0.0012311933],"genre_scores_gemma":[0.9995372,0.00016758358,0.000022802158,0.000025623516,0.000024149243,0.0000010583534,0.00010463017,8.3746454e-7,0.000116219555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997284,0.000057345427,0.000023882618,0.000043156597,0.0000519465,0.00009528789],"domain_scores_gemma":[0.9989011,0.00021100238,0.00050310756,0.00005589103,0.00008147079,0.00024740674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003013926,0.00014934102,0.0002384885,0.0003352536,0.00037536075,0.00068775576,0.00030875285,0.0003452346,0.001930939],"category_scores_gemma":[0.0021708761,0.00014666996,0.0004646059,0.0007415999,0.00030680007,0.00048060407,0.00048241817,0.0008882754,0.00009870538],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015972674,0.000036258112,0.9974764,0.000011542023,0.00009467053,0.000068442976,0.000024408937,0.00008622119,0.00010165678,0.000031168485,0.00007598363,0.0018336145],"study_design_scores_gemma":[0.0000047170374,0.00007991932,0.99910045,0.000006531954,0.000054975597,0.00021260056,0.00013563824,0.00016502819,0.00002950615,0.000080218655,0.00012626979,0.0000041500266],"about_ca_topic_score_codex":0.002905852,"about_ca_topic_score_gemma":0.0055696317,"teacher_disagreement_score":0.002905852,"about_ca_system_score_codex":0.00029975947,"about_ca_system_score_gemma":0.00047179303,"threshold_uncertainty_score":0.0064596534},"labels":[],"label_agreement":null},{"id":"W3081682286","doi":"10.1038/s41391-020-00276-2","title":"External beam radiation therapy improves survival in low-volume metastatic prostate cancer patients: a North American population-based study","year":2020,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Prostate cancer; External beam radiation; Oncology; Radiation therapy; Internal medicine; Population; Benign prostatic hyperplasia (BPH); Prostate; Urology; Cancer","score_opus":0.013981129130959809,"score_gpt":0.2859139883697841,"score_spread":0.27193285923882426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081682286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982589,0.0007906888,0.000037585516,0.0001093278,0.000011329971,0.0000072181874,0.0002754344,0.000003571317,0.0005060239],"genre_scores_gemma":[0.99905246,0.0003853157,0.0000237812,0.000092424016,0.000023057732,0.000005894467,0.00023109608,0.0000015972378,0.00018440511],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996706,0.0001352274,0.000018477569,0.00007341488,0.00004961827,0.000052717227],"domain_scores_gemma":[0.9995203,0.00009800595,0.00016621573,0.000037068403,0.000052525542,0.0001258485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044511256,0.00032582204,0.0005616305,0.00042849308,0.00055315153,0.0006613019,0.00034161014,0.00064153044,0.0014333574],"category_scores_gemma":[0.0009381902,0.00031727276,0.0009028405,0.0012260572,0.00031081252,0.00044794288,0.00029799083,0.0006891993,0.00015763966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011265834,0.00033603993,0.9943228,0.00003114099,0.00059728004,0.00008134012,0.00008473471,0.00008021236,0.00044418123,0.000018896324,0.00029093178,0.0025859382],"study_design_scores_gemma":[0.000054392858,0.0002787331,0.99900216,0.000004665969,0.00022748706,0.000069334,0.0001054937,0.000068026944,0.00002543441,0.000015813004,0.00014438214,0.0000040917066],"about_ca_topic_score_codex":0.009204707,"about_ca_topic_score_gemma":0.015769286,"teacher_disagreement_score":0.009204707,"about_ca_system_score_codex":0.00038867682,"about_ca_system_score_gemma":0.00044462632,"threshold_uncertainty_score":0.018302262},"labels":[],"label_agreement":null},{"id":"W3087626985","doi":"10.1038/s41391-020-00287-z","title":"Response to the Letter to the Editor: “Association between metformin medication, genetic variation and prostate cancer risk”—genotyping and patient categorization, do they matter?","year":2020,"lang":"en","type":"letter","venue":"Prostate Cancer and Prostatic Diseases","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Genotyping; Prostate cancer; Metformin; Categorization; Oncology; Internal medicine; Variation (astronomy); Cancer; Genotype; Genetics; Artificial intelligence; Gene","score_opus":0.0062534608140989946,"score_gpt":0.2453508171191775,"score_spread":0.2390973563050785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087626985","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028503887,0.0006420052,0.000071920884,0.9688357,0.029177275,0.000009405561,0.000102146805,0.00002152745,0.000855038],"genre_scores_gemma":[0.0020245772,0.0006043609,0.00014340441,0.9438909,0.049729317,0.000024165594,0.00004690148,0.000024081875,0.0035122444],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964294,0.001251377,0.00056290167,0.00047052253,0.00087524403,0.00041058398],"domain_scores_gemma":[0.98772997,0.007044387,0.00091712375,0.0002818902,0.002382909,0.0016437141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004969962,0.0008962896,0.0022435328,0.0010135985,0.003259032,0.0034380222,0.002157699,0.036909405,0.0067378986],"category_scores_gemma":[0.031160781,0.000857613,0.0012646435,0.0009950323,0.0018451799,0.002224842,0.0010290267,0.0317217,0.006931906],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008338185,0.000025898176,0.00063250895,0.00003785101,0.000018573042,0.0007622492,0.000051652092,0.000041230425,0.000081591264,0.00047497655,0.994383,0.0034070592],"study_design_scores_gemma":[0.0003543062,0.00016760855,0.0046818336,0.0007653197,0.00012028983,0.003253865,0.0007142788,0.0011971288,0.00041316228,0.0056477757,0.98251814,0.00016629913],"about_ca_topic_score_codex":0.007997537,"about_ca_topic_score_gemma":0.011153339,"teacher_disagreement_score":0.036909405,"about_ca_system_score_codex":0.0038088884,"about_ca_system_score_gemma":0.004861607,"threshold_uncertainty_score":0.027635515},"labels":[],"label_agreement":null},{"id":"W3089279818","doi":"10.1038/s41391-020-00283-3","title":"KLK3 and TMPRSS2 for molecular lymph-node staging in prostate cancer patients undergoing radical prostatectomy","year":2020,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Urology; TMPRSS2; Biochemical recurrence; Lymph node; Prostate-specific antigen; Internal medicine; Oncology; Cancer","score_opus":0.017307091543038874,"score_gpt":0.31126726274884453,"score_spread":0.29396017120580564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089279818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973405,0.0011671649,0.0003356068,0.00011632056,0.000029197161,0.000022189372,0.00045213383,0.000016125956,0.00052065804],"genre_scores_gemma":[0.99906,0.00012456632,0.00037992734,0.000025239598,0.0000164978,0.000015612355,0.00024473385,0.000002280713,0.00013116159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999729,0.000078206256,0.000027717868,0.000051874147,0.000070342925,0.000042895732],"domain_scores_gemma":[0.9993554,0.00019497467,0.00019253689,0.000032262393,0.00010171287,0.00012315241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082141056,0.00032863,0.00032350802,0.0006602734,0.00020351252,0.0004226797,0.00035365415,0.0003655726,0.0014463596],"category_scores_gemma":[0.0018354608,0.00012146323,0.0003874872,0.00047951384,0.00020702978,0.0002589266,0.00037361056,0.00043276555,0.00029621285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003818798,0.00002343362,0.99483126,0.000027308275,0.000030081446,0.00007124187,0.000031764008,0.00018576675,0.0009528448,0.0000126469895,0.00019666403,0.0032551696],"study_design_scores_gemma":[0.000019664534,0.00020355106,0.9959637,0.000017978886,0.00007852308,0.00048929907,0.000106543164,0.0019009765,0.0007071918,0.00007027461,0.00043486134,0.000007482074],"about_ca_topic_score_codex":0.001731359,"about_ca_topic_score_gemma":0.003337045,"teacher_disagreement_score":0.001731359,"about_ca_system_score_codex":0.00032112503,"about_ca_system_score_gemma":0.00045179445,"threshold_uncertainty_score":0.004838586},"labels":[],"label_agreement":null},{"id":"W3089623857","doi":"10.1038/s41391-020-00288-y","title":"Protective effect of pharmacological castration on metabolic perturbations and cardiovascular disease in the hyperglycemic male ApoE−/−:Ins2+/Akita mouse model","year":2020,"lang":"en","type":"erratum","venue":"Prostate Cancer and Prostatic Diseases","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University; St. Joseph’s Healthcare Hamilton","funders":"McMaster University; Ferring; Astellas Pharma Canada; Canadian Urological Association","keywords":"Orchiectomy; Medicine; Androgen deprivation therapy; Internal medicine; Endocrinology; Castration; Prostate cancer; Leptin; Agonist; Testosterone (patch); Hormone; Cancer; Obesity; Receptor","score_opus":0.022990311777736458,"score_gpt":0.29217838294873927,"score_spread":0.2691880711710028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089623857","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68743443,0.09720051,0.023817461,0.02683382,0.08496736,0.00023084806,0.028123992,0.0037938792,0.04759763],"genre_scores_gemma":[0.55444276,0.1022508,0.025545051,0.0073108654,0.0066418177,0.0003101728,0.013676012,0.0014950457,0.28832746],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977607,0.00002392502,0.000034632845,0.00004422534,0.00008505307,0.000035981226],"domain_scores_gemma":[0.9996958,0.000047096975,0.00007799549,0.000042343825,0.00005904254,0.00007783373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036553512,0.0009930029,0.00070823776,0.0010857726,0.00047962696,0.00050665525,0.00067283196,0.00120209,0.0099225715],"category_scores_gemma":[0.00029906354,0.0003327835,0.00065391586,0.0005875211,0.0005273434,0.00059443625,0.00026062838,0.0018386776,0.0023967398],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0132081155,0.0010152468,0.0026725424,0.0017618898,0.00018801262,0.0035284976,0.00023900809,0.00029530338,0.84197605,0.00447378,0.05767703,0.07296466],"study_design_scores_gemma":[0.0012826739,0.004655623,0.04063418,0.00047653346,0.0013939935,0.0062155686,0.00075676147,0.0014108538,0.6157614,0.0021466012,0.3250129,0.00025291322],"about_ca_topic_score_codex":0.0016239068,"about_ca_topic_score_gemma":0.0026702986,"teacher_disagreement_score":0.0099225715,"about_ca_system_score_codex":0.00026860088,"about_ca_system_score_gemma":0.00048019533,"threshold_uncertainty_score":0.033194304},"labels":[],"label_agreement":null},{"id":"W3119443482","doi":"10.1038/s41391-020-00311-2","title":"Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer","year":2021,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; University of Toronto","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Cancer Institute; Departament d'Universitats, Recerca i Societat de la Informació; Xarxa de Bancs de Tumors de Catalunya; Cancer Council Tasmania; World Cancer Research Fund; Prostate Cancer Foundation; Medical Research Council; Canadian Cancer Society Research Institute; Manchester Biomedical Research Centre; National Institutes of Health; DOD Prostate Cancer Research Program; Hellenic Health Foundation; Instituto de Salud Carlos III; Tays; National Institute of Biomedical Imaging and Bioengineering; Cancer Council Victoria; University of Oxford; Deutsche Krebshilfe; National Health and Medical Research Council; Universiti Malaya; Health Technology Assessment Programme; Prostate Cancer Foundation of Australia; Vetenskapsrådet; KU Leuven; Canadian Institutes of Health Research; Bulgarian National Science Fund; Cancerfonden; Fonds Wetenschappelijk Onderzoek; Vlaamse regering; National Institute for Health and Care Research; Gentofte Hospital; Bundesministerium für Bildung und Forschung; Ovarian Cancer Research Fund; Prostate Cancer Canada; Cancer Australia; Australian Government; Norges Forskningsråd; Swedish Cancer Foundation; Fundação para a Ciência e a Tecnologia; ZonMw; U.S. Department of Defense; Cancer Research UK; Cancer Research Coordinating Committee; Royal Marsden NHS Foundation Trust; National Cancer Research Institute; Fundación Marqués de Valdecilla; Deutsches Krebsforschungszentrum; Cancer Research Institute; European Commission; Associazione Italiana per la Ricerca sul Cancro; Breast Cancer Research Foundation","keywords":"Medicine; Prostate cancer; Risk stratification; Single-nucleotide polymorphism; Oncology; Internal medicine; Polygenic risk score; Hazard ratio; Stratification (seeds); Cancer; Genotype; Genetics; Gene; Biology","score_opus":0.016638907708647222,"score_gpt":0.2930057873374157,"score_spread":0.2763668796287685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119443482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98050565,0.0004929917,0.017304763,0.00028881774,0.000020248292,0.0000259452,0.00060445454,0.00012215698,0.00063501345],"genre_scores_gemma":[0.99527574,0.00006335702,0.0040828814,0.00004981033,0.000025153038,0.000009646776,0.00037680153,0.000011864334,0.00010476586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976488,0.0015835287,0.00010020328,0.0003664431,0.00018184348,0.00011913583],"domain_scores_gemma":[0.9904193,0.0068310187,0.0012554596,0.00087417813,0.00027836178,0.0003416905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066327346,0.00077446096,0.0006039905,0.00056697376,0.00025870648,0.0006167523,0.00036352282,0.00055123965,0.0018710133],"category_scores_gemma":[0.011136513,0.00022028813,0.001263977,0.00052965817,0.0003972576,0.00046238338,0.00081073295,0.0009742912,0.00029366638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002804341,0.00022870048,0.90293664,0.00010121015,0.0013548653,0.00013345286,0.00010149761,0.036576733,0.0040972857,0.00039319033,0.0006627571,0.05060934],"study_design_scores_gemma":[0.00031013257,0.002389171,0.7474881,0.000067498615,0.0014600927,0.0007568088,0.000068677255,0.2348064,0.0059865853,0.004675854,0.0019083705,0.00008231688],"about_ca_topic_score_codex":0.0011623334,"about_ca_topic_score_gemma":0.0012089895,"teacher_disagreement_score":0.0066327346,"about_ca_system_score_codex":0.00028634584,"about_ca_system_score_gemma":0.00039938002,"threshold_uncertainty_score":0.03507763},"labels":[],"label_agreement":null},{"id":"W3122268760","doi":"10.1038/s41391-020-00308-x","title":"Clinical implications of genomic alterations in metastatic prostate cancer","year":2021,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"","keywords":"Medicine; Prostate cancer; Oncology; Prostate; Internal medicine; Cancer","score_opus":0.11878480565701459,"score_gpt":0.4820014845827602,"score_spread":0.3632166789257456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3122268760","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000053690466,0.99899,0.000054320604,0.00031061913,0.00015788799,0.0000017193177,0.000022166338,0.000003323817,0.00040636968],"genre_scores_gemma":[0.000519351,0.9984634,0.000098097466,0.0003594272,0.00026306428,0.000002396205,0.000034792323,8.3846726e-7,0.00025859394],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974746,0.00006108803,0.00003684352,0.00004843428,0.00008401071,0.00002218141],"domain_scores_gemma":[0.9992999,0.00043580256,0.00008918199,0.000013887662,0.0001284827,0.000032623077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000729971,0.0007655618,0.0015420744,0.0016323079,0.00016446703,0.0010438315,0.00081615767,0.00105216,0.0038703692],"category_scores_gemma":[0.0017572464,0.00024120497,0.0006677798,0.0019000265,0.00039613555,0.0008491623,0.0006547431,0.0015197217,0.0011057357],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009852987,0.000026219546,0.00042408644,0.01585179,0.00023221424,0.00023848332,0.00003804944,0.00046800697,0.00074814877,0.0019769822,0.034586832,0.9453106],"study_design_scores_gemma":[0.000054594984,0.00009799658,0.002849222,0.011026839,0.0007106879,0.0018168571,0.000089755355,0.00015208912,0.00036336467,0.0035743096,0.97922885,0.000035385852],"about_ca_topic_score_codex":0.0014141,"about_ca_topic_score_gemma":0.0029932687,"teacher_disagreement_score":0.0038703692,"about_ca_system_score_codex":0.00055743783,"about_ca_system_score_gemma":0.0011421297,"threshold_uncertainty_score":0.012947679},"labels":[],"label_agreement":null},{"id":"W3124219898","doi":"10.1038/s41391-021-00403-7","title":"Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24","year":2021,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institut National de la Recherche Scientifique","funders":"National Institute of Biomedical Imaging and Bioengineering; Agence Nationale de la Recherche; National Cancer Institute; National Institute for Health and Care Research; Cancer Research UK","keywords":"Single-nucleotide polymorphism; Ancestry-informative marker; Genetic genealogy; Hazard ratio; Proportional hazards model; Demography; Medicine; African american; Genotype; Biology; Genetics; Internal medicine; Gene; Population; Confidence interval; Environmental health","score_opus":0.024638332198318843,"score_gpt":0.289394839521805,"score_spread":0.26475650732348616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3124219898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973239,0.0003821308,0.00095747324,0.00013981269,0.000018516528,0.0000029648463,0.0003142796,0.000030865194,0.0008299305],"genre_scores_gemma":[0.9992943,0.000057188718,0.00013505113,0.000013881863,0.000012216507,0.0000017617699,0.0001552811,0.000012200951,0.00031803356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846005,0.0006754619,0.000082251856,0.00040379472,0.000103691396,0.0002747364],"domain_scores_gemma":[0.9952049,0.0021772054,0.001015313,0.00080896344,0.0003005146,0.00049307174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002186986,0.00056359504,0.000534528,0.0011867587,0.0006746466,0.001192166,0.0007609273,0.0006868496,0.0058745933],"category_scores_gemma":[0.008024916,0.00035945553,0.001494436,0.0012472579,0.00060672534,0.0007517483,0.0011740951,0.0007583282,0.00062971865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023890204,0.000012760234,0.9951933,0.000009701071,0.0004229585,0.000091130205,0.00014095235,0.00021706337,0.0007237978,0.000115574185,0.000104962885,0.0027288245],"study_design_scores_gemma":[0.000006142105,0.0000613055,0.9969656,0.0000071978443,0.0001821159,0.0002905099,0.00017342986,0.0016143933,0.00018292514,0.0002811294,0.00022606664,0.000009233529],"about_ca_topic_score_codex":0.0058049755,"about_ca_topic_score_gemma":0.0054408205,"teacher_disagreement_score":0.0058745933,"about_ca_system_score_codex":0.000174772,"about_ca_system_score_gemma":0.00032428466,"threshold_uncertainty_score":0.019652486},"labels":[],"label_agreement":null},{"id":"W3126274126","doi":"10.1038/s41391-020-00310-3","title":"Treatment of nonmetastatic castration-resistant prostate cancer: focus on second-generation androgen receptor inhibitors","year":2021,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Bayer HealthCare","keywords":"Medicine; Enzalutamide; Prostate cancer; Oncology; Androgen deprivation therapy; Internal medicine; Androgen receptor; Disease; Adverse effect; Cancer","score_opus":0.059184624419738714,"score_gpt":0.3692282572156028,"score_spread":0.3100436327958641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126274126","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005142293,0.9963736,0.00016891002,0.0016496396,0.00023786353,0.0000049119885,0.00001206322,0.000004681589,0.0010341547],"genre_scores_gemma":[0.005245504,0.9919247,0.00036486392,0.001493795,0.0005230538,0.000010859994,0.000029877394,0.0000034628533,0.00040388355],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99955493,0.00014268915,0.000075220734,0.00007375303,0.000115045856,0.000038269132],"domain_scores_gemma":[0.998686,0.00082574197,0.00019476104,0.00002120169,0.00021679889,0.000055505567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012090638,0.00036965092,0.0008445969,0.0006506646,0.00016383515,0.0007843818,0.000644001,0.0006765472,0.0016149284],"category_scores_gemma":[0.0014148058,0.00012704752,0.0007920986,0.00058602844,0.00036954542,0.00091024255,0.00044521948,0.0017812517,0.00036211716],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018091314,0.00007884674,0.00062413816,0.024332292,0.0002598353,0.00036422533,0.00014403267,0.00078558555,0.0015673094,0.0052867443,0.02998339,0.93639266],"study_design_scores_gemma":[0.00012969758,0.00054531085,0.004076951,0.0218793,0.000631344,0.0040600966,0.00022698836,0.0005449464,0.0010544114,0.0043183677,0.9624906,0.00004195448],"about_ca_topic_score_codex":0.0007154036,"about_ca_topic_score_gemma":0.0024961494,"teacher_disagreement_score":0.0016149284,"about_ca_system_score_codex":0.000530182,"about_ca_system_score_gemma":0.0010077803,"threshold_uncertainty_score":0.0063942075},"labels":[],"label_agreement":null},{"id":"W3126881335","doi":"10.1038/s41391-021-00322-7","title":"ZRSR2 overexpression is a frequent and early event in castration-resistant prostate cancer development","year":2021,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Prevention of Organ Failure; BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Prostate cancer; Transcriptome; Androgen deprivation therapy; Androgen receptor; Gene knockdown; Gene expression profiling; Medicine; Oncology; Biology; Cancer research; Gene; Bioinformatics; Cancer; Gene expression; Internal medicine; Genetics","score_opus":0.022490576941124545,"score_gpt":0.3309283767807692,"score_spread":0.30843779983964464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126881335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896492,0.003785133,0.0027817744,0.00010173896,0.000023576786,0.00004534527,0.0018835958,0.0002394495,0.001490307],"genre_scores_gemma":[0.99329585,0.0012926152,0.0012356831,0.000051757863,0.000009348584,0.000030434365,0.0026338033,0.000020317691,0.001430167],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99977607,0.000018888526,0.000016455395,0.000046170982,0.0000984795,0.000044027507],"domain_scores_gemma":[0.9998319,0.000014824001,0.00008312343,0.00001599694,0.000022947908,0.00003114104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018481504,0.00029694068,0.00025968062,0.00052986573,0.00021044961,0.0003678139,0.00013800673,0.00018457361,0.0017382511],"category_scores_gemma":[0.00012735037,0.0001541248,0.0003957764,0.00041743595,0.00021668739,0.00014384724,0.0002546478,0.0004807658,0.00043396212],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018992236,0.000029497312,0.0069667795,0.00006979194,0.000024362604,0.00012547823,0.000021002239,0.00010255064,0.98966277,0.000087711356,0.00016315625,0.0025569864],"study_design_scores_gemma":[0.000027665003,0.0009843681,0.2544169,0.00002217415,0.00010875017,0.0018016244,0.00013275201,0.0010594804,0.73155564,0.00012245851,0.009746277,0.000021886406],"about_ca_topic_score_codex":0.0007946221,"about_ca_topic_score_gemma":0.001355474,"teacher_disagreement_score":0.0017382511,"about_ca_system_score_codex":0.00033473014,"about_ca_system_score_gemma":0.0002722182,"threshold_uncertainty_score":0.005815029},"labels":[],"label_agreement":null},{"id":"W3132823884","doi":"10.1038/s41391-021-00319-2","title":"Clinical significance of STEAP1 extracellular vesicles in prostate cancer","year":2021,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Lawson Health Research Institute; University of British Columbia","funders":"Networks of Centres of Excellence of Canada; Michael Smith Health Research BC; Prostate Cancer Canada; Natural Sciences and Engineering Research Council of Canada; Government of Canada; Canadian Glycomics Network; Movember Foundation","keywords":"Prostate cancer; Prostate; Medicine; Cancer; Flow cytometry; Oncology; Internal medicine; Pathology; Cancer research; Immunology","score_opus":0.016024451209401897,"score_gpt":0.3142544522330362,"score_spread":0.29823000102363434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132823884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98456466,0.01051523,0.0008662321,0.00029557265,0.000025724958,0.00004491243,0.0005684319,0.0000580486,0.0030610592],"genre_scores_gemma":[0.9984805,0.00072478404,0.00028861585,0.000041528565,0.00001657295,0.0000060698244,0.0002285738,0.0000045834045,0.00020881167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979717,0.00003694035,0.000015353688,0.00004564553,0.00007090805,0.000033918546],"domain_scores_gemma":[0.99954116,0.00010827587,0.00016529919,0.000021127062,0.00010252048,0.00006173782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041614348,0.00015651394,0.0002130876,0.00059085793,0.00034449765,0.0005969034,0.00019952508,0.0003125297,0.0017058793],"category_scores_gemma":[0.0007553056,0.000091765825,0.00018432229,0.0005855377,0.00025215186,0.00022065746,0.0003799619,0.00040891225,0.00021118025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015842572,0.00009480565,0.9095244,0.00041904798,0.00015111256,0.0018367149,0.00014853332,0.00071103894,0.034933478,0.0004391828,0.0013297861,0.048827637],"study_design_scores_gemma":[0.000027232662,0.0005455703,0.96100634,0.000080009035,0.00015566035,0.011675039,0.0003057303,0.0021585142,0.018243669,0.00058458454,0.0051970533,0.000020582262],"about_ca_topic_score_codex":0.00076082756,"about_ca_topic_score_gemma":0.0010136068,"teacher_disagreement_score":0.0017058793,"about_ca_system_score_codex":0.00039921273,"about_ca_system_score_gemma":0.0002861652,"threshold_uncertainty_score":0.0057067275},"labels":[],"label_agreement":null},{"id":"W3136111932","doi":"10.1038/s41391-021-00345-0","title":"Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study","year":2021,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Ferring","keywords":"Medicine; Prostate cancer; Lean body mass; Endocrinology; Internal medicine; Prospective cohort study; Glycated hemoglobin; Urology; Body mass index; Luteinizing hormone; Testosterone (patch); Diabetes mellitus; Hormone; Cancer; Type 2 diabetes; Body weight","score_opus":0.011179617786627488,"score_gpt":0.29430138754657953,"score_spread":0.28312176975995207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136111932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99850684,0.00024241705,0.0000786742,0.00003170339,0.000013451806,0.000011220554,0.0008298822,0.0000036692793,0.00028212304],"genre_scores_gemma":[0.99812,0.00014700556,0.00010779041,0.00004446804,0.000017884366,0.000012652234,0.0011088877,0.0000052252317,0.00043618996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996076,0.00008268469,0.000031864234,0.00013415662,0.000054070613,0.0000896503],"domain_scores_gemma":[0.9994282,0.000045644876,0.00018098287,0.0001253523,0.00004906629,0.00017064843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051826617,0.0005525745,0.00074875937,0.0005787092,0.00066055515,0.000849722,0.00048738858,0.0006131878,0.0019936801],"category_scores_gemma":[0.0007647717,0.00075090374,0.0010078513,0.0014195598,0.00030929846,0.00073059346,0.00055516575,0.0011083579,0.00041141544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019161159,0.0001388497,0.99563867,0.000009823122,0.0002717656,0.00012712604,0.00005945512,0.00003457835,0.0007480692,0.000023491457,0.000157085,0.00087506545],"study_design_scores_gemma":[0.000070242204,0.00027412584,0.9988669,0.0000032631513,0.00011313776,0.00017893066,0.00013213778,0.0000700317,0.00005282828,0.000019596917,0.00021107243,0.00000768659],"about_ca_topic_score_codex":0.008587527,"about_ca_topic_score_gemma":0.010904219,"teacher_disagreement_score":0.008587527,"about_ca_system_score_codex":0.00046071588,"about_ca_system_score_gemma":0.00041277194,"threshold_uncertainty_score":0.017075121},"labels":[],"label_agreement":null},{"id":"W3137551365","doi":"10.1038/s41391-021-00346-z","title":"Comprehensive Lifestyle Improvement Program for Prostate Cancer (CLIPP) is associated with improvement in weight and components of metabolic syndrome in men exposed to androgen deprivation therapy for prostate cancer","year":2021,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of Arizona; American Cancer Society","keywords":"Medicine; Prostate cancer; Androgen deprivation therapy; Metabolic syndrome; Waist; Cancer; Internal medicine; Obesity; Blood pressure; Prostate; Urology; Oncology; Gynecology","score_opus":0.020541543273309582,"score_gpt":0.3007896316176852,"score_spread":0.2802480883443756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137551365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99619895,0.0016849707,0.00010514492,0.0002459967,0.00005137811,0.00007904524,0.0002681676,0.000026242824,0.0013398987],"genre_scores_gemma":[0.9981881,0.00048753567,0.0001570668,0.00014689773,0.00004227359,0.000019738438,0.00030974112,0.000002261891,0.00064631674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997483,0.00009517191,0.000017162822,0.000035592187,0.000052963616,0.00005088611],"domain_scores_gemma":[0.9992526,0.00014850104,0.0002215647,0.000045760542,0.000056259913,0.00027525617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039710198,0.0002064343,0.00039232444,0.00026684525,0.00027448448,0.00031598532,0.00023552106,0.00033756756,0.0018741953],"category_scores_gemma":[0.0015886765,0.00016351131,0.00057036604,0.00054397964,0.0001266009,0.00020200381,0.00034878094,0.0006992706,0.00009204803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022666102,0.012595437,0.7985164,0.0004123128,0.0033521687,0.00018518137,0.00018787633,0.0004143191,0.003147831,0.00011488527,0.001387416,0.15702009],"study_design_scores_gemma":[0.00021827404,0.0018604356,0.99728274,0.000011440636,0.00018097952,0.000021804195,0.000027985901,0.000118857024,0.00006880098,0.000014806101,0.00019073274,0.0000031758138],"about_ca_topic_score_codex":0.008993083,"about_ca_topic_score_gemma":0.014373733,"teacher_disagreement_score":0.008993083,"about_ca_system_score_codex":0.00024412828,"about_ca_system_score_gemma":0.0004792963,"threshold_uncertainty_score":0.017881513},"labels":[],"label_agreement":null},{"id":"W3151408999","doi":"10.1038/s41391-021-00339-y","title":"Long-term outcomes of prostate radiotherapy for newly-diagnosed metastatic prostate cancer","year":2021,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Memorial University of Newfoundland; Ottawa Hospital; Ottawa Regional Cancer Foundation; University of Ottawa","funders":"","keywords":"Medicine; Prostate cancer; Prostate; Androgen deprivation therapy; Oncology; Internal medicine; Radiation therapy; Urology; Proportional hazards model; Population; Cohort; Cancer","score_opus":0.028107309114878583,"score_gpt":0.34211549416891707,"score_spread":0.3140081850540385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3151408999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860139,0.008375044,0.00014539757,0.00041497606,0.00008101759,0.00001256441,0.0020314204,0.000010368263,0.0029154322],"genre_scores_gemma":[0.9974598,0.00074908993,0.00001992174,0.000050513518,0.00005476595,0.0000038100575,0.0012376592,0.0000027605904,0.00042158758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995141,0.000105139574,0.000050699586,0.00006236655,0.000100710444,0.00016700073],"domain_scores_gemma":[0.99766684,0.00040909596,0.0010247008,0.00011742836,0.00026779447,0.00051413476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000706169,0.00020476388,0.0004359621,0.0005298306,0.00053657143,0.00069398695,0.0005863486,0.00052902114,0.0024171248],"category_scores_gemma":[0.0038662474,0.00014969817,0.001413779,0.000800135,0.00025390572,0.0007561107,0.00075797125,0.0009644593,0.00024979253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011248279,0.00013426418,0.98573154,0.00010547041,0.00062007323,0.00022597144,0.00011174882,0.00048027266,0.00017087323,0.00008618306,0.0005625709,0.010646345],"study_design_scores_gemma":[0.000012020446,0.00021748464,0.9985475,0.000026778573,0.00020336396,0.0002505552,0.00012433062,0.00012352045,0.00003451937,0.00007700612,0.00037302598,0.00000991903],"about_ca_topic_score_codex":0.010052639,"about_ca_topic_score_gemma":0.02139437,"teacher_disagreement_score":0.010052639,"about_ca_system_score_codex":0.0010097297,"about_ca_system_score_gemma":0.0006859204,"threshold_uncertainty_score":0.019988298},"labels":[],"label_agreement":null},{"id":"W3157926668","doi":"10.1038/s41391-021-00366-9","title":"Diagnostic yield of fusion magnetic resonance-guided prostate biopsy versus cognitive-guided biopsy in biopsy-naive patients: a head-to-head randomized controlled trial","year":2021,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Biopsy; Prostate cancer; Prostate biopsy; Prostate; McNemar's test; Prostate-specific antigen; Magnetic resonance imaging; Randomized controlled trial; Radiology; Urology; Internal medicine; Cancer","score_opus":0.02844666721220782,"score_gpt":0.32145940397533135,"score_spread":0.2930127367631235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157926668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819032,0.010590888,0.0007816556,0.00086264947,0.0013197667,0.0018050094,0.00062648754,0.00012233015,0.0019880275],"genre_scores_gemma":[0.9931914,0.002044884,0.00071922794,0.0008093603,0.00075144874,0.0010225917,0.00044343152,0.00001789802,0.0009997955],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984125,0.0008351834,0.0000881717,0.0003617293,0.00010088334,0.00020141919],"domain_scores_gemma":[0.99789053,0.000992892,0.00047032043,0.00017860834,0.00013312076,0.0003345587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021668195,0.0026932047,0.0055892174,0.0004831937,0.00073002285,0.0019199501,0.0017332401,0.0032645466,0.006778429],"category_scores_gemma":[0.0046051634,0.0012410537,0.0042268364,0.0006540016,0.002181268,0.0016905377,0.0007484062,0.0044170823,0.001044903],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99341327,0.001221135,0.00048151152,0.00031007544,0.0016920989,0.000016017208,0.000024703775,0.00011771078,0.00026718603,0.00004052607,0.00018280413,0.002233083],"study_design_scores_gemma":[0.9531025,0.038320214,0.0027811702,0.000071669805,0.0041274843,0.000034231445,0.0000483726,0.00065196084,0.00025079408,0.00031204981,0.00026171262,0.000037863985],"about_ca_topic_score_codex":0.0029744047,"about_ca_topic_score_gemma":0.0026404762,"teacher_disagreement_score":0.006778429,"about_ca_system_score_codex":0.0012510825,"about_ca_system_score_gemma":0.0012310833,"threshold_uncertainty_score":0.02267605},"labels":[],"label_agreement":null},{"id":"W3162099604","doi":"10.1038/s41391-021-00378-5","title":"Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease","year":2021,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research; Movember Foundation; Turun Yliopistollinen Keskussairaala; Tays; Academy of Finland; Cancer Research UK; Syöpäsäätiö; National Institutes of Health; Ovarian Cancer Research Fund; Génome Québec; McGill University; Helsingin Yliopisto; Breast Cancer Research Foundation","keywords":"Odds ratio; Prostate cancer; Medicine; Single-nucleotide polymorphism; Oncology; Genome-wide association study; Germline; Internal medicine; Genetics; Population; Gene; Cancer; Bioinformatics; Biology; Genotype","score_opus":0.019750970737134946,"score_gpt":0.32454213157981127,"score_spread":0.3047911608426763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162099604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99305964,0.002428919,0.0019286987,0.00030669762,0.00008233003,0.000019910818,0.0009833014,0.000089767644,0.0011008227],"genre_scores_gemma":[0.99689853,0.0004998504,0.00119014,0.00009458529,0.00008879324,0.000007667778,0.00057263626,0.000010176831,0.0006377515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985635,0.000022513408,0.000011883809,0.000051271192,0.000041201296,0.000016735363],"domain_scores_gemma":[0.9997029,0.000076927994,0.00009714664,0.000027427559,0.00003344837,0.00006214675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019836135,0.00036390166,0.000268669,0.0005591753,0.00030639317,0.00039850338,0.0003028697,0.00044855115,0.0027898187],"category_scores_gemma":[0.00063684606,0.00012987135,0.00052117853,0.00068676483,0.00027608708,0.00015214816,0.00028777335,0.000598735,0.0003764218],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010609467,0.000119813485,0.86214614,0.00023278098,0.00040011425,0.0076860082,0.00029420535,0.00063322217,0.09882022,0.0005705044,0.0016177583,0.026418237],"study_design_scores_gemma":[0.00010075279,0.0005894239,0.95588547,0.000044015545,0.0004016521,0.022715595,0.00020844753,0.0021129732,0.010216219,0.0013367544,0.006342121,0.000046556503],"about_ca_topic_score_codex":0.0010963598,"about_ca_topic_score_gemma":0.0011285874,"teacher_disagreement_score":0.0027898187,"about_ca_system_score_codex":0.00013048406,"about_ca_system_score_gemma":0.00019748494,"threshold_uncertainty_score":0.009332895},"labels":[],"label_agreement":null},{"id":"W3165392750","doi":"10.1038/s41391-021-00395-4","title":"Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis","year":2021,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Enzalutamide; Medicine; Prostate cancer; Adverse effect; Internal medicine; Oncology; Subgroup analysis; Population; Meta-analysis; Cancer; Androgen receptor","score_opus":0.04713426913375306,"score_gpt":0.3554620909676744,"score_spread":0.3083278218339213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165392750","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006881444,0.9908789,0.00043305196,0.00020245388,0.000127272,0.00031203756,0.0008240307,0.00002027411,0.00032052092],"genre_scores_gemma":[0.2655044,0.7276552,0.0019579378,0.0012133518,0.00030895227,0.0015065153,0.0014462367,0.000038288963,0.00036921844],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99202216,0.0038573495,0.0021535442,0.0008962407,0.0008443484,0.00022627624],"domain_scores_gemma":[0.9854124,0.0105071105,0.0027450162,0.0003369999,0.00081079174,0.00018764274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012210231,0.0019170237,0.014511468,0.0049593407,0.00043222954,0.002519179,0.0015126488,0.0015138887,0.0027324297],"category_scores_gemma":[0.023646321,0.0009079622,0.035670005,0.005202219,0.000596677,0.0013013323,0.0012003679,0.0017197889,0.00024284473],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024681329,0.000028534374,0.0028649431,0.3641608,0.6182482,0.00007171776,0.00006298127,0.00057516864,0.00018143996,0.000127565,0.0004755167,0.010734979],"study_design_scores_gemma":[0.0008069834,0.0002489033,0.0027525718,0.020279998,0.97411,0.00005756804,0.000029742745,0.00016370215,0.000097240656,0.00019916805,0.0012351468,0.000018902647],"about_ca_topic_score_codex":0.005710944,"about_ca_topic_score_gemma":0.012964399,"teacher_disagreement_score":0.014511468,"about_ca_system_score_codex":0.0027590245,"about_ca_system_score_gemma":0.0030901576,"threshold_uncertainty_score":0.06457466},"labels":[],"label_agreement":null},{"id":"W3169647790","doi":"10.1038/s41391-021-00399-0","title":"Barriers and facilitators related to undertaking physical activities among men with prostate cancer: a scoping review","year":2021,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Cancer survivorship and care","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Health; University Health Network; University of Toronto; Saskatchewan Health Authority; University of Regina; University of British Columbia; University of Saskatchewan","funders":"","keywords":"CINAHL; Medicine; Facilitator; MEDLINE; Context (archaeology); Prostate cancer; Population; Gerontology; Family medicine; Physical therapy; Cancer; Nursing; Psychology; Psychological intervention; Internal medicine","score_opus":0.020006406356582532,"score_gpt":0.3512317918404573,"score_spread":0.33122538548387476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169647790","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008236807,0.99864143,0.00004577213,0.00013421933,0.000049184313,0.00004561573,0.00009270186,0.0000023240502,0.00016513543],"genre_scores_gemma":[0.005500471,0.99379987,0.00025390444,0.00020736735,0.000022841592,0.00007615448,0.00006324841,0.0000018517868,0.00007430761],"study_design_codex":"systematic_review","study_design_gemma":"qualitative","domain_scores_codex":[0.99765164,0.0006237707,0.0008291975,0.00024591762,0.00048757493,0.00016192246],"domain_scores_gemma":[0.9922896,0.0057418244,0.0012797491,0.000075428805,0.00047878549,0.00013447138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00412754,0.0011862157,0.0038506323,0.004969363,0.00069304276,0.002990535,0.0013172451,0.0022898766,0.0035947396],"category_scores_gemma":[0.016719779,0.0011819983,0.0054893163,0.0064786887,0.00073930726,0.0017947579,0.002188968,0.0018566914,0.00027319137],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016946897,0.00008208132,0.003822293,0.82384056,0.00747457,0.00011931912,0.0008245577,0.0001684789,0.00015060468,0.000404273,0.0030685302,0.15987524],"study_design_scores_gemma":[0.00010418735,0.00013081999,0.012352836,0.9231784,0.03338102,0.00031560092,0.0012570078,0.00008653917,0.00010769244,0.00030613167,0.028724484,0.000055366894],"about_ca_topic_score_codex":0.028173182,"about_ca_topic_score_gemma":0.079801604,"teacher_disagreement_score":0.028173182,"about_ca_system_score_codex":0.002132073,"about_ca_system_score_gemma":0.008845628,"threshold_uncertainty_score":0.056018412},"labels":[],"label_agreement":null},{"id":"W3170529387","doi":"10.1038/s41391-021-00379-4","title":"MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancer","year":2021,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Prostate cancer; MSH2; Oncology; Internal medicine; Immune system; Prostate; Colorectal cancer; Endometrial cancer; Cancer; Immunology; DNA mismatch repair","score_opus":0.051437628430540436,"score_gpt":0.3848719772168978,"score_spread":0.33343434878635736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170529387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99911755,0.00016577824,0.00010569532,0.00002329763,0.0000062508107,0.000005634554,0.00013634088,0.000007315169,0.00043225614],"genre_scores_gemma":[0.9989887,0.00007220362,0.00007649626,0.000024510231,0.000005429684,0.0000053415147,0.00028523552,0.000004942096,0.0005372238],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99986184,0.000020634845,0.00001051003,0.00002717596,0.000026841246,0.00005301764],"domain_scores_gemma":[0.99943095,0.00006332233,0.00014539773,0.00004355684,0.000029642373,0.00028709762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014090055,0.00017761317,0.00023174606,0.0004722112,0.00019049867,0.00033905118,0.00011862701,0.0002515945,0.0020501404],"category_scores_gemma":[0.00034003478,0.00012549873,0.00015291625,0.0002481312,0.00024799825,0.00018489154,0.00028252846,0.00038177348,0.0002982674],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009077611,0.00037091883,0.17416316,0.00008464726,0.00011120711,0.001554538,0.00016532245,0.00015941689,0.8063016,0.00027220967,0.0003394342,0.0073998813],"study_design_scores_gemma":[0.00010790962,0.0029421549,0.93314034,0.000009060754,0.00007907744,0.0083233,0.00038838113,0.00039762355,0.05280287,0.00016414146,0.0016281806,0.000016975668],"about_ca_topic_score_codex":0.00038756238,"about_ca_topic_score_gemma":0.00054261356,"teacher_disagreement_score":0.0020501404,"about_ca_system_score_codex":0.00014514998,"about_ca_system_score_gemma":0.00015947293,"threshold_uncertainty_score":0.006858349},"labels":[],"label_agreement":null},{"id":"W3194802937","doi":"10.1038/s41391-021-00442-0","title":"Associations of fat and muscle mass with overall survival in men with prostate cancer: a systematic review with meta-analysis","year":2021,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Health and Medical Research Council; Medical Research Council","keywords":"Medicine; Prostate cancer; Hazard ratio; Internal medicine; Adipose tissue; Oncology; Sarcopenia; Cancer; Clinical endpoint; Gynecology; Confidence interval; Clinical trial","score_opus":0.09079182574798665,"score_gpt":0.39422410473656694,"score_spread":0.3034322789885803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194802937","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017976081,0.9969285,0.00029177542,0.0001415797,0.0000812816,0.00025547761,0.00035313467,0.000014864766,0.00013582659],"genre_scores_gemma":[0.053343143,0.9423095,0.0016454459,0.0006514329,0.00020134063,0.0011548152,0.0004811521,0.000016319971,0.00019697747],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99194807,0.0035234345,0.0025031243,0.0007709662,0.0009913092,0.00026316973],"domain_scores_gemma":[0.9779578,0.016320378,0.0037333267,0.00045438262,0.0013384245,0.00019564161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011367635,0.0027022657,0.016714482,0.008395707,0.0006755402,0.0032023115,0.002196842,0.0020896432,0.0032256318],"category_scores_gemma":[0.03802126,0.0015237167,0.02720779,0.008780719,0.0007826351,0.0019512288,0.0016316505,0.0014795145,0.00029571398],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063627516,0.000020470661,0.0025279343,0.74449646,0.2396753,0.000106113686,0.000079934136,0.00033392716,0.00015707193,0.000107500375,0.00055486825,0.011304047],"study_design_scores_gemma":[0.00036023743,0.00020882214,0.004263135,0.119523026,0.87213653,0.00015785226,0.000059338898,0.00017546813,0.000111812915,0.00023286398,0.0027401445,0.000030823245],"about_ca_topic_score_codex":0.008077595,"about_ca_topic_score_gemma":0.021964049,"teacher_disagreement_score":0.016714482,"about_ca_system_score_codex":0.0028854802,"about_ca_system_score_gemma":0.0058962563,"threshold_uncertainty_score":0.060118496},"labels":[],"label_agreement":null},{"id":"W3199016966","doi":"10.1038/s41391-021-00447-9","title":"Impact of enzalutamide on patient-reported fatigue in patients with prostate cancer: data from the pivotal clinical trials","year":2021,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Astellas Pharma; Astellas Foundation for Research on Metabolic Disorders; Astellas Pharma US; Pfizer","keywords":"Enzalutamide; Medicine; Prostate cancer; Placebo; Clinical trial; Internal medicine; Androgen deprivation therapy; Docetaxel; Cancer-related fatigue; Disease; Oncology; Cancer; Physical therapy; Pathology; Androgen receptor","score_opus":0.15704249740024048,"score_gpt":0.46620089944171006,"score_spread":0.3091584020414696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199016966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.60867184,0.3659155,0.0015511474,0.004083725,0.0007516425,0.0023500675,0.009778827,0.000110240915,0.0067869998],"genre_scores_gemma":[0.9315099,0.05707124,0.0014677187,0.0018648097,0.00047800146,0.0017153678,0.0051352815,0.000032995245,0.0007245827],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9930114,0.0048209517,0.00095704425,0.00039698274,0.0006026638,0.00021091852],"domain_scores_gemma":[0.97816956,0.011177412,0.0073040705,0.00092076266,0.0016145731,0.00081366743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016742576,0.0011644296,0.0028202906,0.00046242063,0.00030322568,0.0012461969,0.0006941428,0.0009323095,0.0023508316],"category_scores_gemma":[0.018688163,0.00030678048,0.005085658,0.0011195543,0.0005937911,0.0008380369,0.00058242324,0.0016814813,0.00024779877],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6680559,0.0017901242,0.033640735,0.03425397,0.07602692,0.00019435924,0.0004341674,0.0028846692,0.0046293237,0.0005051464,0.011607696,0.16597699],"study_design_scores_gemma":[0.49163917,0.14401427,0.21741451,0.0073538334,0.093257025,0.0009542327,0.00032774737,0.0014788413,0.0032731115,0.0011961897,0.038872022,0.00021904829],"about_ca_topic_score_codex":0.000609109,"about_ca_topic_score_gemma":0.002224061,"teacher_disagreement_score":0.016742576,"about_ca_system_score_codex":0.0005818035,"about_ca_system_score_gemma":0.0010644839,"threshold_uncertainty_score":0.08854425},"labels":[],"label_agreement":null},{"id":"W3208009499","doi":"10.1038/s41391-021-00467-5","title":"Estimating patient health in prostate cancer treatment counseling","year":2021,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute; U.S. Department of Health and Human Services","keywords":"Quartile; Medicine; Concordance; Life expectancy; Prostate cancer; Cancer; Internal medicine; Confidence interval; Environmental health","score_opus":0.01825894897223141,"score_gpt":0.32309940812968774,"score_spread":0.30484045915745633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208009499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841287,0.0018738963,0.0038165266,0.0019116659,0.00003433716,0.00010350015,0.0013013802,0.0000439931,0.006785978],"genre_scores_gemma":[0.99709356,0.00026301874,0.0019192387,0.00009266522,0.00001742379,0.000016988348,0.0002592518,0.00000177755,0.0003360314],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975471,0.001915122,0.000079397,0.0001239916,0.00019763921,0.00013666053],"domain_scores_gemma":[0.98966306,0.008921181,0.0006044267,0.00014989838,0.00030948812,0.00035201755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025693,0.00033195678,0.00043260385,0.0012410596,0.0004362219,0.0010209283,0.00037930682,0.0010713894,0.00307544],"category_scores_gemma":[0.016046545,0.00026232636,0.00065302313,0.0009895944,0.00020908973,0.0008518955,0.0006301029,0.0008991332,0.00021407097],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057584094,0.0005645817,0.93966275,0.000065719876,0.0002062025,0.00011248465,0.00014788608,0.009463201,0.0001152263,0.00064971903,0.000925387,0.047511086],"study_design_scores_gemma":[0.00009705849,0.0019683843,0.8376579,0.00013942103,0.00052726245,0.00044783793,0.0015819429,0.15095818,0.0009601903,0.0036774715,0.0019417234,0.00004263255],"about_ca_topic_score_codex":0.011483884,"about_ca_topic_score_gemma":0.013705403,"teacher_disagreement_score":0.011483884,"about_ca_system_score_codex":0.0008066388,"about_ca_system_score_gemma":0.00083120144,"threshold_uncertainty_score":0.022834063},"labels":[],"label_agreement":null},{"id":"W3215094105","doi":"10.1038/s41391-021-00472-8","title":"Overview of seminal fluid biomarkers for the evaluation of chronic prostatitis: a scoping review","year":2021,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; University of Toronto; McMaster University; Queen's University; McGill University","funders":"","keywords":"Medicine; Prostatitis; Biomarker; Chronic bacterial prostatitis; Internal medicine; Prostate cancer; CINAHL; MEDLINE; Chronic prostatitis/chronic pelvic pain syndrome; Cochrane Library; Oncology; Meta-analysis; Prostate; Cancer","score_opus":0.19986123761157296,"score_gpt":0.5060485448572355,"score_spread":0.30618730724566257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215094105","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003523116,0.9997002,0.000041222174,0.00006938105,0.000038109007,0.000012125841,0.00003303238,0.0000018374166,0.00006885919],"genre_scores_gemma":[0.00029598523,0.9993424,0.00013420521,0.00009914139,0.00003647128,0.00001626089,0.00003562357,6.4577904e-7,0.00003929531],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99845695,0.00036057056,0.00051114475,0.00023471759,0.0003576569,0.000078982164],"domain_scores_gemma":[0.99413425,0.0044636996,0.00070439256,0.00006883972,0.0005455326,0.00008336473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039603156,0.0018192884,0.006149208,0.008677667,0.0005236626,0.003097835,0.002016241,0.002694392,0.004185735],"category_scores_gemma":[0.009560229,0.00084952684,0.00506928,0.0072456077,0.0007734992,0.0023205953,0.0018032737,0.0019942087,0.0007351436],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026434695,0.000072714894,0.00058836327,0.49879852,0.0030396245,0.00017723751,0.00013692261,0.00033973032,0.0005524827,0.0011169764,0.008545635,0.48636755],"study_design_scores_gemma":[0.00021299231,0.00032591878,0.004118933,0.68305033,0.02458077,0.001287212,0.00030625984,0.00030076058,0.00050126115,0.0021039727,0.28310052,0.00011104183],"about_ca_topic_score_codex":0.0069281487,"about_ca_topic_score_gemma":0.011753442,"teacher_disagreement_score":0.008677667,"about_ca_system_score_codex":0.0015247775,"about_ca_system_score_gemma":0.0056759194,"threshold_uncertainty_score":0.020944357},"labels":[],"label_agreement":null},{"id":"W32989260","doi":"10.1038/s41391-020-00288-y","title":"Numerical studies on the separation dynamics of a strap-on rocket booster in the next-generation computing system","year":2008,"lang":"en","type":"dissertation","venue":"Prostate Cancer and Prostatic Diseases","topic":"Rocket and propulsion systems research","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McMaster University; Canadian Urological Association","keywords":"Booster (rocketry); Aerospace engineering; Separation (statistics); Aeronautics; Dynamics (music); Rocket (weapon); Astronautics; Computer science; Engineering; Physics; Machine learning; Acoustics","score_opus":0.07264023446706222,"score_gpt":0.34735169655152537,"score_spread":0.2747114620844632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W32989260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9198829,0.0006559223,0.04018087,0.0011449802,0.00019042715,0.00007505537,0.00035748296,0.0002854139,0.037226927],"genre_scores_gemma":[0.98542976,0.00013523747,0.007879314,0.00006832944,0.000012358964,0.000028605908,0.000116814364,0.00003890236,0.0062906207],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99992466,0.000014319043,0.0000024206054,0.000009391132,0.000020886326,0.000028431117],"domain_scores_gemma":[0.99956816,0.00019258671,0.000053753774,0.000022709675,0.00009037823,0.0000724791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002665292,0.0002852918,0.00044548418,0.00034719866,0.0008185913,0.0006864946,0.0005774807,0.0007581349,0.004536101],"category_scores_gemma":[0.0009691571,0.00015307163,0.00038235314,0.0004140159,0.000561482,0.00049812475,0.00044467702,0.0006174769,0.00029505923],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021201602,0.00010069295,0.0031701792,0.00007803435,0.000036227033,0.00021853615,0.00010793838,0.97291654,0.0068058097,0.009964217,0.0013740106,0.005015804],"study_design_scores_gemma":[0.000009121582,0.0000193184,0.00034966494,0.0000021065887,0.0000034119919,0.000008269894,0.000019138108,0.9984769,0.00047145094,0.00042388844,0.000212079,0.0000046739656],"about_ca_topic_score_codex":0.014721398,"about_ca_topic_score_gemma":0.009490611,"teacher_disagreement_score":0.014721398,"about_ca_system_score_codex":0.00067655626,"about_ca_system_score_gemma":0.0008075247,"threshold_uncertainty_score":0.029271424},"labels":[],"label_agreement":null},{"id":"W4205452410","doi":"10.1038/s41391-021-00483-5","title":"Have we mis-PRONOUNCEd the cardiovascular risk of GnRH agonists? A critical appraisal of the PRONOUNCE trial","year":2022,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Critical appraisal; Internal medicine; Bioinformatics; Endocrinology; Alternative medicine; Pathology","score_opus":0.05274383398176026,"score_gpt":0.36704382290785115,"score_spread":0.3142999889260909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205452410","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023885584,0.99430555,0.00007859506,0.0037296002,0.0011400958,0.00003773338,0.00008823098,0.000004070405,0.00037730148],"genre_scores_gemma":[0.007560863,0.9737741,0.0005014266,0.015221895,0.0023793501,0.00010969085,0.00010718298,0.000013558964,0.00033199607],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9903784,0.0053951154,0.0021251752,0.0006472548,0.0012534057,0.0002008068],"domain_scores_gemma":[0.9358161,0.05605863,0.00420289,0.0009432375,0.0025386119,0.00044057553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025428288,0.0009645963,0.008935281,0.0015865186,0.00049481896,0.0032561263,0.0028828406,0.0044742236,0.007918376],"category_scores_gemma":[0.059756856,0.0006462495,0.0050935727,0.0019670068,0.0013455944,0.0027687885,0.0011609476,0.0061367163,0.00088666874],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010865426,0.0000736273,0.0008731447,0.45503888,0.03332645,0.00026769054,0.00034713696,0.00022746364,0.0005056951,0.005657916,0.048284147,0.44453245],"study_design_scores_gemma":[0.015400886,0.0019334796,0.0045735636,0.4912009,0.12455255,0.0007782487,0.00058431894,0.00029263532,0.00057881273,0.010131408,0.34979865,0.00017450748],"about_ca_topic_score_codex":0.0028918819,"about_ca_topic_score_gemma":0.0067370175,"teacher_disagreement_score":0.025428288,"about_ca_system_score_codex":0.002189526,"about_ca_system_score_gemma":0.004015191,"threshold_uncertainty_score":0.13447922},"labels":[],"label_agreement":null},{"id":"W4211072433","doi":"10.1038/s41391-022-00504-x","title":"Exercise in advanced prostate cancer elevates myokine levels and suppresses in-vitro cell growth","year":2022,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Exercise and Physiological Responses","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Health and Medical Research Council; Medical Research Council; Movember Foundation","keywords":"Myokine; DU145; Medicine; Prostate cancer; Internal medicine; Endocrinology; GDF15; Aerobic exercise; Prostate; Oncology; Cancer; LNCaP; Urology","score_opus":0.012485506817174512,"score_gpt":0.28545875989785924,"score_spread":0.2729732530806847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211072433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994898,0.00031609388,0.000040617208,0.000012984391,0.0000040662603,0.000015612832,0.000028750155,0.000004908342,0.00008727477],"genre_scores_gemma":[0.99905723,0.00030539,0.00011855126,0.00002114678,0.000010438676,0.000035149755,0.00015783343,0.0000013715827,0.00029288602],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991953,0.00002214971,0.0000051495763,0.000012026292,0.000015286674,0.000025944679],"domain_scores_gemma":[0.99990785,0.000012248922,0.000023527922,0.0000071061827,0.0000068394716,0.00004247456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018651117,0.00023473441,0.00042776068,0.00010760435,0.00012597855,0.00018946867,0.00013932154,0.00015306623,0.0014567863],"category_scores_gemma":[0.00017365074,0.00008846871,0.00017660699,0.00013178613,0.0001928951,0.00008842004,0.0002045502,0.00038464816,0.00015676995],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.090683274,0.012595756,0.05675408,0.00082166516,0.00038695155,0.00024392513,0.00023830663,0.000865786,0.74926835,0.000059312875,0.0006905927,0.08739196],"study_design_scores_gemma":[0.004289598,0.31054893,0.63046104,0.000041349595,0.0002856615,0.0007074102,0.00019847162,0.0013141069,0.049521685,0.00010241758,0.0025123328,0.0000169617],"about_ca_topic_score_codex":0.00047511255,"about_ca_topic_score_gemma":0.00091909117,"teacher_disagreement_score":0.0014567863,"about_ca_system_score_codex":0.00011236913,"about_ca_system_score_gemma":0.00018733476,"threshold_uncertainty_score":0.0048734546},"labels":[],"label_agreement":null},{"id":"W4212776446","doi":"10.1038/s41391-021-00488-0","title":"Real-world patient characteristics associated with survival of 2 years or more after radium-223 treatment for metastatic castration-resistant prostate cancer (EPIX study)","year":2022,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Bayer HealthCare; Bayer","keywords":"Medicine; Prostate cancer; Radium-223; Oncology; Castration; Internal medicine; Cancer; Radium; Prostate; Overall survival; Urology; Hormone; Bone metastasis","score_opus":0.038605976680587344,"score_gpt":0.3466598766266834,"score_spread":0.30805389994609605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212776446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99644715,0.00066043716,0.00006925639,0.000041782903,0.0000062815484,0.000019593977,0.002496321,0.000002829588,0.0002564417],"genre_scores_gemma":[0.99654406,0.00014773077,0.00007213025,0.000033880162,0.000012376224,0.000025382475,0.0030671202,0.0000018128544,0.0000955013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994802,0.00018251361,0.00006971362,0.00012701128,0.00007544398,0.00006519078],"domain_scores_gemma":[0.99731654,0.00035481362,0.0018240958,0.0001643842,0.00012529208,0.00021485468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009517822,0.00019633946,0.00032926194,0.00048763814,0.00021535541,0.00059737975,0.00032527515,0.00033544574,0.0012340118],"category_scores_gemma":[0.002444762,0.00014967118,0.00044363842,0.00090450275,0.00018632754,0.00044070496,0.00048973504,0.00041397283,0.0001361856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011210635,0.00004105948,0.9965737,0.00004645551,0.00019399762,0.000053733937,0.000039648137,0.000087684166,0.00013081983,0.000019526098,0.0002513628,0.0014409121],"study_design_scores_gemma":[0.00006735976,0.00028019655,0.9985098,0.000015361726,0.00007712706,0.00025878407,0.000057715333,0.00013058913,0.00005151149,0.000017641238,0.00052797457,0.000005842611],"about_ca_topic_score_codex":0.0015209335,"about_ca_topic_score_gemma":0.0023334825,"teacher_disagreement_score":0.0015209335,"about_ca_system_score_codex":0.0003047957,"about_ca_system_score_gemma":0.00026384287,"threshold_uncertainty_score":0.0050335526},"labels":[],"label_agreement":null},{"id":"W4213184389","doi":"10.1038/s41391-022-00497-7","title":"Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score","year":2022,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Alberta; Princess Margaret Cancer Centre; Institut National de la Recherche Scientifique; University of Toronto","funders":"National Institute of Biomedical Imaging and Bioengineering; Norges Forskningsråd; Prostate Cancer Foundation; Cancer Research UK; National Cancer Institute; National Institute for Health and Care Research","keywords":"Medicine; Prostate cancer; Risk stratification; Oncology; Polygenic risk score; Internal medicine; Cancer; Stratification (seeds); Hazard ratio; Prostate-specific antigen; Gene; Genetics; Biology; Single-nucleotide polymorphism; Genotype","score_opus":0.019118665076995056,"score_gpt":0.2945898242105578,"score_spread":0.27547115913356274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213184389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87964964,0.00079925096,0.11381201,0.0017761083,0.00006635321,0.00007739003,0.001928416,0.000584425,0.0013063967],"genre_scores_gemma":[0.97687596,0.00013197631,0.020403448,0.00016708988,0.00007215832,0.00005055761,0.0017945251,0.00004488418,0.0004592685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979609,0.0013520494,0.00006776189,0.00037166252,0.00013811725,0.00010947428],"domain_scores_gemma":[0.9940951,0.0036999602,0.00063962664,0.0008771079,0.00039766412,0.000290502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0080709,0.0006314477,0.00096865813,0.00081060163,0.00042990583,0.0009003056,0.00084515644,0.000372978,0.0017353625],"category_scores_gemma":[0.009188096,0.00021750543,0.0017657545,0.00072064885,0.000461305,0.0006292651,0.0014616945,0.0012536293,0.0002936815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021896877,0.0004728566,0.6171889,0.0001916956,0.0026676748,0.0003904765,0.00037945632,0.21652456,0.003047484,0.0032437884,0.0073660794,0.14633736],"study_design_scores_gemma":[0.00029219524,0.000689492,0.09105256,0.000043181783,0.0006158655,0.00028842088,0.000086333304,0.8947552,0.00074208714,0.009118214,0.0022533268,0.00006319111],"about_ca_topic_score_codex":0.004317733,"about_ca_topic_score_gemma":0.005005302,"teacher_disagreement_score":0.0080709,"about_ca_system_score_codex":0.00051732326,"about_ca_system_score_gemma":0.00092889584,"threshold_uncertainty_score":0.04268354},"labels":[],"label_agreement":null},{"id":"W4213301220","doi":"10.1038/s41391-022-00514-9","title":"Real-world utilization and outcomes of docetaxel among older men with metastatic prostate cancer: a retrospective population-based cohort study in Canada","year":2022,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University of British Columbia; BC Cancer Agency; Cancer Care Ontario; Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Calgary; University of Ottawa; McGill University; University of Alberta; Jewish General Hospital; Ottawa Hospital; University of Toronto; McMaster University; Juravinski Cancer Centre; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Docetaxel; Medicine; Prostate cancer; Tolerability; Internal medicine; Cabazitaxel; Population; Retrospective cohort study; Oncology; Cohort; Neutropenia; Febrile neutropenia; Cancer; Androgen deprivation therapy; Chemotherapy; Adverse effect","score_opus":0.017530384419952312,"score_gpt":0.31834282231287525,"score_spread":0.30081243789292295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213301220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916078,0.0011752363,0.000093916824,0.00027405887,0.000015769992,0.000036444642,0.005733957,0.000010713447,0.0010521573],"genre_scores_gemma":[0.99738306,0.0005260023,0.000099250195,0.00009758705,0.000008040236,0.000009660647,0.0015432166,0.0000049293176,0.0003282729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988906,0.00008286591,0.00010917873,0.00024438076,0.00031268224,0.0003602821],"domain_scores_gemma":[0.99753344,0.00013293918,0.0007331961,0.00013277878,0.00085545523,0.0006121661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005525956,0.00036467158,0.00058080786,0.0012150002,0.0017208372,0.0017896558,0.0012035503,0.00073595496,0.0014421111],"category_scores_gemma":[0.0022382236,0.00061318924,0.0011344866,0.0047216956,0.00064526754,0.000585177,0.0008149046,0.0010069151,0.00017811413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007087293,0.000023735247,0.9983865,0.000015081618,0.00010340213,0.00005133276,0.00015970152,0.00006307261,0.000054097134,0.00004093752,0.00035277058,0.00067843957],"study_design_scores_gemma":[0.0000089460145,0.000021548003,0.9985863,0.000018583974,0.00005993234,0.000082678554,0.0005405054,0.00021947587,0.000027121341,0.000016582579,0.00040804193,0.000010232651],"about_ca_topic_score_codex":0.97967774,"about_ca_topic_score_gemma":0.9850038,"teacher_disagreement_score":0.020322263,"about_ca_system_score_codex":0.018725146,"about_ca_system_score_gemma":0.018362846,"threshold_uncertainty_score":0.13586104},"labels":[],"label_agreement":null},{"id":"W4220938355","doi":"10.1038/s41391-022-00530-9","title":"Correction: Estimating patient health in prostate cancer treatment counseling","year":2022,"lang":"en","type":"erratum","venue":"Prostate Cancer and Prostatic Diseases","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute","keywords":"Medicine; Prostate cancer; Oncology; Benign prostatic hyperplasia (BPH); Cancer treatment; Internal medicine; Cancer; Gynecology","score_opus":0.0204009576083393,"score_gpt":0.27091732660682605,"score_spread":0.2505163689984867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220938355","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002727193,0.0009708433,0.0021668195,0.092297636,0.8799472,0.000048507776,0.01634882,0.00083496916,0.007112521],"genre_scores_gemma":[0.035849586,0.005039712,0.015545665,0.12217029,0.27725708,0.0006719715,0.015530613,0.0048211417,0.52311397],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99310946,0.0019652438,0.0010809816,0.00081395474,0.002596166,0.00043420005],"domain_scores_gemma":[0.91147953,0.030226458,0.0028988088,0.006205402,0.047274202,0.0019154877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007027041,0.0024623405,0.0020576084,0.0039050921,0.0024556185,0.004397611,0.0033671998,0.0059163584,0.13936526],"category_scores_gemma":[0.17640008,0.0013041197,0.001758433,0.004571598,0.0017018361,0.0027505609,0.0020452675,0.010357873,0.05488375],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016334121,0.0000024552699,0.00007487158,0.000044494893,0.00000772693,0.000045982455,0.000010845191,0.00008048536,0.0000068749714,0.00060960127,0.99699354,0.002106893],"study_design_scores_gemma":[0.00020924263,0.000019157147,0.0023535285,0.0007558983,0.000100838355,0.00037618875,0.00015171507,0.001752049,0.00039730305,0.0069502764,0.9868543,0.00007939811],"about_ca_topic_score_codex":0.12814936,"about_ca_topic_score_gemma":0.11978956,"teacher_disagreement_score":0.13936526,"about_ca_system_score_codex":0.0057552406,"about_ca_system_score_gemma":0.009948087,"threshold_uncertainty_score":0.46622324},"labels":[],"label_agreement":null},{"id":"W4223517915","doi":"10.1038/s41391-022-00538-1","title":"Accuracy of SelectMDx compared to mpMRI in the diagnosis of prostate cancer: a systematic review and diagnostic meta-analysis","year":2022,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Meta-analysis; Internal medicine; Predictive value; Cancer","score_opus":0.09456226304865617,"score_gpt":0.39296900358737646,"score_spread":0.2984067405387203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223517915","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004688636,0.9940057,0.00033902953,0.00011502965,0.00013130461,0.000072722294,0.0004686838,0.000017231796,0.00016164257],"genre_scores_gemma":[0.21481481,0.77973735,0.0020445858,0.0011758376,0.00038289695,0.0003058404,0.001133049,0.00004395988,0.00036170587],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99309057,0.0027389461,0.0020185458,0.0011486163,0.0007931236,0.00021025729],"domain_scores_gemma":[0.98228663,0.014032393,0.0021352535,0.00050347217,0.0008777538,0.00016451489],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.008767054,0.0024446864,0.01419176,0.0045327093,0.0006299738,0.002846279,0.0023005763,0.0026581578,0.0035614716],"category_scores_gemma":[0.031013064,0.0016484539,0.035418663,0.0054601314,0.0008795564,0.0019266008,0.0018255493,0.002372016,0.00043550663],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024578322,0.000026213072,0.010703791,0.25082746,0.71981245,0.000102561695,0.00009962317,0.00040086577,0.0002608373,0.000104904204,0.00069769396,0.014505762],"study_design_scores_gemma":[0.0005222794,0.00010974526,0.0054148096,0.010197153,0.9824771,0.000077580284,0.000038247566,0.00013181783,0.00008230286,0.0001223566,0.0008004921,0.000026042582],"about_ca_topic_score_codex":0.012388188,"about_ca_topic_score_gemma":0.028988918,"teacher_disagreement_score":0.99123293,"about_ca_system_score_codex":0.001863894,"about_ca_system_score_gemma":0.0025457044,"threshold_uncertainty_score":0.046365142},"labels":[],"label_agreement":null},{"id":"W4224216381","doi":"10.1038/s41391-022-00544-3","title":"The impact of PSMA PET on the treatment and outcomes of men with biochemical recurrence of prostate cancer: a systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Women's College Hospital; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Biochemical recurrence; Prostate cancer; Meta-analysis; Internal medicine; Oncology; Prostate-specific antigen; Urology; Cancer; Prostatectomy","score_opus":0.06316476489103198,"score_gpt":0.3858713664288084,"score_spread":0.3227066015377764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224216381","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035939673,0.99553114,0.00021364613,0.00008882244,0.00010368848,0.000045615514,0.0002750136,0.0000103489865,0.00013776282],"genre_scores_gemma":[0.13129388,0.8656964,0.00097531267,0.00077379216,0.00023076095,0.00016384016,0.00054436614,0.0000206901,0.0003009501],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99684554,0.0012947818,0.0008656544,0.0004773395,0.00036466043,0.00015188425],"domain_scores_gemma":[0.99298614,0.005266246,0.001022043,0.00022841954,0.00039104687,0.00010605014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047241948,0.0020679582,0.012340057,0.0026382355,0.0004599585,0.0022403118,0.0015275606,0.002192636,0.003159022],"category_scores_gemma":[0.015232791,0.0013708462,0.028294817,0.004209679,0.0005499489,0.0012041556,0.0012416099,0.0022763156,0.00031613687],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027677373,0.00003908993,0.006362543,0.2569243,0.71402276,0.00011708379,0.00007056131,0.00055060565,0.00029717427,0.00010369843,0.0007771722,0.017967276],"study_design_scores_gemma":[0.00044466095,0.00014049414,0.0049346406,0.0102095045,0.9825309,0.00006742809,0.000032870885,0.00011723957,0.00007202566,0.00012951977,0.0012970265,0.00002374896],"about_ca_topic_score_codex":0.011233189,"about_ca_topic_score_gemma":0.025611363,"teacher_disagreement_score":0.012340057,"about_ca_system_score_codex":0.0014859255,"about_ca_system_score_gemma":0.00209809,"threshold_uncertainty_score":0.02498418},"labels":[],"label_agreement":null},{"id":"W4230627165","doi":"10.1038/pcan.2013.42","title":"Erratum: Accurate prediction of repeat prostate biopsy outcomes by a mitochondrial DNA deletion assay","year":2013,"lang":"en","type":"erratum","venue":"Prostate Cancer and Prostatic Diseases","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McMaster University; Prostate Cancer Canada; Pancreatic Cancer Action Network","keywords":"Medicine; Prostate cancer; Paragraph; Section (typography); Mitochondrial DNA; Prostatic Diseases; Prostate biopsy; Prostate; Urology; Internal medicine; Cancer; Computer science; Biology; Gene; Genetics","score_opus":0.007712916097166349,"score_gpt":0.26645118914416627,"score_spread":0.2587382730469999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230627165","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0049672434,0.006150828,0.0032699343,0.13978575,0.8312676,0.00011850249,0.003211963,0.00060161995,0.010626573],"genre_scores_gemma":[0.11216418,0.02056498,0.026704319,0.2249695,0.27100235,0.0004105456,0.00724122,0.0016957527,0.33524716],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.998437,0.00021345187,0.0003790663,0.00016233345,0.00067857315,0.000129557],"domain_scores_gemma":[0.99023205,0.0034541811,0.0006557976,0.00055648194,0.004613389,0.0004881749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016858373,0.0010704773,0.0011338601,0.0017481118,0.0012537666,0.0011330794,0.0013386582,0.004028695,0.009960493],"category_scores_gemma":[0.024483513,0.0007130108,0.00065543613,0.0009947574,0.00093824876,0.00070863235,0.00059631316,0.003925204,0.008560249],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016200492,0.000029984365,0.0015611065,0.00016953361,0.000029756133,0.0029919283,0.000029542058,0.00017206614,0.00037376193,0.00035905157,0.9719848,0.022136455],"study_design_scores_gemma":[0.00015478258,0.00016739196,0.017049054,0.0006431916,0.00020805681,0.0136177,0.0001982541,0.0016024605,0.0046634125,0.0015107015,0.96005946,0.00012559038],"about_ca_topic_score_codex":0.010355551,"about_ca_topic_score_gemma":0.0143144885,"teacher_disagreement_score":0.010355551,"about_ca_system_score_codex":0.001722563,"about_ca_system_score_gemma":0.0021998242,"threshold_uncertainty_score":0.0333212},"labels":[],"label_agreement":null},{"id":"W4249337928","doi":"10.1038/s41391-021-00408-2","title":"Correction: Protective effect of pharmacological castration on metabolic perturbations and cardiovascular disease in the hyperglycemic male ApoE−/−:Ins2+/Akita mouse model","year":2021,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Adipose Tissue and Metabolism","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Castration; Disease; Internal medicine; Endocrinology; Pharmacology; Hormone","score_opus":0.018903675251515824,"score_gpt":0.29354004588820765,"score_spread":0.27463637063669183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249337928","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035541628,0.0055602393,0.0071048387,0.042663574,0.9294461,0.000056327528,0.0054100943,0.0023080865,0.0038966478],"genre_scores_gemma":[0.12517963,0.030381897,0.032013156,0.040372018,0.2745628,0.0004982106,0.017433837,0.005339652,0.47421885],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99886537,0.00014885375,0.00015012914,0.00021620885,0.0004631709,0.00015626183],"domain_scores_gemma":[0.99545896,0.00082732894,0.00055312365,0.00054242165,0.0018628346,0.00075539225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010823662,0.0013185184,0.0011181623,0.001446987,0.0008736457,0.001057825,0.0021210164,0.003891792,0.051897094],"category_scores_gemma":[0.008451383,0.0007062343,0.0009854697,0.0010677767,0.0010827307,0.0011396713,0.0009220774,0.0055357763,0.016491996],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005214583,0.000040370385,0.0002729596,0.0010778735,0.000081836035,0.0012100772,0.00006346207,0.00016294591,0.01076163,0.0023628455,0.9617315,0.021713044],"study_design_scores_gemma":[0.00023461568,0.00012311748,0.0037906133,0.00029263095,0.00014874773,0.0037303953,0.00009460789,0.0006831288,0.015841264,0.0016020447,0.9733844,0.00007455001],"about_ca_topic_score_codex":0.0039259084,"about_ca_topic_score_gemma":0.0044084094,"teacher_disagreement_score":0.051897094,"about_ca_system_score_codex":0.00095199666,"about_ca_system_score_gemma":0.002161825,"threshold_uncertainty_score":0.17361307},"labels":[],"label_agreement":null},{"id":"W4255724847","doi":"10.1038/pcan.2013.39","title":"Erratum: Oxidative stress in prostate cancer: changing research concepts towards a novel paradigm for prevention and therapeutics","year":2013,"lang":"en","type":"erratum","venue":"Prostate Cancer and Prostatic Diseases","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McMaster University; Prostate Cancer Canada; Pancreatic Cancer Action Network","keywords":"Prostate cancer; Medicine; Oxidative stress; Cancer; Prostate; Section (typography); Prostatic Diseases; Oncology; Internal medicine; Gynecology","score_opus":0.03717370129247432,"score_gpt":0.37023567504961086,"score_spread":0.33306197375713653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255724847","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010793878,0.003785605,0.00021264776,0.06648289,0.9272131,0.000017080185,0.00013610664,0.00005683701,0.001987812],"genre_scores_gemma":[0.005045031,0.03265526,0.0025067516,0.18284157,0.6711289,0.00009776448,0.00052883755,0.00033923867,0.10485657],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99715614,0.00043798733,0.00062587153,0.0002688657,0.0012794733,0.00023161586],"domain_scores_gemma":[0.98248166,0.0047215726,0.001243398,0.00069377705,0.009752528,0.0011070978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034905605,0.0022510556,0.001992443,0.0035182207,0.0029820334,0.0035031259,0.0025840276,0.009703164,0.015117588],"category_scores_gemma":[0.029577848,0.0011897853,0.0016686408,0.0022329818,0.0029025988,0.002539486,0.0014215906,0.01267052,0.013312509],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038505492,0.000013330894,0.000090901565,0.00016089677,0.000011856755,0.0005686148,0.000019945755,0.000034876,0.000050530543,0.0005448877,0.9915959,0.0068696016],"study_design_scores_gemma":[0.000045016277,0.00004712148,0.0008387029,0.00063941354,0.00006456382,0.0015522856,0.0001312206,0.00012646565,0.00030828212,0.0013351175,0.9948638,0.000048056732],"about_ca_topic_score_codex":0.01149879,"about_ca_topic_score_gemma":0.020108743,"teacher_disagreement_score":0.015117588,"about_ca_system_score_codex":0.003584672,"about_ca_system_score_gemma":0.005759556,"threshold_uncertainty_score":0.05057335},"labels":[],"label_agreement":null},{"id":"W4281626690","doi":"10.1038/s41391-022-00561-2","title":"Pharmacotherapy vs. minimally invasive therapies as initial therapy for moderate-to-severe benign prostatic hyperplasia: a cost-effectiveness study","year":2022,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Université de Montréal; University Health Network","funders":"Boston Scientific Corporation","keywords":"Pharmacotherapy; Medicine; Urology; Internal medicine; Surgery","score_opus":0.0497370714989069,"score_gpt":0.39393206180953577,"score_spread":0.3441949903106289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281626690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93479645,0.05513479,0.0015206959,0.0009184408,0.00038637486,0.0023066017,0.0016646065,0.000049900988,0.0032222157],"genre_scores_gemma":[0.99064153,0.0068387478,0.0010498101,0.00026959667,0.00013749601,0.00040946563,0.00033588172,0.000008029971,0.00030934863],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.996581,0.0023685864,0.00021656798,0.0002782671,0.0002732954,0.00028237817],"domain_scores_gemma":[0.9950023,0.0034158446,0.00080413296,0.00012173315,0.00011689626,0.00053909735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026165822,0.0017502934,0.0039902553,0.0017752782,0.00035150058,0.0017189371,0.001169092,0.0019815227,0.0060033053],"category_scores_gemma":[0.0059822807,0.00070126826,0.009458659,0.0016333549,0.001157337,0.0019275381,0.001034109,0.002275901,0.00023879566],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8685135,0.007814377,0.0060454197,0.006125534,0.014533507,0.00022036629,0.00009158233,0.008439189,0.0010449365,0.00085323025,0.0005111602,0.08580716],"study_design_scores_gemma":[0.48406592,0.35220665,0.052325178,0.0024498308,0.07524479,0.0009930151,0.0006149009,0.02464156,0.001853427,0.0020435615,0.0032402491,0.00032086452],"about_ca_topic_score_codex":0.004694986,"about_ca_topic_score_gemma":0.004243231,"teacher_disagreement_score":0.0060033053,"about_ca_system_score_codex":0.003954316,"about_ca_system_score_gemma":0.0016644249,"threshold_uncertainty_score":0.028690755},"labels":[],"label_agreement":null},{"id":"W4282031579","doi":"10.1038/s41391-022-00548-z","title":"The EXPANDER-1 trial: introduction of the novel Urocross™ Expander System for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)","year":2022,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; International Prostate Symptom Score; Lower urinary tract symptoms; Quality of life (healthcare); Urology; Prostate; Implant; Adverse effect; Hyperplasia; Sexual function; Surgery; Internal medicine","score_opus":0.021329982566132808,"score_gpt":0.31137756849217135,"score_spread":0.2900475859260385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282031579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869343,0.007218654,0.00064174284,0.00042316975,0.00026043248,0.0013107369,0.00059280294,0.000068683396,0.0025493547],"genre_scores_gemma":[0.9821253,0.0045475843,0.0015905527,0.0010634622,0.0005231732,0.0020099953,0.0012008641,0.00002181833,0.006917208],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997634,0.000100642515,0.000013246119,0.000050542763,0.000029208197,0.00004298936],"domain_scores_gemma":[0.9996321,0.000118118725,0.000107542066,0.00003528205,0.000017846922,0.00008910518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009954268,0.000785517,0.0010443212,0.00024210098,0.0001861764,0.00065233704,0.00057151477,0.0011630019,0.0042015035],"category_scores_gemma":[0.00064213143,0.00022117354,0.0009738053,0.00016777907,0.0004520805,0.00058523193,0.00024345212,0.0018304451,0.0005689345],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8600957,0.01507098,0.0022468665,0.0018058507,0.00070561166,0.00015793047,0.00014218602,0.00061135256,0.01519022,0.00039999664,0.0018111819,0.101762146],"study_design_scores_gemma":[0.6491012,0.33192578,0.008780918,0.00013831136,0.0006600704,0.0003558567,0.000044453864,0.00088614586,0.004632051,0.0002366286,0.0032051655,0.000033436256],"about_ca_topic_score_codex":0.0002827912,"about_ca_topic_score_gemma":0.00077423296,"teacher_disagreement_score":0.0042015035,"about_ca_system_score_codex":0.0002983843,"about_ca_system_score_gemma":0.0005448966,"threshold_uncertainty_score":0.014055431},"labels":[],"label_agreement":null},{"id":"W4283327878","doi":"10.1038/s41391-022-00554-1","title":"Statins and prostate cancer—hype or hope? The epidemiological perspective","year":2022,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Prostate Cancer Foundation; Government of Canada; Irish Research eLibrary; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Irish Cancer Society; Canadian Urological Association; University of Pennsylvania","keywords":"Medicine; Prostate cancer; Epidemiology; Perspective (graphical); Cancer; Prostate; Oncology; Internal medicine","score_opus":0.0446620209449704,"score_gpt":0.3659264531777882,"score_spread":0.3212644322328178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283327878","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00088874454,0.78048706,0.0003124056,0.21441206,0.002792729,0.000003848853,0.0001518644,0.000010187136,0.000941082],"genre_scores_gemma":[0.01687257,0.90939224,0.0005551328,0.050703853,0.021907354,0.000012591959,0.00010288059,0.000006792399,0.00044656015],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969459,0.0016182265,0.00036636865,0.00031220747,0.00056780834,0.00018935057],"domain_scores_gemma":[0.96381396,0.027995614,0.00324565,0.0010649199,0.0026102136,0.0012696555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007842799,0.00052720297,0.002108009,0.0021845389,0.000687939,0.0032985823,0.0010107182,0.0048148907,0.0042116307],"category_scores_gemma":[0.02002859,0.00041944973,0.0013220469,0.0023157606,0.002854328,0.005977502,0.0019950762,0.0073220124,0.00072078104],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011028078,0.00020228828,0.019490026,0.024515806,0.0028649622,0.0008367785,0.001174337,0.0011957857,0.00088254036,0.08469932,0.25361213,0.6094232],"study_design_scores_gemma":[0.00021414708,0.00062213966,0.025596846,0.03614024,0.0014348683,0.0023280755,0.0029867205,0.0008443341,0.00022892193,0.17792477,0.7514647,0.00021425984],"about_ca_topic_score_codex":0.0047409297,"about_ca_topic_score_gemma":0.0049759382,"teacher_disagreement_score":0.007842799,"about_ca_system_score_codex":0.0013134405,"about_ca_system_score_gemma":0.0024841405,"threshold_uncertainty_score":0.041477144},"labels":[],"label_agreement":null},{"id":"W4283744491","doi":"10.1038/s41391-022-00557-y","title":"Statins and prostate cancer—hype or hope? The biological perspective","year":2022,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Canada Research Chairs; Government of Canada","keywords":"Prostate cancer; Medicine; Statin; Mechanism (biology); Mevalonate pathway; Cancer; HMG-CoA reductase; Bioinformatics; Oncology; Dutasteride; Limiting; Internal medicine; Reductase; Pharmacology; Enzyme; Biology; Biochemistry","score_opus":0.04015042872091809,"score_gpt":0.348658487370053,"score_spread":0.3085080586491349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283744491","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001972342,0.9985233,0.00002739854,0.0008019667,0.00033505366,8.5099e-7,0.000009070521,0.0000026788277,0.00028000935],"genre_scores_gemma":[0.00023308689,0.99825186,0.000045950303,0.00059075654,0.0005475994,0.0000023213165,0.000012606158,6.932627e-7,0.0003150245],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971133,0.00007417215,0.0000362497,0.000039890194,0.00010322257,0.000035181998],"domain_scores_gemma":[0.99936694,0.00032548772,0.00006320781,0.000018074074,0.00014407001,0.00008226103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011857942,0.0009838927,0.002237012,0.001793745,0.00040094042,0.0020329896,0.0012754361,0.00231303,0.0047883657],"category_scores_gemma":[0.0016528567,0.00031456508,0.0005930346,0.0025336035,0.0008118145,0.0022695593,0.0010550924,0.0039970516,0.002314186],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031946527,0.00008790122,0.00023217357,0.012777832,0.00019094125,0.00027378995,0.00005990628,0.0003463925,0.0009053713,0.011078199,0.15130758,0.82242036],"study_design_scores_gemma":[0.00005578208,0.0000774948,0.00048982754,0.0032835559,0.00012987743,0.00052691734,0.00006161044,0.00008761579,0.000109300614,0.003784834,0.99137044,0.000022774066],"about_ca_topic_score_codex":0.002499891,"about_ca_topic_score_gemma":0.005587164,"teacher_disagreement_score":0.0047883657,"about_ca_system_score_codex":0.0010468045,"about_ca_system_score_gemma":0.0018737868,"threshold_uncertainty_score":0.016018689},"labels":[],"label_agreement":null},{"id":"W4283814976","doi":"10.1038/s41391-022-00560-3","title":"Development and validation of a multivariable prognostic model in de novo metastatic castrate sensitive prostate cancer","year":2022,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Ottawa Hospital; University of Ottawa; University of Toronto; Ottawa Regional Cancer Foundation; Mount Sinai Hospital","funders":"","keywords":"Medicine; Prostate cancer; Internal medicine; Confidence interval; Proportional hazards model; Oncology; Prognostic variable; Multivariate statistics; Multivariate analysis; Cancer; Statistics","score_opus":0.037057405412189125,"score_gpt":0.3325120029562708,"score_spread":0.2954545975440817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283814976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84736615,0.0008786647,0.14340632,0.0011075105,0.00027607993,0.0002880885,0.0042151776,0.0011363653,0.0013255666],"genre_scores_gemma":[0.96814954,0.00021659773,0.027532272,0.000067534296,0.00007389543,0.00012541909,0.0030224288,0.00005039082,0.0007619479],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99908173,0.00039364406,0.00009082021,0.0001341834,0.00019640547,0.000103171435],"domain_scores_gemma":[0.9969427,0.0017505324,0.0002277224,0.00018551697,0.00074392656,0.00014956463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004874973,0.0007298639,0.000893524,0.0012657932,0.00047009994,0.0013650501,0.0010660934,0.00046996525,0.0013797731],"category_scores_gemma":[0.008925241,0.0003206356,0.000991968,0.000817165,0.00015103271,0.00047657604,0.0008180213,0.0009671932,0.00043735045],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019048403,0.0008303342,0.6895327,0.0001691216,0.0011594036,0.0003157035,0.0001540441,0.10916685,0.0048273,0.0012287049,0.0057560983,0.18495487],"study_design_scores_gemma":[0.00013140647,0.0005455609,0.092346676,0.000039598322,0.0005389785,0.00031969757,0.00007067693,0.900202,0.0020358602,0.0011930144,0.0025391686,0.00003732597],"about_ca_topic_score_codex":0.007916289,"about_ca_topic_score_gemma":0.00747937,"teacher_disagreement_score":0.007916289,"about_ca_system_score_codex":0.0005677644,"about_ca_system_score_gemma":0.0018523248,"threshold_uncertainty_score":0.025781631},"labels":[],"label_agreement":null},{"id":"W4283816500","doi":"10.1038/s41391-022-00570-1","title":"Modifiable risk factors for prostate cancer in low- and lower-middle-income countries: a systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; Population Health Research Institute; McMaster University; Hamilton Health Sciences","funders":"","keywords":"Medicine; Prostate cancer; Odds ratio; Cohort study; Environmental health; Epidemiology; Population; Cohort; Incidence (geometry); Lower risk; Meta-analysis; Demography; Internal medicine; Cancer; Confidence interval","score_opus":0.06019216684122588,"score_gpt":0.35365986511016034,"score_spread":0.2934676982689345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283816500","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032413169,0.9955716,0.00028057382,0.00007681882,0.00010217333,0.000080537146,0.00051807007,0.00001785608,0.00011098599],"genre_scores_gemma":[0.11834894,0.8779941,0.0015398484,0.0006587659,0.00013983616,0.0002727219,0.0007242007,0.00002672824,0.00029482448],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9965228,0.00112017,0.0011406706,0.0005818919,0.00039262645,0.00024184585],"domain_scores_gemma":[0.99550986,0.0029475912,0.00087224826,0.00021545644,0.00035331093,0.00010160741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00478705,0.002943588,0.016995177,0.004783869,0.0005913864,0.0026404331,0.0019101624,0.0020355445,0.004477381],"category_scores_gemma":[0.011836299,0.0019096023,0.034463026,0.007178822,0.00062812364,0.0017275113,0.0019978543,0.0020630448,0.00041555674],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012803875,0.000028439137,0.0056940443,0.31125763,0.668187,0.00013533644,0.00009542471,0.0003449868,0.00024417124,0.000101850965,0.0007986682,0.011832015],"study_design_scores_gemma":[0.00036226094,0.000072626695,0.0046014036,0.013197828,0.9801348,0.00007534249,0.000054784083,0.00006559485,0.00006514338,0.00010300189,0.0012409609,0.0000263777],"about_ca_topic_score_codex":0.015566115,"about_ca_topic_score_gemma":0.0420223,"teacher_disagreement_score":0.016995177,"about_ca_system_score_codex":0.0018246328,"about_ca_system_score_gemma":0.003083081,"threshold_uncertainty_score":0.030951023},"labels":[],"label_agreement":null},{"id":"W4295347092","doi":"10.1038/s41391-022-00591-w","title":"Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsy","year":2022,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Congressionally Directed Medical Research Programs; National Cancer Institute; Division of Cancer Prevention, National Cancer Institute; U.S. Department of Health and Human Services; U.S. Department of Defense","keywords":"Medicine; Prostate cancer; Prostate biopsy; Biomarker; Biopsy; Prostate; Receiver operating characteristic; Radiology; Imaging biomarker; Prospective cohort study; Magnetic resonance imaging; Area under the curve; Internal medicine; Cancer","score_opus":0.010512731530779388,"score_gpt":0.2873279415369159,"score_spread":0.2768152100061365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295347092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988564,0.00038818808,0.00017060578,0.000014335182,0.000020997772,0.000022585036,0.00014836178,0.000005149127,0.0003734089],"genre_scores_gemma":[0.9993374,0.00006537633,0.00012305404,0.000015576441,0.000015345337,0.000010343899,0.0002479623,0.000003676992,0.00018131743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838877,0.00064038794,0.00012784523,0.00041657843,0.00024255371,0.00018396304],"domain_scores_gemma":[0.99432147,0.0027104742,0.00097013573,0.0006488543,0.00065055664,0.0006985307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003337513,0.0008313317,0.0009095433,0.0007463973,0.0003913204,0.0011872376,0.0007938123,0.0009346241,0.001616072],"category_scores_gemma":[0.0071375836,0.0006550858,0.00083625404,0.0008289196,0.0005572357,0.0011400328,0.0006607585,0.00091013836,0.00045965103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026589992,0.0005079232,0.9666021,0.000035809833,0.0005312241,0.000041130836,0.00010797856,0.00023737857,0.0011280344,0.000040625328,0.000081989776,0.004095724],"study_design_scores_gemma":[0.0003850275,0.0052440795,0.9918984,0.000009963536,0.00035714838,0.00015284709,0.00012077716,0.0011076231,0.00040508326,0.00005601441,0.00024542486,0.00001748892],"about_ca_topic_score_codex":0.0014790883,"about_ca_topic_score_gemma":0.0016736247,"teacher_disagreement_score":0.003337513,"about_ca_system_score_codex":0.00031671548,"about_ca_system_score_gemma":0.00036081267,"threshold_uncertainty_score":0.017650664},"labels":[],"label_agreement":null},{"id":"W4295427493","doi":"10.1038/s41391-022-00529-2","title":"Association of dynamic change in patient-reported pain with survival in metastatic castrate sensitive prostate cancer—exploratory analysis of LATITUDE study","year":2022,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Toronto; Ottawa Regional Cancer Foundation; Mount Sinai Hospital; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Prostate cancer; Hazard ratio; Internal medicine; Proportional hazards model; Confidence interval; Progression-free survival; Oncology; Docetaxel; Cancer; Overall survival","score_opus":0.029086505424184957,"score_gpt":0.33040945056274856,"score_spread":0.3013229451385636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295427493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99907434,0.00018295036,0.00006181159,0.000016775095,0.0000033114982,0.0000024120488,0.00041868706,0.0000024097887,0.00023733951],"genre_scores_gemma":[0.9995927,0.000034867102,0.000020914486,0.0000042745964,0.000004096375,0.00000215282,0.0002771257,0.0000015440984,0.00006228015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99947137,0.0002384577,0.000037856753,0.00008875088,0.00006387789,0.00009963467],"domain_scores_gemma":[0.99857795,0.00038643475,0.00048164808,0.00018176409,0.00009732657,0.00027484875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065466325,0.00023960642,0.00039397913,0.0005130642,0.0003063041,0.0006238977,0.00033190963,0.00028381625,0.0014726565],"category_scores_gemma":[0.0019327641,0.00016201106,0.0010058733,0.00083360035,0.00027661744,0.00029754627,0.00058548775,0.00040225353,0.00014684293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066456717,0.000029074972,0.99761033,0.000009227031,0.00020691394,0.000040631632,0.000054816075,0.00009018692,0.00034083967,0.000019226054,0.000048303973,0.0008858998],"study_design_scores_gemma":[0.0000055006117,0.00011400995,0.99948406,0.0000012279904,0.00004160925,0.000057071695,0.00008991885,0.00009535768,0.000028712122,0.000011688421,0.00006786265,0.0000028506659],"about_ca_topic_score_codex":0.0058059166,"about_ca_topic_score_gemma":0.0069370056,"teacher_disagreement_score":0.0058059166,"about_ca_system_score_codex":0.00025523044,"about_ca_system_score_gemma":0.0002799605,"threshold_uncertainty_score":0.011544228},"labels":[],"label_agreement":null},{"id":"W4303650164","doi":"10.1038/s41391-022-00592-9","title":"Clinical characteristics associated with falls in patients with non-metastatic castration-resistant prostate cancer treated with apalutamide","year":2022,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Janssen Research and Development","keywords":"Medicine; Prostate cancer; Oncology; Internal medicine; Urology; Cancer","score_opus":0.0189712351618547,"score_gpt":0.31427866208773236,"score_spread":0.29530742692587764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4303650164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987601,0.0003434477,0.000027695996,0.00007414626,0.000011971553,0.0000050653534,0.00017878205,0.0000023656262,0.00059633865],"genre_scores_gemma":[0.99960536,0.00006973585,0.00001815662,0.000027818029,0.000013125904,0.0000028080158,0.0001672699,7.84742e-7,0.00009501774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997775,0.000040583975,0.000042527055,0.00003259842,0.000052737643,0.00005406866],"domain_scores_gemma":[0.9990484,0.00018543127,0.00039153654,0.00002314903,0.000078180376,0.00027325473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014826891,0.00020012887,0.00050627097,0.00049121684,0.00036074733,0.00054186437,0.00026660366,0.00046816404,0.0012928909],"category_scores_gemma":[0.0014381628,0.00014752698,0.00060459354,0.000907765,0.0001995597,0.0003030387,0.00025991147,0.00064669305,0.00013126791],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072058575,0.000076405486,0.99724764,0.000011462883,0.00008361942,0.00032465503,0.000028252889,0.000058206107,0.00025604657,0.000016002086,0.00009359128,0.0010834159],"study_design_scores_gemma":[0.000014704534,0.00018713198,0.99886775,0.000004308966,0.00003814459,0.00048537212,0.000108226144,0.00015008927,0.00003454981,0.000022637758,0.00008270989,0.000004290268],"about_ca_topic_score_codex":0.0051076002,"about_ca_topic_score_gemma":0.007632564,"teacher_disagreement_score":0.0051076002,"about_ca_system_score_codex":0.00033426713,"about_ca_system_score_gemma":0.0004726478,"threshold_uncertainty_score":0.010155737},"labels":[],"label_agreement":null},{"id":"W4307339801","doi":"10.1038/s41391-022-00607-5","title":"Association between age and efficacy of combination systemic therapies in patients with metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"European Association of Urology","keywords":"Medicine; Internal medicine; Prostate cancer; Oncology; Docetaxel; Hazard ratio; Meta-analysis; Systemic therapy; Hormone therapy; Subgroup analysis; Randomized controlled trial; Cancer; Breast cancer; Confidence interval","score_opus":0.05073892592964981,"score_gpt":0.35402135942795904,"score_spread":0.30328243349830925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307339801","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005839046,0.9928779,0.0003083394,0.00009634053,0.000120471384,0.00008071099,0.00046147857,0.000018510085,0.00019718557],"genre_scores_gemma":[0.2123242,0.78329325,0.0015437737,0.0010240839,0.00023445059,0.00027539447,0.000796611,0.00003193904,0.00047633323],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.996947,0.00122547,0.00087645144,0.00047157236,0.0003243387,0.00015514583],"domain_scores_gemma":[0.99407226,0.004242883,0.0010582927,0.00020254213,0.00030924217,0.000114664515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004360806,0.0020355599,0.01262694,0.0025897769,0.0003911466,0.002077047,0.0016139637,0.0019971156,0.0041800006],"category_scores_gemma":[0.011573675,0.0013033523,0.029597547,0.004448179,0.0005069417,0.0013189738,0.001230503,0.002135969,0.0003472382],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033131393,0.000035888683,0.0055347444,0.23603855,0.7416875,0.00011161613,0.00007188563,0.00046386506,0.00029427776,0.00008999847,0.0007253347,0.011633215],"study_design_scores_gemma":[0.0007018176,0.00015701988,0.0044826525,0.007263382,0.98596317,0.000058198504,0.00003168791,0.00010579615,0.000056358724,0.00009952959,0.0010584126,0.000022013743],"about_ca_topic_score_codex":0.008038163,"about_ca_topic_score_gemma":0.023864496,"teacher_disagreement_score":0.01262694,"about_ca_system_score_codex":0.0014485837,"about_ca_system_score_gemma":0.001817976,"threshold_uncertainty_score":0.023062468},"labels":[],"label_agreement":null},{"id":"W4310456889","doi":"10.1038/s41391-022-00624-4","title":"Acute effect of high-intensity interval aerobic exercise on serum myokine levels and resulting tumour-suppressive effect in trained patients with advanced prostate cancer","year":2022,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Exercise and Physiological Responses","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Health and Medical Research Council; Movember Foundation","keywords":"Medicine; Myokine; Prostate cancer; Aerobic exercise; Internal medicine; Oncology; Cancer; Urology","score_opus":0.006677441030649445,"score_gpt":0.27275859769054955,"score_spread":0.2660811566599001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310456889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996018,0.00013848544,0.000029555466,0.000013579685,0.000008049673,0.000010614641,0.000022905613,0.0000029685448,0.00017204444],"genre_scores_gemma":[0.9996252,0.00006412449,0.000035706176,0.00001794822,0.000015268817,0.000010982172,0.000051422925,7.660276e-7,0.00017865183],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9999163,0.000025715603,0.000005781546,0.0000138349,0.000008720812,0.000029571731],"domain_scores_gemma":[0.9997943,0.000058791007,0.000020239519,0.0000118262615,0.000008210505,0.000106634885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001665581,0.0003152989,0.0004483921,0.00013609616,0.0002116136,0.00020364142,0.00010359014,0.00026635441,0.0012138844],"category_scores_gemma":[0.0004950287,0.00014734687,0.00025560157,0.00016382984,0.00021012439,0.00013423723,0.00020583169,0.0005658983,0.000113570146],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41934046,0.026583213,0.22238313,0.0004432523,0.00083749794,0.0014735023,0.0011442114,0.001847296,0.26254797,0.000115581475,0.0005414471,0.062742464],"study_design_scores_gemma":[0.002117833,0.0825919,0.9059524,0.00001122069,0.00022646398,0.00023881617,0.00025328124,0.00084384705,0.00731126,0.000041036805,0.00039180438,0.000020199805],"about_ca_topic_score_codex":0.000774844,"about_ca_topic_score_gemma":0.0010245807,"teacher_disagreement_score":0.0012138844,"about_ca_system_score_codex":0.00011890833,"about_ca_system_score_gemma":0.00017005455,"threshold_uncertainty_score":0.004060805},"labels":[],"label_agreement":null},{"id":"W4310593800","doi":"10.1038/s41391-022-00613-7","title":"Ethnic differences in prostate-specific antigen levels in men without prostate cancer: a systematic review","year":2022,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"NIHR School for Primary Care Research; Science and Engineering Research Board; National Institute for Health and Care Research; Department of Health and Social Care; Cancer Research UK","keywords":"Medicine; Prostate cancer; Prostate-specific antigen; Prostate; Oncology; Ethnic group; Benign prostatic hyperplasia (BPH); Internal medicine; PCA3; Cancer; Urology; Gynecology","score_opus":0.1061190220799398,"score_gpt":0.38183346931281387,"score_spread":0.2757144472328741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310593800","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025148427,0.99609536,0.00008344223,0.00025923795,0.00007618703,0.00016650844,0.00055444223,0.0000060911184,0.00024399713],"genre_scores_gemma":[0.055902854,0.9414074,0.0004898232,0.00085518707,0.00009650049,0.0006276018,0.00047594655,0.000008263871,0.00013651463],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9923799,0.002786228,0.002828684,0.0006888428,0.0010783934,0.00023788838],"domain_scores_gemma":[0.96923333,0.022791937,0.005678928,0.00037257897,0.0016624923,0.00026070973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006792344,0.0010680264,0.0082408395,0.0061910413,0.0005563465,0.0023139114,0.0015789166,0.0017236384,0.0035304537],"category_scores_gemma":[0.03682347,0.0008972701,0.0069706906,0.0088411225,0.0007954915,0.002012722,0.001208472,0.0009703767,0.00022510941],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020258104,0.000009936434,0.0029227892,0.9676578,0.015326426,0.00009344629,0.00023242937,0.000065733315,0.00007611213,0.00012798443,0.0010380016,0.012246766],"study_design_scores_gemma":[0.0002643057,0.00014847699,0.016095625,0.85726297,0.11496906,0.00039633835,0.0004939661,0.00008025439,0.00014421191,0.00027920934,0.009826486,0.000039151448],"about_ca_topic_score_codex":0.012114072,"about_ca_topic_score_gemma":0.026787484,"teacher_disagreement_score":0.012114072,"about_ca_system_score_codex":0.0028818208,"about_ca_system_score_gemma":0.0071409736,"threshold_uncertainty_score":0.035921812},"labels":[],"label_agreement":null},{"id":"W4315648076","doi":"10.1038/s41391-023-00645-7","title":"Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): look to the future","year":2023,"lang":"en","type":"editorial","venue":"Prostate Cancer and Prostatic Diseases","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Prostatitis; Medicine; Chronic prostatitis/chronic pelvic pain syndrome; Pelvic pain; Chronic pain; Urology; Prostate; Internal medicine; Physical therapy; Surgery","score_opus":0.009404022162840446,"score_gpt":0.30854635203348985,"score_spread":0.2991423298706494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315648076","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014420765,0.024902007,0.000040361923,0.027842512,0.94649273,0.0000098428145,0.000021813781,0.00002014611,0.00065618294],"genre_scores_gemma":[0.00017331951,0.0136051355,0.00004709595,0.020859381,0.96304166,0.000013777425,0.000014953529,0.0000097714565,0.002235037],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99377763,0.0016883239,0.0009107334,0.00053511205,0.0027101468,0.00037799444],"domain_scores_gemma":[0.9683194,0.014286389,0.002288397,0.00051810406,0.009833814,0.0047538686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009610808,0.003680325,0.006094272,0.0045871004,0.0037352373,0.00932533,0.0041306713,0.023749871,0.013023212],"category_scores_gemma":[0.030994298,0.001633526,0.003839643,0.0025023858,0.002888724,0.007056164,0.0025057946,0.025274863,0.00877163],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006040667,0.000014880958,0.000031149688,0.0006914852,0.00003307365,0.00010739189,0.000011914841,0.00002090645,0.000023610562,0.0002291337,0.9917344,0.0070417672],"study_design_scores_gemma":[0.0002945155,0.000091837246,0.0005255868,0.0029892446,0.00023961552,0.0006783845,0.000119330376,0.00022371906,0.000060961014,0.0015565488,0.9931728,0.000047442587],"about_ca_topic_score_codex":0.0037832449,"about_ca_topic_score_gemma":0.010572139,"teacher_disagreement_score":0.023749871,"about_ca_system_score_codex":0.0046616257,"about_ca_system_score_gemma":0.005765424,"threshold_uncertainty_score":0.050827384},"labels":[],"label_agreement":null},{"id":"W4322736746","doi":"10.1038/s41391-023-00654-6","title":"Length of positive surgical margins after radical prostatectomy: Does size matter? – A systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Meta-analysis; Biochemical recurrence; Prostatectomy; Urology; Hazard ratio; Internal medicine; Subgroup analysis; Cochrane Library; Surgical margin; Prostate cancer; Confidence interval; Cancer","score_opus":0.033275331544429416,"score_gpt":0.35206227228702297,"score_spread":0.31878694074259356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322736746","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003505898,0.9951864,0.00038633918,0.00020170701,0.0001482075,0.00017489247,0.00025393735,0.000014538091,0.00012813113],"genre_scores_gemma":[0.19331136,0.80032706,0.0021443518,0.0013249237,0.00057689875,0.001209152,0.00071824255,0.000039483042,0.00034855676],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9885294,0.0054611815,0.0032234648,0.0012913888,0.0011657812,0.00032876112],"domain_scores_gemma":[0.9675876,0.02417341,0.005201007,0.0009818068,0.0017204597,0.00033562694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018320035,0.0030537564,0.023549557,0.0060042413,0.0006922731,0.0041806577,0.0024316276,0.0030294992,0.0038845208],"category_scores_gemma":[0.043066975,0.0018303554,0.05097899,0.006777229,0.0010720509,0.00235938,0.0016574148,0.002130202,0.00034383094],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018484702,0.000027681182,0.0038423385,0.29090017,0.69407505,0.000098578246,0.00006820701,0.0003960338,0.00013332676,0.000114380804,0.00040368905,0.0080921],"study_design_scores_gemma":[0.00035640367,0.00017180016,0.0028523963,0.018754013,0.9765905,0.00006862684,0.00003436636,0.00012004765,0.00005861618,0.00017471178,0.00079998607,0.000018543911],"about_ca_topic_score_codex":0.0055986894,"about_ca_topic_score_gemma":0.010414072,"teacher_disagreement_score":0.023549557,"about_ca_system_score_codex":0.0026526544,"about_ca_system_score_gemma":0.0033643045,"threshold_uncertainty_score":0.09688681},"labels":[],"label_agreement":null},{"id":"W4323842692","doi":"10.1038/s41391-023-00656-4","title":"Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis","year":2023,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Enzalutamide; Medicine; Prostate cancer; Meta-analysis; Oncology; Internal medicine; Adverse effect; Urology; Cancer; Androgen receptor","score_opus":0.05492487006638911,"score_gpt":0.35954915034050244,"score_spread":0.3046242802741133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323842692","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007627312,0.06967074,0.0025549438,0.08113209,0.76267743,0.0009636052,0.07582813,0.0013398372,0.0050705113],"genre_scores_gemma":[0.08797411,0.21714967,0.019904993,0.14887807,0.2844548,0.01267689,0.060720846,0.0059821424,0.16225855],"study_design_codex":"not_applicable","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98697287,0.0040181023,0.003782147,0.0013405654,0.0030432981,0.0008430267],"domain_scores_gemma":[0.9512055,0.019475417,0.0069576474,0.002233481,0.01906609,0.001061874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01575707,0.003637711,0.007039296,0.0054636905,0.0010483894,0.0041969437,0.004931263,0.004264787,0.15144281],"category_scores_gemma":[0.17354684,0.0023335447,0.0098766135,0.009203755,0.001001992,0.0038665289,0.0020813884,0.006399311,0.026930355],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067383563,0.000009160475,0.0004721382,0.0712624,0.0032132554,0.00017981145,0.000097337295,0.00017622903,0.00011588262,0.0008064756,0.9072723,0.015721284],"study_design_scores_gemma":[0.0064914892,0.00022584831,0.009067932,0.09159947,0.02626211,0.0010444445,0.00028764384,0.0010689752,0.0007563568,0.00681016,0.8558816,0.00050405704],"about_ca_topic_score_codex":0.020011192,"about_ca_topic_score_gemma":0.026293298,"teacher_disagreement_score":0.15144281,"about_ca_system_score_codex":0.00365718,"about_ca_system_score_gemma":0.010541926,"threshold_uncertainty_score":0.50662667},"labels":[],"label_agreement":null},{"id":"W4366518804","doi":"10.1038/s41391-023-00669-z","title":"Ablative minimally invasive surgical therapies for benign prostatic hyperplasia: A review of Aquablation, Rezum, and transperineal laser prostate ablation","year":2023,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Centre Hospitalier de l’Université de Montréal; Impact; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Ablative case; Sexual function; Lower urinary tract symptoms; Prostate; Urology; Ablation; Surgery; Internal medicine; Radiation therapy; Cancer","score_opus":0.058798612619583274,"score_gpt":0.3899531316350408,"score_spread":0.33115451901545756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366518804","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000055165212,0.9996507,0.0000375091,0.00003761101,0.000044442215,0.0000034612572,0.000009846587,0.0000017602113,0.00015952082],"genre_scores_gemma":[0.00027502057,0.9993832,0.00009897323,0.00008312845,0.00004638954,0.0000032966352,0.000013732273,6.5952264e-7,0.00009558095],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9996995,0.00005096837,0.000072904666,0.000056457648,0.00010128348,0.000018874258],"domain_scores_gemma":[0.9993368,0.00044005964,0.00009987458,0.000011296779,0.00008674458,0.000025338153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000782269,0.0009321291,0.0024456228,0.0035295142,0.00025850305,0.0010909894,0.001077051,0.0009977672,0.003937417],"category_scores_gemma":[0.0011579803,0.00038146263,0.0014928366,0.0032139856,0.00041200538,0.0012232851,0.00065961806,0.0014957642,0.0008639111],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017484666,0.00011662971,0.00021252947,0.10377539,0.0005129454,0.0001627855,0.00007298306,0.0003252681,0.0016457429,0.0012674103,0.0133066075,0.8784268],"study_design_scores_gemma":[0.000197774,0.0006369494,0.0031061063,0.041431103,0.0029778506,0.0025965339,0.00017830846,0.00029947088,0.000995139,0.0014929455,0.94599366,0.00009431127],"about_ca_topic_score_codex":0.001514009,"about_ca_topic_score_gemma":0.003802048,"teacher_disagreement_score":0.003937417,"about_ca_system_score_codex":0.00040417543,"about_ca_system_score_gemma":0.0009928505,"threshold_uncertainty_score":0.013171971},"labels":[],"label_agreement":null},{"id":"W4385954425","doi":"10.1038/s41391-023-00710-1","title":"The impact of race on survival in metastatic prostate cancer: a systematic literature review","year":2023,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"Pfizer","keywords":"Medicine; Prostate cancer; Incidence (geometry); MEDLINE; Systematic review; Cochrane Library; Cancer; Oncology; Internal medicine; Meta-analysis; Race (biology); Gynecology; Demography","score_opus":0.04688910629029521,"score_gpt":0.40488839809511395,"score_spread":0.35799929180481876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385954425","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027859262,0.9951652,0.000110483816,0.00039188523,0.000073130155,0.00023886774,0.0009020992,0.0000074789073,0.00032483006],"genre_scores_gemma":[0.041713532,0.95540893,0.00065878645,0.000698328,0.000111509355,0.0007581421,0.0005211415,0.0000072383414,0.00012229306],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99227965,0.0030174872,0.0027685123,0.0006085945,0.0010647209,0.00026103668],"domain_scores_gemma":[0.95904505,0.03058166,0.007145122,0.0004464226,0.002432969,0.0003487592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008053107,0.00114277,0.006782787,0.010265065,0.0006670185,0.0022567518,0.0016073204,0.0017189549,0.0052790274],"category_scores_gemma":[0.05408089,0.0008219688,0.008894315,0.012118211,0.00079565105,0.0021595005,0.0014886772,0.0009900843,0.00029266745],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021206684,0.000010101572,0.0022764213,0.9655362,0.012308054,0.000081467646,0.00021953408,0.0000883255,0.00006061319,0.00014465992,0.0013481916,0.017714493],"study_design_scores_gemma":[0.00019997233,0.00016690684,0.009998546,0.89567184,0.083922386,0.00034187277,0.0003178592,0.00009808775,0.000083173225,0.00022167536,0.008945564,0.000032094922],"about_ca_topic_score_codex":0.013736427,"about_ca_topic_score_gemma":0.038870376,"teacher_disagreement_score":0.013736427,"about_ca_system_score_codex":0.003501137,"about_ca_system_score_gemma":0.010175991,"threshold_uncertainty_score":0.042589426},"labels":[],"label_agreement":null},{"id":"W4386127056","doi":"10.1038/s41391-023-00683-1","title":"Correction to: Clinical characteristics associated with falls in patients with non-metastatic castration-resistant prostate cancer treated with apalutamide","year":2023,"lang":"en","type":"erratum","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Oncology; Internal medicine; Urology; Cancer","score_opus":0.022149767776735517,"score_gpt":0.3300304014083722,"score_spread":0.3078806336316367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386127056","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001660308,0.0008647653,0.00020148288,0.037324376,0.95746964,0.000023520366,0.0024540653,0.00009149106,0.0014046294],"genre_scores_gemma":[0.019994736,0.0109874895,0.0035941878,0.105600774,0.6869203,0.00044554833,0.009305399,0.0012103107,0.16194126],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969427,0.00048093547,0.0007449481,0.00041143375,0.0010701147,0.0003498845],"domain_scores_gemma":[0.9734737,0.0059089167,0.0016857628,0.0012398006,0.015942113,0.0017496032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036994833,0.0024939445,0.0025739232,0.0036405104,0.0019356036,0.0030162828,0.0032902122,0.005250619,0.06161893],"category_scores_gemma":[0.05430037,0.0010172984,0.002218449,0.002940484,0.0010826148,0.0013480387,0.0013546325,0.007995056,0.022084838],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034257995,0.000004598134,0.00020142147,0.0001206154,0.000016684919,0.00012473275,0.0000090709045,0.000029073051,0.000009202282,0.000119606484,0.9968587,0.002472024],"study_design_scores_gemma":[0.00034370524,0.000042158837,0.005606855,0.0014025025,0.00019711409,0.0012452537,0.000180231,0.0005217,0.0002249489,0.0011333202,0.9890286,0.00007362125],"about_ca_topic_score_codex":0.043105915,"about_ca_topic_score_gemma":0.047308885,"teacher_disagreement_score":0.06161893,"about_ca_system_score_codex":0.0034850766,"about_ca_system_score_gemma":0.007485751,"threshold_uncertainty_score":0.20613581},"labels":[],"label_agreement":null},{"id":"W4387259785","doi":"10.1038/s41391-023-00730-x","title":"Top-down holmium laser enucleation of the prostate (HoLEP) versus traditional HoLEP for the treatment of benign prostatic hyperplasia (BPH): 1-year outcomes of a randomized controlled trial","year":2023,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Thunder Bay Regional Health Sciences Centre","funders":"","keywords":"Enucleation; Medicine; Prostate; Urology; Hyperplasia; Randomized controlled trial; Benign prostatic hyperplasia (BPH); Surgery; Internal medicine","score_opus":0.03823540526901807,"score_gpt":0.32958657592886925,"score_spread":0.29135117065985117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387259785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974756,0.018114038,0.0009779547,0.0006227538,0.0012437456,0.0020491169,0.00068157876,0.00009555578,0.0014592272],"genre_scores_gemma":[0.9874687,0.005949268,0.0010443706,0.000750129,0.000822821,0.0016178683,0.0005355087,0.000020644211,0.0017906692],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982924,0.0009109709,0.00012633853,0.00033559935,0.00013617567,0.0001985663],"domain_scores_gemma":[0.9977876,0.001063611,0.0005008358,0.0001673362,0.00010841141,0.00037221832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024935745,0.0023208703,0.0058214306,0.00052622746,0.0005583043,0.0016425772,0.0014859941,0.0028463425,0.0052508754],"category_scores_gemma":[0.0033478388,0.00092499395,0.004354172,0.00062733126,0.0017572072,0.001858112,0.0007467627,0.0036378165,0.0006181281],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9909107,0.0013040822,0.00039255776,0.00071739743,0.0018877181,0.000022073878,0.000022565217,0.00013037428,0.0003394276,0.00004334536,0.00013988759,0.0040899883],"study_design_scores_gemma":[0.96196944,0.03261391,0.0019921414,0.00008361536,0.0024638593,0.000021706393,0.00003341415,0.0003315066,0.00016951298,0.00012597952,0.00017573421,0.000019259338],"about_ca_topic_score_codex":0.0018678539,"about_ca_topic_score_gemma":0.0022378562,"teacher_disagreement_score":0.0058214306,"about_ca_system_score_codex":0.00092393515,"about_ca_system_score_gemma":0.000951823,"threshold_uncertainty_score":0.017565906},"labels":[],"label_agreement":null},{"id":"W4387878193","doi":"10.1038/s41391-023-00742-7","title":"Characteristics of incidental prostate cancer in the United States","year":2023,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Prostate cancer; Prostatectomy; Proportional hazards model; Confidence interval; Urology; Internal medicine; Radiation therapy; Cancer; Hazard ratio; Prostate; Epidemiology; Oncology","score_opus":0.017821757292355977,"score_gpt":0.3081621804524668,"score_spread":0.2903404231601108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387878193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991422,0.0007396789,0.00009260644,0.00016914682,0.000025279096,0.000016027876,0.0046663578,0.000013113521,0.0028558855],"genre_scores_gemma":[0.99723804,0.00025631677,0.000047492485,0.000077335026,0.000020711652,0.000008754423,0.0019966415,0.0000036008278,0.0003510451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995295,0.00007733419,0.000085331034,0.00008761123,0.000106618434,0.0001136429],"domain_scores_gemma":[0.9970799,0.0003841946,0.0014058297,0.00009512531,0.00031123622,0.0007238122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034643637,0.0001791241,0.00040157654,0.0015390042,0.00058067805,0.00066734373,0.0003556181,0.00047171637,0.0029949597],"category_scores_gemma":[0.002235629,0.0002720109,0.0005252325,0.0025074268,0.00031569414,0.0006215184,0.0005903738,0.0005047226,0.0003075237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004539881,0.000026732829,0.9989698,0.0000088550605,0.000024030345,0.00004826663,0.000028573095,0.000033945176,0.000054976324,0.000017005032,0.00023128025,0.0005110667],"study_design_scores_gemma":[0.0000020196499,0.000025367515,0.99932754,0.0000056805525,0.000008302918,0.00018453613,0.00016604412,0.000053659405,0.000013813916,0.0000108119675,0.00019923052,0.000002951743],"about_ca_topic_score_codex":0.034031224,"about_ca_topic_score_gemma":0.04280114,"teacher_disagreement_score":0.034031224,"about_ca_system_score_codex":0.0005628285,"about_ca_system_score_gemma":0.0008702107,"threshold_uncertainty_score":0.06766623},"labels":[],"label_agreement":null},{"id":"W4387965704","doi":"10.1038/s41391-023-00741-8","title":"Retreatment rates and postprocedural complications are higher than expected after BPH surgeries: a US healthcare claims and utilization study","year":2023,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Benign prostatic hyperplasia (BPH); Health care; Urology; Intensive care medicine; Prostate cancer; Internal medicine","score_opus":0.06641816263541847,"score_gpt":0.3845345658157966,"score_spread":0.31811640318037815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387965704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99850535,0.00015235436,0.000079815756,0.00005678935,0.000003885036,0.000009563255,0.00095199555,0.000003706116,0.00023656747],"genre_scores_gemma":[0.99916065,0.00005148027,0.00005580855,0.00002930503,0.000007140054,0.0000066346097,0.00064309355,0.0000014695083,0.000044415854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989409,0.0003068722,0.00017508495,0.00021946126,0.0002178766,0.00013975907],"domain_scores_gemma":[0.9969934,0.0004988005,0.0015684972,0.00027663293,0.00026116974,0.0004015232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014459513,0.00020619428,0.00025400936,0.0011286793,0.00035822604,0.0007465837,0.0004575795,0.00057128165,0.0011408248],"category_scores_gemma":[0.0034220438,0.00031147996,0.0006983365,0.0017966426,0.00024324606,0.00071557844,0.00061156874,0.00062070653,0.00020374356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003043421,0.00002395534,0.9995159,0.0000031718196,0.000030072186,0.000017504237,0.000038884024,0.000011756025,0.000026550559,0.000007654959,0.000047459584,0.00024668634],"study_design_scores_gemma":[0.000004067889,0.000037635808,0.9995478,0.0000033932004,0.000013973432,0.00008231485,0.0000981702,0.00012755081,0.000014447842,0.0000076012966,0.00006078025,0.0000021771018],"about_ca_topic_score_codex":0.011432843,"about_ca_topic_score_gemma":0.012101337,"teacher_disagreement_score":0.011432843,"about_ca_system_score_codex":0.00043856978,"about_ca_system_score_gemma":0.0005223326,"threshold_uncertainty_score":0.022732615},"labels":[],"label_agreement":null},{"id":"W4389565536","doi":"10.1038/s41391-023-00756-1","title":"Correction: Retreatment rates and postprocedural complications are higher than expected after BPH surgeries: a US healthcare claims and utilization study","year":2023,"lang":"en","type":"erratum","venue":"Prostate Cancer and Prostatic Diseases","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Benign prostatic hyperplasia (BPH); Health care; MEDLINE; Urology; Prostate cancer; Internal medicine; Cancer","score_opus":0.033973500070847026,"score_gpt":0.3344032237324358,"score_spread":0.30042972366158877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389565536","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003927766,0.0010819884,0.00036475097,0.10578592,0.8811559,0.000035103007,0.0063324347,0.00035091778,0.0045001796],"genre_scores_gemma":[0.044136226,0.012320872,0.0064694467,0.19630268,0.48294535,0.0004958209,0.014422407,0.0027816799,0.2401255],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99502325,0.00065331795,0.0011099994,0.0006164593,0.002107937,0.00048901443],"domain_scores_gemma":[0.96017796,0.011694767,0.003901694,0.001922459,0.020333901,0.0019693184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046323934,0.0019418815,0.0014729896,0.0028076353,0.0027122214,0.003606659,0.0029802548,0.006010084,0.06666478],"category_scores_gemma":[0.08586091,0.0011386919,0.0014601175,0.0035137564,0.0015673536,0.0022790853,0.0014320695,0.010569432,0.03138704],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017710488,0.0000042507722,0.00019834418,0.00006484594,0.0000067837295,0.00012396209,0.000015518044,0.00002020363,0.00000892488,0.00024975347,0.99673647,0.002553237],"study_design_scores_gemma":[0.00014500503,0.000028916442,0.0050490056,0.0011632292,0.000062234525,0.0012578267,0.00024531904,0.00040830066,0.00030602596,0.0017896112,0.9894533,0.00009121052],"about_ca_topic_score_codex":0.0365469,"about_ca_topic_score_gemma":0.03475786,"teacher_disagreement_score":0.06666478,"about_ca_system_score_codex":0.0036517163,"about_ca_system_score_gemma":0.007831846,"threshold_uncertainty_score":0.2230159},"labels":[],"label_agreement":null},{"id":"W4390698406","doi":"10.1038/s41391-023-00766-z","title":"Genomic classifiers and prognosis of localized prostate cancer: a systematic review","year":2024,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Prostate cancer; Prostatectomy; Oncology; Internal medicine; Prostate; MEDLINE; Cancer; Retrospective cohort study; Data extraction","score_opus":0.035063571256035334,"score_gpt":0.3527046226654967,"score_spread":0.31764105140946136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390698406","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000619473,0.99885356,0.00006331835,0.00008350573,0.00004706955,0.000021700725,0.00022445928,0.000002993374,0.00008400799],"genre_scores_gemma":[0.014116451,0.98480797,0.00027657652,0.00035454484,0.000076275006,0.00004610699,0.00024397435,0.000002687852,0.00007543527],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9986547,0.00046745263,0.0003884647,0.00023005939,0.0002050541,0.000054287153],"domain_scores_gemma":[0.99371487,0.0048611667,0.0009058732,0.000107686115,0.00032522113,0.00008522809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026701307,0.0010792973,0.0055126376,0.0028586155,0.00030676118,0.0013231535,0.0012787825,0.0012753456,0.0042423545],"category_scores_gemma":[0.012042404,0.0006388138,0.0074092364,0.0044024196,0.00047233523,0.0012463044,0.0008765929,0.001112539,0.00032827054],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084087055,0.000050752973,0.007414308,0.7751441,0.0773295,0.00014655653,0.00017557893,0.00051213295,0.00029102003,0.00037446176,0.005889951,0.13183069],"study_design_scores_gemma":[0.0011822197,0.00052900915,0.026597269,0.39592627,0.5394427,0.00055652123,0.00032585993,0.00037488024,0.00025121425,0.0013226528,0.033362955,0.00012843561],"about_ca_topic_score_codex":0.008513033,"about_ca_topic_score_gemma":0.027633935,"teacher_disagreement_score":0.008513033,"about_ca_system_score_codex":0.0009796269,"about_ca_system_score_gemma":0.003131452,"threshold_uncertainty_score":0.016926944},"labels":[],"label_agreement":null},{"id":"W4392021861","doi":"10.1038/s41391-024-00805-3","title":"Clinical implications of AR alterations in advanced prostate cancer: a multi-institutional collaboration","year":2024,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; Genomic Health; Foundation Medicine; Genentech; EMD Serono; Bausch Health; Astellas Pharma; Eisai; Seagen; Calithera Biosciences; Advanced Accelerator Applications; Endocyte; Sanofi; Exelixis; Clovis Oncology; Sanofi Genzyme; Pfizer; Incyte; F. Hoffmann-La Roche; Prostate Cancer Foundation; Bristol-Myers Squibb; AstraZeneca; Cardinal Health; Amgen","keywords":"Prostate cancer; Medicine; Context (archaeology); Internal medicine; Oncology; Androgen receptor; Bioinformatics; Cancer; Biology","score_opus":0.03927864963026682,"score_gpt":0.4294667207368856,"score_spread":0.39018807110661874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392021861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99328715,0.001257741,0.0004649273,0.0015539837,0.000030808475,0.00009336363,0.0014797703,0.000022380342,0.0018098304],"genre_scores_gemma":[0.9981,0.0002886682,0.00047906413,0.00017753408,0.000031020256,0.000038704642,0.00077356707,0.0000070671695,0.00010434688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9895487,0.005381231,0.00095011154,0.0013596778,0.0018233896,0.0009369379],"domain_scores_gemma":[0.9736588,0.0059100115,0.012619771,0.0015413923,0.002352115,0.003917875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0098372055,0.00021281793,0.00040906802,0.0017832774,0.0013746958,0.0016906206,0.00115327,0.0004861342,0.0020375552],"category_scores_gemma":[0.014520587,0.00027195486,0.00052236125,0.0035495919,0.00054464967,0.0011307467,0.00461333,0.0007667325,0.00022715813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120533536,0.000053672116,0.9934109,0.00003501158,0.00007602041,0.00014600172,0.00034760914,0.00006653599,0.0001401503,0.00007407218,0.0005927258,0.0049368367],"study_design_scores_gemma":[0.000029033969,0.00020244454,0.99465793,0.00006548192,0.00008617639,0.0008251867,0.001948113,0.00045637746,0.00014074503,0.00014354207,0.0014235027,0.000021447235],"about_ca_topic_score_codex":0.010842351,"about_ca_topic_score_gemma":0.016953923,"teacher_disagreement_score":0.010842351,"about_ca_system_score_codex":0.0014871039,"about_ca_system_score_gemma":0.0034329304,"threshold_uncertainty_score":0.05202478},"labels":[],"label_agreement":null},{"id":"W4395465718","doi":"10.1038/s41391-024-00832-0","title":"Cardiovascular risk in ADT recipients: does the type of ADT matter?","year":2024,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Electroconvulsive Therapy Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; Hamilton Health Sciences","funders":"","keywords":"Medicine; Internal medicine; Prostate cancer; Oncology; Intensive care medicine","score_opus":0.010067875396093379,"score_gpt":0.29249981310558837,"score_spread":0.282431937709495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395465718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96538,0.027601628,0.00026827003,0.0014801051,0.00031572455,0.000029984778,0.0003030629,0.000004512877,0.0046166424],"genre_scores_gemma":[0.9942246,0.0035183465,0.00011988233,0.00073040003,0.00072865485,0.000014399626,0.00020468756,0.0000042961283,0.00045466478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857545,0.0007996418,0.00016361279,0.00014754468,0.00014888166,0.00016493614],"domain_scores_gemma":[0.9965146,0.0017010738,0.00089591154,0.00030750912,0.00018661388,0.0003942475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003113019,0.0004290025,0.001220722,0.0009017217,0.00066527294,0.0017428917,0.0006176632,0.0022253976,0.0031586979],"category_scores_gemma":[0.0062743006,0.00039876217,0.0021696442,0.0017155886,0.0007299936,0.0015835696,0.00042278128,0.0014993693,0.00034012538],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060590343,0.00037892713,0.97744787,0.00025733144,0.0028229868,0.0002420351,0.00018459863,0.000061297156,0.0005288136,0.00031785405,0.00038591985,0.01131344],"study_design_scores_gemma":[0.00027742778,0.0011615247,0.9943902,0.00013731941,0.0016813442,0.0003675542,0.0004314748,0.00013467575,0.00010741661,0.0005733304,0.0007194491,0.000018347271],"about_ca_topic_score_codex":0.0013017866,"about_ca_topic_score_gemma":0.002269094,"teacher_disagreement_score":0.0031586979,"about_ca_system_score_codex":0.00021631006,"about_ca_system_score_gemma":0.00041357524,"threshold_uncertainty_score":0.016463399},"labels":[],"label_agreement":null},{"id":"W4395669138","doi":"10.1038/s41391-024-00843-x","title":"Prevalence and determinants of shared decision-making for PSA testing in the United States","year":2024,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University Health Network; Centre Hospitalier de l’Université de Montréal","funders":"Boston Scientific Corporation","keywords":"Medicine; Prostate-specific antigen; Prostate cancer; Environmental health; Oncology; Internal medicine; Cancer","score_opus":0.03240527838853168,"score_gpt":0.3527498911289772,"score_spread":0.3203446127404455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395669138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99833196,0.00026974294,0.000049670252,0.0004868073,0.000007824276,0.0000062202525,0.00022764318,0.0000026394732,0.00061753084],"genre_scores_gemma":[0.99973935,0.000056154677,0.000021898444,0.00004053864,0.0000056408526,0.0000019415986,0.00009611143,6.7010643e-7,0.000037799215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968676,0.0015830442,0.00033472528,0.0003124969,0.0003846449,0.0005174435],"domain_scores_gemma":[0.98631,0.0052300086,0.0056193927,0.0007065058,0.00069606234,0.0014380006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002436895,0.0001604638,0.00035656505,0.00090525026,0.0007640509,0.0013060594,0.00066138693,0.000779681,0.0023234345],"category_scores_gemma":[0.01413235,0.00037154852,0.0006097604,0.001396945,0.00062539196,0.00077696756,0.0012065195,0.0011959552,0.00013412963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007199672,0.00009537898,0.99766433,0.0000065977833,0.00007865784,0.00003038383,0.00025396777,0.00010665926,0.000021549515,0.00008576502,0.00020672397,0.001378054],"study_design_scores_gemma":[0.0000100234,0.000046807207,0.9969221,0.000028443097,0.00003308102,0.0001270035,0.0014048766,0.0009683277,0.000027246764,0.0002286473,0.00019401494,0.000009448117],"about_ca_topic_score_codex":0.04129932,"about_ca_topic_score_gemma":0.04341281,"teacher_disagreement_score":0.04129932,"about_ca_system_score_codex":0.00085272593,"about_ca_system_score_gemma":0.0016728123,"threshold_uncertainty_score":0.082117856},"labels":[],"label_agreement":null},{"id":"W4395689328","doi":"10.1038/s41391-024-00842-y","title":"Editorial comment on “Reevaluating ‘Top-Down’ HoLEP: the case for anterior fibromuscular stroma as a surgical landmark”","year":2024,"lang":"en","type":"editorial","venue":"Prostate Cancer and Prostatic Diseases","topic":"Urologic and reproductive health conditions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thunder Bay Regional Health Sciences Centre","funders":"","keywords":"Medicine; Landmark; Prostatectomy; Stroma; General surgery; Prostate cancer; Pathology; Artificial intelligence; Internal medicine; Computer science","score_opus":0.015501453828597727,"score_gpt":0.3606249941383368,"score_spread":0.3451235403097391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395689328","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007828881,0.0030291453,0.00016703013,0.24282727,0.7521614,0.00002550246,0.00007696664,0.00008106822,0.0015532535],"genre_scores_gemma":[0.00054027,0.0017196867,0.00013565084,0.19170573,0.80179554,0.000029554465,0.000023221202,0.00003631062,0.004014044],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945273,0.0010212045,0.0007652634,0.0008222866,0.0022370364,0.0006268496],"domain_scores_gemma":[0.98074645,0.009297854,0.0017009561,0.0005442831,0.005105178,0.002605228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070974063,0.0026359414,0.0037400757,0.0026126315,0.003892912,0.006337582,0.0047943844,0.044004347,0.0103742555],"category_scores_gemma":[0.038258716,0.0016164406,0.0028019608,0.001377244,0.0036193135,0.0046972977,0.002092921,0.039456163,0.010132597],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028675298,0.000006812825,0.00003811248,0.000089320856,0.000013231388,0.0002789413,0.00001607882,0.000012632946,0.00003425774,0.00022306961,0.99744946,0.0018092635],"study_design_scores_gemma":[0.00017738674,0.00005100672,0.000504111,0.0007009947,0.0001077954,0.0009018646,0.000113918606,0.00021450662,0.00018252661,0.0016870884,0.9953003,0.000058517926],"about_ca_topic_score_codex":0.0033664447,"about_ca_topic_score_gemma":0.008997288,"teacher_disagreement_score":0.044004347,"about_ca_system_score_codex":0.0039328192,"about_ca_system_score_gemma":0.004204553,"threshold_uncertainty_score":0.03753513},"labels":[],"label_agreement":null},{"id":"W4399645653","doi":"10.1038/s41391-024-00847-7","title":"Can ChatGPT provide high-quality patient information on male lower urinary tract symptoms suggestive of benign prostate enlargement?","year":2024,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Lower urinary tract symptoms; Wilcoxon signed-rank test; International Prostate Symptom Score; Prostate; Rating scale; Quality of life (healthcare); Prostatitis; Urinary system; Urology; Prostate cancer; Reference range; Internal medicine; Physical therapy; Mann–Whitney U test; Psychology; Cancer","score_opus":0.033335023317050946,"score_gpt":0.36566810068130834,"score_spread":0.3323330773642574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399645653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96311164,0.004240041,0.011419189,0.0034440996,0.00044913674,0.0014362566,0.0044191475,0.0011356125,0.010344895],"genre_scores_gemma":[0.9643766,0.0017712825,0.027727444,0.0010281797,0.00038073905,0.00087397353,0.0022894703,0.00012486732,0.0014274929],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9891773,0.0068499153,0.000899876,0.00066352374,0.0020338965,0.00037560757],"domain_scores_gemma":[0.8761336,0.0846377,0.012886013,0.006326841,0.01646338,0.003552453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015942536,0.00043386593,0.0007582671,0.0028614304,0.00045250193,0.0018327528,0.00086489087,0.0010633771,0.0057713995],"category_scores_gemma":[0.12226965,0.00027562343,0.0006559648,0.0017572148,0.0005877712,0.0018773815,0.0022228612,0.0005089537,0.0018501352],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003947565,0.0007740202,0.48863733,0.005128249,0.00027951147,0.001268924,0.008569564,0.000749128,0.005475077,0.00030023127,0.01988699,0.46498343],"study_design_scores_gemma":[0.00039924093,0.004343258,0.92246825,0.0026195988,0.0007313211,0.0050506894,0.006796604,0.0078590885,0.010220412,0.0010962439,0.038144495,0.00027072508],"about_ca_topic_score_codex":0.0016603029,"about_ca_topic_score_gemma":0.002501629,"teacher_disagreement_score":0.015942536,"about_ca_system_score_codex":0.00072064676,"about_ca_system_score_gemma":0.0013899913,"threshold_uncertainty_score":0.084313154},"labels":[],"label_agreement":null},{"id":"W4399871440","doi":"10.1038/s41391-024-00860-w","title":"Correction: Editorial comment on “Reevaluating ‘Top-Down’ HoLEP: the case for anterior fibromuscular stroma as a surgical landmark”","year":2024,"lang":"en","type":"erratum","venue":"Prostate Cancer and Prostatic Diseases","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Thunder Bay Regional Health Sciences Centre","funders":"","keywords":"Medicine; Landmark; General surgery; Prostatectomy; Stroma; Prostate cancer; Cartography; Pathology; Internal medicine; Geography","score_opus":0.016266861465252584,"score_gpt":0.3374429133390448,"score_spread":0.3211760518737922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399871440","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012124251,0.0014685127,0.00017013743,0.2478145,0.74880946,0.00001772702,0.00013106278,0.00007260845,0.0013948522],"genre_scores_gemma":[0.002838924,0.00289038,0.00047686117,0.2908894,0.68866336,0.00006568576,0.00008437501,0.00013299104,0.013958095],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99562234,0.0008747745,0.0006986686,0.00064997026,0.0015094782,0.0006447089],"domain_scores_gemma":[0.9801722,0.009470466,0.0018534056,0.0007504565,0.0061592436,0.0015941863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048332545,0.002341128,0.002300361,0.0029756818,0.003821892,0.0050992644,0.004466993,0.032473557,0.015118127],"category_scores_gemma":[0.05484173,0.0015841095,0.0021699653,0.0014806604,0.0045755296,0.0034674713,0.0024134032,0.03151265,0.010605381],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002203659,0.000004029679,0.0000572572,0.00007747874,0.000011078368,0.0011030653,0.00003236362,0.000015198453,0.000030948595,0.00036353458,0.99687177,0.0014112997],"study_design_scores_gemma":[0.00010076715,0.000026141435,0.0006444692,0.0006437892,0.00007223501,0.0026905371,0.00018253397,0.00016040026,0.00020632448,0.0017482332,0.9934675,0.000057050187],"about_ca_topic_score_codex":0.0096708005,"about_ca_topic_score_gemma":0.0155914035,"teacher_disagreement_score":0.032473557,"about_ca_system_score_codex":0.005262727,"about_ca_system_score_gemma":0.0051150587,"threshold_uncertainty_score":0.050575137},"labels":[],"label_agreement":null},{"id":"W4400092630","doi":"10.1038/s41391-024-00849-5","title":"Should systematic prostatic biopsies be discontinued?","year":2024,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Benign prostatic hyperplasia (BPH); Prostatic Diseases; Prostate cancer; Urology; Prostatitis; Prostate-specific antigen; Prostate; Internal medicine; Cancer","score_opus":0.07504688716547503,"score_gpt":0.3909105715789114,"score_spread":0.3158636844134364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400092630","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002790133,0.9970126,0.00007059858,0.001550751,0.00040559875,0.000009271997,0.00004541737,0.0000057464176,0.00062098855],"genre_scores_gemma":[0.006597267,0.986279,0.0003659267,0.005020892,0.0011067551,0.000027031694,0.000100283425,0.000004869709,0.0004978962],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99877447,0.00046728356,0.00033733266,0.00014372106,0.00020485056,0.00007234803],"domain_scores_gemma":[0.99608153,0.0023432795,0.0009697366,0.000086814485,0.00035851047,0.00016019151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025018181,0.00066413713,0.0036240248,0.0014166671,0.00031330893,0.0010804038,0.00089697697,0.0021212648,0.007813046],"category_scores_gemma":[0.008212971,0.00044783464,0.0023273572,0.0014295841,0.00070668233,0.001618179,0.0005022838,0.0029753197,0.0010054038],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012360908,0.000088036315,0.0015260954,0.11534207,0.0017990461,0.00046745167,0.000121697216,0.0003330517,0.0005704365,0.0017252535,0.041772667,0.83501816],"study_design_scores_gemma":[0.0028214962,0.00088308076,0.018376717,0.25479406,0.013263324,0.0043500164,0.0004880069,0.00026335064,0.00066112203,0.005421231,0.6985582,0.00011943223],"about_ca_topic_score_codex":0.0048538963,"about_ca_topic_score_gemma":0.01685606,"teacher_disagreement_score":0.007813046,"about_ca_system_score_codex":0.0009817937,"about_ca_system_score_gemma":0.0041400874,"threshold_uncertainty_score":0.026137233},"labels":[],"label_agreement":null},{"id":"W4400499206","doi":"10.1038/s41391-024-00866-4","title":"Rare histological prostate cancer subtypes: Cancer-specific and other-cause mortality","year":2024,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Prostate cancer; Cancer; Oncology; Internal medicine; Prostate; Pathology","score_opus":0.04409642639417035,"score_gpt":0.33727226163179497,"score_spread":0.29317583523762464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400499206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939936,0.0013508444,0.001502013,0.0001077345,0.000012550553,0.000021233816,0.0023776689,0.0000420978,0.0005922243],"genre_scores_gemma":[0.9983588,0.00012553633,0.000312181,0.000015757658,0.0000118923945,0.0000068076715,0.0011114544,0.000004315334,0.00005323411],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936527,0.00021288518,0.00005879762,0.00013585338,0.00013856059,0.00008863769],"domain_scores_gemma":[0.9962638,0.0007438032,0.0021457723,0.00026635523,0.00022984765,0.00035039862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016140215,0.0002565836,0.00033633306,0.0012977226,0.00014259425,0.00042205944,0.00049853756,0.00020068954,0.0014713542],"category_scores_gemma":[0.004264274,0.0001399847,0.0009715354,0.0013269627,0.00023653667,0.0002710143,0.0005619081,0.0004472189,0.00012070948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005811869,0.0000057806396,0.99743974,0.000024469615,0.00015747274,0.000017492584,0.0000119663,0.00049963145,0.000039989973,0.000054468892,0.000112434485,0.00157833],"study_design_scores_gemma":[0.000010668979,0.000082975384,0.9967186,0.000012968039,0.00011642965,0.00036151253,0.000040705178,0.0020470398,0.000079268146,0.00019005087,0.0003336305,0.0000060703633],"about_ca_topic_score_codex":0.0056283143,"about_ca_topic_score_gemma":0.009085355,"teacher_disagreement_score":0.0056283143,"about_ca_system_score_codex":0.0004195029,"about_ca_system_score_gemma":0.00050496706,"threshold_uncertainty_score":0.01119113},"labels":[],"label_agreement":null},{"id":"W4400662215","doi":"10.1038/s41391-024-00867-3","title":"Effects of high-intensity interval training on cardiometabolic biomarkers in patients with prostate cancer undergoing active surveillance: a randomized controlled trial","year":2024,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Cancer survivorship and care","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Prostate cancer; High-intensity interval training; Randomized controlled trial; Oncology; Internal medicine; Confidence interval; Benign prostatic hyperplasia (BPH); Urology; Cancer","score_opus":0.006773571917156871,"score_gpt":0.2591775528120912,"score_spread":0.2524039808949343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400662215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836948,0.008489498,0.0006549883,0.0007609783,0.0011668336,0.002868775,0.0006955093,0.00010259991,0.0015659477],"genre_scores_gemma":[0.98813486,0.003535199,0.001060048,0.0009392459,0.00092843705,0.002881442,0.00077163504,0.00001635876,0.0017327244],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99905974,0.00040260682,0.0000828477,0.00023773247,0.00005249883,0.00016449917],"domain_scores_gemma":[0.9986669,0.0004284957,0.0002850254,0.00011789208,0.000089460504,0.0004123252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016793509,0.002328377,0.0048081507,0.0004751207,0.0008517243,0.0013825425,0.0012821382,0.0030886992,0.007834989],"category_scores_gemma":[0.0023708222,0.0010392888,0.003065918,0.0007291811,0.0015475294,0.0012268901,0.0007160467,0.004409182,0.00088324945],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9903257,0.003721952,0.0005350515,0.00043003092,0.0014224862,0.000012162957,0.000019490588,0.000107203356,0.00034897993,0.00002639804,0.00016663356,0.0028839542],"study_design_scores_gemma":[0.9659782,0.029576313,0.0022141156,0.000057098077,0.001637728,0.000008648642,0.000022894546,0.00020110565,0.00008430312,0.00006024407,0.00014751224,0.000011881182],"about_ca_topic_score_codex":0.0028730293,"about_ca_topic_score_gemma":0.003140978,"teacher_disagreement_score":0.007834989,"about_ca_system_score_codex":0.0008054019,"about_ca_system_score_gemma":0.0011769414,"threshold_uncertainty_score":0.026210666},"labels":[],"label_agreement":null},{"id":"W4401182174","doi":"10.1038/s41391-024-00877-1","title":"Reply to RE: Can ChatGPT provide high-quality patient information on male lower urinary tract symptoms suggestive of benign prostate enlargement?","year":2024,"lang":"en","type":"editorial","venue":"Prostate Cancer and Prostatic Diseases","topic":"Health Promotion and Cardiovascular Prevention","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Lower urinary tract symptoms; Urinary system; Urology; Prostate cancer; Prostate; Benign prostatic hyperplasia (BPH); Gynecology; Internal medicine; Cancer","score_opus":0.009029561163314314,"score_gpt":0.3097635020618186,"score_spread":0.30073394089850425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401182174","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007876092,0.0022893231,0.00011291668,0.35542694,0.6399507,0.00004808552,0.00018644353,0.00008813707,0.0018186683],"genre_scores_gemma":[0.00064151076,0.0015362956,0.00013126348,0.36664447,0.6210249,0.00008212395,0.000079596415,0.00005619809,0.009803637],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99274045,0.0014631961,0.0011986805,0.00079611334,0.0031525234,0.00064900646],"domain_scores_gemma":[0.9664483,0.013583695,0.002275383,0.00082889834,0.0120333675,0.004830308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010122463,0.0027429601,0.0041498067,0.0033609616,0.0046819914,0.0069906157,0.004262165,0.037237965,0.018970475],"category_scores_gemma":[0.05637652,0.002048479,0.002766242,0.0015712985,0.002637913,0.0047046733,0.0022894475,0.0381037,0.020210132],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044746306,0.000015982578,0.0000732602,0.00011870263,0.000023934415,0.00010586607,0.000018006649,0.000010948238,0.000028438546,0.00011031324,0.9976005,0.0018493744],"study_design_scores_gemma":[0.0003319495,0.00009099025,0.0013071594,0.0007688627,0.00023616137,0.00038394533,0.00018785257,0.00028572883,0.00016547935,0.0010215066,0.99514425,0.00007601686],"about_ca_topic_score_codex":0.0061487975,"about_ca_topic_score_gemma":0.013841637,"teacher_disagreement_score":0.037237965,"about_ca_system_score_codex":0.0047707055,"about_ca_system_score_gemma":0.005327736,"threshold_uncertainty_score":0.063462496},"labels":[],"label_agreement":null},{"id":"W4401515835","doi":"10.1038/s41391-024-00865-5","title":"Pembrolizumab plus enzalutamide for metastatic castration-resistant prostate cancer progressing on enzalutamide: cohorts 4 and 5 of the phase 2 KEYNOTE-199 study","year":2024,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Université Laval","funders":"Medical Research Council","keywords":"Enzalutamide; Medicine; Prostate cancer; Pembrolizumab; Clinical endpoint; Internal medicine; Cohort; Oncology; Response Evaluation Criteria in Solid Tumors; Cancer; Phases of clinical research; Urology; Surgery; Clinical trial; Immunotherapy; Androgen receptor","score_opus":0.04024679531211643,"score_gpt":0.39768706055211306,"score_spread":0.3574402652399966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401515835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98923373,0.0026175845,0.00042436,0.00060472736,0.00022126474,0.0018405024,0.0021007773,0.00007037874,0.0028867242],"genre_scores_gemma":[0.9839356,0.002955096,0.0014658198,0.0014105405,0.00022573167,0.001616491,0.004689147,0.00004091749,0.0036605885],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99941504,0.00026616213,0.000025007897,0.00009290303,0.00006176118,0.00013922756],"domain_scores_gemma":[0.9994299,0.00008919316,0.000108314634,0.00005339602,0.000037283113,0.000281899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018970808,0.0014126201,0.0019586857,0.00040364353,0.0005064283,0.0012751938,0.0009774957,0.0010541049,0.0032145171],"category_scores_gemma":[0.0011888229,0.00055956584,0.0022882887,0.00038299392,0.0007071674,0.001169488,0.00046838232,0.0035919896,0.00082397676],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8708204,0.026324034,0.00652032,0.00075763406,0.0038312988,0.00015465119,0.00022438698,0.0021945597,0.010699874,0.00033671022,0.005600572,0.07253548],"study_design_scores_gemma":[0.7083957,0.25840902,0.022313708,0.00010231693,0.0019762048,0.0001770902,0.000119930744,0.0010604133,0.0017469028,0.00038412202,0.0052645197,0.000050029106],"about_ca_topic_score_codex":0.0031938474,"about_ca_topic_score_gemma":0.009615285,"teacher_disagreement_score":0.0032145171,"about_ca_system_score_codex":0.0015513764,"about_ca_system_score_gemma":0.0020308846,"threshold_uncertainty_score":0.011256039},"labels":[],"label_agreement":null},{"id":"W4402282016","doi":"10.1038/s41391-024-00886-0","title":"Cardiovascular events among men with prostate cancer treated with androgen receptor signaling inhibitors: a systematic review, meta-analysis, and network meta-analysis","year":2024,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Innovációs és Technológiai Minisztérium; Medizinische Universität Wien; European Association of Urology; Universität Wien","keywords":"Medicine; Enzalutamide; Prostate cancer; Internal medicine; Heart failure; Androgen deprivation therapy; Atrial fibrillation; Meta-analysis; Relative risk; Oncology; Androgen receptor; Cardiology; Cancer; Confidence interval","score_opus":0.06336574411383952,"score_gpt":0.34931513731522806,"score_spread":0.28594939320138857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402282016","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014031614,0.98198396,0.0012141971,0.00031361028,0.0001962364,0.00026672575,0.0015899598,0.00005230069,0.0003512476],"genre_scores_gemma":[0.42557153,0.5647825,0.0040518628,0.0009870278,0.00040709614,0.0015212718,0.0021904453,0.000055366207,0.00043298103],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99100167,0.0050024954,0.0018646409,0.0010625533,0.0007650621,0.00030353313],"domain_scores_gemma":[0.982005,0.014049449,0.002102456,0.0006623278,0.0009696861,0.00021114307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011802137,0.0024716882,0.013744434,0.0056164004,0.00060892035,0.002363515,0.0019185634,0.0016726444,0.0026245909],"category_scores_gemma":[0.027681421,0.0013156496,0.03969442,0.0068137404,0.00046655422,0.0011798369,0.001398589,0.0017083016,0.0002079509],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016130327,0.000021694581,0.008620811,0.11488074,0.8675724,0.0001037863,0.000046079844,0.00090027426,0.00014348388,0.000111642876,0.00056577753,0.0054202355],"study_design_scores_gemma":[0.00032044822,0.000083350795,0.0037392643,0.005178472,0.98945963,0.000051614934,0.000018021321,0.00029848499,0.00005230939,0.00014624141,0.0006384371,0.000013707257],"about_ca_topic_score_codex":0.008250658,"about_ca_topic_score_gemma":0.014268159,"teacher_disagreement_score":0.013744434,"about_ca_system_score_codex":0.0018422033,"about_ca_system_score_gemma":0.002198461,"threshold_uncertainty_score":0.062416434},"labels":[],"label_agreement":null},{"id":"W4403195121","doi":"10.1038/s41391-024-00902-3","title":"Publisher Correction: Cardiovascular events among men with prostate cancer treated with androgen receptor signaling inhibitors: a systematic review, meta-analysis, and network meta-analysis","year":2024,"lang":"en","type":"erratum","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Meta-analysis; Prostate cancer; Medicine; Androgen receptor; Oncology; Benign prostatic hyperplasia (BPH); Internal medicine; Urology; Cancer; Bioinformatics; Biology","score_opus":0.0332910402351508,"score_gpt":0.29902909023236957,"score_spread":0.2657380499972188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403195121","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000861096,0.0019638317,0.00088604615,0.064747974,0.9242364,0.00007737918,0.005652041,0.0005344804,0.0018157943],"genre_scores_gemma":[0.016385807,0.016643157,0.012436979,0.24885125,0.49043947,0.0019618727,0.012707801,0.0051097525,0.19546391],"study_design_codex":"not_applicable","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9825644,0.004333051,0.004179296,0.0021082931,0.005992243,0.000822689],"domain_scores_gemma":[0.89973044,0.035463315,0.0074472413,0.0070886016,0.04760992,0.0026604373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019397128,0.003694713,0.004261291,0.0060461923,0.003334716,0.005853969,0.0059507424,0.006644433,0.11603343],"category_scores_gemma":[0.23577875,0.0024743748,0.0045540486,0.0075572305,0.002265668,0.003926397,0.0027982646,0.014104719,0.04466913],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046311296,0.0000025545435,0.000055291577,0.0005147531,0.00005021141,0.000083378385,0.000020881345,0.0000347123,0.000015594129,0.0003148018,0.9963037,0.002557765],"study_design_scores_gemma":[0.00060782355,0.000039698607,0.0012626537,0.0044650887,0.0006517641,0.00064179103,0.00010942065,0.0004632082,0.00033912118,0.0044738115,0.9868154,0.00013030681],"about_ca_topic_score_codex":0.023638315,"about_ca_topic_score_gemma":0.031502,"teacher_disagreement_score":0.11603343,"about_ca_system_score_codex":0.005267264,"about_ca_system_score_gemma":0.014801655,"threshold_uncertainty_score":0.38817048},"labels":[],"label_agreement":null},{"id":"W4403589113","doi":"10.1038/s41391-024-00910-3","title":"Undetected Cribriform and Intraductal Prostate Cancer at biopsy is associated with adverse outcomes","year":2024,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Fundação para a Ciência e a Tecnologia","keywords":"Medicine; Prostate cancer; Cribriform; Adverse effect; Biopsy; Benign prostatic hyperplasia (BPH); Oncology; Urology; Internal medicine; Radiology; Cancer; Carcinoma","score_opus":0.012195919384550892,"score_gpt":0.28178299601180073,"score_spread":0.26958707662724984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403589113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861936,0.008202955,0.0004694033,0.00049490016,0.000090807174,0.000018655455,0.0008732275,0.000021642792,0.003634907],"genre_scores_gemma":[0.9985013,0.0005907636,0.00014890794,0.000080156104,0.00006696258,0.0000029005807,0.00030076707,0.00000406577,0.00030411454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988244,0.00024611375,0.00012708783,0.00019980571,0.00034783815,0.00025476428],"domain_scores_gemma":[0.99212646,0.0016989134,0.0038866457,0.00050346146,0.0008300786,0.0009544894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008935338,0.00034678646,0.00047796094,0.001136315,0.0005863539,0.0012975693,0.00084337126,0.0008214113,0.0031242352],"category_scores_gemma":[0.009618437,0.00036084247,0.0008359389,0.0015874117,0.00056132063,0.00081482343,0.00088292634,0.0014996507,0.0002682843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009370196,0.000011684992,0.9975789,0.000024069037,0.00008478897,0.000096897355,0.000020539273,0.000033196302,0.00012987982,0.000026977646,0.00009610131,0.0018033034],"study_design_scores_gemma":[0.000002163352,0.000031978263,0.99858594,0.000023004955,0.000069808986,0.00062245474,0.00009009743,0.00015315568,0.00008714955,0.00009004966,0.00023759094,0.0000065343584],"about_ca_topic_score_codex":0.011715138,"about_ca_topic_score_gemma":0.017077183,"teacher_disagreement_score":0.011715138,"about_ca_system_score_codex":0.0005441526,"about_ca_system_score_gemma":0.00096030714,"threshold_uncertainty_score":0.023293912},"labels":[],"label_agreement":null},{"id":"W4404120194","doi":"10.1038/s41391-024-00897-x","title":"Comprehensive review of cardiovascular disease in prostate cancer: epidemiology, risk factors, therapeutics and prevention strategies","year":2024,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; St. Joseph’s Healthcare Hamilton; Population Health Research Institute; McMaster University","funders":"","keywords":"Medicine; Prostate cancer; Epidemiology; Disease; Oncology; Internal medicine; Cancer","score_opus":0.08630483636490754,"score_gpt":0.402857363091276,"score_spread":0.31655252672636847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404120194","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000042313088,0.99954104,0.00003881383,0.000109336754,0.00008379958,0.0000055454448,0.00003735453,0.000003079093,0.00013872421],"genre_scores_gemma":[0.00019716505,0.9993623,0.000108461005,0.00012326454,0.00009926342,0.0000046556966,0.000031555435,4.698953e-7,0.00007281262],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99955124,0.00009988335,0.00011330783,0.00006511029,0.00014350004,0.000026929709],"domain_scores_gemma":[0.9988368,0.00072826026,0.0001717173,0.000018805637,0.00019349532,0.000050926043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010959749,0.0010668605,0.002661143,0.003152879,0.00024786446,0.0011916539,0.0010075959,0.0010258044,0.00471107],"category_scores_gemma":[0.002020822,0.00038625998,0.0015874141,0.0035582883,0.0002594836,0.0009933808,0.00077887124,0.0015818599,0.0009695492],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001926615,0.00012903239,0.0004070751,0.16131952,0.0010233809,0.00014122971,0.00007480166,0.00039979283,0.00093249575,0.001408609,0.04503152,0.78893983],"study_design_scores_gemma":[0.00015403761,0.00040449155,0.005003856,0.07262852,0.004234191,0.0012033351,0.00014293822,0.0002571615,0.00032226974,0.0019964913,0.913572,0.0000807732],"about_ca_topic_score_codex":0.0026537487,"about_ca_topic_score_gemma":0.006488276,"teacher_disagreement_score":0.00471107,"about_ca_system_score_codex":0.0005984326,"about_ca_system_score_gemma":0.0026197298,"threshold_uncertainty_score":0.015760064},"labels":[],"label_agreement":null},{"id":"W4405128969","doi":"10.1038/s41391-024-00924-x","title":"Talazoparib plus enzalutamide versus olaparib plus abiraterone acetate and niraparib plus abiraterone acetate for metastatic castration-resistant prostate cancer: a matching-adjusted indirect comparison","year":2024,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"Pfizer","keywords":"Abiraterone acetate; Medicine; Enzalutamide; Olaparib; Prostate cancer; Oncology; Internal medicine; Confidence interval; Hazard ratio; Urology; Cancer; Androgen deprivation therapy; Poly ADP ribose polymerase; Chemistry","score_opus":0.060146084737071254,"score_gpt":0.3616965064831839,"score_spread":0.3015504217461127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405128969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97436476,0.010806282,0.003993053,0.00036470176,0.0006949544,0.0026102779,0.0027110244,0.00010653686,0.004348497],"genre_scores_gemma":[0.991855,0.001129341,0.0022606787,0.00024144116,0.00014822463,0.0018314883,0.00084165786,0.000016860427,0.0016751891],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99290085,0.005389817,0.0003823799,0.0005787339,0.0004199732,0.00032828326],"domain_scores_gemma":[0.9964317,0.0020455825,0.0008443626,0.00030387664,0.00014475251,0.00022968325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005359843,0.0016982696,0.0031157015,0.0007732442,0.00019873012,0.0008378006,0.0012937924,0.001026392,0.007597291],"category_scores_gemma":[0.0075040613,0.0005265042,0.0066377823,0.0005501332,0.00058173056,0.0007500066,0.0011158414,0.0018967775,0.00050801],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93555814,0.0013215513,0.0050428,0.0022418043,0.028105523,0.00005458852,0.00009220201,0.0032175793,0.0013119698,0.0006564393,0.0006495422,0.021747822],"study_design_scores_gemma":[0.5681544,0.26694167,0.04638412,0.0006076145,0.08482718,0.00030783686,0.00023894174,0.017075906,0.003995041,0.0042454167,0.0070589697,0.00016288228],"about_ca_topic_score_codex":0.0010926052,"about_ca_topic_score_gemma":0.0015271737,"teacher_disagreement_score":0.007597291,"about_ca_system_score_codex":0.00099401,"about_ca_system_score_gemma":0.00082579796,"threshold_uncertainty_score":0.028345883},"labels":[],"label_agreement":null},{"id":"W4406493207","doi":"10.1038/s41391-024-00932-x","title":"Prognostic value of MR visibility/invisibility in men on Active Surveillance","year":2025,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Male Breast Health Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Visibility; Invisibility; Radiology; Value (mathematics); Internal medicine; Artificial intelligence; Statistics; Optics","score_opus":0.01144968647408547,"score_gpt":0.3369216406675268,"score_spread":0.3254719541934413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406493207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955576,0.0016320477,0.00009734603,0.00012383498,0.00002100102,0.000005366643,0.00026136506,0.00000798157,0.0022933444],"genre_scores_gemma":[0.99953985,0.00015220113,0.000022306105,0.000011761488,0.000026152722,8.497386e-7,0.000106114676,0.0000014743399,0.00013926858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966645,0.00011047003,0.000033155422,0.000045069228,0.00004731754,0.0000976278],"domain_scores_gemma":[0.99765044,0.00064909825,0.00096298254,0.00017348478,0.00012100453,0.00044304947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007075907,0.00039552333,0.0003581716,0.0013423312,0.0004527013,0.0011229673,0.00045366568,0.0007044436,0.0027065175],"category_scores_gemma":[0.0055080834,0.00026769738,0.00067295413,0.0012993525,0.0005887726,0.00087778305,0.00081177003,0.00089580845,0.00020200862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045759062,0.00002840211,0.99666256,0.00001663753,0.00008988984,0.000099951976,0.00009142059,0.000056490375,0.00014499002,0.000045526816,0.00005074187,0.0022558998],"study_design_scores_gemma":[0.000008236244,0.00021557795,0.99851185,0.000009722435,0.000103072074,0.00031152362,0.00031115577,0.0001504453,0.00007604887,0.00008083965,0.00021551218,0.0000059493186],"about_ca_topic_score_codex":0.002794613,"about_ca_topic_score_gemma":0.0026784763,"teacher_disagreement_score":0.002794613,"about_ca_system_score_codex":0.00016035764,"about_ca_system_score_gemma":0.0002540333,"threshold_uncertainty_score":0.009054244},"labels":[],"label_agreement":null},{"id":"W4407193911","doi":"10.1038/s41391-025-00947-y","title":"Stereotactic body radiotherapy: a second chance for radio-recurrent prostate cancer","year":2025,"lang":"en","type":"editorial","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute for Oil Sands Innovation, University of Alberta; Université de Genève","keywords":"Medicine; Prostate cancer; Radiation therapy; Oncology; Prostate; Cancer; Radiology; Internal medicine","score_opus":0.010146510378280465,"score_gpt":0.31981581829038946,"score_spread":0.309669307912109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407193911","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000033316574,0.02346722,0.00009902066,0.035851598,0.9390704,0.000013547077,0.00002623476,0.00003430326,0.0014042628],"genre_scores_gemma":[0.000303174,0.007544494,0.00004714562,0.026828382,0.961746,0.0000129759055,0.000014978195,0.000013094975,0.003489763],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99517304,0.0012161565,0.0006920714,0.00055921194,0.0020330735,0.0003264534],"domain_scores_gemma":[0.9847558,0.007953452,0.0011941281,0.0003829367,0.0035813511,0.0021323273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067320867,0.003693741,0.0043819146,0.0038902117,0.00316818,0.0062301103,0.0038900732,0.031313464,0.010243543],"category_scores_gemma":[0.019847713,0.0017258594,0.0042323126,0.0015068925,0.002784822,0.004410262,0.002105523,0.03155306,0.007805967],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057515936,0.000010964595,0.00002686463,0.0003747948,0.000044297904,0.00025903297,0.000008907576,0.000031928987,0.000049342445,0.00028174563,0.99170834,0.0071462668],"study_design_scores_gemma":[0.00019511994,0.00008764961,0.0004670023,0.0009670672,0.00020142624,0.0013773199,0.000037493082,0.00023632695,0.00009977267,0.0011401589,0.99514884,0.000041802432],"about_ca_topic_score_codex":0.0028563116,"about_ca_topic_score_gemma":0.008117656,"teacher_disagreement_score":0.031313464,"about_ca_system_score_codex":0.004699202,"about_ca_system_score_gemma":0.0030103948,"threshold_uncertainty_score":0.035603106},"labels":[],"label_agreement":null},{"id":"W4408062148","doi":"10.1038/s41391-025-00953-0","title":"Extended LUTS medication use following BPH surgical treatment: a US healthcare claims analysis","year":2025,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Benign prostatic hyperplasia (BPH); Health care; Prostate cancer; Internal medicine; Urology; Gynecology","score_opus":0.02567362548762452,"score_gpt":0.37903728068676373,"score_spread":0.3533636551991392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408062148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953419,0.00037795125,0.00008078408,0.00009194316,0.0000040032737,0.000015779231,0.0037568014,0.0000049701675,0.0003258002],"genre_scores_gemma":[0.99627566,0.00016332115,0.0001045054,0.000039867384,0.000014327573,0.000012027964,0.003341713,0.0000017142748,0.000046785688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908376,0.00021814958,0.00020271122,0.00014758007,0.000247136,0.00010066718],"domain_scores_gemma":[0.9954738,0.0006728261,0.003064861,0.00019289643,0.00025740077,0.00033819093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000999916,0.00023459346,0.00033701994,0.0019366513,0.00028479937,0.00064104423,0.00043850704,0.00042451842,0.0012519915],"category_scores_gemma":[0.0027458328,0.00024199691,0.00079947355,0.0032639569,0.00025213696,0.00050684967,0.00080296723,0.0005445469,0.0001806503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057778587,0.000022750726,0.9990075,0.000012653029,0.000060518243,0.0000287504,0.00002381506,0.000059435504,0.000039394847,0.000011774747,0.00010987456,0.00056576356],"study_design_scores_gemma":[0.0000055777527,0.000032552765,0.99926883,0.000008691833,0.000027615448,0.00009806318,0.00007021754,0.00032398792,0.000019982266,0.000013130198,0.00012883182,0.0000025612178],"about_ca_topic_score_codex":0.013624155,"about_ca_topic_score_gemma":0.013673333,"teacher_disagreement_score":0.013624155,"about_ca_system_score_codex":0.0004489329,"about_ca_system_score_gemma":0.00054220617,"threshold_uncertainty_score":0.027089715},"labels":[],"label_agreement":null},{"id":"W4408765892","doi":"10.1038/s41391-025-00965-w","title":"Whack-a-met: serial SABR for repeated oligoprogression in metastatic CRPC","year":2025,"lang":"en","type":"editorial","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"SABR volatility model; Medicine; Prostate cancer; Internal medicine; Cancer","score_opus":0.01645618948184608,"score_gpt":0.37102001010847885,"score_spread":0.3545638206266328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408765892","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000672337,0.024447067,0.00021011863,0.044921793,0.9281668,0.000044951703,0.00007762255,0.0000857872,0.0019786437],"genre_scores_gemma":[0.0005812611,0.008322046,0.00013008909,0.03190843,0.95384306,0.00003557852,0.00003588726,0.00002919487,0.00511443],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958274,0.0011939463,0.0006768125,0.00044572644,0.0015725455,0.00028360414],"domain_scores_gemma":[0.9869486,0.00641997,0.001131875,0.00031069736,0.0033099866,0.0018789252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0077172522,0.0038028806,0.005140057,0.0027695128,0.0020765204,0.0052111917,0.0035966907,0.02100312,0.011597291],"category_scores_gemma":[0.022516567,0.0014971595,0.004345364,0.0012704838,0.0016931922,0.0031299714,0.0013964436,0.026500577,0.007984137],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019224663,0.0000203528,0.000037741873,0.0005751054,0.00008689258,0.00015988364,0.000008907537,0.000047235648,0.000072590876,0.00026024148,0.98352975,0.015008967],"study_design_scores_gemma":[0.0010455578,0.00028528093,0.00079340587,0.0017223135,0.00054275757,0.0008728255,0.000039336202,0.000605517,0.00024161792,0.0011973275,0.9925954,0.00005884556],"about_ca_topic_score_codex":0.0025225529,"about_ca_topic_score_gemma":0.006883077,"teacher_disagreement_score":0.02100312,"about_ca_system_score_codex":0.0038070178,"about_ca_system_score_gemma":0.0025716152,"threshold_uncertainty_score":0.040813208},"labels":[],"label_agreement":null},{"id":"W4408858614","doi":"10.1038/s41391-025-00956-x","title":"New kids on the block: MRI guided transrectal focused US, TULSA, focal laser ablation, histotripsy – a comprehensive review","year":2025,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; McGill University; University Health Network","funders":"American Cancer Society","keywords":"Medicine; Ablation; Laser ablation; Focused ultrasound; Prostatitis; Magnetic resonance imaging; Radiology; Prostate; Laser; Ultrasound; Internal medicine; Optics; Cancer","score_opus":0.022913402879085113,"score_gpt":0.2915905373623215,"score_spread":0.2686771344832364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408858614","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006921614,0.9992061,0.00009604973,0.00009130408,0.0001046481,0.000003996614,0.000013141787,0.0000047860444,0.0004106701],"genre_scores_gemma":[0.00031813033,0.9988379,0.00018462629,0.00014690003,0.0001261927,0.0000047790595,0.000027106244,0.0000018055403,0.00035258644],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998216,0.000027132888,0.00003286494,0.00003977572,0.00006248154,0.000016156793],"domain_scores_gemma":[0.9996375,0.00021379926,0.0000553984,0.000007611903,0.0000637628,0.000021926848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056797685,0.0007897268,0.0013961723,0.002654867,0.00021441946,0.0010218463,0.00069111853,0.0009478118,0.0046210596],"category_scores_gemma":[0.00086536445,0.00032673345,0.00070719136,0.0019749985,0.0003702011,0.0011858433,0.00056151004,0.0014511856,0.0017815018],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082058585,0.00006550103,0.00015409436,0.024019768,0.00009863337,0.00010442129,0.00003835953,0.00022522865,0.0012047914,0.0011362178,0.019072508,0.95379835],"study_design_scores_gemma":[0.000052596548,0.0002657984,0.0014854368,0.011516092,0.00037710436,0.0020923067,0.00010309833,0.00016818813,0.00070309674,0.0013390617,0.9818518,0.000045488705],"about_ca_topic_score_codex":0.0014369984,"about_ca_topic_score_gemma":0.00335714,"teacher_disagreement_score":0.0046210596,"about_ca_system_score_codex":0.00033151117,"about_ca_system_score_gemma":0.001054901,"threshold_uncertainty_score":0.015459001},"labels":[],"label_agreement":null},{"id":"W4408914774","doi":"10.1038/s41391-025-00961-0","title":"Does biodegradable peri-rectal spacer mitigate treatment toxicities in radiation therapy for localised prostate cancer—a systematic review and meta-analysis","year":2025,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Prostate cancer; Radiation therapy; Oncology; Meta-analysis; Prostate; Urology; Internal medicine; Cancer","score_opus":0.02284981164868175,"score_gpt":0.32217379782186467,"score_spread":0.2993239861731829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408914774","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017848654,0.98030925,0.00048549997,0.00017785706,0.00022319744,0.00013416664,0.00042907783,0.00002425905,0.0003680626],"genre_scores_gemma":[0.52750367,0.4675661,0.0016086033,0.0015824594,0.00030175742,0.0002399228,0.0005507044,0.000047220583,0.0005995602],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9963995,0.0015563916,0.0010121198,0.00054425246,0.00031743723,0.00017027446],"domain_scores_gemma":[0.9934343,0.004116643,0.00175014,0.00029483333,0.00028449623,0.00011967205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053322506,0.00164349,0.009175855,0.0015783183,0.0003666287,0.002302565,0.0013996649,0.0022036037,0.0037328056],"category_scores_gemma":[0.015546712,0.0010961901,0.027705476,0.0023953961,0.000686224,0.0014305981,0.0010056314,0.002095838,0.0003297158],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010956765,0.00006991345,0.006161127,0.22476518,0.73374546,0.00009345003,0.00012590543,0.00064125785,0.0005273834,0.00013698079,0.00055516494,0.0222214],"study_design_scores_gemma":[0.0024609321,0.0009141754,0.006542433,0.009636652,0.97795594,0.00007540441,0.00006186623,0.00016398932,0.00013817374,0.00020774503,0.0018092502,0.000033389133],"about_ca_topic_score_codex":0.005258849,"about_ca_topic_score_gemma":0.015060067,"teacher_disagreement_score":0.009175855,"about_ca_system_score_codex":0.0014110738,"about_ca_system_score_gemma":0.0013247852,"threshold_uncertainty_score":0.02819997},"labels":[],"label_agreement":null},{"id":"W4409231464","doi":"10.1038/s41391-025-00964-x","title":"The association between statin use, genetic variation, and prostate cancer risk","year":2025,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; McGill University; University Health Network","funders":"Canadian Cancer Society Research Institute; Prostate Cancer Canada; Canadian Urological Association","keywords":"Medicine; Prostate cancer; Oncology; Statin; Internal medicine; Variation (astronomy); Cancer","score_opus":0.005431739109984552,"score_gpt":0.2558825652535446,"score_spread":0.25045082614356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409231464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926636,0.004469862,0.0004799886,0.0004107417,0.00003413654,0.0000055308265,0.000521533,0.00002199561,0.0013926964],"genre_scores_gemma":[0.99879444,0.0005433678,0.00019451616,0.000046603232,0.000030802767,0.0000020021953,0.00010802435,0.0000041217145,0.00027614567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923706,0.00033149007,0.00007652812,0.00013737712,0.000120100805,0.00009754372],"domain_scores_gemma":[0.99847037,0.0006025236,0.0004078771,0.000187708,0.000108108936,0.00022343299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006262876,0.0002000127,0.00033603885,0.0006501222,0.00029971806,0.00055805215,0.00028765132,0.00057459774,0.0018378445],"category_scores_gemma":[0.0024359839,0.00021289384,0.00071236154,0.0012812158,0.00028335527,0.00018086955,0.00030367437,0.0005564134,0.00014045252],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058385136,0.000032297437,0.992751,0.000022676977,0.00080525706,0.00011099381,0.000039988994,0.00010648549,0.0020897996,0.00014311257,0.000099506266,0.0032150114],"study_design_scores_gemma":[0.000007377059,0.000056843957,0.99882513,0.0000049781993,0.00017689819,0.00016539595,0.00002776185,0.00030201997,0.00014972789,0.00009352582,0.0001860416,0.0000043902382],"about_ca_topic_score_codex":0.011997455,"about_ca_topic_score_gemma":0.010165286,"teacher_disagreement_score":0.011997455,"about_ca_system_score_codex":0.00022573573,"about_ca_system_score_gemma":0.00038190925,"threshold_uncertainty_score":0.023855269},"labels":[],"label_agreement":null},{"id":"W4409586979","doi":"10.1038/s41391-025-00973-w","title":"Endoscopic enucleation vs. robot-assisted simple prostatectomy for large prostates: a systematic review and meta-analysis of patients’ perspectives","year":2025,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Enucleation; Urology; Prostatectomy; Meta-analysis; Benign prostatic hyperplasia (BPH); Prostate; Surgery; Internal medicine; Cancer","score_opus":0.05572728893046221,"score_gpt":0.3998648696323548,"score_spread":0.3441375807018926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409586979","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007952156,0.9908716,0.00026750672,0.0001252917,0.00017726378,0.000082308135,0.0002955731,0.000010759495,0.00021744595],"genre_scores_gemma":[0.28889963,0.7063814,0.0013498929,0.0015975174,0.00039688952,0.00023759814,0.00064468704,0.00003795824,0.00045438932],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9958567,0.0018171447,0.0012111727,0.00058977935,0.00034011484,0.00018515908],"domain_scores_gemma":[0.9940904,0.0043316553,0.0010236705,0.00016653434,0.0002701573,0.000117541786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005812055,0.0018989966,0.012416901,0.0018837812,0.0004020147,0.0021266937,0.0015297658,0.0018459125,0.0036181835],"category_scores_gemma":[0.01278377,0.0010511175,0.031266302,0.0029072494,0.000584641,0.0015695811,0.0012046254,0.0025791395,0.00033084655],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010599005,0.00004144491,0.00481322,0.22276446,0.7429322,0.00010610837,0.000108626315,0.000357138,0.0003412145,0.00012341628,0.00062504766,0.017188119],"study_design_scores_gemma":[0.002639117,0.0003851842,0.004877676,0.0104985135,0.97958976,0.00008102191,0.00007549776,0.00010477438,0.000092973976,0.00021267023,0.001412794,0.000030020885],"about_ca_topic_score_codex":0.00492949,"about_ca_topic_score_gemma":0.016480304,"teacher_disagreement_score":0.012416901,"about_ca_system_score_codex":0.0014088362,"about_ca_system_score_gemma":0.0014285735,"threshold_uncertainty_score":0.0307374},"labels":[],"label_agreement":null},{"id":"W4409709577","doi":"10.1038/s41391-025-00974-9","title":"Endoscopic enucleation of the prostate (EEP) versus transurethral resection of the prostate (TURP): advantages and implications","year":2025,"lang":"en","type":"editorial","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Université de Montréal","funders":"","keywords":"Enucleation; Medicine; Prostate; Transurethral resection of the prostate; Urology; Resection; Benign prostatic hyperplasia (BPH); Surgery; Internal medicine; Cancer","score_opus":0.009737563922734574,"score_gpt":0.3094050017086821,"score_spread":0.29966743778594757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409709577","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000035871166,0.015607231,0.00007618873,0.031032803,0.9521087,0.000014691736,0.000036818717,0.00002226064,0.0010653757],"genre_scores_gemma":[0.00035853632,0.008278887,0.00008800536,0.027234651,0.9611801,0.0000176444,0.00001662547,0.000014735927,0.0028107814],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99534637,0.0011491529,0.00079315784,0.0005649295,0.0018646367,0.0002816848],"domain_scores_gemma":[0.9756883,0.01518586,0.0014160109,0.00035299055,0.005101221,0.0022556926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009282364,0.0028985129,0.0044346554,0.0026023486,0.0025369604,0.0058330107,0.0036561969,0.019169824,0.008079387],"category_scores_gemma":[0.029756162,0.0012439905,0.0034960916,0.0017101429,0.0023005763,0.0038995151,0.0010549221,0.027788723,0.0056878184],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024602847,0.00003215566,0.000045917488,0.0009720233,0.00007701313,0.00015696046,0.00001264687,0.00005397472,0.00007330816,0.00057461543,0.9847098,0.013045545],"study_design_scores_gemma":[0.0005325574,0.00017065344,0.0009704058,0.0021834602,0.00041593806,0.0006340248,0.00006676476,0.00032874302,0.00022022026,0.002097194,0.992322,0.000058093534],"about_ca_topic_score_codex":0.003622391,"about_ca_topic_score_gemma":0.008068801,"teacher_disagreement_score":0.019169824,"about_ca_system_score_codex":0.0041508377,"about_ca_system_score_gemma":0.0035772843,"threshold_uncertainty_score":0.049090445},"labels":[],"label_agreement":null},{"id":"W4410051475","doi":"10.1038/s41391-025-00975-8","title":"Addition of zoledronic acid to enzalutamide and androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: the randomized phase II BONENZA trial","year":2025,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Astellas Pharma Global Development; Astellas Pharma Europe","keywords":"Medicine; Enzalutamide; Prostate cancer; Androgen deprivation therapy; Zoledronic acid; Oncology; Internal medicine; Randomized controlled trial; Hormone therapy; Androgen; Urology; Cancer; Hormone; Androgen receptor; Breast cancer","score_opus":0.021572863110218818,"score_gpt":0.3525904308068917,"score_spread":0.33101756769667284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410051475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9738038,0.013470877,0.0009237491,0.0018224147,0.0012634108,0.0018934462,0.0023526382,0.00024973034,0.004219991],"genre_scores_gemma":[0.9791351,0.0062652268,0.0015024501,0.0019223853,0.00054993277,0.001691478,0.0029639713,0.000059384984,0.005910159],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993942,0.0002985854,0.000029226268,0.00011630603,0.000049591403,0.00011216403],"domain_scores_gemma":[0.9993888,0.00015744496,0.00012839602,0.00005718916,0.000035706726,0.00023237521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015789384,0.0021956176,0.0035058032,0.00051744777,0.00040438626,0.0014905483,0.001317624,0.0015954906,0.0075145164],"category_scores_gemma":[0.0015284918,0.0007199346,0.0028523307,0.00057756994,0.001488162,0.0012571011,0.00063710404,0.0038669768,0.0012139607],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97794056,0.0020291882,0.00050488836,0.0005190457,0.001556605,0.000023120401,0.000042245854,0.00072398415,0.0013591797,0.0001830315,0.0011455038,0.013972605],"study_design_scores_gemma":[0.96636784,0.029455591,0.001750021,0.00003353858,0.0007751294,0.000038621045,0.000024459945,0.00031206393,0.00021786487,0.00022155824,0.00078907574,0.000014287566],"about_ca_topic_score_codex":0.0029073446,"about_ca_topic_score_gemma":0.006623335,"teacher_disagreement_score":0.0075145164,"about_ca_system_score_codex":0.0011873625,"about_ca_system_score_gemma":0.0013428318,"threshold_uncertainty_score":0.025138557},"labels":[],"label_agreement":null},{"id":"W4410385888","doi":"10.1038/s41391-025-00982-9","title":"Correction: Extended LUTS medication use following BPH surgical treatment: a US healthcare claims analysis","year":2025,"lang":"en","type":"erratum","venue":"Prostate Cancer and Prostatic Diseases","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Benign prostatic hyperplasia (BPH); Health care; Family medicine; Prostate cancer; Internal medicine","score_opus":0.014911984386473861,"score_gpt":0.32348821865946686,"score_spread":0.308576234272993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410385888","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004309513,0.0011752596,0.0004808719,0.121749185,0.8588144,0.000041837542,0.012181117,0.000382558,0.004743741],"genre_scores_gemma":[0.04654124,0.013040241,0.0074800784,0.23244137,0.43151355,0.0005871463,0.025175475,0.0023765438,0.24084425],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9939663,0.0009679144,0.0013464165,0.00073266705,0.002426649,0.0005601394],"domain_scores_gemma":[0.9580388,0.013879707,0.00446074,0.0022227457,0.019388502,0.0020094991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051823696,0.0018681606,0.0016738764,0.003364628,0.0026542027,0.0039863684,0.002994228,0.005851855,0.07480604],"category_scores_gemma":[0.09689544,0.001156398,0.0017567571,0.0044319155,0.001499842,0.0022228158,0.0017319319,0.010494636,0.033931013],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018211193,0.0000041523294,0.00018271968,0.000063421074,0.000008491871,0.00012022552,0.0000146948605,0.000021321623,0.0000065866057,0.00026148136,0.9969805,0.0023182498],"study_design_scores_gemma":[0.00014997234,0.000028545523,0.004723633,0.0013829006,0.00006744323,0.0011101136,0.00022656575,0.00043999043,0.00023553113,0.0019500453,0.9895983,0.00008684669],"about_ca_topic_score_codex":0.031361468,"about_ca_topic_score_gemma":0.03452787,"teacher_disagreement_score":0.07480604,"about_ca_system_score_codex":0.0034672965,"about_ca_system_score_gemma":0.008261426,"threshold_uncertainty_score":0.2502511},"labels":[],"label_agreement":null},{"id":"W4410581252","doi":"10.1038/s41391-025-00984-7","title":"Feasibility and safety study of the Flostent™ system (RAPID-I)","year":2025,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Tolerability; Adverse effect; Retrievability; International Prostate Symptom Score; Urology; Surgery; Randomized controlled trial; Prostate cancer; Lower urinary tract symptoms; Prostate; Internal medicine; Cancer","score_opus":0.024726593548239445,"score_gpt":0.33241577026328306,"score_spread":0.3076891767150436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410581252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99482745,0.0017864486,0.0012636108,0.0001305006,0.00007243067,0.0010248038,0.0002205366,0.000028015094,0.0006460892],"genre_scores_gemma":[0.9939413,0.0008952315,0.0027803406,0.00033031803,0.00025972864,0.00068819633,0.00041677238,0.000009889954,0.0006782668],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9985403,0.0007118174,0.000089670895,0.00019048867,0.0003453086,0.00012246416],"domain_scores_gemma":[0.9977507,0.0006321307,0.00078288984,0.00019996206,0.0002642824,0.00037001842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050533316,0.00055389036,0.00085617433,0.00031666717,0.00026325966,0.0005959001,0.00052608503,0.00068235135,0.0023641887],"category_scores_gemma":[0.0023263355,0.00032575522,0.0008963596,0.0001969477,0.00060444,0.0006072292,0.00029184963,0.0009037593,0.00044325794],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36986482,0.0863141,0.092532374,0.004162519,0.0024793898,0.00078661717,0.00093731727,0.0013439306,0.16015284,0.00056248344,0.0020328958,0.27883083],"study_design_scores_gemma":[0.014657212,0.93955195,0.03218605,0.00005564802,0.0006515261,0.0004645163,0.00007439345,0.00051838235,0.009337581,0.000053903157,0.0024257647,0.000023165467],"about_ca_topic_score_codex":0.00020496662,"about_ca_topic_score_gemma":0.00027935553,"teacher_disagreement_score":0.0050533316,"about_ca_system_score_codex":0.00028295277,"about_ca_system_score_gemma":0.00081538147,"threshold_uncertainty_score":0.026724875},"labels":[],"label_agreement":null},{"id":"W4410614150","doi":"10.1038/s41391-025-00985-6","title":"New BPH therapy classification: what really FITs?","year":2025,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Cardiovascular Syncope and Autonomic Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Benign prostatic hyperplasia (BPH); Urology; Prostate cancer; Internal medicine","score_opus":0.03543995476494347,"score_gpt":0.34884583260125734,"score_spread":0.31340587783631385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410614150","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005900948,0.99835783,0.000072795505,0.0007800067,0.0003392618,0.000003098319,0.000026684676,0.000005944238,0.00035539517],"genre_scores_gemma":[0.0005377649,0.9977976,0.00018324006,0.0007174279,0.00049463875,0.0000052201676,0.00005083135,0.0000018040658,0.00021143646],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995394,0.000088212386,0.00010762217,0.000094783136,0.00013010167,0.00003996176],"domain_scores_gemma":[0.9989924,0.0004939146,0.00016152028,0.000019498928,0.0002479519,0.00008479744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013697109,0.0009775995,0.0035687264,0.002420231,0.000345923,0.002055522,0.0014778607,0.0013354141,0.0038729303],"category_scores_gemma":[0.001862157,0.00032001198,0.0012731313,0.002397284,0.0006525192,0.002537167,0.00091583846,0.0028089322,0.0014021097],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001299157,0.00005549787,0.0006131317,0.025224946,0.00036694593,0.000102921054,0.000058003345,0.00025004556,0.00025774213,0.0019351506,0.046814736,0.924191],"study_design_scores_gemma":[0.0001471771,0.00021301098,0.0040965537,0.049802598,0.0016083337,0.0014476405,0.0002802063,0.000395661,0.00012852205,0.00468729,0.9371131,0.00007999484],"about_ca_topic_score_codex":0.0027528272,"about_ca_topic_score_gemma":0.0062784613,"teacher_disagreement_score":0.0038729303,"about_ca_system_score_codex":0.0010051726,"about_ca_system_score_gemma":0.002028027,"threshold_uncertainty_score":0.012956262},"labels":[],"label_agreement":null},{"id":"W4410951098","doi":"10.1038/s41391-025-00990-9","title":"Artificial intelligence may enhance the role of magnetic resonance imaging in prostate cancer focal therapy","year":2025,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; St Joseph's Health Centre; Victoria Hospital; London Health Sciences Centre; Western University","funders":"Canadian Cancer Society Research Institute","keywords":"Medicine; Prostate cancer; Magnetic resonance imaging; Prostate; Cancer; Oncology; Radiology; Internal medicine","score_opus":0.023483295927285357,"score_gpt":0.3555196738412958,"score_spread":0.3320363779140104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410951098","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008498645,0.9983797,0.00016861486,0.0002849581,0.00012441182,0.0000036007962,0.000010080034,0.0000044520034,0.0009391913],"genre_scores_gemma":[0.0010593884,0.99788254,0.00028146844,0.00026892408,0.00016785064,0.0000046284313,0.000017838265,0.0000011184962,0.0003161718],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981076,0.00005775279,0.000024861774,0.000026240641,0.00006546408,0.000014919747],"domain_scores_gemma":[0.999368,0.0004465268,0.000060151677,0.000012257378,0.00009100701,0.000022004822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006973217,0.0007033237,0.0012989418,0.001742841,0.00017691494,0.0011814423,0.00068668986,0.0011072626,0.0041420916],"category_scores_gemma":[0.0010616715,0.00021163339,0.00074426725,0.0015752307,0.00050683494,0.001089346,0.0006088766,0.0020992465,0.0012403865],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007889916,0.00009198288,0.00019220673,0.02105945,0.00018943501,0.00014326004,0.000044442742,0.00066029147,0.0009632726,0.0069991667,0.012919787,0.9566578],"study_design_scores_gemma":[0.000056466695,0.0002253255,0.001857709,0.010216864,0.00046631927,0.0011429448,0.00007280533,0.0005580615,0.0006741008,0.0074962303,0.9771872,0.000045938763],"about_ca_topic_score_codex":0.0015758316,"about_ca_topic_score_gemma":0.002669297,"teacher_disagreement_score":0.0041420916,"about_ca_system_score_codex":0.00055780617,"about_ca_system_score_gemma":0.0008344742,"threshold_uncertainty_score":0.013856709},"labels":[],"label_agreement":null},{"id":"W4412079359","doi":"10.1038/s41391-025-00996-3","title":"Thulium fiber laser versus holmium MOSESTM laser enucleation of the prostate for the treatment of benign prostatic hyperplasia: a randomized prospective clinical study","year":2025,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thunder Bay Regional Health Sciences Centre","funders":"Boston Scientific Corporation","keywords":"Medicine; Enucleation; Prostate; Urology; Hyperplasia; Benign prostatic hyperplasia (BPH); Internal medicine; Surgery; Cancer","score_opus":0.031200218340641496,"score_gpt":0.38479853811232695,"score_spread":0.35359831977168543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412079359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946253,0.002061145,0.0004883224,0.000184676,0.00035998467,0.0015377628,0.0002135071,0.000028929455,0.00050050847],"genre_scores_gemma":[0.991097,0.002242789,0.0012118571,0.00052055303,0.0010315687,0.0018933688,0.00029523854,0.000022444021,0.0016852735],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.995993,0.0024161425,0.00030231406,0.00051414367,0.00029200304,0.00048246552],"domain_scores_gemma":[0.99526054,0.0021799759,0.00082695857,0.00048183696,0.00025778872,0.0009929002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048967525,0.0025063097,0.0063074687,0.0009639243,0.000938036,0.001691978,0.001708954,0.0033886575,0.0063090916],"category_scores_gemma":[0.004072417,0.0014044711,0.0029279706,0.0010856129,0.0039581265,0.0021504282,0.00074029004,0.003361139,0.00085541146],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9892229,0.006896282,0.00029478484,0.00011103985,0.0002982551,0.000012502722,0.000022781845,0.00005638943,0.0008117584,0.000024768073,0.00003667892,0.0022118492],"study_design_scores_gemma":[0.7385344,0.25699666,0.002409153,0.000024097433,0.0007927363,0.00002793118,0.000055744826,0.00028988725,0.0005462379,0.00009776834,0.00019531258,0.000030156802],"about_ca_topic_score_codex":0.0016685098,"about_ca_topic_score_gemma":0.002258624,"teacher_disagreement_score":0.0063090916,"about_ca_system_score_codex":0.0010973148,"about_ca_system_score_gemma":0.0017318322,"threshold_uncertainty_score":0.025896788},"labels":[],"label_agreement":null},{"id":"W4413912521","doi":"10.1038/s41391-025-01019-x","title":"Response to correspondence regarding “The association between statin use, genetic variation, and prostate cancer risk”","year":2025,"lang":"en","type":"letter","venue":"Prostate Cancer and Prostatic Diseases","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Cancer Society Research Institute; Prostate Cancer Canada; Canadian Urological Association","keywords":"Medicine; Prostate cancer; Oncology; Benign prostatic hyperplasia (BPH); Internal medicine; Statin; Association (psychology); Variation (astronomy); Cancer","score_opus":0.008864349763016133,"score_gpt":0.26434898578616406,"score_spread":0.2554846360231479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413912521","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000476576,0.00074689504,0.000088763074,0.9595208,0.03621847,0.00003099854,0.0002573473,0.000042129475,0.002617944],"genre_scores_gemma":[0.001763787,0.00038550558,0.00012940705,0.9651779,0.024543397,0.00005186874,0.00006488554,0.00002023705,0.007863032],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974618,0.0007149619,0.00026754418,0.00038415965,0.00074071094,0.00043086582],"domain_scores_gemma":[0.9938567,0.0035710575,0.00042207676,0.00016315411,0.0009672708,0.0010196608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003936544,0.0009511984,0.0019335295,0.0008427584,0.004292245,0.0031741008,0.0018970959,0.03697427,0.009356054],"category_scores_gemma":[0.016191201,0.00081664504,0.0015427521,0.0007673586,0.0016829025,0.00189106,0.0013597809,0.03173427,0.007984236],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012350001,0.000048298774,0.0006856639,0.00003611775,0.00002272359,0.0005889674,0.000060565042,0.00003990112,0.000105386425,0.0006411272,0.9940235,0.0036243885],"study_design_scores_gemma":[0.0003336683,0.00016765673,0.005148433,0.00042906965,0.000093288865,0.0008972534,0.00062633306,0.0007199011,0.00038011014,0.0039716116,0.98711026,0.0001223277],"about_ca_topic_score_codex":0.013148047,"about_ca_topic_score_gemma":0.027290497,"teacher_disagreement_score":0.03697427,"about_ca_system_score_codex":0.0040576877,"about_ca_system_score_gemma":0.004806964,"threshold_uncertainty_score":0.031299114},"labels":[],"label_agreement":null},{"id":"W4414050960","doi":"10.1038/s41391-025-01023-1","title":"Outcomes of robot-assisted radical prostatectomy with novel robotic platforms vs da Vinci multiport systems: a systematic review and network meta-analysis","year":2025,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Prostatectomy; Perioperative; Prostate cancer; Robotic surgery; Learning curve; MEDLINE","score_opus":0.06688749583260736,"score_gpt":0.35491400171800735,"score_spread":0.2880265058854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414050960","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005691492,0.99310064,0.0003291017,0.00007724249,0.000106357926,0.00008486292,0.00041294607,0.000013005577,0.00018438025],"genre_scores_gemma":[0.16796976,0.8282909,0.00123653,0.00080849364,0.00022223889,0.00027689643,0.0007843479,0.00003620384,0.00037462867],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.996307,0.0012487482,0.0012689895,0.00057228474,0.00043277472,0.000170146],"domain_scores_gemma":[0.99401337,0.0040576686,0.001230833,0.00019251245,0.00040553507,0.00010012266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004983558,0.002197253,0.013265184,0.0031338807,0.00045230403,0.0024546317,0.001593017,0.0017369053,0.0035291337],"category_scores_gemma":[0.013205208,0.001164423,0.031279277,0.0050257547,0.00057605637,0.001421996,0.0014615378,0.0021636002,0.00031809052],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030477839,0.00003019377,0.00480979,0.30718726,0.66935456,0.0000867962,0.00007875062,0.00043110587,0.00026848482,0.0001046421,0.00064466806,0.013956001],"study_design_scores_gemma":[0.0007054841,0.00017124243,0.0040997113,0.0123845665,0.98097056,0.00007484789,0.000048649068,0.00010275746,0.00007086422,0.00014085266,0.0012049141,0.00002543952],"about_ca_topic_score_codex":0.00739921,"about_ca_topic_score_gemma":0.019279651,"teacher_disagreement_score":0.013265184,"about_ca_system_score_codex":0.0017171884,"about_ca_system_score_gemma":0.0019948056,"threshold_uncertainty_score":0.026355922},"labels":[],"label_agreement":null},{"id":"W4414380021","doi":"10.1038/s41391-025-01026-y","title":"Addition of a surgery-specific module to a perioperative, telemedicine program for improving functional outcomes after radical prostatectomy: a prospective, multicenter, non-randomized study","year":2025,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Telemedicine; Perioperative; Rehabilitation; MEDLINE; Telehealth; Coronavirus disease 2019 (COVID-19)","score_opus":0.014156619129162771,"score_gpt":0.3088850841029522,"score_spread":0.2947284649737894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414380021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973573,0.00064004975,0.00016799974,0.00012470497,0.00015083833,0.0009617471,0.0001238313,0.000019357527,0.00045406132],"genre_scores_gemma":[0.99472576,0.0009430855,0.0010334149,0.00041477327,0.00044855103,0.0015200305,0.00030535043,0.000008278235,0.00060067256],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99633324,0.0018580281,0.00036014916,0.0005984321,0.0003552581,0.00049489987],"domain_scores_gemma":[0.99604225,0.0014880879,0.0007334509,0.00029588686,0.00019947256,0.0012408097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027647559,0.0012911384,0.0021902516,0.00084554026,0.0009761168,0.0012965526,0.0014546099,0.0024355738,0.0054500424],"category_scores_gemma":[0.0048294812,0.00079351355,0.0029776886,0.0010819951,0.0014287566,0.0016307312,0.0012161256,0.0030195967,0.00057425996],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7270196,0.20921974,0.012322951,0.00078188424,0.0031703392,0.000043306954,0.00020956328,0.00063903566,0.0010911945,0.000064731925,0.00029862951,0.045139074],"study_design_scores_gemma":[0.30474427,0.6469813,0.043565083,0.00013270293,0.002667716,0.000028601671,0.00015311773,0.000615494,0.0006154594,0.00008484891,0.00037355142,0.000037838516],"about_ca_topic_score_codex":0.003703,"about_ca_topic_score_gemma":0.004277256,"teacher_disagreement_score":0.0054500424,"about_ca_system_score_codex":0.0011681708,"about_ca_system_score_gemma":0.0027858817,"threshold_uncertainty_score":0.018232226},"labels":[],"label_agreement":null},{"id":"W4414507863","doi":"10.1038/s41391-025-01022-2","title":"Endoscopic simulators in benign prostatic hyperplasia surgical training: a scoping review","year":2025,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Surgical Simulation and Training","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University; Université de Montréal","funders":"","keywords":"Hyperplasia; Benign prostatic hyperplasia (BPH); Prostate cancer; Prostatic Diseases; Endoscopy; Prostate; Prostatectomy","score_opus":0.06546987327917642,"score_gpt":0.42145509320576957,"score_spread":0.35598521992659315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414507863","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000087337125,0.9995726,0.000027779579,0.000051768977,0.000049618233,0.0000130331455,0.000033962486,0.0000018625752,0.00016216122],"genre_scores_gemma":[0.00062044925,0.9990758,0.000086673135,0.0000940541,0.000026611782,0.000013658264,0.000027484248,9.432258e-7,0.000054268465],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99842083,0.00039394828,0.00056776614,0.00019266823,0.000343793,0.00008091412],"domain_scores_gemma":[0.9916728,0.006662101,0.00094803603,0.0000760075,0.00052975246,0.00011136689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028348377,0.0012799602,0.0040376424,0.007866428,0.00047177836,0.002935478,0.0015935722,0.0024563125,0.007723783],"category_scores_gemma":[0.010622632,0.0007862456,0.0030904852,0.008229931,0.00073130406,0.002096623,0.0018086332,0.001494712,0.00076237816],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014054263,0.00006683581,0.00045441955,0.6547838,0.0016309795,0.000107489686,0.00020054042,0.0002791401,0.0002618298,0.00065392937,0.006249965,0.33517048],"study_design_scores_gemma":[0.00012881708,0.00018379836,0.0028692926,0.83585405,0.011616043,0.00071680377,0.00043196327,0.00012935283,0.00018960399,0.00059926964,0.1472273,0.000053680567],"about_ca_topic_score_codex":0.0074521913,"about_ca_topic_score_gemma":0.016775852,"teacher_disagreement_score":0.007866428,"about_ca_system_score_codex":0.0013997996,"about_ca_system_score_gemma":0.0054112175,"threshold_uncertainty_score":0.025838614},"labels":[],"label_agreement":null},{"id":"W4415468626","doi":"10.1038/s41391-025-01038-8","title":"STEAP1-targeted strategies in advanced prostate cancer: a review on therapeutic and diagnostic implications","year":2025,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Prostate cancer; Prostate; Prostate disease; Disease; Therapeutic approach; Benign prostatic hyperplasia (BPH); Prostate-specific antigen; Prostatic disease","score_opus":0.01948177346396031,"score_gpt":0.3711199151684267,"score_spread":0.3516381417044664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415468626","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017035315,0.999067,0.000103240185,0.00022323371,0.00009208936,0.000005328379,0.00001983834,0.0000039652055,0.00031486043],"genre_scores_gemma":[0.001377167,0.9976713,0.00020304043,0.0003183481,0.00012740065,0.000009183174,0.000044771292,0.000001514843,0.00024737496],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999795,0.000038899594,0.000037210757,0.000040718787,0.0000612776,0.000026968535],"domain_scores_gemma":[0.9995877,0.00025732035,0.0000518241,0.000008291769,0.00007071837,0.000024228251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009865378,0.0007313936,0.0017980369,0.0015654035,0.00021119394,0.0011553608,0.00078959845,0.0010734223,0.0024829947],"category_scores_gemma":[0.0010815869,0.00031477207,0.0009754972,0.0013113974,0.00039246076,0.0012644472,0.00064327044,0.0018161729,0.0007994861],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003781453,0.00011710967,0.00037985164,0.025200855,0.00028433136,0.0002439181,0.00006418818,0.00064467284,0.0036894782,0.0024892816,0.019533064,0.94697505],"study_design_scores_gemma":[0.0001502714,0.0006766016,0.0020053792,0.008383765,0.0010646132,0.0016657276,0.000120822835,0.00045322892,0.0020353906,0.002785342,0.9805972,0.00006156947],"about_ca_topic_score_codex":0.000623585,"about_ca_topic_score_gemma":0.0017809592,"teacher_disagreement_score":0.0024829947,"about_ca_system_score_codex":0.0005255713,"about_ca_system_score_gemma":0.0008789105,"threshold_uncertainty_score":0.008306384},"labels":[],"label_agreement":null},{"id":"W4415681017","doi":"10.1038/s41391-025-01017-z","title":"Imaging in focal therapy: advanced ultrasound imaging and mpMRI—a comprehensive review","year":2025,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Women's College Hospital","funders":"","keywords":"Prostate cancer; Prostatectomy; Erectile dysfunction; Magnetic resonance imaging; Randomized controlled trial; Risk stratification; Ultrasound; Functional imaging; Prostate","score_opus":0.022112128569101986,"score_gpt":0.36171128862800805,"score_spread":0.33959916005890606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415681017","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000030042267,0.99962103,0.000027828895,0.000072441886,0.000058033038,0.0000034618247,0.000012973507,0.0000020291636,0.00017218267],"genre_scores_gemma":[0.00021005938,0.9993617,0.0000744061,0.00015703238,0.000089077505,0.0000036204328,0.0000198522,7.169739e-7,0.000083581835],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99960274,0.0000871051,0.00009605001,0.00006923014,0.00011519056,0.000029639297],"domain_scores_gemma":[0.9988513,0.0006769121,0.00021506654,0.000019767342,0.00018259091,0.000054466185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010008796,0.0012421388,0.0025756413,0.0046307575,0.00022193106,0.0016889555,0.0011593114,0.0013208606,0.0052553075],"category_scores_gemma":[0.0021260637,0.0004883505,0.00111471,0.0047186264,0.00059246144,0.001910485,0.0009814033,0.0016565409,0.0015434023],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014663702,0.00007718213,0.0003206869,0.08515735,0.00038674477,0.00014633902,0.00006330787,0.00044292034,0.00075775094,0.0011167014,0.031015435,0.88036907],"study_design_scores_gemma":[0.000139056,0.0003045331,0.0030787806,0.05984336,0.0021982538,0.002588718,0.0001793739,0.00031179743,0.0003978351,0.001650222,0.92921764,0.00009042353],"about_ca_topic_score_codex":0.0025890858,"about_ca_topic_score_gemma":0.006191018,"teacher_disagreement_score":0.0052553075,"about_ca_system_score_codex":0.00081782916,"about_ca_system_score_gemma":0.0021723341,"threshold_uncertainty_score":0.017580748},"labels":[],"label_agreement":null},{"id":"W4415763898","doi":"10.1038/s41391-025-01047-7","title":"DARolutamide ObservationaL (DAROL) study in patients with nonmetastatic castration-resistant prostate cancer: prespecified third interim analysis","year":2025,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Calgary","funders":"Bayer HealthCare; Bayer","keywords":"Interim analysis; Prostate cancer; Observational study; Prostate; Benign prostatic hyperplasia (BPH); Interim; Clinical trial; Exploratory analysis","score_opus":0.031569331184562975,"score_gpt":0.3435905932434047,"score_spread":0.31202126205884173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415763898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894022,0.0011918083,0.0016515601,0.00012049722,0.000044157146,0.00089578435,0.0045425813,0.0000720613,0.0020794019],"genre_scores_gemma":[0.9895092,0.00024503408,0.0018126983,0.00023166178,0.000050779094,0.0007081768,0.0065950193,0.000019823765,0.0008275881],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9983193,0.0008988987,0.00009166824,0.00018094473,0.00028399407,0.00022518204],"domain_scores_gemma":[0.9977417,0.00053876115,0.0008029581,0.0004222297,0.0001712012,0.00032322694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004062747,0.0004930386,0.001225593,0.00026552912,0.00032009132,0.00082608557,0.000464196,0.0003401168,0.0023137587],"category_scores_gemma":[0.0026860368,0.00027550047,0.002439052,0.00034607423,0.0002584503,0.00036648824,0.00046073433,0.0009362043,0.00033164964],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5951944,0.004858784,0.32193074,0.0006442622,0.012252064,0.00044183887,0.00017765594,0.0026679374,0.0067214957,0.00042747046,0.0041531986,0.050530218],"study_design_scores_gemma":[0.14015397,0.0797626,0.74570674,0.000095212556,0.0116765555,0.0008213383,0.00010367635,0.0041176314,0.0065307654,0.00054098613,0.01040724,0.00008332766],"about_ca_topic_score_codex":0.00070798263,"about_ca_topic_score_gemma":0.0017104434,"teacher_disagreement_score":0.004062747,"about_ca_system_score_codex":0.00045249762,"about_ca_system_score_gemma":0.0012576316,"threshold_uncertainty_score":0.021486104},"labels":[],"label_agreement":null},{"id":"W4417156284","doi":"10.1038/s41391-025-01062-8","title":"Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancer","year":2025,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Kingston General Hospital; Queen's University","funders":"National Institutes of Health; A. Alfred Taubman Medical Research Institute; Prostate Cancer Foundation","keywords":"Prostate cancer; Risk assessment; Prostate; Distribution (mathematics); Cancer; Prostatectomy","score_opus":0.020558269840450165,"score_gpt":0.3271274442168431,"score_spread":0.3065691743763929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417156284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9681275,0.0007999774,0.025155667,0.0006709035,0.000020057758,0.00010484917,0.0036504301,0.00015859149,0.0013119827],"genre_scores_gemma":[0.99090636,0.000088369685,0.0070518586,0.000081554186,0.000023989789,0.000049398743,0.0016941521,0.000013060261,0.00009134795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99690104,0.0014511069,0.00030079146,0.00077299494,0.00044190846,0.0001321629],"domain_scores_gemma":[0.990355,0.0044631003,0.0027387857,0.0012376691,0.00087000884,0.0003355398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064438637,0.00045627175,0.0007581739,0.0023026634,0.0003285774,0.0014959652,0.0006879102,0.0005429602,0.001258094],"category_scores_gemma":[0.019972315,0.00016643092,0.0006437534,0.002287762,0.00030579406,0.000761881,0.0012776112,0.0006737984,0.00030423078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015691742,0.000020659805,0.9849272,0.000020425578,0.0001267799,0.000021912192,0.000054293847,0.0015724812,0.00025767623,0.00017529479,0.00043562325,0.012230782],"study_design_scores_gemma":[0.00006712992,0.00029343605,0.9383318,0.000045665256,0.00035422735,0.00041747733,0.00027976508,0.05485439,0.0008225342,0.002664105,0.001834502,0.000035138542],"about_ca_topic_score_codex":0.002784127,"about_ca_topic_score_gemma":0.0041451156,"teacher_disagreement_score":0.0064438637,"about_ca_system_score_codex":0.00058235804,"about_ca_system_score_gemma":0.00082449085,"threshold_uncertainty_score":0.034078777},"labels":[],"label_agreement":null},{"id":"W4417164098","doi":"10.1038/s41391-025-01054-8","title":"Efficacy and safety of treatments for metastatic castration-sensitive prostate cancer: A comprehensive network meta-analysis including final ARANOTE data","year":2025,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Mount Sinai Hospital","funders":"National Cancer Institute; Bayer HealthCare","keywords":"Prostate cancer; Prostate; Safety profile; Benign prostatic hyperplasia (BPH); Prostatectomy; MEDLINE","score_opus":0.1944706597870142,"score_gpt":0.4340507174531086,"score_spread":0.2395800576660944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417164098","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06312941,0.91078,0.009988204,0.001272424,0.00058581756,0.0008073561,0.010414316,0.00032505576,0.0026974452],"genre_scores_gemma":[0.8862392,0.093757,0.00812138,0.001971913,0.00038780898,0.0015299758,0.006674198,0.00023643633,0.001082163],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9781506,0.015946904,0.0022633001,0.002005143,0.001245959,0.0003881287],"domain_scores_gemma":[0.9756127,0.018776672,0.0027287607,0.0017224798,0.0008832146,0.00027607116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028446784,0.002652034,0.010813969,0.004015778,0.00045217405,0.0025770748,0.0020555425,0.001558395,0.004203645],"category_scores_gemma":[0.035512216,0.0011304865,0.053743962,0.004305927,0.0005363078,0.0015777135,0.001664975,0.0023444614,0.0004526581],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043277484,0.000017957213,0.0049729296,0.024711074,0.9579141,0.000067105524,0.000027454222,0.0024204538,0.00021060194,0.00014791352,0.00069361576,0.0044891196],"study_design_scores_gemma":[0.0010823698,0.00019915319,0.004321114,0.0015107082,0.99016917,0.00005826179,0.0000151195045,0.00084566115,0.00008870918,0.00041539402,0.001273937,0.000020443991],"about_ca_topic_score_codex":0.007050107,"about_ca_topic_score_gemma":0.011698483,"teacher_disagreement_score":0.028446784,"about_ca_system_score_codex":0.0017292275,"about_ca_system_score_gemma":0.0013812378,"threshold_uncertainty_score":0.15044272},"labels":[],"label_agreement":null},{"id":"W7117024168","doi":"10.1038/s41391-025-01071-7","title":"Reducing adverse effects in hypofractionated radiotherapy for prostate cancer: Clinical evidence and emerging mitigation strategies","year":2025,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Adverse effect; Prostate cancer; Clinical trial; Toxicity; Radiation therapy; Prostate; Margin (machine learning); Benign prostatic hyperplasia (BPH)","score_opus":0.02118533809114328,"score_gpt":0.3843843133786186,"score_spread":0.36319897528747536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117024168","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.052970313,0.9181593,0.002978323,0.0155863995,0.0009570162,0.00024362798,0.0004298582,0.0000697357,0.0086053945],"genre_scores_gemma":[0.33647892,0.64059275,0.009580515,0.008423665,0.0021484531,0.00025145477,0.00046169627,0.000040806357,0.0020217574],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985342,0.00073321105,0.00012067454,0.00013871126,0.00037526767,0.000097887605],"domain_scores_gemma":[0.9961372,0.0022669898,0.00084377825,0.00013361922,0.0004373954,0.00018093323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031716046,0.0007658143,0.0011641956,0.00050764694,0.00031402605,0.0011608109,0.0011461851,0.000955864,0.005499053],"category_scores_gemma":[0.008076147,0.00022776885,0.0018420385,0.0005658047,0.00056836376,0.0008042958,0.0007226659,0.0017223746,0.00029527675],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058981203,0.0027245258,0.011434192,0.023350127,0.0042950762,0.00010210581,0.0003028826,0.0030825292,0.0030232172,0.0038087917,0.0064365407,0.93554187],"study_design_scores_gemma":[0.014779224,0.07930823,0.32177502,0.091828264,0.03856145,0.0014229704,0.0027975268,0.005134175,0.012447705,0.039681856,0.39182353,0.00044002855],"about_ca_topic_score_codex":0.0038919232,"about_ca_topic_score_gemma":0.009433286,"teacher_disagreement_score":0.005499053,"about_ca_system_score_codex":0.00078445993,"about_ca_system_score_gemma":0.0023338487,"threshold_uncertainty_score":0.018396199},"labels":[],"label_agreement":null},{"id":"W942976050","doi":"10.1038/pcan.2015.34","title":"Association of male circumcision with risk of prostate cancer: a meta-analysis","year":2015,"lang":"en","type":"review","venue":"Prostate Cancer and Prostatic Diseases","topic":"Genital Health and Disease","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of the Environment, Conservation and Parks","funders":"","keywords":"Medicine; Prostate cancer; Meta-analysis; Oncology; Benign prostatic hyperplasia (BPH); Gynecology; Association (psychology); MEDLINE; Internal medicine; Urology; Cancer","score_opus":0.06542205174241596,"score_gpt":0.3850417715613481,"score_spread":0.31961971981893217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W942976050","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016861787,0.9814534,0.0006111881,0.00012643592,0.00017870362,0.000045205845,0.00039261102,0.000022292463,0.00030840607],"genre_scores_gemma":[0.2997722,0.6957501,0.0017602474,0.00074826827,0.00034040614,0.000107121115,0.0008008492,0.000027148693,0.0006935338],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.998635,0.00054060697,0.00028447292,0.00029097745,0.00014894095,0.000099929406],"domain_scores_gemma":[0.99726236,0.0019640431,0.00035769196,0.00013906487,0.00020436104,0.00007249406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002506591,0.0018803657,0.0061555062,0.001189263,0.00036567613,0.0013529655,0.0013578404,0.0015698285,0.0034238657],"category_scores_gemma":[0.006001476,0.0010736473,0.021177668,0.0023927381,0.00029297482,0.000848415,0.00083122763,0.0017776281,0.00029082553],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065975273,0.000091807866,0.024784967,0.09689225,0.8423287,0.0003475595,0.00009124035,0.0009898725,0.0007399641,0.00016146609,0.0013703959,0.025604205],"study_design_scores_gemma":[0.00048599628,0.00026686533,0.015734067,0.0029647364,0.9782653,0.0001653751,0.000044353914,0.00022967745,0.00013312197,0.00017978811,0.0015020849,0.000028617163],"about_ca_topic_score_codex":0.006411994,"about_ca_topic_score_gemma":0.013615821,"teacher_disagreement_score":0.006411994,"about_ca_system_score_codex":0.00059260346,"about_ca_system_score_gemma":0.00097542984,"threshold_uncertainty_score":0.013256252},"labels":[],"label_agreement":null}]}